Dr. Baliga's 'Got Knowledge Doc?' PODKASTS: Recent Episodes

Dr RR Baliga, MD, MBA

Dr RR Baliga's 'Got Knowledge Doc?' Podcasts for Physicians and Physician Extenders.

Not medical advice or medical opinion

www.MasterMedFacts.com

🌿 Could a physician writing over 1,700 years ago help inspire a Nobel Prize–winning discovery?

Ge Hong (283–343 CE) was far more than an alchemist. In Emergency Formulae at an Elbow's Length, he emphasized practical medicine, first aid, careful observation, and experimentation. His description of Artemisia annua for malaria later inspired the work that led to artemisinin and the 2015 Nobel Prize. 🏆

In this episode of the Great Doctors Series, discover how curiosity, resilience, and evidence-based thinking allowed Ge Hong's ideas to echo across the centuries. ⚕️📜

#MedicalHistory #GeHong #TraditionalChineseMedicine #FirstAid #Artemisinin #MedicalEducation #GreatDoctors #MedicalPodcasts #HistoryOfMedicine

🩺 Why do patients faint—and who is at highest risk? This outstanding NEJM Clinical Practice review provides a practical, evidence-based approach to syncope, emphasizing meticulous history taking, orthostatic blood pressure measurement, ECG, risk stratification, and mechanism-directed management.

It also highlights the close relationship between syncope and unexplained falls in older adults, helping clinicians identify patients who require urgent evaluation while avoiding unnecessary hospitalization.

🎙️ #Syncope #Cardiology #EmergencyMedicine #MedicalEducation #NEJM #MedicalPodcasts

🍯🧠 Did sugar help build the human brain? This fascinating Science review challenges the long-held belief that meat alone drove human evolution.

The authors argue that natural sugars from fruits and honey—and later cooked starch—provided the glucose essential for our expanding brains, reproduction, and survival.

The review integrates metabolism, anthropology, genetics, archaeology, and nutrition into a compelling new framework for understanding our evolutionary journey. A thought-provoking read for clinicians, scientists, and anyone interested in human origins. #HumanEvolution #Nutrition #MedicalPodcasts #Science

The new 2026 ACC Concise Clinical Guidance highlights why influenza, COVID-19, pneumococcal, RSV, and shingles vaccines should be considered an essential part of cardiovascular prevention. Strong evidence shows reductions in hospitalization, myocardial infarction, heart failure, stroke, and even mortality in selected populations. Prevention extends beyond statins and blood pressure control—it also includes timely immunization.

🎙️ In this episode of Dr RR Baliga's Podkast for the Kurious Doc, we explore the evidence, practical recommendations, and clinical pearls every cardiovascular clinician should know. #Cardiology #Vaccines #PreventiveCardiology #MedicalEducation

🫀 Can multivessel CABG be performed through a small thoracotomy without sacrificing safety? The randomized MIST Trial published in The Lancet suggests the answer is yes—for carefully selected patients treated by experienced teams.

Patients undergoing minimally invasive CABG experienced faster physical recovery at 1 month, fewer transfusions, and shorter ventilation times, with no apparent safety penalty through 12 months.

An important trial that shifts attention toward patient-centered recovery after cardiac surgery. 🎙️ #CardiacSurgery #CABG #MinimallyInvasiveSurgery #EvidenceBasedMedicine #MedicalEducation

🧬 Can one rare gene reshape our approach to metabolic disease?

A remarkable Nature study analyzing more than one million individuals identifies FNIP1 as a key regulator of energy metabolism. Rare loss-of-function variants were associated with healthier lipid profiles, lower liver fat, improved glycaemia, favorable fat distribution, and substantially lower cardiometabolic disease risk. Mechanistic studies in human hepatocytes and mice strengthen the biological story, making FNIP1 an exciting potential therapeutic target. A fascinating example of how human genetics can illuminate tomorrow's treatments. 🚀🫀 #Nature #Genetics #Cardiology #Metabolism #PrecisionMedicine

🫀 Can fixing the lymphatic system slow mitral valve degeneration in Marfan syndrome? This elegant JCI study identifies defective lymphangiogenesis and reduced ZFP36-mediated anti-inflammatory signaling as previously unrecognized drivers of myxomatous mitral valve disease. In a mouse model, restoring lymphatic function with VEGF-C156S or activating ZFP36 with fingolimod reduced inflammation and valve thickening, opening an exciting avenue for disease-modifying therapies. A fascinating mechanistic advance with real translational promise. 🎙️ #Cardiology #MarfanSyndrome #ValveDisease #Lymphatics #MedicalResearch

🩺 Can a physician diagnose disease simply by feeling your pulse?

Nearly 1,800 years ago, Wang Shuhe (c. 180–270 CE) transformed pulse-taking into a systematic science through the Maijing (The Pulse Classics). His work shaped Traditional Chinese Medicine for centuries and emphasized that careful observation often reveals what technology cannot. 📖

In this episode of the Great Doctors Series, we explore how one physician elevated diagnosis into an art—and why attentive listening remains one of medicine's greatest skills. 👋⚕️

#MedicalHistory #TraditionalChineseMedicine #PulseDiagnosis #MedicalEducation #GreatDoctors #MedicalPodcasts #Medicine #HistoryOfMedicine

🥩 Can eating less protein promote healthier aging? This comprehensive review examines how protein restriction—and specifically limiting methionine, isoleucine, and valine—modulates key longevity pathways including FGF21, GCN2, and mTOR. Experimental evidence consistently demonstrates improvements in metabolic health, mitochondrial function, senescence, and lifespan, while early human studies suggest favorable metabolic effects. Although long-term clinical outcome data are still needed, the review challenges conventional assumptions that "more protein is always better." A fascinating update for clinicians and researchers interested in nutrition, aging, and precision medicine. 🎙️ #Longevity #Nutrition #HealthyAging #MedicalResearch

🌍 Why is the global LDL-C burden still rising despite decades of progress?

The latest JAMA Global Burden of Disease 2023 analysis reveals a striking paradox: age-standardized cardiovascular risk attributable to LDL-C has fallen, yet absolute deaths and disability continue to increase because of population growth and aging. The message is clear—earlier detection, broader access to statins, and stronger preventive strategies remain essential, particularly in middle-income countries. 🫀📉

🫀 Can the gut microbiome trigger atrial fibrillation? This elegant JCI study suggests that the microbial metabolite trimethylamine N-oxide (TMAO) is independently associated with AF and mechanistically promotes arrhythmia through muscarinic receptor–mediated autonomic dysfunction.

In multiple mouse models, inhibiting microbial TMA production delayed AF onset and attenuated atrial remodeling. While clinical intervention studies are still needed, the work highlights the gut–heart axis as a promising preventive target for AF. A fascinating glimpse into the future of cardiovascular therapeutics. 🔬🦠💓

🫀❤️ Does the heart have its own "little brain"? This remarkable Cell study identifies two distinct intrinsic cardiac neuron populations with complementary roles: Npy⁺ neurons maintain baseline cardiac function and coronary perfusion, while Ddah1⁺ neurons preserve electrical stability during extreme stress. The work opens the door to cell-type–specific neuromodulation for arrhythmias, heart failure, and sudden cardiac death. A fascinating glimpse into the future of neurocardiology. 🎙️🔬 #Cardiology #Neurocardiology #HeartBrainAxis #MedicalEducation #MedicalPodcasts

🧬 Can changing just one essential amino acid influence aging?

This fascinating Nature Aging study found that lifelong dietary valine restriction improved metabolic health, reduced frailty, lowered cellular senescence and cancer burden in both sexes, and increased median lifespan by 23% in male mice. The work suggests that amino acid composition—not simply total protein intake—may be a key determinant of healthy aging.

While these findings are limited to mice, they provide compelling mechanistic insights and an exciting direction for precision nutrition research. 🎙️ #HealthyAging #Longevity #NutritionScience

💨 Can your breath reveal how efficiently you're burning fat?

A new study describes a smartphone-assisted handheld breath acetone detector that enables accurate, non-invasive monitoring of fat metabolism at home. Validated against laboratory mass spectrometry, the device tracked metabolic responses to exercise, ketogenic diets, and fasting while demonstrating excellent agreement with reference testing. This technology could complement continuous glucose monitoring and advance personalized metabolic care, obesity management, and preventive medicine. 📱🧬🏃‍♂️

#DigitalHealth #Metabolism #PrecisionMedicine #MedicalPodcasts

🩺 Great Doctors Series | Hua Tuo (c. 140–208 CE)

Centuries before modern anesthesia, Hua Tuo was described as using a herbal anesthetic, performing surgery, advancing acupuncture, and creating the famous Five Animal Exercises (Wuqinxi). His remarkable story blends innovation, compassion, and scientific curiosity, making him one of history's most influential physicians. Join me as we explore the life and legacy of this extraordinary medical pioneer in the latest episode of the Great Doctors Series.

🎙️ Dr RR Baliga's Podkast for the Kurious Doc – Where Curiosity Meets Clarity!

#MedicalHistory #HuaTuo #TraditionalChineseMedicine #MedicalPodcasts #GreatDoctors #Innovation #Surgery #Acupuncture #MedicalEducation

🧬 Can chemical protein aging be reversed? This fascinating study introduces CMLase, an engineered enzyme that removes Nε-carboxymethyl-lysine (CML)—a stable advanced glycation end product (AGE) long believed to be irreversible.

Ex vivo, CMLase repaired AGE damage in aged human lens, skin, and arterial tissues, providing the first proof-of-concept that age-related protein damage may be enzymatically reversible.

While clinical translation remains distant, this work opens an exciting new frontier in regenerative medicine and healthy aging. 🎙️ #Aging #ProteinRepair #RegenerativeMedicine #MedicalPodcasts

🫀 HFpEF has entered a new era. The 2026 ACC Expert Consensus Decision Pathway highlights a practical approach to diagnosing HFpEF, distinguishing mimics, applying diagnostic scoring systems, and implementing evidence-based therapies including SGLT2 inhibitors while aggressively managing comorbidities.

The accompanying infographic distills the guideline into high-yield clinical pearls for busy clinicians.

This serves as a quick reference at the point of care. 📚❤️ #Cardiology #HeartFailure #HFpEF #MedicalEducation #Guidelines #EvidenceBasedMedicine #MedicalPodcasts

🧬🫀 Can successful gene therapy still leave the heart vulnerable?

A fascinating NEJM correspondence describes a patient with Duchenne muscular dystrophy who developed early and delayed cardiotoxicity after microdystrophin gene therapy. Despite higher cardiac vector copy numbers, myocardial microdystrophin expression remained low and heterogeneous, raising important questions about efficacy, safety, and long-term surveillance. An important reminder that motor improvement may not mirror cardiac benefit. Join me as I unpack the clinical implications on Dr RR Baliga's Podkast for the Kurious Doc—Where Curiosity Meets Clarity! 🎙️🫀

🧬 Can a thymus-derived peptide help overcome age-related resistance to cancer immunotherapy?

A fascinating new study identifies thymulin as a key regulator of age-associated inflammation. In preclinical models, thymulin reduced pro-inflammatory myeloid activity, inhibited NF-κB signaling, enhanced T-cell immunity, and restored responsiveness to anti-PD-L1 therapy in aged hosts. While clinical translation remains to be established, the work highlights the intriguing thymus–myeloid axis as a potential therapeutic target in older adults with cancer.

🎙️ More insights on Dr RR Baliga's Podkast for the Kurious Doc—Where Curiosity Meets Clarity!

☕❤️ Does coffee help—or harm—the heart?

The latest American Heart Association Scientific Statement reviews the evidence behind caffeine and cardiovascular disease. The take-home message is reassuring: moderate coffee consumption (≈3–5 cups/day or ≤400 mg caffeine/day) is generally safe for most adults and is associated with lower risks of coronary artery disease, heart failure, stroke, atrial fibrillation, hypertension, and type 2 diabetes. The caution? High-dose energy drinks are a different story.

Join me as we separate myths from evidence—one cup at a time. ☕🫀🎙️

#Cardiology #Coffee #Caffeine #HeartHealth #EvidenceBasedMedicine #MedicalEducation #MedicalPodcasts #PreventiveCardiology #AHA #PhysicianEducation

🫀 Could tiny plastic particles become the next major cardiovascular risk factor?

A fascinating new European Heart Journal study found that micro- and nanoplastics were detected most frequently in patients presenting with ST-segment elevation myocardial infarction, alongside higher inflammatory markers, smoking exposure, and PM2.5 pollution.

While causality remains unproven, the accompanying editorial positions plastics as an emerging component of the cardiovascular exposome.

🌍 This research reminds us that protecting heart health may increasingly require reducing environmental exposures—not just traditional risk factors.

#Cardiology #EnvironmentalHealth #MedicalPodcasts #HeartDisease #Prevention

🌿 Great Doctors Series | Zhang Zhongjing (c. 150–219 CE)

Long before antibiotics and modern epidemiology, Zhang Zhongjing transformed medicine through careful observation, precise diagnosis, and individualized treatment. His Shanghan Zabing Lun became one of the most influential medical texts in history and laid the foundation for the Cold Damage School of Traditional Chinese Medicine. His emphasis on treating the patient—not just the disease—continues to inspire physicians nearly 1,800 years later. A timeless lesson in clinical reasoning, compassion, and evidence-informed practice. 📜⚕️🌏

#MedicalHistory #TraditionalChineseMedicine #ClinicalReasoning #GreatDoctors #MedicalEducation #HistoryOfMedicine #MedicalPodcasts

🩺 Can dual antithrombotic therapy after PCI be safely shortened to just 1 month in patients with atrial fibrillation?

The OPTIMA-AF trial suggests that an earlier transition to DOAC monotherapy significantly reduces clinically relevant bleeding while maintaining similar protection against death and thromboembolic events. Although the findings require confirmation in broader populations, this study could influence how we individualize antithrombotic therapy after PCI.

🎙️ In this episode of Dr RR Baliga's Podkast for the Kurious Doc, we review the trial, its clinical implications, and the important caveats for everyday practice. #Cardiology #AtrialFibrillation #PCI #MedicalEducation

🫀 Should dual antiplatelet therapy continue beyond 12 months?

The DAPT-MVD trial (NEJM 2026) suggests that carefully selected patients with multivessel coronary artery disease who remain event-free after one year of therapy may benefit from another 12 months of clopidogrel plus aspirin. The result? Fewer cardiovascular events—driven largely by fewer myocardial infarctions—without more clinically relevant bleeding in this low-bleeding-risk cohort. ⚖️

A timely reminder that the future of DAPT lies in precision patient selection, not a one-size-fits-all approach. 🩺📚 #Cardiology #DAPT #MedicalEducation #MedicalPodcasts #NEJM

🧬 What if aging is driven not only by accumulated damage, but by the failure of our immune system to take out the cellular "trash"?

This fascinating Science study identifies impaired clearance of senescent neutrophils by tissue-resident macrophages as a reversible driver of multiorgan aging.

Blocking the EP2 receptor restored immune housekeeping and improved cognition, frailty, muscle, cardiac, and liver function in aged mice. An elegant mechanistic study that opens exciting possibilities for future geroscience therapeutics.

🎙️ #Aging #Immunology #Geroscience #MedicalEducation #MedicalPodcasts

🥤 Does fructose really raise blood pressure—or is it the food source that matters?

A fascinating 25-year prospective study published in Circulation followed >25,000 participants from childhood into adulthood and found that total fructose intake was not the culprit. Instead, sugar-sweetened beverages and high fruit juice intake increased hypertension risk, while whole fruit did not. Replacing sugary drinks with whole fruit, water, or milk substantially lowered risk. 🍎💧

The takeaway? Think food matrix, not just nutrients. An important lesson for clinicians, parents, and public health. #Hypertension #Cardiology #Nutrition #PreventiveMedicine #MedicalPodcasts

🧠 Can a simple blood test predict who will develop cognitive impairment years before symptoms appear?

A landmark multicohort JAMA study shows that elevated plasma p-Tau217 strongly predicts progression to cognitive impairment and faster cognitive decline in cognitively normal older adults. The greatest value today is in improving risk stratification and enriching prevention trials—not routine screening of asymptomatic individuals. A major step toward precision prevention of Alzheimer's disease. 🔬🩸

#Alzheimers #Neurology #Biomarkers #PrecisionMedicine #BrainHealth #MedicalEducation #MedicalPodcasts

🧬 Could the thymus be an overlooked marker—and perhaps future target—of biological ageing?

This Nature feature highlights evidence linking smaller or absent thymic tissue with higher risks of death, cancer, cardiovascular disease, and poorer outcomes after cancer immunotherapy. 🔬

Regeneration strategies are advancing, but the evidence remains largely correlational.

💡 Clinical pearl: thymic involution may reflect declining immune reserve, yet no rejuvenation therapy is ready for routine care.

⚕️ Galen of Pergamum (129–c. 199 CE) was not just a physician—he was a medical empire in one mind.

A surgeon, anatomist, philosopher, and prolific writer, Galen shaped medicine for more than 1,300 years. From treating gladiators in Pergamum to serving Roman emperors, he fused observation, experiment, and argument into a system that dominated anatomy, physiology, pathology, and therapeutics for centuries. 🏛️📚

Some of his ideas were later corrected, but his influence was immense: he preserved, organized, and expanded ancient medical knowledge on a scale few others ever matched.

A reminder that in science, even errors can become stepping stones when driven by curiosity, discipline, and relentless inquiry. 🧠✨

#Galen #MedicalHistory #HistoryOfMedicine #AncientMedicine #MedicalEducation

🫀 Treat BP and Cholesterol Early in Obesity: Protect the Future 🎯?

A Lancet analysis of 978,425 adults across seven countries found that blood pressure and non-HDL cholesterol gaps between obesity and normal body mass index have narrowed, especially in older adults—likely reflecting greater use of antihypertensive and lipid-lowering therapy. Yet young adults with obesity remain undertreated and at higher risk.

💡 The lesson: treatment works, but risk has not disappeared. Prevention must begin earlier. ⚠️

🧠 Can dementia be avoided? A thoughtful Nature feature reminds us: lifestyle matters, but it is not a magic shield. Physical activity, social engagement, vascular risk control, hearing and vision care, and healthier environments may reduce risk — yet trials show modest cognitive benefits and no guaranteed prevention.

The key message for clinicians: advise brain-healthy habits honestly, without blame. Prevention is personal, vascular, sensory, and societal. 🌍✨

#Dementia #Alzheimers #BrainHealth #HealthyAging #Prevention #MedicalPodcasts

🥄 In ICU nutrition, more is not always better. This NEJM review highlights a phase-specific approach: begin enteral nutrition early when feasible, use restrictive energy delivery during acute catabolism, avoid routine high-dose protein—especially in acute kidney injury—and advance feeding gradually as physiology recovers. 🧬💪

Prevention of refeeding syndrome, glucose control, and careful bedside monitoring remain essential. Precision nutrition may be the next frontier in critical care.

🎯 #CriticalCare #Nutrition #MedicalPodcasts

🧬 We may all share a birthday, but our organs do not age at the same pace.

This insightful Nature Medicine review examines epigenetic, proteomic, cellular, imaging, and artificial intelligence–based aging clocks—and their potential to predict disease, guide prevention, and assess whether aging can be modified.

🧬 New Nature Medicine review reframes immune aging as a clinical-trial target, not just a biologic curiosity.

The authors propose five criteria for immune-aging biomarkers: immune relevance, temporal association, internal validity, predictive value, and responsiveness.

Key message: move beyond single markers like CRP or IL-6 toward multidimensional, dynamic, standardized measures such as iAge, IMM-AGE, and functional immune-response assays.

The future endpoint may be immune resilience. 🛡️ #Geroscience #Healthspan #Immunology #Biomarkers #MedicalPodcasts

🍷 Alcohol-related liver disease is no longer a "late-stage liver clinic" problem—it is a primary care, cardiometabolic, addiction medicine, and transplant challenge.

This JAMA Review highlights rising mortality, underdiagnosis, modern tools such as AUDIT, PEth, FIB-4, VCTE, and ELF testing, and the central therapeutic truth: sustained abstinence changes prognosis.

Early fibrosis detection may also motivate behavior change.

A must-read for clinicians caring for patients where alcohol, obesity, diabetes, and liver risk intersect. 🩺🔍 #LiverDisease #ALD #MedicalPodcasts #Hepatology

⚕️ Soranus of Ephesus (c. 98–138 CE) stands among the most important physicians of the ancient world—especially for women's health.

A leading representative of the Methodic school, he practiced in Alexandria and Rome, wrote with unusual clarity, and left a lasting mark through his great treatise on gynecology and midwifery. His work addressed pregnancy, childbirth, newborn care, bandaging, fractures, and acute and chronic disease with a practical, disciplined voice. 👶📚

What makes Soranus especially striking is his balance: method without rigidity, scholarship without vanity, and clinical writing without needless ornament. He reminds us that the best medicine is often both precise and humane. ✨

#MedicalHistory #Soranus #Gynecology #WomensHealth #HistoryOfMedicine #MedicalEducation

🧬 New Nature study: fatty liver may do more than coexist with colorectal cancer liver metastases — it may shape their biology. Steatotic livers were linked to more aggressive "replacement" metastases, driven by fatty acid oxidation, MYC stabilization, proline synthesis, and collagen remodeling.

The practical pearl: liver-fat content may become a biomarker for prognosis and trial selection, especially for MYC-targeted therapy.

Metabolism is not background noise — it may be the soil that scripts metastatic fate. 🎯

🧠 New Science Advances study: plasma growth/differentiation factor-15 (GDF15) measured in midlife and late life predicted long-term dementia risk, with the strongest signal for vascular dementia. The study links GDF15 to cerebral small vessel disease, neurodegeneration, phosphorylated tau, and neuroimmune activation—suggesting this blood biomarker may be more than a bystander. 🩸🔬 Key clinical pearl: dementia prevention may need to look beyond amyloid and focus earlier on vascular–immune biology. #Dementia #GDF15 #Neuroinflammation #VascularDementia #MedicalPodcasts

🩺 In 1776, physicians were not just healers—they were signers, soldiers, governors, judges, and architects of a new republic. This NEJM Perspective reminds us that 5 Declaration signers were doctors, and asks a timely question: as health policy now shapes vaccines, research, insurance, and public trust, have physicians become too distant from national leadership? 🇺🇸

From bedside to body politic, the call for civic engagement still echoes.

#MedicalHistory #PhysicianLeadership #HealthPolicy #NEJM #MedicalPodcasts

🩸 Antiplatelet therapy is no longer "aspirin for all" or "DAPT by habit." The 2026 ACC Scientific Statement reframes care around precision: ischemic risk, bleeding risk, PCI/ACS context, PAD or stroke phenotype, surgery, anticoagulation, and adherence. The modern message: choose the right agent, right intensity, and right duration—then reassess. Platelets may be small, but the decisions are not. ⚖️🔬

Source: 2026 ACC Scientific Statement on antiplatelet therapy.

❤️ New JACC statement, big clinical reset: the 2026 Second Universal Definition of Heart Failure moves us beyond rigid EF cutoffs toward a more useful bedside framework—define the syndrome, identify the stage, seek the cause, respect geography and social context, and follow the trajectory.

The key message: improved EF is not "cured HF," and pre-HF is a prevention window hiding in plain sight.

For clinicians: less "What's the EF?" and more "What's the cause, stage, trajectory, and context?" 🫀🌍 #HeartFailure #Cardiology #JACC #MedicalPodcasts

🩸 New JACC/ACC 2026 Scientific Statement spotlight: DOACs are now central to stroke and venous thromboembolism prevention—but not "one size fits all." The practical message: choose the right agent, dose correctly, avoid DOACs in mechanical valves and rheumatic mitral stenosis, reassess renal/liver function, bleeding risk, drug interactions, adherence, and cost. In anticoagulation, the prescription is only the opening move; follow-up is where safety lives. ⚖️💊 #Cardiology #DOACs #AFib #VTE #MedicalPodcasts

⚕️ Long before "holistic medicine" became fashionable, Asclepiades of Prusa was already practicing it in Rome.

He challenged humoral doctrine, proposed that illness arose from disrupted motion of atoms through bodily pores, and treated patients with diet, exercise, massage, bathing, music, and humane attention rather than harsh dogma alone. His motto was memorable: cito, tuto, jucunde — swiftly, safely, and sweetly. 🍷🛁🎵

What stands out most is not only his theory, but his temperament: kind, patient-centered, and notably humane toward those with mental illness.

A reminder that medicine advances not only by sharper ideas, but by gentler hands. ✨

#MedicalHistory #Asclepiades #HolisticMedicine #HistoryOfMedicine #PatientCare

💊 Statins save lives—but muscle concerns still derail uptake and adherence. Two timely papers sharpen the story: Science Advances unpacks a biologic mechanism linking statins to reduced protein prenylation, YAP, NLRP3 activation, and myopathy; The Lancet Digital Health offers a validated clinical prediction model for serious muscle disorders in statin-eligible patients.

The message: most patients remain at low absolute risk, but better biology + better prediction can make statin conversations calmer, clearer, and more personalized. 💪📊🫀

#Cardiology #Statins #MedicalPodcasts #PrecisionMedicine

🧬 Why are early-onset cancers rising in newer generations?

A Nature Medicine study of 154,169 UK Biobank participants found that biological aging increased across birth cohorts and was linked to higher early-onset solid cancer risk: HR 1.08 per standard deviation age-gap increase, driven by lung, gastrointestinal, and uterine cancers.

Proteomics added a clue: immune aging tracked with lung cancer, adipose aging with colorectal cancer.

⏳ The clock may be ticking earlier than we thought.

#CancerPrevention #PrecisionMedicine #BiologicalAging #MedicalPodcasts

🧬 Can a diet improve healthspan without worsening frailty?

In this Cell Metabolism study, a low-protein longevity diet supplemented with moderate methionine reduced fat mass and frailty, preserved lean mass, improved insulin sensitivity, and increased GH, GLP-1, and FGF21 in aged mice. Western and ketogenic diets moved the needle the wrong way: more fat, more frailty, worse metabolic signals.

The clinical message: optimize protein quality and methionine balance—not extremes. 🌱⚖️

#Longevity #Healthspan #Frailty #Nutrition #MedicalPodcasts

🫀 New Nature study, old cholesterol mystery: why does LDL clearance falter under chronic dietary cholesterol stress?

Feng et al. identify a RAS–Ral–RalBP1/REPS1–CTSA pathway that diverts LDL receptor (LDLR) away from recycling and toward lysosomal degradation—independent of PCSK9. CTSA inhibition preserved LDLR and improved LDL/VLDL clearance in preclinical models.

Translation? Not clinic-ready yet, but potentially a fresh LDLR-sparing axis beyond statins, ezetimibe, and PCSK9 therapy. 🎯

#Cardiology #Lipidology #LDL #LDLR #Atherosclerosis #PrecisionMedicine #MedicalPodcasts

🫀⚡ Can artificial intelligence discover ECG findings that generations of cardiologists overlooked?

This remarkable Nature study trained a deep-learning model on population-scale ECGs and uncovered a previously undescribed biomarker—a subtle slurred terminal R-wave downstroke in lead aVL—that identifies patients at high risk of sudden cardiac death. Most high-risk individuals had preserved left ventricular ejection fraction, highlighting the limitations of current screening. A fascinating example of AI moving beyond prediction to scientific discovery. 🤖🔬❤️

🫀🤖 One ECG. One algorithm. One life-changing diagnosis.

This Nature Medicine case shows how AI-enhanced ECG analysis identified previously unrecognized structural heart disease in a 45-year-old man discharged from the ED after an apparent asthma flare. Urgent echocardiography revealed severe LV dysfunction and mitral regurgitation; genetic testing later showed an LMNA variant. Six months later, he underwent successful heart transplantation.

AI-ECG may become medicine's new safety net: detecting what is hidden, accelerating care, and changing lives. ⚡🏥

#Cardiology #AIinMedicine #HeartFailure #DigitalHealth #MedicalPodcasts

⚕️ What if the best doctor is not the one with the grandest theory—but the one who learns most carefully from patients?

Heraclides of Tarentum, a leading voice of the Empiric school, argued that medicine should be grounded in observation, comparison, outcomes, and experience rather than endless abstract debate. In that sense, he feels strikingly modern. 📚🔬

He helped shift medicine toward practical therapeutics and careful clinical judgment, reminding us that healing begins not with intellectual showmanship, but with humility, attention, and the disciplined study of what actually works. 🌿

A timeless lesson for every era: listen, observe, learn, and treat the patient in front of you. ✨

#MedicalHistory #Heraclides #EvidenceBasedMedicine #ClinicalMedicine #HistoryOfMedicine

🧠🍬 Beyond plaques and tangles, could Alzheimer's disease also be driven by excess protein "sugar-coating"?

A new Nature Metabolism study identifies brain hyperglycosylation as a conserved metabolic feature of AD, driven by increased N-glycan biosynthesis. Lowering glycosylation improved memory in mouse models, while glucosamine worsened outcomes and showed concerning real-world signals in dementia cohorts.

A sweet pathway with bitter implications. ⚠️🧬

#AlzheimersDisease #Glycomics #Neurodegeneration #MedicalPodcasts

Low back pain is everywhere—but the best care is often beautifully simple. 🩺

This JAMA review reminds us: most cases are nonspecific, routine imaging rarely helps, bed rest is passé, and movement is medicine. 🚶‍♂️

Acute pain: reassure, keep active, consider heat/NSAIDs. Chronic pain: exercise, CBT, and multidisciplinary care.

The lumbar gospel: scan less, move more, prescribe wisely. 🦴✨

#LowBackPain #PrimaryCare #MedicalEducation #MedicalPodcasts

🧬 Why do some dangerous mutations stay silent while others strike? This fascinating Nature feature explores mutational buffering, especially the role of HSP90 and other heat-shock proteins in masking harmful variants, shaping disease risk, enabling tumour drug resistance, and even influencing evolution.

A sharp reminder that genotype is only part of the story—context, stress, and molecular chaperones matter too.

🔥💊 #Genetics #PrecisionMedicine #CancerBiology #MedicalPodcasts

🧬 How are proteins distributed across the human body—and how do they change in cancer?

A landmark Nature study mapped >13,600 proteins across 2,856 samples spanning 58 tissues, 251 tissue subtypes, fetal development, and 25 cancers. 🔬

Key findings: ✅ 1,717 tissue-enriched proteins identified ✅ 8,940 cancer-associated protein changes ✅ 402 tissue-specific drug targets linked to 2,598 drugs ✅ 41 promising tumor-enriched therapeutic targets

This remarkable atlas provides a roadmap for precision medicine, biomarker discovery, drug repurposing, and understanding organ-specific toxicity. 🚀🧬🏥

#Proteomics #CancerResearch #PrecisionMedicine #DrugDiscovery #MedicalPodcasts #NatureJournal #Oncology #Biomarkers #SystemsBiology #TranslationalMedicine

🧬 Can a blood test reveal which cells in your body are aging fastest?

In this fascinating Nature Medicine study, investigators analyzed >7,000 plasma proteins from 60,542 individuals to develop cellular aging clocks for more than 40 cell types. 🔬

Key findings: 🧠 Older astrocytes predicted higher Alzheimer's disease risk 💪 Accelerated skeletal muscle aging forecast amyotrophic lateral sclerosis 🚬 Respiratory epithelial aging identified smokers at particularly high lung cancer risk 📈 Accumulated cellular aging strongly predicted mortality

A remarkable step toward measuring biological aging at cellular resolution and identifying both vulnerability and resilience. #Aging #Proteomics #PrecisionMedicine #MedicalPodcasts #Alzheimers #Longevity #Biomarkers

🧬 Exciting advances in rare disease diagnostics!

A new NEJM report shows that long-read genome sequencing (lrGS) can function as a first-tier diagnostic test, achieving a higher diagnostic yield than standard approaches (19.2% vs. 16.5%) and an impressive 96.4% concordance. 🚀

Beyond identifying conventional variants, lrGS improves haplotype phasing, detects novel variants, and provides epigenetic insights through DNA methylation analysis. In a modeled real-world cohort of 15,150 patients, lrGS increased diagnostic yield by 2.5 percentage points.

A glimpse into the future of precision medicine and rare disease care. 🧬🔍📈 #Genomics #RareDisease #PrecisionMedicine #MedicalPodcasts #NEJM

⚕️🧠 Long before modern physiology, Erasistratus (c. 304–250 BCE) was asking a revolutionary question: How does the body actually work?

Working in Alexandria alongside Herophilus, he helped establish one of history's first great anatomy schools. He described heart valves, distinguished sensory from motor nerves, linked nerves to the brain, and recognized that the heart functions as a pump rather than the center of thought.

Although some of his theories—such as arteries carrying pneuma rather than blood—proved incorrect, his commitment to observation and anatomical investigation helped lay the foundations of physiology and neuroscience. 🔬

His story reminds us that scientific progress often begins not with having all the answers, but with asking better questions. 🌍✨

#Erasistratus #Physiology #Neuroscience #MedicalHistory #HistoryOfMedicine #MedicalEducation

🚀 Major advance in nephrology and cardiorenal medicine!

The INFINITY pooled analysis (14,574 participants) demonstrates that finerenone reduces CKD progression, kidney failure, heart failure hospitalization, cardiovascular death, and even all-cause mortality across a broad spectrum of chronic kidney disease—not just type 2 diabetes. 🩺❤️🩺

Benefits were remarkably consistent across glycemic status, CKD etiology, eGFR, albuminuria, and SGLT2 inhibitor use. Hyperkalemia remains the key safety consideration but serious events were uncommon.

Could finerenone become a foundational therapy for CKD regardless of diabetes status? 🔬📈

#CKD #Nephrology #Cardiology #Finerenone #CardioRenal #MedicalPodcasts #INFINITYTrial #KidneyDisease #HeartFailure #PrecisionMedicine

🧬💤🏃‍♂️ Can lifestyle modify the cardiovascular risk associated with clonal haematopoiesis (CH)?

In this elegant Nature study, investigators demonstrate that sleep and exercise exert mutation-specific effects on CH. Moderate-to-vigorous physical activity was associated with lower prevalence of non-DNMT3A CH in large human cohorts, while mechanistic studies revealed that uninterrupted sleep and exercise can suppress JAK2V617F- and TET2-driven clonal expansion and reduce atherosclerosis. 🔬❤️

The message is clear: lifestyle is not merely preventive—it may selectively reprogram mutant cells and reshape cardiovascular risk. #Cardiology #PrecisionMedicine #CHIP #Atherosclerosis #MedicalPodcasts 🧬🛡️

🔥 Can a gout flare trigger a heart rhythm problem?

A fascinating study from England and Sweden found that patients with gout experienced a significantly higher risk of developing tachyarrhythmias—predominantly atrial fibrillation/flutter—within 30 days of a gout flare, with signals extending up to 60 days in self-controlled analyses. ❤️⚡

The findings reinforce the concept that acute inflammation may transiently destabilize cardiac electrical activity. For clinicians, a gout flare may be more than a joint event—it could be a cardiovascular warning sign warranting heightened vigilance. 🩺📈

#Gout #AtrialFibrillation #Cardiology #Rheumatology #Inflammation #MedicalPodcasts #CardioRheumatology #PreventiveCardiology #Lancet #Arrhythmia

🚑 How much fluid is too much in septic shock?

The ARISE FLUIDS trial tackled one of critical care's most debated questions: should clinicians prioritize early vasopressors with restricted fluids or continue a more liberal fluid strategy?

📊 Among 963 patients with septic shock, early vasopressors reduced fluid exposure by >1 liter and significantly lowered pulmonary edema (0.6% vs 5.0%; P

🎯 Yet there was no difference in 90-day days alive and out of hospital or mortality.

A landmark study reminding us that in septic shock, physiology is complex and more fluid is not always better—but less fluid is not necessarily superior either. #Sepsis #CriticalCare #EmergencyMedicine #NEJM #MedicalEducation

The new 2026 AHA/ACC/ADA/ASN Cardiovascular–Kidney–Metabolic (CKM) Guideline reframes chronic disease through a unified lens connecting obesity, diabetes, chronic kidney disease, and cardiovascular disease.

Key themes: ✅ CKM staging across the life course ✅ PREVENT risk assessment for personalized care ✅ Early detection of kidney and cardiometabolic risk ✅ Lifestyle and weight management as foundational therapy ✅ Evidence-based use of SGLT2 inhibitors and GLP-1–based therapies ✅ Team-based, patient-centered care

A landmark step toward integrated prevention and better long-term outcomes. #Cardiology #Nephrology #Diabetes #Obesity #CKM #PreventiveCardiology #MedicalPodcasts #PrecisionMedicine #HeartFailure #KidneyDisease

🫀 The 2026 ACC/AHA Multisociety Guideline on the Management of Dyslipidemia marks a major shift in preventive cardiology. Key updates include universal Lp(a) testing at least once in adulthood, greater emphasis on ApoB, adoption of the PREVENT risk equations, return of LDL-C treatment goals, and more aggressive use of nonstatin therapies to achieve risk-based targets.

The message is simple: identify risk earlier, lower atherogenic lipoproteins more effectively, and prevent ASCVD before it occurs.

📚 A landmark roadmap for clinicians committed to precision cardiovascular prevention. #Cardiology #PreventiveCardiology #Lipidology #ASCVD #MedicalEducation #MedicalPodcasts

Reference: Blumenthal RS et al. 2026 ACC/AHA Multisociety Guideline on the Management of Dyslipidemia. JACC 2026.

⚕️🧠 Before modern anatomy labs, there was Herophilus (335–280 BCE)—the physician often called the Father of Anatomy.

Working in Alexandria, he became the first known scientist to systematically dissect human cadavers, transforming medicine from speculation into observation. He distinguished arteries from veins, studied the pulse with a water clock, described the retina and optic nerve, and boldly argued that the brain—not the heart—is the seat of intelligence.

Although all of his original books were lost, his discoveries survived through later physicians and helped lay the foundation for modern anatomy, neurology, and clinical medicine. 🔬📚

A powerful reminder that scientific progress begins with curiosity, careful observation, and the courage to challenge accepted beliefs. 🌍✨

#Herophilus #MedicalHistory #Anatomy #Neurology #HistoryOfMedicine #MedicalEducation

🫀🔥 Is cholesterol the whole story behind heart disease? Increasingly, the answer appears to be no.

A fascinating Nature Medicine review explores how cardiovascular inflammation is emerging as a major driver of atherosclerosis, myocardial infarction, stroke, and heart failure. From AI-enhanced coronary CT imaging to novel therapies targeting IL-6, IL-1, NLRP3 inflammasomes, and regulatory T cells, cardiology is entering the era of cardio-immunology.

The future may involve not only lowering LDL cholesterol but also identifying and treating residual inflammatory risk. 🚀❤️

#Cardiology #Inflammation #Atherosclerosis #HeartFailure #PrecisionMedicine #CardioOncology #MedicalEducation #MedicalPodcast

🫁🔬 Can a simple blood test identify people at risk for lung cancer years before diagnosis?

A remarkable new study in Cell describes a 14-protein plasma signature that predicts lung cancer more than 5 years before clinical detection. The work links air pollution, EGFR-driven tumorigenesis, and IL-1β–mediated inflammation to a shared tumor-promoting state and suggests a path toward molecular cancer prevention. Most intriguingly, the signature may help identify individuals most likely to benefit from anti–IL-1β therapy.

A fascinating glimpse into the future of precision prevention. 🚀🧬 #LungCancer #PrecisionMedicine #CancerPrevention #MedicalPodcasts #Oncology #Biomarkers

🧬 Groundbreaking NEJM report! Two highly sensitized kidney transplant candidates (cPRA ~99.995–99.998%) underwent successful transplantation after dual CD19- and BCMA-targeted CAR-T therapy. 🎯

Rather than simply removing antibodies, investigators targeted the cells that produce them—memory B cells and plasma cells. The result? Profound reduction in anti-HLA antibodies, successful transplantation, and no donor-specific antibody rebound during follow-up. 🚀

This study expands the horizon of CAR-T beyond oncology and may herald a new era in transplant immunology.

📖 NEJM 2026: Bhoj et al. #KidneyTransplant #CART #TransplantImmunology #PrecisionMedicine #MedicalInnovation #MedEd 🩺

💥 What if an immune cell could defend the body by literally exploding?

A fascinating new study in Cell describes "ruptoblasts," a previously unknown cytotoxic cell type in planarian flatworms. Triggered by activin signaling, these cells undergo an explosive form of death called ruptosis, releasing potent diffusible factors that rapidly kill nearby cells and bacteria. 🧬⚡

The work links hormone surveillance with immune defense and uncovers a mechanism distinct from apoptosis, pyroptosis, necroptosis, and ferroptosis. A remarkable glimpse into ancient evolutionary solutions to immunity. 🔬🛡️

#Immunology #CellBiology #PrecisionMedicine #MedicalEducation #MedicalPodcasts #ScienceCommunication #Ruptoblasts #Nature #CellJournal #Innovation

📱❤️ Can your smartphone become a heart monitor?

A landmark Nature study demonstrates that passive heart-rate monitoring using a smartphone's front-facing camera can accurately measure heart rate and resting heart rate during everyday phone use—without a wearable device. The AI-powered system achieved industry accuracy standards across diverse skin tones and showed strong correlation with cardiovascular fitness and obesity risk factors.

This work may democratize heart-health monitoring for billions worldwide. 🌍💓

#Cardiology #DigitalHealth #AIinMedicine #mHealth #PreventiveCardiology #MedicalPodcasts #NatureJournal #HeartRateMonitoring #PrecisionMedicine #Innovation

🍷 How much alcohol is truly safe?

A landmark Burden of Proof study published in Nature Health analyzed 843 cohort and case-control studies examining alcohol and 20 major health outcomes.

Key findings: ✅ Even low levels of alcohol increased the risk of several cancers. ✅ Higher alcohol intake increased risk across all outcomes studied. ✅ Low-to-moderate intake showed possible associations with lower risks of type 2 diabetes, dementia, and some cardiovascular diseases—but these findings remain observational and uncertain.

The takeaway: alcohol's health effects are complex, but cancer risk begins earlier than many realize.

#Alcohol #PublicHealth #Cardiology #CancerPrevention #PreventiveMedicine #MedicalEducation #MedicalPodcast

🏮⚕️ More than 2,300 years ago, the legendary Chinese physician Bian Que (Qin Yueren) taught a lesson that remains central to medicine today: detect disease early.

Known for his four-step diagnostic method—Looking 👁️, Listening 👂, Inquiring 💬, and Taking the Pulse ❤️—Bian Que emphasized careful observation and individualized care long before modern diagnostic technology existed.

His famous story of warning the Lord of Cai illustrates a timeless truth: diseases are easiest to treat before symptoms become severe.

Whether history, legend, or a blend of both, Bian Que's legacy continues to inspire practitioners of Traditional Chinese Medicine and reminds us that great physicians first learn to observe, listen, and understand. 🌿✨

#MedicalHistory #TraditionalChineseMedicine #BianQue #MedicalEducation #HistoryOfMedicine

🧠 Alzheimer's disease remains the leading cause of dementia worldwide, but the field is changing rapidly.

New advances in genetics, blood-based biomarkers, amyloid and tau PET imaging, and disease-modifying therapies are transforming how we diagnose and manage this devastating condition. From APOE genetics to plasma p-tau217 and anti-amyloid treatments, we are entering an era of earlier detection and more personalized care.

🎙️ In Dr RR Baliga's Podkast for the Curious Doc, we explore the science, clinical implications, and future directions of Alzheimer's disease.

#AlzheimersDisease #Dementia #Neurology #BrainHealth #PrecisionMedicine #Biomarkers #MedicalEducation #MedicalPodcasts

🩺💊 Which blood pressure medications do patients tolerate best?

A major JAMA network meta-analysis of 716 randomized trials involving 159,362 participants found important differences in adverse effects and treatment discontinuation across antihypertensive regimens.

🏆 ARB + CCB combinations ranked as the most tolerated therapy. ✅ ARB-containing regimens consistently performed best. ⚠️ CCBs were associated with more edema and treatment discontinuation. ⚠️ ACE inhibitors remained the leading cause of cough.

The message is clear: tolerability influences adherence, and adherence influences outcomes.

🎙️ Discussed on Dr RR Baliga's Podkast for the Kurious Doc.

#Hypertension #Cardiology #JAMA #BloodPressure #MedicalEducation #MedicalPodcasts #Prevention #CardiovascularMedicine #EvidenceBasedMedicine #PatientCare

🧬 Aging leaves a molecular fingerprint—and we can now read it.

A remarkable Nature study analyzed >11,000 transcriptomes across mice, rats, macaques, and humans to identify universal transcriptomic hallmarks of ageing. The investigators developed highly accurate gene-expression clocks that predict biological age, mortality risk, lifespan modulation, and responses to rejuvenation interventions.

Key themes included inflammation, interferon signaling, mitochondrial dysfunction, chromatin remodeling, and extracellular matrix changes. Notably, CDKN1A (p21) and LGALS3 emerged as important mortality-associated markers.

🎙️ Featured on Dr RR Baliga's Podkast for the Kurious Doc.

#Aging #Longevity #Transcriptomics #PrecisionMedicine #Geroscience #MedicalPodcasts #NatureJournal #HealthyAging #Biomarkers #AIinMedicine

🫀 Coronary microvascular dysfunction is no longer a "hidden" diagnosis.

The new FLOW-CMD Registry published in The Lancet demonstrates that coronary microvascular dysfunction frequently coexists with obstructive coronary artery disease and significantly increases adverse cardiovascular outcomes.

Patients with CMD had: ⚠️ Higher cardiac death ⚠️ More repeat revascularization ⚠️ Increased heart failure hospitalization risk

This study reminds us that ischemic heart disease is more than epicardial stenosis alone. Coronary physiology — CFR, IMR, and FFR — may reshape future risk stratification and management.

🎙️ Featured on Dr RR Baliga's Podkast for the Kurious Doc: Where Curiosity Meets Clarity!

#Cardiology #CoronaryMicrovascularDysfunction #InterventionalCardiology #HeartFailure #MedicalPodcasts

🫀 Fascinating new study in the The New England Journal of Medicine explores "Stem-Cell–Derived Biologic Ventricular Assist Tissue (BioVAT)" for advanced heart failure. Investigators demonstrated that engineered heart-muscle patches derived from induced pluripotent stem cells increased ventricular wall thickness, modestly improved left ventricular ejection fraction, and enhanced quality of life in patients with severe heart failure.

This may represent an important step toward true cardiac remuscularization — moving beyond support devices toward biologic repair itself. 🔬❤️

#Cardiology #HeartFailure #StemCells #RegenerativeMedicine #BioVAT #MedicalPodcasts

🧬 Could a single infusion replace decades of lipid-lowering therapy?

The new NEJM study on VERVE-102 explores in vivo base editing of PCSK9 using CRISPR-inspired adenine base editing technology. In this phase 1 trial, a one-time infusion produced LDL cholesterol reductions up to 62% with durable effects extending beyond 1 year. ❤️

This may represent a major shift from chronic pharmacotherapy toward "once-and-done" genomic cardiovascular prevention.

The science, safety, clinical implications, and future of gene-editing cardiology on "Dr RR Baliga's Podkast for the Kurious Doc." 🎙️🧠

#Cardiology #CRISPR #PCSK9 #PrecisionMedicine #Genomics #LDL #NEJM #MedicalInnovation #PreventiveCardiology #medicalpodca

⚕️ Long before modern preventive medicine, Diocles of Carystus emphasized something remarkably familiar today: hygiene, exercise, balanced diet, sleep, and daily discipline.

A physician of 4th century BCE Greece, Diocles helped advance anatomy, surgery, nutrition, and holistic health. Some ancient sources even credit him with being among the first to use the term "anatomy." 🧠

His philosophy was simple yet profound: health depends on harmony between the body, mind, environment, and daily habits. 🌿

A timeless reminder that medicine is not only about treating disease—but about preserving healt

⚖️🚀 RETATRUTIDE may redefine obesity medicine.

In the Phase 3 TRIUMPH-1 trial, Lilly's triple agonist (GIP/GLP-1/glucagon) achieved an astonishing 28.3% average weight loss at 80 weeks, with some patients exceeding 30% weight reduction — territory once associated mainly with bariatric surgery. 📉

Even the 4 mg dose achieved nearly 20% weight loss with fewer discontinuations. Significant improvements were also seen in waist circumference, triglycerides, systolic BP, and hsCRP. ❤️

A fascinating glimpse into the future of cardiometabolic therapeutics.

🎙️ Dr RR Baliga's Podkast for the Kurious Doc

#Obesity #Retatrutide #GLP1 #Cardiology #Endocrinology #WeightLoss #Medical

🧪 New in JAMA: 4% tetrasodium EDTA significantly reduced ICU catheter complications in a multicenter randomized clinical trial.

Among 1,468 critically ill patients, EDTA locking solution lowered the composite risk of bloodstream infection, catheter occlusion requiring alteplase, and catheter removal due to occlusion. The strongest signal? Fewer catheter blockages and smoother ICU workflow. 💉🏥

A simple locking strategy with meaningful implications for patient safety, nursing workload, and catheter longevity.

#CriticalCare #ICU #Cardiology #InfectionPrevention #JAMA #MedicalEducation #MedicalPodcasts #CVAD #Research

🌙🧠 Fascinating new insights from Science reveal that sleep is far more than "rest." During non-rapid eye movement sleep, neuromodulators synchronize into ~50-second oscillatory rhythms that coordinate vascular pulsations, cerebrospinal fluid flow, and glymphatic clearance of amyloid-β and tau.

This elegant systems-level biology may explain why aging, psychiatric disease, stress, cardiovascular disease, and even common medications can increase dementia risk.

Sleep may be the brain's nightly cleansing symphony. 💤🌊

#Sleep #Neuroscience #Dementia #BrainHealth #GlymphaticSystem #MedicalPodcasts #Cardiology #Neurology #Alzheimers #Science

🧪❤️ Are preservatives in ultra-processed foods quietly increasing cardiovascular risk?

A major analysis from the NutriNet-Santé cohort published in the European Heart Journal followed >112,000 participants and linked several commonly used food additives with higher rates of hypertension and cardiovascular disease.

Notable signals emerged for sodium nitrite, potassium sorbate, sulphites, erythorbates, citric acid, and ascorbic acid additives.

This study reminds us that nutrition science is moving beyond calories and macronutrients toward the biological effects of industrial food processing itself. 🍔⚠️

Fresh foods may still be the best "cardiovascular preservative." 🫀

#Cardiology #Nutrition #PreventiveCardiology #HeartDisease #Hypertension #MedicalPodcast

🦠 The INTEGRAL-1 trial in The Lancet delivers exciting data for resistant urinary tract infections. Cefepime–nacubactam achieved both noninferiority AND superiority vs imipenem–cilastatin in complicated UTI and acute pyelonephritis.

⚡ Strong microbiological eradication, promising ESBL activity, and favorable safety profiles suggest an important future role in carbapenem-sparing strategies.

#UTI #Lancet #AntimicrobialResistance #ESBL #InfectiousDiseases #MedicalPodcasts

😴💊 Could a pill transform the treatment of obstructive sleep apnea?

The SynAIRgy Phase 3 trial of AD109 (aroxybutynin + atomoxetine) showed significant reductions in apnea–hypopnea index and hypoxic burden in patients unable to tolerate CPAP therapy. 🌙🫁

A once-nightly oral therapy targeting upper airway neuromuscular dysfunction may represent a new frontier in sleep medicine. Fascinating data with important implications for cardiovascular and metabolic health. 🫀📊

#SleepApnea #OSA #AD109 #SleepMedicine #RespiratoryMedicine #MedicalPodcasts #ClinicalTrials #PrecisionMedicine

⚕️ "If you want to understand the health of a population, look at the air they breathe, the water they drink, and the places where they live."

More than 2,400 years ago, Hippocrates transformed medicine by arguing that disease had natural—not supernatural—causes. His emphasis on clinical observation, ethics, prognosis, professionalism, and compassionate care laid the foundation for modern medicine.

The Hippocratic Oath remains one of the most enduring ethical pledges in human history. 📜✨

A timeless reminder that great medicine begins not only with science—but with humility, observation, and humanity

💊 Can weight loss achieved with injectable GLP-1 therapies be maintained using an oral agent?

The ATTAIN-MAINTAIN phase 3b trial published in Nature Medicine evaluated once-daily oral orforglipron after prior tirzepatide or semaglutide therapy. Patients maintained substantially more prior weight reduction versus placebo over 52 weeks, while preserving cardiometabolic benefits. 🌍⚖️

A fascinating glimpse into the future of scalable obesity care: oral incretin therapy may improve adherence, accessibility, and long-term maintenance.

#Obesity #GLP1 #Orforglipron #NatureMedicine #Cardiology #Endocrinology #MedicalPodcast #PhysicianEducation

👁️ New NEJM correspondence highlights a potentially important ophthalmic signal linked to dulaglutide therapy. Two patients developed choroidal lymphoid hyperplasia with painless visual loss within months of GLP-1 receptor agonist initiation. Remarkably, ocular and systemic findings rapidly resolved after stopping dulaglutide.

As GLP-1 therapies expand across diabetes, obesity, and cardiometabolic medicine, clinicians should remain vigilant for emerging ocular adverse events.

A fascinating intersection of endocrinology, immunology, and ophthalmology. 🔬💉👓

#NEJM #GLP1 #Dulaglutide #Ophthalmology #Diabetes #Retina #Cardiology #ObesityMedicine #PrecisionMedicine #MedicalEducation

🫀 Scar. Signal. Survival.

A major new JAMA study from the NHLBI Hypertrophic Cardiomyopathy Registry followed 2,698 patients for nearly 7 years and demonstrated that advanced cardiac magnetic resonance imaging and NT-proBNP markedly improve prediction of adverse outcomes in hypertrophic cardiomyopathy.

📌 Key findings: • Late gadolinium enhancement (fibrosis burden) strongly predicted events • LGE ≥9% of LV mass substantially increased risk • LV mass index, LV systolic dysfunction, and NT-proBNP independently predicted outcomes • Traditional markers alone may miss important risk signals

This work moves HCM risk assessment beyond simple wall thickness toward a multidimensional precision cardiology approach.

📖 JAMA. Published online May 11, 2026. #Cardiology #HCM #HypertrophicCardiomyopathy #CardiacMRI #CMR #HeartFailure #SuddenCardiacDeath #PrecisionMedicine #CardioTwitter #JAMA

🧠 Six landmark stroke investigations published in NEJM, JAMA, and Lancet are redefining modern reperfusion science.

🔹 ORIENTAL-MeVO: Thrombectomy improved outcomes in selected medium-vessel occlusion strokes. 🔹 TNK-PLUS: Bridging tenecteplase before EVT in the late window showed no added benefit. 🔹 CHOICE-2: Intra-arterial alteplase after successful thrombectomy improved excellent recovery but raised mortality concerns. 🔹 INSTANT: Early tirofiban after inadequate tenecteplase response improved 90-day outcomes. 🔹 TAPIS: Early ticagrelor + aspirin after thrombolysis improved functional recovery without excess major bleeding. 🔹 ATLAS: EVT benefited large-core stroke patients up to 24 hours after onset.

Together, these studies shift the conversation from simply reopening arteries toward optimizing tissue-level reperfusion, patient selection, and microvascular recovery. 🚑⚡

#Stroke #Neurology #Thrombectomy #JAMA #NEJM #Lancet #Neurointervention #Tenecteplase #Tirofiban #Cardiology

😴🧠 How much sleep is "just right" for healthy ageing?

A remarkable Nature study of ~500,000 UK Biobank participants demonstrated a striking U-shaped relationship between sleep duration and biological ageing across 23 ageing clocks, 17 organs, and 3 omics platforms. 🌙🧬

Both short (8 h) sleep were associated with accelerated ageing, higher systemic disease burden, and increased all-cause mortality. The biologic "sweet spot" appeared to be ~6–8 hours/night. ⏳❤️

An elegant reminder that sleep is not passive rest — it is active systemic repair.

Source: The MULTI Consortium et al. Nature (2026) DOI: 10.1038/s41586-026-1052

🫀 Old drug. New evidence. Renewed relevance.

Two major JAMA studies published in 2026 revisit the role of digoxin/digitalis glycosides in modern cardiovascular care.

📊 A meta-analysis of 9,013 patients with HFmrEF/HFrEF showed reduced worsening heart failure events without increased mortality.

🌍 The Dig-RHD randomized trial from India demonstrated that digoxin reduced death or worsening heart failure in symptomatic rheumatic heart disease with minimal toxicity.

Key message: 💊 Digoxin may still have an important role as affordable adjunctive therapy—especially in resource-limited settings and carefully selected patients.

Sometimes the oldest medicines still have new stories to tell.

#Cardiology #HeartFailure #Digoxin #RheumaticHeartDisease #JAMA #Digitalis #HFmrEF #HFrEF #GlobalHealth #CardioTwitte

🐍⚕️ Before modern hospitals, there were the healing temples of Asclepius — where medicine, ritual, dreams, and compassion converged.

Son of Apollo, trained by the wise centaur Chiron, Asclepius became the enduring symbol of healing in Greek civilization. His daughters — Hygieia, Panacea, and Iaso — represented health, cure, and recovery itself.

Even today, the Rod of Asclepius remains the universal emblem of medicine. 🌿

A reminder that the art of healing has always been more than science alone — it is wisdom, empathy, and hope.

🧬 Predict. Prevent. Protect: The APOL1 Proteomic Revolution

A fascinating new study in Nature Medicine describes a 9-protein APOL1 Proteomic Risk Score (APRS) capable of predicting kidney disease progression years before chronic kidney disease becomes clinically apparent.

Among individuals of African ancestry with APOL1 high-risk genotypes and preserved kidney function, APRS achieved a remarkable time-dependent AUC of ~86%, substantially outperforming traditional clinical scores and polygenic risk tools.

This work moves us closer to precision nephrology: identifying who is truly at risk, enriching clinical trials, and potentially guiding targeted therapies such as inaxaplin.

A powerful example of proteomics transforming static genetic risk into dynamic clinical prediction. 🔬🩺

Li C et al. Nature Medicine. 2026. doi:10.1038/s41591-026-04337

🧠🎙️ New infographic from Dr RR Baliga's Podkast for the Kurious Doc: "Colonoscopy, Cancer & Competing Risks."

Two major 2026 studies from The Lancet and JAMA reshape how we think about colorectal cancer screening and surveillance.

🔹 The NordICC trial showed reduced colorectal cancer incidence with colonoscopy, but no significant mortality reduction after 13 years. 🔹 In adults ≥75 years with prior adenomas, non-colorectal cancer mortality far exceeded colorectal cancer risk, highlighting the importance of frailty and individualized decision-making.

Key lesson: the future of colon cancer screening is not "more colonoscopies," but smarter, patient-centered precision prevention. 🎯

#ColorectalCancer #Colonoscopy #CancerPrevention #Gastroenterology #PrecisionMedicine #Frailty #JAMA #Lancet #MedicalEducation

🧠 Three major stroke trials published in JAMA this week may reshape adjunctive reperfusion strategies in acute ischemic stroke.

🔹 TNK-PLUS: Tenecteplase before thrombectomy in late-window stroke showed no added functional benefit. 🔹 CHOICE-2: Intra-arterial alteplase after successful thrombectomy improved excellent neurological recovery, though mortality signals warrant caution. 🔹 INSTANT: Early tirofiban after inadequate tenecteplase response significantly improved 90-day outcomes in non-large vessel occlusion stroke.

Together, these studies highlight a growing shift from merely reopening arteries toward optimizing microvascular reperfusion and tissue recovery.

🧬 Tumours are not just masses of cells—they are organized ecosystems.

A remarkable Nature study by Zhang et al. mapped >10 million spatial transcriptomes across cancers and identified 9 conserved "spatial ecotypes" within the tumour microenvironment. Even more striking: these ecotypes could be detected non-invasively from plasma cell-free DNA using deep learning.

Higher SE7/SE8 predicted better immunotherapy outcomes, while SE4 forecast resistance and poorer survival. A powerful step toward blood-based spatial oncology and precision immunotherapy. 🚀🩸🔬

Zhang W, Brown EL, Usmani A, et al. Nature. 2026. doi:10.1038/s41586-026-10452-4

🧠💤 Can the unconscious brain still process meaning?

A remarkable Nature study used Neuropixels recordings from the human hippocampus during general anesthesia and found preserved oddball detection, semantic encoding, syntactic processing, and even prediction of upcoming words.

The anesthetized brain was not silent—it adapted, learned, and contextualized language despite loss of consciousness. These findings challenge classical theories tightly linking higher cognition to conscious awareness.

Katlowitz KA et al. Nature. 2026. https://doi.org/10.1038/s41586-026-10448-0 🎙️

A fascinating Lancet RCT shows once-weekly semaglutide may redefine alcohol use disorder treatment. 🎯

In 108 adults with AUD and obesity, semaglutide reduced heavy drinking days by –13.7 percentage points vs placebo (p=0.0015) and improved craving, consumption, and biomarkers. 📉

With an NNT of ~4.3 and a manageable safety profile, GLP-1 therapy signals a shift from abstinence to precision harm reduction. 💡

Efficacy. Safety. Meaningful impact.

Is this the beginning of a new era in addiction medicine? 🧠💉

What does it take to be remembered for 3,000 years? 🏺

Meet Imhotep—chancellor, architect of the Step Pyramid, and later revered as a god of healing. From stone structures that defy time to ideas that shaped medicine and myth, his legacy is both historical and philosophical.

As highlighted in early narratives, he was not just a builder of monuments—but a builder of meaning.

A timeless reminder: true impact is not just what we create—but what endures. ✨

#GreatDoctors #HistoryOfMedicine #Innovation #AncientWisdom #Leadership

❤️ New in Circulation: the 2026 AHA Dietary Guidance to Improve Cardiovascular Health distills prevention into 9 elegant features—maintain healthy weight, emphasize vegetables/fruits, choose whole grains, favor healthier proteins and unsaturated fats, minimize ultraprocessed foods, added sugars, and sodium, and avoid starting alcohol for health. Food, here, is not garnish; it is strategy. 🥗🌾🩺 #Cardiology #Prevention #Nutrition

🧬⚠️ Genes. Toxins. Tumors.

A compelling Nature Medicine study uncovers how the exposome—our lifetime environmental exposures—leaves epigenetic fingerprints linked to early-onset colorectal cancer.

🚜 A striking signal: picloram exposure shows consistent association across cohorts and real-world US data. 📊 Reinforces known risks (smoking, diet, education) while revealing novel environmental drivers.

💡 The message is clear: cancer prevention may begin far upstream—in policy, environment, and early-life exposures.

#ColorectalCancer #Exposome #Epigenetics #PrecisionMedicine #PublicHealth

Can AI think like a physician? 🧠🤖

A landmark Science 2026 study shows LLMs outperform physicians in structured diagnostic reasoning across NEJM cases and real-world emergency scenarios. 📊

Accuracy gains were striking—especially in early triage where uncertainty is highest. Yet, the story is not replacement, but partnership. 🤝

The real challenge now: translating benchmark brilliance into safe, equitable, real-world care. ⚖️

AI is no longer a tool—it's becoming a colleague. The question is: how do we train, trust, and integrate it? 🚀

A quiet revolution in tuberculosis diagnostics is here. 🧪🌍

This NEJM study shows that MiniDock MTB, a rapid swab-based molecular test, delivers Xpert-level accuracy with minimal training and no adverse events—all in a near–point-of-care format. ⏱️🧠

Key insights: 🔹 Sensitivity: 85.7% (sputum), 79.6% (tongue) 🔹 Specificity: >97–99% 🔹 Strong performance vs smear microscopy (+24% sensitivity) 🔹 Usability score: 75—ready for real-world deployment

The implications are profound: 👉 Noninvasive testing for patients unable to produce sputum 👉 Decentralized diagnostics in resource-limited settings 👉 A realistic path to closing the global TB detection gap

From central labs to community clinics—this is how access scales. 🚀

📖 Yerlikaya et al., NEJM 2026

#Tuberculosis #GlobalHealth #Diagnostics #PointOfCare #PublicHealth #InfectiousDiseases #PrecisionMedicine #MedicalInnovation #HealthEquity #TBElimination

A meal may be more than nutrition—it may be immunotherapy. 🍽️⚡

In a striking Nature study, T cells sampled just 6 hours after feeding showed enhanced metabolic fitness, cytokine production, and persistence compared to the fasted state. 🧠🔥

Mechanistically, chylomicron-derived lipids → LDLR → mTORC1 → protein translation, fueling durable immune function.

Even more compelling: postprandial CAR-T cells demonstrated superior cytotoxicity.

Clinical implication? Timing may matter—before vaccines, before cell therapy, before immune engagement. ⏱️

Feed. Fuel. Fight. 🛡️✨

BP Lowering in CKD: Consistent. Comprehensive. Compelling. 📉🫀

A landmark individual-participant meta-analysis (285K+ patients) shows that every 5 mm Hg reduction in systolic BP reduces major cardiovascular events by ~10%—across all CKD stages.

Key insight: the benefit holds even at lower BP levels and across drug classes. ⚖️ But in CKD + diabetes, the effect attenuates—reminding us that biology resists simplicity. 🧠

The message is clear: BP control remains one of the most powerful, scalable tools in CKD care.

Precision is next. Implementation is everything. 🚀

🌿 Balance. Body. Beginnings.

Long before modern medicine spoke of personalization and prevention, Charaka articulated a remarkably sophisticated vision of health—rooted in balance, biology, and behavior.

From the Charaka Samhita to the concept of doshas (vata, pitta, kapha), his work reflects an early systems-based approach that continues to echo in today's precision and lifestyle medicine.

This infographic from Dr RR Baliga's Podkast for the Kurious Doc 🎙️🧠 explores how ancient insights still inform modern thinking

✨ Where curiosity meets clarity #Ayurveda #MedicalHistory #HolisticHealth #PrecisionMedicine #LifestyleMedicine

⚡🫀 Shock. Silence. Success — A landmark New England Journal of Medicine trial redefines first-line therapy in persistent AF.

In AVANT GUARD, pulsed field ablation (PFA) outperformed antiarrhythmic drugs: 📊 Success: 56% vs 30% 📉 HR: 0.46 (P 💓 Lower arrhythmia burden (−6.5%)

Safety remained comparable, with primary events at 5.1%.

A compelling case for early, energy-based rhythm control—precision over pharmacology.

#Cardiology #Electrophysiology #AtrialFibrillation #NEJM #Innovation

A fascinating Science (2026) study reveals why the heart is remarkably resistant to cancer.

Mechanical load—through contraction and pressure—suppresses tumor proliferation via epigenetic remodeling.

Unloading the heart doubled cancer cell proliferation, while load reduced histone methylation and chromatin compaction through Nesprin-2–mediated mechanotransduction.

A striking paradigm: the beating heart is not just a pump—but a biomechanical tumor suppressor. 🫀⚙️🧬 @ICOSociety

A simple idea, executed elegantly.

In the NEJM TRIDENT trial, a single low-dose triple antihypertensive pill reduced recurrent stroke after intracerebral hemorrhage (HR 0.61) and improved BP control (50% vs 26%).

Yet, only half reached target—reminding us that pills alone don't solve therapeutic inertia.

The message is clear: simplify treatment, intensify targets, and build systems that ensure control.

One pill helps. Systems save lives. 💊📉🧠

A pivotal JAMA randomized trial introduces an epigenetic twist to frontline therapy in high-risk DLBCL. Adding tucidinostat (HDAC inhibitor) to R-CHOP improved event-free survival (HR 0.72, P=0.02) and increased complete response rates (73% vs 62%) in MYC/BCL2 double-expressor lymphoma. Toxicity was higher but manageable.

A quiet but meaningful shift—targeting biology, not just burden.

#DLBCL #Lymphoma #Oncology #PrecisionMedicine #JAMA #ClinicalTrials

A pragmatic Lancet RCT (SCOUT) reshapes UTI management. In 768 women, nitrofurantoin achieved the highest clinical resolution at day 7 (74%) vs single-dose fosfomycin (59%), with a significant 15.5% absolute difference. Pivmecillinam and two-dose fosfomycin performed intermediately. Adverse events were mild across groups.

The message is clear: convenience may cost efficacy. Short-course regimens—especially nitrofurantoin—should be preferred over single-dose fosfomycin. A timely reminder that in antimicrobial stewardship, simplicity must not trump success

A large nationwide cohort study in JAMA compared amoxicillin-clavulanate vs amoxicillin for acute sinusitis in >500,000 adults. Treatment failure was low (~3%) with no significant difference between groups (RR 0.96). However, broader-spectrum therapy increased secondary infections, including yeast and C. difficile.

The message is clear: narrow-spectrum amoxicillin remains a rational first-line choice for uncomplicated sinusitis—balancing efficacy, safety, and stewardship.

Sometimes, the quiet drug wins the loud debate.

A quiet revolution in medicine began not in a laboratory—but in a dialogue. 🌿

Punarvasu Atreya, one of the earliest architects of Ayurveda, transformed healing into a disciplined science through teaching, inquiry, and debate. His legacy—preserved in the Charaka Samhita and Bhela Samhita—shaped centuries of clinical reasoning and holistic care.

From Takshashila to modern medicine, his influence endures: listen deeply, question rigorously, heal compassionately. 🩺

A reminder that the best physicians are not just healers—but teachers of wisdom. ✨

A thoughtful, practice-shaping study in NEJM explores a long-standing clinical dilemma: can we truly move the needle in post-thrombotic syndrome?

The C-TRACT trial shows that endovascular therapy (iliac-vein stenting) significantly improves symptom burden and quality of life in patients with moderate–severe disease—measured rigorously using VCSS, VEINES-QOL, and SF-36. The magnitude of benefit is clinically meaningful.

But every intervention casts a shadow.

👉 Bleeding risk was ~3-fold higher, largely driven by intensified antithrombotic therapy. 👉 Durability beyond 6 months remains unknown.

This is not a simple "yes or no" trial—it is a study in nuance, trade-offs, and patient-centered decision making.

For the right patient—severe symptoms, clear iliac obstruction, acceptable bleeding risk—EVT may offer a path from limitation to liberation.

The vein opens. The patient breathes. The clinician pauses.

Science advances not in absolutes—but in balance. ⚖️🩺

A landmark study in the New England Journal of Medicine shows that hypertension control is no longer just about prescribing medications—it's about systems, teams, and sustained engagement. 🩺📊

In a cluster-randomized trial across underserved populations, a multifaceted, team-based strategy—combining protocol-driven care, health coaching, and home BP monitoring—achieved a significant additional reduction of −6.4 mm Hg in systolic BP (P and improved adherence.

The message is clear: 👉 Evidence works—but only when implemented well 👉 Teams outperform individuals 👉 Bridging disparities requires design, not hope

This is not just a clinical advance—it's a public health blueprint for scalable hypertension control.

#Hypertension #Cardiology #PopulationHealth #HealthEquity #ImplementationScience

Sex hormones shape cardiovascular risk in subtle yet powerful ways. From estrogen-driven changes in coagulation to formulation-specific differences in VTE risk, the nuance matters. Transdermal estradiol offers a safer path, while ethinyl estradiol reminds us that dose and route are destiny. The key is not avoidance—but precision: matching therapy to individual risk.

Three takeaways: • Formulation matters • First year matters • Patient factors matter

#Cardiology #Thrombosis #PrecisionMedicine #HormoneTherapy

A landmark JAMA study on transcatheter tricuspid valve replacement (TTVR) offers compelling real-world evidence 🫀

✅ 98.4% procedural success

✅ Near-complete TR elimination (97.7% at 30 days)

✅ Significant improvement in symptoms & quality of life

⚠️ Trade-off: ~16% new pacemaker rate in device-naïve patients

In an elderly, high-risk cohort, TTVR delivers what surgery often cannot—restoration without incision, relief without delay.

A meaningful step forward in structural heart disease—where the right heart finally takes center stage ✨

A quiet shift, yet a profound one. 🧠

The OCEANIC-STROKE trial introduces asundexian, a Factor XIa inhibitor that lowers recurrent ischemic stroke risk (HR 0.74) without increasing major bleeding—a long-sought balance in antithrombotic therapy.

For decades, we traded efficacy for safety. Now, we may finally have both. ⚖️

The implications extend beyond stroke—to a broader rethinking of thrombosis itself: can we uncouple clot from bleed?

This study suggests we can.

#StrokePrevention #Cardiology #Neurology #ClinicalTrials #Anticoagulation #PrecisionMedicine

🧠 Brain metastases remain a clinical frontier—common, complex, and still lethal.

In Science Signaling, Chafe et al. unpack the biology: Blood Brain Barrier traversal, metabolic rewiring, and immune evasion.

Key insight: metastasis is not just spread—it is adaptation.

From adenosine-driven immunosuppression to neuronal-like tumor states, new therapeutic doors are opening.

Precision oncology must now think beyond the primary tumor.

#BrainMetastases #Oncology #NeuroOncology #Immunotherapy #PrecisionMedicine

What if the roots of modern surgery were written over 2,000 years ago? 🩺📜

Meet Suśruta—a pioneer whose Suśruta Saṃhitā laid the foundations of plastic surgery, cataract procedures, and structured medical training. From rhinoplasty to hands-on simulation using natural models, his approach was remarkably ahead of its time.

A reminder that innovation is often rediscovery—and that the future of medicine is deeply anchored in its past. 🌍✨

#HistoryOfMedicine #Ayurveda #Surgery #MedicalEducation #Innovation

🧠💊 Stop. Test. Rethink.

A compelling new study in JAMA shows that ~26% of adults ≥60 years can safely discontinue levothyroxine, maintaining normal thyroid function—especially those on low doses (≤50 μg/day).

📉 No meaningful decline in quality of life

📊 Clear dose-response signal

⚠️ Raises concerns about lifelong overtreatment

The message is elegant:

Not every prescription deserves permanence.

Time to reassess, deprescribe, and individualize—particularly in our older patients.

#Thyroid #Endocrinology #Deprescribing #Geriatrics #PrecisionMedicine

A fascinating step forward in Nature—where immunology meets cardiology. 🧬❤️

This study shows that engineered dendritic cells can locally reprogram the immune response, reduce fibrosis, and improve cardiac function—without systemic immunosuppression.

The insight is simple, yet profound:

👉 Heart failure is not just hemodynamic—it is immunologic.

From FAP-targeted delivery to checkpoint-mediated tolerance (PD-L1, CTLA4-Ig, IL-10), this work opens the door to a new therapeutic paradigm—precision immunotherapy for heart failure. 🚀

The seeds of reversal may lie not in drugs alone—but in cells that teach the immune system to heal. 🌱 @HFSA

🧠⏳ Age. Biology. Truth.

A compelling Perspective in the New England Journal of Medicine challenges one of medicine's quiet assumptions: that age equals risk.

Two patients may share a birth year—but not a biology. From epigenetic clocks to physiological reserve, the evidence is clear: chronologic age is an imperfect proxy for clinical decision-making

⚠️ The consequence? Missed prevention in the young, withheld therapy in the old.

✨ The opportunity? A shift toward biologically grounded, precision care—where treatment aligns not with years lived, but with resilience retained.

The future of medicine may not ask "How old are you?"

…but rather, "How well are you aging?"

Why do GLP-1 therapies transform some patients—and barely move the needle in others? 🧬💉

A recent Nature study (~28,000 participants) identifies GLP1R and GIPR variants linked to both weight loss efficacy and GI side effects.

📊 Signal: modest for weight loss, stronger for tolerability

🧠 Insight: genetics + clinical factors explain ~25% variability

🚀 Implication: early steps toward precision obesity therapeutics

The future may not be "one drug fits all," but one genome, one strategy.

Master athletes challenge one of medicine's most elegant assumptions: that fitness always protects.

In the Journal of the American College of Cardiology (JACC) consensus statement on athletes with abnormal cardiovascular findings, a paradox emerges—higher fitness, yet distinct patterns of risk: atrial fibrillation, coronary calcium, myocardial fibrosis.

The lesson is not to discourage exercise—but to refine our lens.

For the clinician: risk stratification must be individualized.

For the athlete: performance and prudence must coexist.

🏃‍♂️ The heart adapts.

⚡ The heart remembers.

🫀 The heart deserves respect.

#Cardiology #SportsCardiology #Prevention #JACC #PrecisionMedicine

A compelling study in PLOS Medicine: sustained moderate-to-vigorous physical activity across midlife is associated with a ~50% reduction in all-cause mortality in women (target trial emulation).

Not intensity, not intermittence—consistency is the signal.

For clinicians, the prescription is enduring: move often, move steadily, move for life. 🏃‍♀️💓

#PLOSMedicine #PreventiveCardiology #LifestyleMedicine #HealthyAging

The origins of medicine are not merely scientific—they are deeply philosophical. In our Great Doctors Series, we begin with Dhanvantari, the divine physician of Ayurveda, emerging from myth into method. From the Ocean of Milk to the clinics of today, this episode explores how healing began as a sacred science. For students and physicians alike, it is a reminder that medicine is not just practiced—it is inherited, refined, and reimagined across centuries. 🌿🩺✨

🎬 "Before medicine became a science, it was a gift—from the gods to humanity."

A fascinating and somewhat unsettling observation from JACC: Asia: nearly 1 in 4 STEMI patients in New Delhi had no traditional risk factors—no hypertension, diabetes, dyslipidemia, or smoking.

Yet outcomes tell a different story. Despite fewer signs of heart failure at presentation, these patients had worse left ventricular dysfunction and identical in-hospital and 1-year mortality compared with those with standard risk factors.

This "SMuRF-less paradox" challenges our conventional risk models. It reminds us that absence of risk factors is not absence of risk.

We may need to think beyond the usual suspects—toward genetics, inflammation, lipoprotein(a), and healthcare access delays—to truly understand and prevent cardiovascular disease.

A humbling lesson: treat aggressively, think broadly, and never be reassured by a "clean" risk profile.

A thoughtful and important JACC State-of-the-Art Review reframes cardiogenic shock not as a single ICU event, but as a longitudinal survivorship journey.

The article highlights recovery, remission, native heart survival, PICS, HF GDMT optimization, and the need for structured multidisciplinary postshock clinics focused on function, cognition, quality of life, and recurrent risk after discharge.

A timely call to move from rescue alone to rescue plus recovery.

A landmark 10-year follow-up of the HOST-EXAM trial published in The Lancet challenges a century-old assumption: aspirin may no longer be the default for lifelong secondary prevention after PCI.

Clopidogrel demonstrated a sustained reduction in ischemic and bleeding events (HR 0.86, p=0.005), with benefits that accumulated over time—yet without a mortality difference.

The implication is subtle but profound: we may be witnessing the quiet reshaping of antiplatelet strategy.

In cardiology, tradition often lingers—but data, eventually, prevails.

🫀 In the New England Journal of Medicine, the SMART-DECISION trial asks a practical modern question: after myocardial infarction, should stable patients without heart failure or marked left ventricular systolic dysfunction remain on beta-blockers indefinitely?

In this randomized noninferiority trial, stopping beta-blockers after at least 1 year was noninferior to continuing them for the composite of death, recurrent myocardial infarction, or hospitalization for heart failure. A provocative study that may help us prune old habits with newer evidence.

The New England Journal of Medicine has now given us randomized trial evidence for a question long guided more by extrapolation than by direct proof: in patients with established atherosclerotic cardiovascular disease, targeting LDL cholesterol to

Elegant trial, practical message: when risk is high, lower may truly be better. 🫀📉🎯 Journal: New England Journal of Medicine.

New in Circulation: the 2026 AHA Dietary Guidance to Improve Cardiovascular Health distills prevention into 9 elegant features—maintain healthy weight, emphasize vegetables/fruits, choose whole grains, favor healthier proteins and unsaturated fats, minimize ultraprocessed foods, added sugars, and sodium, and avoid starting alcohol for health. Food, here, is not garnish; it is strategy. 🥗🌾🩺 #Cardiology #Preven

📚 From prisons to clinics to classrooms — what really shapes us?

I've been exploring the philosophical work of Michel Foucault, and one idea keeps echoing:

👉 Power isn't just something imposed from above — it quietly operates through systems, language, and everyday norms.

From how we define "normal" to how institutions like schools, hospitals, and prisons function, Foucault challenges us to rethink what we take for granted.

🔍 His work invites us to ask:

Who defines truth?
How do labels shape identity?
When does care become control?

Whether you're in education, healthcare, research, or leadership, these questions feel surprisingly relevant today.

🧠 Sometimes the most powerful shift is not in changing the world — but in seeing it differently.

#Philosophy #Foucault #CriticalThinking #Education #Healthcare #Leadership #IntellectualCuriosity #IdeasThatMatter

Left atrial appendage closure—promise meets proof, and proof meets pause.

In The New England Journal of Medicine, two pivotal trials draw a nuanced arc:

CHAMPION-AF shows noninferior stroke prevention with less bleeding vs direct oral anticoagulants, while CLOSURE-AF tempers enthusiasm—failing noninferiority in older, high-risk patients with meaningful procedural risk.

The message is elegant and sobering: innovation must bow to evidence, and patient selection remains paramount.

In atrial fibrillation, the art lies not in closing the appendage—but in opening judgment.

Evolocumab steps into primary prevention—quietly, convincingly. In JAMA, the VESALIUS-CV analysis shows that high-risk patients with diabetes without known atherosclerosis experienced a 31% relative reduction in first MACE (HR 0.69), with LDL-C lowered to ~52 mg/dL. The signal is clear: earlier, deeper lipid lowering matters. Yet questions remain—cost, long-term safety, and who benefits most. Are we ready to treat risk before disease declares itself? 🧠💉📉 #JAMA #Cardiology #Prevention

A quiet valve, a loud message. 🫀

The 10-year follow-up of the RECOVERY trial in The New England Journal of Medicine shows that early surgery in asymptomatic very severe aortic stenosis is not premature—it is protective.

A striking reduction in cardiovascular mortality (HR 0.10, P=0.002) and sustained divergence of Kaplan–Meier curves challenge the long-held "watchful waiting" paradigm.

Perhaps we are not treating symptoms—but preventing myocardial destiny.

#Cardiology #AorticStenosis #NEJM #PrecisionMedicine

Cardiology stands at a quiet inflection point.

We have spent decades treating plaque—yet the real opportunity lies upstream: preventing atheroma before it begins. Emerging evidence reminds us that cumulative LDL exposure, not just snapshots of risk, shapes lifelong cardiovascular destiny.

A shift is underway:

→ From 10-year risk to lifetime risk

→ From reactive care to proactive prevention

→ From treating disease to preserving vascular resilience

Lower LDL earlier. Sustain it longer.

That is not just prevention—it is strategy, science, and stewardship.

#Cardiology #Prevention #Atherosclerosis #LDL #PrecisionMedicine

Resistant Hypertension remains one of the most under-recognized yet high-risk phenotypes in cardiovascular medicine.

Nearly 1 in 5 treated patients meet criteria for apparent resistance—and up to half may reflect nonadherence or white-coat effect.

This concise visual series distills key insights from a recent JAMA review on diagnosis, pathophysiology, and stepwise management—including the pivotal role of spironolactone and emerging therapies like renal denervation.

Precision begins with correct classification. Treatment begins with clarity. 💡

#Hypertension #Cardiology #PrecisionMedicine #JAMA

Sound. Mask. Mastery 🎼

A fascinating insight from C. V. Raman reminds us that hearing is not just perception—it is physics in motion. His 1926 Nature note reveals how lower tones quietly veil higher ones, shaping what we think we hear.

In music—and in science—what is hidden often matters most.

#Acoustics #CVRaman #Psychoacoustics #SoundScience #NatureJournal

Yajnavalkya: Vedic Sage • Radical Thinker • Timeless Voice 🕉️📜✨

What does it mean to know the Self? Long before modern philosophy, Yajnavalkya in the Brihadaranyaka Upanishad asked—and answered—with striking clarity.

"Neti, Neti" (not this, not this) strips illusion, revealing the essence of consciousness—Atman as Brahman.

In dialogues with Maitreyi and Gargi, he models fearless inquiry, intellectual rigor, and spiritual depth.

Ancient, yet urgent. Subtle, yet transformative.

#IndianPhilosophy #Vedanta #Yajnavalkya #Consciousness #Wisdom

Emerging insights from Nature Spotlight on Nutrition sharpen a simple truth: what we eat matters—but when and how may matter just as much. Morning coffee aligns with lower cardiovascular mortality, plant-forward diets sculpt a favorable microbiome, early-life sugar exposure imprints lifelong risk, and not all potatoes are equal—fried forms carry harm, not the humble baked.

Nutrition is no longer advice—it is biology, timing, and destiny intertwined.

Dopamine is not just the "pleasure chemical"—it is the brain's teaching signal 🧠✨

New insights (from Nature) suggest dopamine shapes how we learn, prioritize, and act—not only through reward, but also via attention, action, and even threat detection 🎯🔁

This evolving paradigm has profound implications for ADHD, addiction, and behavioral medicine 🩺

I've summarized the science into a concise slide deck for clinicians and learners.

Curious to hear your thoughts—are we ready to move beyond the reward model? 🚀

A striking study in Science Translational Medicine reveals that the blood–brain barrier remains disrupted years after retirement in contact-sport athletes. This persistent leakiness is linked to systemic inflammation, complement activation, and measurable cognitive decline.

Notably, imaging of BBB dysfunction outperformed conventional blood biomarkers—offering a potential path toward early detection of CTE risk in living individuals.

The key insight: it's not single concussions, but the cumulative burden of head trauma that shapes long-term brain health.

The thymus—long dismissed as vestigial in adults—re-emerges as a powerful biomarker of health and therapeutic response.

Two Nature (2026) studies demonstrate that AI-derived thymic health independently predicts all-cause mortality, cardiovascular death, and cancer risk, while also forecasting immunotherapy outcomes across tumor types—performing comparably to PD-L1 and tumor mutation burden.

This reframes aging as an immunologic continuum. The thymus may not just reflect health—it may define it.

#PrecisionMedicine #Immunology #CardioOncology #AIinMedicine

A quiet shift is underway in metabolic medicine. A recent Nature study shows that continuous data from wearables—heart rate, sleep, activity—combined with routine labs can detect insulin resistance years before traditional tests. Not snapshots, but a "movie" of physiology.

This opens a wider window for prevention: simpler interventions, earlier action, better outcomes. The future may lie not in waiting for thresholds, but in tracking trajectories.

#Nature #PrecisionHealth #Wearables #DiabetesPrevention #CardioMetabolic

LVAD patients are increasingly encountered in emergency rooms and ICUs, yet many clinicians remain uncertain about initial management.

A recent JACC State-of-the-Art Review provides a practical framework for recognizing and treating LVAD emergencies, from pump thrombosis and right-heart failure to arrhythmias and GI bleeding.

Key pearls:

LVAD patients may lack a palpable pulse,
Doppler is preferred for MAP measurement, and
Chest compressions should not be delayed if cardiac arrest is confirmed.
First check power connection
Understanding pump parameters and echocardiographic clues can rapidly guide diagnosis and life-saving therapy.

Jiddu Krishnamurti challenged one of humanity's deepest assumptions—that wisdom must come from teachers, traditions, or systems. Instead, he argued that genuine understanding begins with self-observation and choiceless awareness.

In this short slide set, I summarize the life and ideas of Jiddu Krishnamurti (1895–1986)—the thinker who famously declared:

"Truth is a pathless land."

📚 The slides explore:

• His early life and break from the Theosophical movement

• Core ideas from Freedom from the Known

• The role of education and self-inquiry

• Why his ideas still resonate in psychology, philosophy, and education

👩‍⚕️ I also included a special slide connecting his insights to healthcare practice, highlighting how self-awareness and attentive observation can deepen patient care.

Krishnamurti once suggested that real change begins not in systems—but in the transformation of the mind itself.

Curious to explore?

#Philosophy #Krishnamurti #FreedomFromTheKnown #SelfAwareness #Consciousness #Education #Psychology #Mindfulness #CriticalThinking #LifelongLearni

🧠🦠 Microbes. Metabolites. Memory.

A fascinating new Nature study reveals a gut–brain pathway driving age-related cognitive decline.

Expansion of Parabacteroides goldsteinii in aging microbiomes increases medium-chain fatty acids, activating GPR84 signaling in peripheral myeloid cells. The resulting inflammation suppresses vagal sensory signaling, blunting hippocampal neuronal activation and impairing memory.

Even more intriguing: interventions restoring gut–brain communication improved cognition in mice.

This work highlights the gut microbiome as a therapeutic target for cognitive aging—suggesting that microbiome modulation, vagal stimulation, or GPR84 inhibition may one day help protect memory.

Lipids remain central to cardiovascular prevention.

The 2026 ACC/AHA Dyslipidemia Guideline introduces several important shifts:

• PREVENT equations replace older ASCVD risk calculators

• Lipoprotein(a) measurement recommended at least once in all adults

• ApoB helps identify residual lipoprotein risk

• Coronary artery calcium scoring refines treatment decisions

• LDL-C targets return, with

• South Asian ancestry is treated as a "risk enhancer,"

Earlier identification and aggressive risk reduction remain the cornerstone of preventing atherosclerotic cardiovascular disease.

Reference: Blumenthal RS et al. JACC 2026.

🧬🧠❤️ The Immune System Is Not Just Defense — It Is Physiology

A superb Science Review (Nahrendorf, Ginhoux, Swirski, 2025) reframes immunity as a systems integrator, shaping brain function, heart rhythm, metabolism, pregnancy, and tissue repair—quietly maintaining homeostasis across the lifespan.

Immune cells are not visitors; they are residents, communicators, and regulators in every organ system.

🧩 Defense meets regulation.

🧩 Immunology meets physiology.

📖 Science, August 2025 — a must-read for clinicians, physiologists, and systems thinkers.

A fascinating new study reveals a previously underappreciated pathway for tau clearance in the brain.

Researchers show that tanycytes—specialized hypothalamic glial cells—actively transport tau from cerebrospinal fluid into the bloodstream. In Alzheimer disease, these cells become fragmented and dysfunctional, impairing tau clearance and potentially accelerating neurodegeneration.

This work opens an intriguing avenue: could restoring tanycyte function enhance tau removal and slow Alzheimer progression?

A small cellular gatekeeper may hold an important clue in the battle against dementia.

Source: Sauvé F et al. Tanycytic degeneration impairs tau clearance and contributes to Alzheimer's disease pathology. Cell Press Blue, 2026.

Obesity is not simply excess weight—it is a metabolic and inflammatory state that can reshape cancer biology.

Adipose tissue alters hormones, insulin signaling, inflammatory cytokines, and immune responses, creating conditions that favor tumor development.

Evidence now links obesity with cancers of the breast, colon, endometrium, pancreas, liver, kidney, and esophagus.

Understanding these mechanisms opens the door to precision prevention strategies, from weight management to metabolic therapies.

The message from translational science is clear: metabolism and malignancy are deeply intertwined.

#CancerResearch #ObesityScience #TranslationalMedicine

🧬 Apolipoprotein M (ApoM) is emerging as a key regulator of vascular biology.

ApoM, an HDL-associated lipocalin, transports sphingosine-1-phosphate (S1P) and selectively activates S1PR1 signaling in endothelial cells.

This pathway stabilizes the endothelial barrier, promotes nitric-oxide mediated vasodilation, and suppresses vascular inflammation.

Clinical studies increasingly link lower ApoM levels with cardiometabolic disease, CKD, and heart failure risk.

New therapies—including ApoM-fusion biologics and selective S1PR1 agonists—may harness this pathway for vascular protection.

The ApoM–S1P axis may represent a new frontier in precision cardiovascular medicine.

📚 Simone de Beauvoir (1908–1986) — philosopher, writer, and architect of modern feminism.

Her groundbreaking book The Second Sex (1949) reshaped global conversations on gender with one powerful line:

"One is not born, but becomes, a woman."

She challenged stereotypes, defended women's autonomy, and influenced second-wave feminism worldwide.

Her ideas still echo in medicine, education, ethics, and leadership today.

Freedom. Responsibility. Equality. 💡✊📖

🫁 Pulmonary Embolism in 2026 — A Precision Framework

The new AHA/ACC Acute Pulmonary Embolism Guideline redefines how we classify and treat PE.

Key updates:

• Category A–E clinical classification integrating hemodynamics, biomarkers, and RV imaging

• Age-adjusted D-dimer and YEARS algorithm to reduce unnecessary imaging

• CT pulmonary angiography as preferred diagnostic modality

• RV/LV ratio reporting for objective risk stratification

• LMWH → DOAC preferred for anticoagulation

• Advanced therapies for cardiopulmonary failure

• Mandatory 1-year follow-up to screen for CTEPD

The message is clear: Stratify early. Treat precisely. Monitor longitudinally.

Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting ~37.6 million people globally, with prevalence expected to double in the coming decades.

A recent Lancet Seminar (2026) highlights several key principles shaping modern AF care:

• Stroke prevention with oral anticoagulation remains the cornerstone

• Early rhythm control strategies improve cardiovascular outcomes

• Catheter ablation is increasingly used as first-line therapy

• Lifestyle modification—weight loss, exercise, alcohol reduction—reduces AF burden

• Integrated care models such as the ABC pathway and AF-CARE improve outcomes

The future of AF management is holistic, preventive, and patient-centred.

#Cardiology #AtrialFibrillation #StrokePrevention #Electrophysiology #PrecisionMedicine

🧬✨ Can we make the ageing immune system young again?

A fascinating Nature study shows that a three-part mRNA cocktail (DFI) can temporarily rejuvenate T cells in aged mice, improving responses to vaccines and cancer immunotherapy—without breaking immune tolerance. By turning the liver into a short-term factory for key immune signals (DLL1, FLT3L, IL-7), the authors demonstrate that immune ageing is modifiable, not fixed.

This elegant work—covered by Heidi Ledford in Nature—opens provocative questions about immune resilience, ageing biology, and the future of mRNA beyond vaccines. 🧠🛡️

📄 Friedrich MJ et al., Nature 2025 | News & Views: Ledford H.

🔗 doi:10.1038/s41586-025-09873-4 | doi:10.1038/d41586-025-04082-5

🧬 Protein Restriction, Aging, and Longevity ⏳

A remarkable new study in Cell shows that moderate protein restriction—especially when started in midlife—can reprogram aging biology across 41 organs, improving metabolic and cardiovascular health. 🫀⚙️

Using deep multi-organ proteomics in mice and human plasma validation, the authors demonstrate benefits mediated through ↓ IGF-1, ↓ mTOR, ↑ AMPK, and activation of brown adipose tissue. Importantly, the data also caution that extreme protein restriction may provoke inflammation, underscoring that moderation matters. ⚠️🎯

A powerful example of how nutrition shapes the biology of aging—organ by organ, pathway by pathway.

📖 Cell (2025)

#Aging #Longevity #ProteinRestriction #MetabolicHealth #CardiovascularHealth #Proteomics #PrecisionNutrition

Resistant hypertension remains one of the most stubborn challenges in cardiovascular medicine.

The Bax24 phase 3 trial, published in The Lancet (2026), evaluated baxdrostat, a selective aldosterone synthase inhibitor, in patients already receiving multiple antihypertensive agents.

Key findings:

• −16.6 mmHg reduction in 24-hour ambulatory SBP

• −14.0 mmHg placebo-corrected difference (p

• 71% achieved BP control (

• Acceptable safety profile, with hyperkalemia in 3%

These data highlight the growing importance of aldosterone dysregulation in resistant hypertension and suggest that targeted aldosterone synthase inhibition may represent a new therapeutic frontier.

Reference: Azizi M et al. Effect of Baxdrostat on Ambulatory Blood Pressure in Resistant Hypertension (Bax24). Lancet 2026.

🏃‍♀️🏋️‍♂️ Does variety in physical activity matter for longevity? A large prospective analysis suggests it does: people who engaged in a wider mix of activity types tended to have lower all-cause mortality, even after accounting for total activity and key covariates. 🌈📉

Key practical takeaway: don't just "do more"—do different (walk + cycle + swim + strength, etc.). ✅🫀

As always, this is observational data (residual confounding + self-report remain). Still, it's a compelling nudge toward diversity in movement as a realistic, patient-friendly goal. 💡👟

#PhysicalActivity #Prevention #Cardiology #PublicHealth #LifestyleMedicine

Chronic diarrhea affects approximately 6–7% of adults, and the vast majority of cases are noninfectious.

The most common causes are irritable bowel syndrome with diarrhea and functional diarrhea.

A systematic approach matters:

• Screen with CBC, CMP, fecal calprotectin, IgA-tTG

• Identify alarm features

• Biopsy for microscopic colitis when needed

• Start with lifestyle + low-FODMAP

• Escalate to targeted therapy thoughtfully

Precision in diagnosis leads to precision in therapy.

#Gastroenterology #InternalMedicine #EvidenceBasedMedicine

Jean-Paul Sartre (1905–1980) forced a generation to confront a radical idea: existence precedes essence.

We are not born with a fixed nature — we create ourselves through choices. That freedom is powerful… and unsettling. 🧠

In Being and Nothingness and Existentialism Is a Humanism, Sartre explored authenticity vs. "bad faith" — the temptation to hide from responsibility.

Philosopher, playwright, activist, public intellectual — he believed ideas must live in the world. ✍️🔥

Freedom is not optional. It is our condition.

Can lifting light weights help lift grades? 💪📚

A recent cross-sectional study reports that adolescents engaging in regular muscle-strengthening exercise demonstrated better performance in literacy, mathematics, and language outcomes. 📊🧠 Even after adjusting for sociodemographic and lifestyle factors, the association persisted—highlighting a potential link between resistance training and cognitive or academic performance.

For clinicians, educators, and policymakers, this reinforces a simple message: physical strength and intellectual growth may not be separate domains—they may be synergistic.

Train the body. Shape the brain. Elevate the future. 💪✨

Type 1 Diabetes is more than high sugar — it is autoimmunity, absolute insulin deficiency, and lifelong vigilance. 🧬💉

Early recognition of polyuria, polydipsia, and weight loss can prevent diabetic ketoacidosis. Timely diagnosis with islet autoantibodies and C-peptide testing guides care. 📊

Modern insulin strategies and continuous glucose monitoring have transformed outcomes — yet microvascular and macrovascular risks remain.

Precision, persistence, partnership. 🩺

Sepsis: Detect. Treat. Survive.

Sepsis remains a major global health threat, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Early recognition, prompt antibiotics, and timely hemodynamic support save lives. ⏱️💉💧

The latest The Lancet Seminar (Feb 26, 2026) highlights evolving definitions, pathobiology, global burden, and the need for precision-guided care. 🌍🧬

From prevention to recovery, sepsis demands vigilance across all health systems. 🚑🏥

#Sepsis #CriticalCare #Infection #ICU #PatientSafety

Can the aging brain still make new neurons?

A landmark 2026 Nature study analyzed 355,997 human hippocampal nuclei using single-nucleus RNA sequencing and ATAC sequencing. Neurogenesis persists into adulthood—but chromatin accessibility collapses early in Alzheimer's disease.

SuperAgers showed a 2.5-fold increase in immature neurons and a preserved resilience signature.

Epigenetics may be the earliest battlefield in cognitive decline. 🧠

Radiation. Regions. Responsibility. 🌍⚡

A JAMA study (INCAPS-4) analyzing 19,302 patients across 101 countries reveals striking global disparities in radiation exposure from cardiac imaging.

Median CCTA dose in Africa: 25.2 mSv

Western Europe: 4.6 mSv

Low-income nations had 96% higher CCTA doses.

Technology and training—not just access—determine safety.

As CAD rises worldwide, dose optimization must become a global quality benchmark.

Can a single bolus change the fate of a devastating stroke? 🧠💉

The TRACE-5 trial (Lancet 2026) shows that tenecteplase within 24 h for basilar artery occlusion improves excellent functional outcomes (38% vs 29%; RR 1.50, p=0.014) without increased haemorrhage or mortality. 📊

Pragmatic design. No mandatory advanced imaging. Feasible globally. 🌍

If confirmed beyond Asian cohorts, this could reshape late-window stroke care.

Single shot. Shifted scale. Strong signal. 🚑📈

Ludwig Wittgenstein (1889–1951) reshaped modern philosophy by asking a deceptively simple question: How does language work? 🧠

In the Tractatus, he argued that language "pictures" reality — and that what cannot be clearly said must be passed over in silence. Later, in Philosophical Investigations, he reversed course: meaning is not fixed — it is use, embedded in "language games." 🎯

His lasting insight? Many philosophical problems are really linguistic confusions. Clarity is not cosmetic — it is transformative. ✨

In medicine, law, policy, or everyday life, careful language is careful thinking

Light smoking is not harmless. 🚬

A powerful New England Journal of Medicine Perspective highlights the rising challenge of nondaily and low-intensity smokers in Latin America. Even fewer than 10 cigarettes per day carry meaningful cardiovascular and cancer risk — yet these smokers often underestimate harm and receive limited cessation support.

The future of tobacco control must address the "light" smoker with tailored counseling, pharmacotherapy, and smarter primary-care integration.

🧠 Alzheimer's doesn't begin when memory fails — it begins years earlier.

A new Cell Reports Medicine study identifies PPP2R5C, a brain-derived protein detectable in blood, that declines before significant Tau hyperphosphorylation.

📉 ↓ 61% in amnestic mild cognitive impairment

📊 AUC 0.85 for Alzheimer's diagnosis

🔬 Mechanism: activates Protein Phosphatase 2A and ULK1-driven autophagy to regulate Tau

A blood signal before symptoms.

Early detection means earlier intervention.

🧠 Can a simple blood test tell us when Alzheimer's symptoms will begin?

A new Nature Medicine study introduces a plasma p-tau217 "molecular clock" that estimates time to symptom onset with an error margin of ~3–4 years. By modeling the rise of phosphorylated tau in cognitively unimpaired individuals, investigators move from predicting if to predicting when.

⏳ Implication: smarter prevention trials, earlier intervention windows, and biologically timed enrollment.

⚠️ Not ready for routine screening—but a compelling proof of concept.

The era of temporal precision in neurodegeneration may have begun.

The brain's "skull drains" are far from passive plumbing.

In Nature (2026), Monaghan et al. show that dural venous sinuses actively constrict, dilate, and even rearrange endothelial borders in a phenomenon called "ruffling" to support immune surveillance.

RAMP1 regulates vasomotion. RAMP2 regulates immune boundary dynamics. Blocking RAMP2 impairs antiviral defense.

The meninges are not coverings. They are regulated neuroimmune interfaces. 🧠🛡️

Can we finally modulate post-stroke inflammation? 🧠

The EMPHASIS trial (Lancet 2026) randomized 1,724 patients with acute ischemic stroke to short-course oral minocycline within 72h.

Result: higher rates of excellent 90-day outcome (mRS 0–1 52.6% vs 47.4%; RR 1.11, p=0.0061) without safety concerns.

A cheap, generic drug showing signal in late neuroprotection.

Inflammation may not just follow stroke — it may shape recovery. 🔬

🦴 Rotator cuff "tears" are nearly universal after age 40.

In a population-based Finnish study (n=602), 99% had ≥1 MRI abnormality — including 96% of asymptomatic shoulders. Even full-thickness tears were usually silent, and adjusted analyses eliminated differences between painful and painless shoulders .

Lesson? After 40, imaging abnormalities are common — causality is not.

Treat function. Treat symptoms. Treat patients — not scans.

Sri Aurobindo (1872–1950) lived two extraordinary lives in one lifetime — revolutionary nationalist and visionary yogi.

From the Alipore trial to the quietude of Pondicherry, he shifted the conversation from political freedom to inner evolution. His Integral Yoga proposed something radical: not escape from the world, but transformation of it — a movement from mind to "Supermind," from human to supramental consciousness.

The Life Divine, The Synthesis of Yoga, and Savitri remain profound explorations of human potential and spiritual evolution.

A thinker of synthesis — East and West, action and contemplation, nation and cosmos.

Chronic lymphoedema may not just be about fluid. It may be about cholesterol. 🧬

In human tissue and translational mouse models, impaired lymphatic drainage led to excess dermal cholesterol deposition, adipocyte dysfunction, fibrosis, and swelling — even when plasma cholesterol was normal.

Clearing tissue cholesterol with cyclodextrin restored lymphatic architecture and reduced oedema.

Clear the cholesterol. Restore the flow

Psychedelic medicine is moving from the margins to mainstream neuroscience. 🧠✨

A recent Nature Medicine review synthesizes the biology behind the renaissance: 5-HT2A signaling, acute brain desynchronization, and a subacute plasticity window driven by BDNF–TrkB pathways.

The promise is real — rapid effects in depression, PTSD, and addiction — but so are the challenges: expectancy, unblinding, scalability, and safety.

Entropy. Plasticity. Psychiatry. 🔬

A field worth watching — carefully, rigorously, and responsibly.

Are statins as risky as labels suggest? 📊

In a 154,664-patient individual-participant meta-analysis of 23 double-blind RCTs, only 4 of 66 listed adverse effects were confirmed — mainly small, dose-related liver enzyme elevations.

No causal signal for cognitive decline, depression, sleep disturbance, neuropathy, or kidney injury.

Absolute excess risks were tiny (

Cardiovascular benefit still overwhelmingly outweighs risk. Evidence matters. 💡

IgA nephropathy remains the most common immune-mediated glomerular disease worldwide — and up to 50% of patients may progress to kidney failure within a decade. 🧬

The 2025 KDIGO guidance emphasizes early biopsy (proteinuria ≥0.5 g/day), tight BP control (

Proteinuria remains the key modifiable driver. Precision nephrology is here — and measurable. 🩺📉

Genes. Glands. Vessels. 💊

Hypertension therapy is entering a new era. The latest Lancet review highlights RNA-based silencing of angiotensinogen, selective aldosterone synthase inhibition, non-steroidal mineralocorticoid receptor antagonists, endothelin receptor blockade, and natriuretic peptide enhancement.

These therapies move beyond ACE inhibitors and ARBs toward durable, mechanism-driven blood pressure control—especially for resistant hypertension and multimorbidity.

The future may not be just lowering pressure, but reshaping pathways. 🔬🫀

☕🧠 Can your daily coffee protect your brain?

In a JAMA study of 131,821 adults followed for up to 43 years, moderate caffeinated coffee and tea intake was associated with a lower risk of dementia and modestly better cognition.

The sweet spot: 2–3 cups of coffee or 1–2 cups of tea per day. Notably, decaffeinated coffee showed no benefit.

A compelling population-level prevention signal—simple habits, long horizons, meaningful impact.

Bertrand Russell showed that clear thinking is a moral act 🧠✨

As a founder of analytic philosophy, he taught us to question assumptions, sharpen language, and let logic guide both ideas and action 📐📘

From Principia Mathematica to public debates on freedom and peace, Russell reminds us that clarity, courage, and doubt belong together 🕊️📚

🧠🩸 A finger-prick may change how we detect Alzheimer's disease.

A new Nature Medicine study shows that dried capillary blood spots can reliably measure key Alzheimer's biomarkers—p-tau217, GFAP, and neurofilament light—with strong concordance to venous plasma and cerebrospinal fluid results.

📊 In the DROP-AD multicenter study (7 sites, 337 participants), capillary p-tau217 correlated strongly with plasma (r≈0.74) and predicted amyloid pathology with good accuracy (AUC ≈0.86).

🚀 Why this matters:

• Enables minimally invasive, scalable, and potentially remote testing

• Expands access for population screening, prevention trials, and underserved groups (including Down syndrome)

• Moves us closer to earlier, equitable detection—though not yet ready for routine clinical decision-making

Small drop. Big signal. The future of Alzheimer's research may be at our fingertips. ✨

🧬 Why Coronary Artery Disease Runs in Families

Coronary artery disease is not just lifestyle—it is deeply genetic. Rare monogenic disorders like familial hypercholesterolemia and hundreds of common variants together shape lifelong risk, with polygenic risk scores identifying individuals whose inherited risk rivals traditional factors 🫀.

The good news: genetic risk is modifiable. Early LDL lowering, healthy lifestyles, and precision prevention deliver the greatest benefit in those at highest inherited risk 🔬.

A timely synthesis from The New England Journal of Medicine (2026) that reframes CAD—from destiny to opportunity.

🧬⚖️ Cancer and Acute Coronary Syndromes: Precision Where It Matters Most

As cancer survival improves, more patients live long enough to face acute coronary syndromes (ACS)—often with competing risks of death, bleeding, and ischaemia. Yet these patients have been largely excluded from ACS trials, leaving clinicians to navigate uncertainty.

A landmark Lancet study introduces ONCO-ACS, the first cancer-specific, externally validated risk tool that simultaneously predicts 6-month mortality, major bleeding, and ischaemic events using 11 routine admission variables. 📊🧠

The result: actionable, bedside precision—helping tailor invasive strategy, antiplatelet intensity, and duration to the dominant risk for each patient.

This is a major step toward personalised cardio-oncology care, moving beyond one-size-fits-all scores to nuanced, patient-centred decisions. 🎯💡

🫀 Rethinking DCD Heart Transplantation

A new JAMA Original Investigation reports encouraging early outcomes using rapid recovery with extended ultraoxygenated preservation (REUP) for donation after circulatory death (DCD) heart transplantation—without donor heart reanimation or machine perfusion.

🔬 In a 24-patient case series, REUP achieved 96% 30-day survival, low primary graft dysfunction (4%), and minimal early rejection, even with older donors and prolonged ischemic times.

⚖️ By avoiding reanimation, REUP may reduce ethical concerns, cost, and logistical complexity, while expanding the usable donor pool.

🌍 A potentially scalable, globally relevant step forward in transplant medicine.

Sometimes progress is not about doing more—but about doing just enough, better.

⏰🧬 Timing matters in cancer.

A superb JCI Review, Rhythms of risk: the intersection of clocks, cancer, and chronotherapy, shows how circadian clocks regulate cell cycle, DNA repair, metabolism, immunity, hypoxia, and even metastasis—and how circadian disruption (e.g., night-shift work) can reshape cancer risk and treatment response. ⚖️💊

The takeaway: clock biology is context-specific, and aligning therapy with circadian phase may enhance efficacy while reducing toxicity—an underused lever in precision oncology. 🎯

Worth a careful read for clinicians, scientists, and trialists thinking about the fourth dimension of cancer: time. ⏱️

🫀 Residual Risk in Coronary Artery Disease

Even after "optimal" therapy, many patients remain at risk. Why? Because atherosclerosis is more than LDL—it's thrombosis 🩸, inflammation 🔥, and metabolism ⚖️ working in concert.

This FAQ-based slide deck distills contemporary insights on residual thrombotic, lipid, metabolic, and inflammatory risk, and highlights emerging therapies—from dual-pathway inhibition 💊 to GLP-1 receptor agonists 🧬 and colchicine—that help close the gap between treatment and outcomes.

📊 Key message: precision, not complacency.

#Cardiology #SecondaryPrevention #ResidualRisk #CAD #PrecisionMedicine

Swami Vivekananda reminded the world that spiritual strength and social service are inseparable 🕉️🔥

From Chicago in 1893 to India's national awakening, his message was simple yet radical: each soul is potentially divine—and serving humanity is serving the Divine 🌍🤝

More than a monk or philosopher, Vivekananda remains a timeless call to courage, compassion, and inner awakening ✨📚

🫀🧠🛡️ Sense. Signal. Scar.

A striking Cell study reframes myocardial infarction as a systems disease, not a heart-only event. Using single-cell and spatial transcriptomics in murine MI, the authors identify a triple-node heart–brain–immune loop: TRPV1-positive vagal sensory neurons (injury sensing) → hypothalamic paraventricular nucleus AT1aR neurons (central integration) → superior cervical ganglion IL-1β signaling (sympathetic–immune effector arm).

Intervening at any node improved ejection fraction, reduced infarct size, and normalized autonomic balance—pointing to neuroimmune modulation as a new therapeutic frontier beyond myocardium-centric care.

📌 Key takeaway: Treat the circuit, not just the scar.

📖 Yadav et al., Cell (2026)

🦵🌙 Restless Legs Syndrome: more than a sleep complaint

RLS affects ~3% of adults and is frequently missed or misdiagnosed as insomnia or anxiety. The latest evidence underscores three practical shifts: think iron (even when "normal"), choose gabapentinoids first, and beware dopaminergic augmentation.

For internists and frontline clinicians, recognizing RLS early can meaningfully improve sleep, mood, and quality of life—and may even reduce downstream cardiovascular risk. 🧠🩺💤

#RestlessLegsSyndrome #SleepMedicine #InternalMedicine #IronDeficiency #Gabapentinoids #Augmentation #PLMS #ClinicalPractice

🧠🩺 Why cancers behave the way they do—and why treatments fail

For internists, cancer is not just an oncologic diagnosis but a systems disease: driven by dysregulated growth, immune evasion, metabolic reprogramming, inflammation, and adaptive resistance.

The Hallmarks of Cancer framework offers a unifying clinical lens—explaining recurrence, cachexia, immunotherapy variability, and late relapse—without drowning us in molecular minutiae.

Understanding how tumors survive stress, therapy, and time sharpens prognosis, improves cross-disciplinary care, and strengthens bedside reasoning.

🔬 From biology to bedside. 🧩 From mechanisms to meaning. 📈 From treatment to trajectory.

📟🪑🏃‍♂️ A striking accelerometer-based analysis in The Lancet suggests that small, realistic behavior shifts could translate into meaningful mortality gains at the population level. For the least active adults, +5 minutes/day of moderate-to-vigorous physical activity (MVPA) was associated with preventing ~6% of deaths; applying a similar increase broadly (excluding the most active) could prevent ~10%. Reducing sedentary time by 30 minutes/day was associated with preventing ~3% (high-risk) to ~7% (population) of deaths (with smaller—but still meaningful—effects in UK Biobank).

🎯 Practical takeaway: "5 minutes more exercise, 30 minutes less sitting." Small hinges, big doors.

(Ekelund et al., The Lancet, 2026)

🦵❤️ Peripheral Artery Disease is not just a leg problem—it's a life-threatening cardiovascular signal.

Up to 60% of patients are asymptomatic, yet PAD doubles to triples the risk of myocardial infarction, stroke, and death. Evidence is clear: exercise therapy, statins, antiplatelet or rivaroxaban-based strategies, blood-pressure control, and GLP-1/SGLT2 therapies save limbs and lives.

🚶‍♂️💊🫀 When walking hurts—or quietly fades—cardiovascular risk rises. PAD deserves the same urgency as coronary disease.

#PeripheralArteryDisease #PreventiveCardiology #Claudication #ExerciseMedicine #Atherosclerosis #CardioVascularRisk

🫀 What do the 2026 AHA Statistics really tell us?

The latest AHA update makes one message unmistakably clear: prevention works—but only when systems work. From Life's Essential 8 🧭 to the rise of cardiovascular–kidney–metabolic (CKM) health 🩺🧪, the data show that blood pressure control, sleep 😴, physical activity 🚶‍♂️, nutrition 🥗, and nicotine cessation 🚭 shape not only heart outcomes, but brain health 🧠, equity ⚖️, and healthcare costs 💰.

The challenge ahead isn't discovering new risk factors—it's implementing what we already know, at scale and with fairness. Prevention is no longer aspirational; it's clinical, economic, and moral necessity.

Sri Ramakrishna Paramahamsa showed that spiritual truth is lived, not debated 🌼🙏

Through devotion, deep experience, and simple parables, he taught that all religions are different paths to the same Reality 🛤️✨

His enduring message—serve humanity as the Divine—continues to inspire seekers, caregivers, and leaders alike ❤️🌍

CRT—now framed as cardiac physiologic pacing—remains a cornerstone for HFrEF patients with LVEF ≤50% and either high ventricular pacing burden or a wide QRS, with the biggest gains in LBBB and QRS ≥150 ms. ⚡🫀📈

Traditional biventricular pacing has randomized-trial evidence (>10,000 patients) showing better symptoms, quality of life, remodeling, fewer HF hospitalizations, and survival benefit in selected groups; meanwhile His bundle and left bundle branch pacing are rapidly expanding options, with large randomized trials underway to define comparative efficacy and safety. 🧠🔧🔬

🩺 Hypertension control in the U.S. has stalled—despite better meds, better evidence, and better tools. 📉 The "paradox" isn't a mystery so much as a systems problem: therapeutic inertia, fragmented care, cost barriers, and inconsistent use of validated home BP monitoring. 🧩

What works is boring (and therefore powerful): standardized treatment protocols, team-based care, rapid follow-up, combination therapy when appropriate, and performance feedback loops. 🧰📊

If we treat BP control like a reliable system—rather than a heroic, one-visit effort—we can move the curve again. 🎯❤️ #Hypertension #PrimaryCare #Cardiology #QualityImprovement #PopulationHealth

🧬 Why does cancer mostly strike later in life? This review frames an elegant answer: evolution built layered anti-cancer "barriers" optimized to protect us through reproductive years—not indefinitely. 🛡️

With aging, those safeguards fray: tissues remodel, epigenetic "noise" rises, inflammation smolders, and immune surveillance softens—so clones that were once contained can progress. 🕰️🔥

A favorite reminder is 🐘 Peto's paradox: bigger, longer-lived species aren't overwhelmed by cancer, suggesting nature can evolve stronger defenses when fitness demands it.

Takeaway: late-life cancer risk isn't just "more mutations"—it's changing context + weakening constraints. ✅

🏃‍♀️🏋️‍♂️ Does variety in physical activity matter for longevity? A large prospective analysis suggests it does: people who engaged in a wider mix of activity types tended to have lower all-cause mortality, even after accounting for total activity and key covariates. 🌈📉

Key practical takeaway: don't just "do more"—do different (walk + cycle + swim + strength, etc.). ✅🫀

As always, this is observational data (residual confounding + self-report remain). Still, it's a compelling nudge toward diversity in movement as a realistic, patient-friendly goal. 💡👟

#PhysicalActivity #Prevention #Cardiology #PublicHealth #LifestyleMedicine

🧠❤️ Rewiring the Heart—Literally

A striking Science Translational Medicine study shows that early reconnection of the right vagus nerve to the heart preserves ventricular mechanics, synchrony, and myocardial health—even when only ~20% of vagal fibers regenerate. 🧵🫀

Using a clinically relevant minipig model, the authors demonstrate that loss of parasympathetic input drives oxidative stress, inflammation, and premature cardiac aging—while targeted nerve repair reverses these pathways, independent of heart rate. 📉➡️📈

Implications: thoracic surgery, heart–lung transplantation, and the future of autonomic cardioprotection. Sometimes, saving the heart means listening to the nerve. 🎧💡

📖 Science Translational Medicine, Dushpanova et al., 2025

Friedrich Nietzsche challenged the modern mind to think bravely, live honestly, and create meaning rather than inherit it 🧠⚡

From "God is dead" to self-overcoming, his ideas push us to confront nihilism and affirm life with courage and creativity 🔥🎭

More than a philosopher, Nietzsche remains a provocation—asking each of us: what values will you create? 🚀📚

Did you know the fat around our arteries is more than just padding? 🧬🩺 Recent findings show that deleting PRDM16 in perivascular adipose tissue transforms protective beige fat into fibrotic tissue, upregulating QSOX1 and driving hypertension 🩸📈.

Activating brown fat or targeting QSOX1 could offer novel therapies. As internists, staying curious about adipose–vascular cross-talk might reshape how we tackle hypertension. 💡🔥

#Cardiology #InternalMedicine #Hypertension"

🧬🧠❤️ The Immune System Is Not Just Defense — It Is Physiology

A superb Science Review (Nahrendorf, Ginhoux, Swirski, 2025) reframes immunity as a systems integrator, shaping brain function, heart rhythm, metabolism, pregnancy, and tissue repair—quietly maintaining homeostasis across the lifespan.

Immune cells are not visitors; they are residents, communicators, and regulators in every organ system.

🧩 Defense meets regulation.

🧩 Immunology meets physiology.

📖 Science, August 2025 — a must-read for clinicians, physiologists, and systems thinkers.

🧬💥 New cardio-oncology insight: DNA-damaging chemotherapy (highlighting carboplatin) can reprogram the heart's immune "resident staff"—specifically CCR2− cardiac-resident macrophages—followed by monocyte-driven repopulation that looks "resident-like." 🫀🛡️

In a mouse model, this post-chemo macrophage landscape was linked to less adverse remodeling after hypertensive stress (AngII/PE), with reduced fibrosis and cardiomyocyte hypertrophy and lower remodeling gene signals. 📉🔬

Take-home: beyond myocytes, chemotherapy may shift the cardiac immune baseline that shapes later injury responses—an underappreciated axis for survivorship risk (and resilience). ✅

#CardioOncology #Chemotherapy #Immunology #Macrophages #HeartFailure #CancerSurvivorship #PrecisionMedicine

🧠💧 How does the brain clean itself—and defend itself?

A landmark Neuron review unifies two once-separate stories: brain waste clearance and immune surveillance. The glymphatic system, powered by CSF flow, sleep, and vascular pulsatility, works hand-in-glove with meningeal lymphatics to clear toxins (β-amyloid, tau) and present brain antigens to the immune system.

💤 Sleep is not rest—it's maintenance.

🛡️ Clearance is not plumbing—it's immunity in motion.

🧠 When this system falters, neurodegeneration follows.

A must-read for anyone interested in sleep, Alzheimer's disease, neuroimmunology, and brain health.

📘 Neuron, 2025.

🏆 How do world-class performers really develop?

A fascinating Science review (Güllich et al., 2025) overturns a deeply held belief: early stars are rarely future legends. Across sports, science, music, and chess, peak performers often showed slower early progress, less early specialization, and more multidisciplinary practice.

The lesson is lyrical in its simplicity: breadth before depth, patience before acceleration. For educators, mentors, and institutions, this challenges how we identify talent and design training—short-term brilliance may come at the cost of long-term greatness.

📖 Science (2025): Recent discoveries on the acquisition of the highest levels of human performance

🏃‍♀️ Exercise is not lifestyle advice—it's cancer biology.

A landmark analysis of 443,768 adults from the UK Biobank and NHANES shows that regular aerobic physical activity (≈117–500 min/week) is associated with:

• 21% lower risk of inflammation-related cancers

• 34% lower all-cancer mortality

Mechanistically, exercise:

🔬 Reduces chronic low-grade inflammation

🧬 Reverses immunosenescence (↓ Mki67⁺ immune cells)

🛡️ Expands functional innate and adaptive immunity

Strikingly, the mortality benefit rivals—or exceeds—that of many modern anticancer therapies.

📖 Jin et al., Cell Reports Medicine, 2025

In the era of sedentary epidemics, movement may be our most scalable precision therapy.

#CancerPrevention #PhysicalActivity #Immunosenescence #Inflammaging #ExerciseIsMedicine #Aging #Oncology #PublicHealth

🫀 Europe puts the heart first.

The EU Safe Hearts Plan is a bold, evidence-based roadmap to tackle Europe's leading cause of death—cardiovascular disease—through prevention 🛡️, early detection 🔍, better treatment 🏥, smart digital tools 🤖, and a relentless focus on equity ⚖️.

With clear targets (including a 25% reduction in premature cardiovascular mortality by 2035 🎯), this plan signals a shift from reactive care to lifelong, personalized, and data-driven heart health—for every citizen, in every region.

Strong hearts. Smarter systems. A healthier Europe. ❤️🇪🇺

🧠🦠 Why does abdominal pain affect women more? Science offers a cellular answer.

A new Science study uncovers an estrogen-tuned gut pain circuit in which peptide YY–secreting enteroendocrine cells activate serotonin-releasing cells, sensitizing gut sensory nerves—especially in females. Hormones, microbes, and diet converge locally in the colon to amplify visceral pain, offering a biologically grounded explanation for menstrual-cycle variability and female-predominant disorders like irritable bowel syndrome.

📖 Venkataraman et al., Science (Dec 2025)

Precision medicine begins by taking sex seriously.

📚🇩🇰 Søren Kierkegaard (1813–1855): the philosopher of choice, anxiety, and becoming

Kierkegaard argued that the highest human task isn't just knowing the good—it's embodying it: becoming a self through commitment, responsibility, and inwardness. His framing of "existence" as the lived work of becoming helped spark what we now call existentialism. 🧭✨

In health care, his lens feels especially modern: moral distress, burnout, and "decision-fatigue" often intensify when we drift into autopilot—or when we outsource conscience to the "crowd." Kierkegaard's counter is tough-love and oddly hopeful: choose deliberately, live authentically, and let anxiety be a signal of freedom—not a verdict

🧬 When immunity saves—and harms—at the same time

A striking NEJM correspondence reveals that patients receiving immune checkpoint inhibitors often sustain molecularly detectable multiorgan damage—weeks to months before symptoms appear. Using cell-free DNA methylation mapping, investigators show that immune-related adverse events are systemic, not isolated organ toxicities—the visible clinic finding is just the tip of the iceberg 🧊🧬

This work reframes irAEs as a global loss of immune tolerance and opens the door to early, molecular surveillance—particularly relevant for cardio-oncology and precision medicine.

📍 Source: The New England Journal of Medicine, December 2025

#Immunotherapy #CardioOncology #PrecisionMedicine #cfDNA #NEJM #TranslationalScience

🍷⏳ Why Hangovers Get Worse as We Age — Science, Not Sentiment

Ever wondered why the same drink that once sparkled now punishes? A Well Informed piece from The Economist explains how aging physiology—less body water, slower metabolism, disrupted sleep, and toxic metabolites—turns modest indulgence into a morning reckoning. 🧠💤☠️

The takeaway is not abstinence, but wisdom: sip slowly, hydrate deliberately, respect sleep, and never underestimate biology. Aging, like good scholarship, rewards those who read the fine print. 📖🍸

🧬✨ Can we make the ageing immune system young again?

A fascinating Nature study shows that a three-part mRNA cocktail (DFI) can temporarily rejuvenate T cells in aged mice, improving responses to vaccines and cancer immunotherapy—without breaking immune tolerance. By turning the liver into a short-term factory for key immune signals (DLL1, FLT3L, IL-7), the authors demonstrate that immune ageing is modifiable, not fixed.

This elegant work—covered by Heidi Ledford in Nature—opens provocative questions about immune resilience, ageing biology, and the future of mRNA beyond vaccines. 🧠🛡️

📄 Friedrich MJ et al., Nature 2025 | News & Views: Ledford H.

🔗 doi:10.1038/s41586-025-09873-4 | doi:10.1038/d41586-025-04082-5

🧬 Protein Restriction, Aging, and Longevity ⏳

A remarkable new study in Cell shows that moderate protein restriction—especially when started in midlife—can reprogram aging biology across 41 organs, improving metabolic and cardiovascular health. 🫀⚙️

Using deep multi-organ proteomics in mice and human plasma validation, the authors demonstrate benefits mediated through ↓ IGF-1, ↓ mTOR, ↑ AMPK, and activation of brown adipose tissue. Importantly, the data also caution that extreme protein restriction may provoke inflammation, underscoring that moderation matters. ⚠️🎯

A powerful example of how nutrition shapes the biology of aging—organ by organ, pathway by pathway.

📖 Cell (2025)

#Aging #Longevity #ProteinRestriction #MetabolicHealth #CardiovascularHealth #Proteomics #PrecisionNutrition

🧬 Rethinking Neutrophils: From Lone Cells to Living Systems 🧠⚔️

For over a century, neutrophils were seen as short-lived foot soldiers of immunity.

This new Cell review reframes them as something far more interesting: a coordinated, adaptive collective.

✨ Key ideas:

• Short-lived cells, long-term memory

• Two compartments: granulopoietic + mature

• Plastic, circadian, tissue-adaptive behavior

• Major implications for inflammation, cancer, and immunotherapy

A powerful example of how systems thinking can transform classical immunology.

📖 Worth a deep read: The Neutrophil Collective — Cell (2025)

#Immunology #Neutrophils #InnateImmunity #SystemsBiology #CancerImmunology #MedicalEducation #TranslationalScience

⏰🫀 Does the heart care about the time of day? Yes—profoundly.

A new study in the Journal of Experimental Medicine reveals a circadian checkpoint in neutrophils that determines how much damage occurs after myocardial infarction. Morning ischemia triggers more injury, while nighttime CXCL12–CXCR4 signaling reprograms neutrophils, relocating them into the infarct core and sparing healthy myocardium—without impairing antimicrobial defense. 🌙🧬

This work reframes infarct biology from how much ischemia to when it happens and opens the door to chronotherapy for cardiovascular disease. Timing, it seems, is tissue. 🕰️✨

Exploring Hegel's Vision of Progress and Freedom 🌍🔄✨

Reflecting on Georg Wilhelm Friedrich Hegel's remarkable insight that history is a dynamic journey toward greater human freedom. His dialectical lens — the idea that contradictions are not dead ends but engines of development — offers a powerful way to think about institutions, leadership, and change. 🔍💡

From Phenomenology of Spirit to Philosophy of Right, Hegel challenges us to see ourselves as part of a larger unfolding story where reason, community, and ethical life evolve together. His work continues to influence modern political thought, social theory, and the way we understand progress itself. 📚🌱

A timely reminder: growth often emerges through tension, dialogue, and transformation — not avoidance.

#Hegel #Philosophy #GermanIdealism #Leadership #History #Ethics #IntellectualLeadership #Progress

🫀🧬 Cardio-Oncology: where modern cancer cures meet the heart

As cancer survival improves, cardiovascular toxicity has emerged as a defining challenge of our time. From BTK inhibitor–associated atrial fibrillation ⚡, to immune checkpoint inhibitor myocarditis 🔥, to VEGF-driven hypertension 🩸, the heart increasingly pays the price of precision oncology.

This FAQ-driven, clinician-ready Cardio-Oncology resource, grounded in the 2025 ACC Concise Clinical Guidance published in the Journal of the American College of Cardiology (JACC), translates complexity into clarity—highlighting permissive cardiotoxicity, multidisciplinary care 🤝, and practical decision-making that protects both survival and the heart ❤️.

Because in modern medicine, we should never have to choose between curing cancer and caring for the heart.

🧬 Prediabetes remission is not just metabolic—it's cardiovascular medicine. ❤️

A new analysis in The Lancet Diabetes & Endocrinology shows that achieving remission to normoglycaemia—not merely delaying diabetes—was associated with a ~50% reduction in cardiovascular death or heart failure hospitalisation, with benefits persisting for 20–30 years across U.S. and Chinese cohorts ⏳📉.

🔍 The message is profound and practical: normalize glucose early, protect the heart long-term. Remission may represent a measurable, durable, and globally applicable prevention target, alongside weight loss and lifestyle change.

This is prevention with a memory—and a legacy. 🧠❤️

🔬 New Insights on MASLD from JAMA 🍃

I recently reviewed an excellent JAMA article on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)—now recognized as the most common chronic liver disease worldwide. The review highlights how metabolic dysfunction, inflammation, and fibrosis converge to drive long-term risks, including cardiovascular disease, hepatocellular carcinoma, and extrahepatic cancers.

Key advances include better noninvasive fibrosis assessment (FIB-4, elastography), strong evidence for lifestyle-driven weight loss, and new therapeutic momentum with resmetirom and semaglutide for MASH with fibrosis.

As MASLD incidence accelerates globally, this synthesis underscores the urgency of early detection, metabolic risk control, and multidisciplinary care. 🌍💡

In this week's exploration, I dive into the brain's hidden "plumbing"—the glymphatic and meningeal lymphatic systems—drawing from a remarkable report in Science magazine (Dec 2025).

The piece outlines emerging Alzheimer's strategies ranging from VEGF-C and Aquaporin-4 gene therapy to vasomotion drugs, CO₂ breathing, massage-based lymphatic stimulation, and even experimental lymphovenous surgery.

A quiet revolution is underway—hope flowing through the brain's deepest channels. 💧🌊

#Neuroscience #Alzheimers #ScienceMagazine #BrainHealth

🌍 New WHO Guidance on GLP-1 Therapies: A Turning Point in Obesity Care 💉📘

The latest JAMA report highlights a pivotal moment in global health: the WHO's evidence-informed guideline on GLP-1 therapies for adults living with obesity. With over 1 billion people affected worldwide, this chronic, relapsing disease demands integrated, equitable, lifelong care.

The guidance underscores two essentials:

💊 Long-term GLP-1 therapy for those living with obesity

🤝 Intensive behavioral support to amplify and sustain benefits

But the message is clear—medication alone is not enough. True progress requires strong health systems, equitable access, and person-centered prevention and care.

A timely call to action for clinicians, policymakers, and health leaders everywhere. 🌱🌐

Delving into the latest JAHA review on immune checkpoint inhibitors and the heart has been illuminating 🔍❤️.

As immunotherapy transforms cancer care, we're learning that unleashed T-cells can also stir the silent storms within vulnerable plaques ⚡🩺.

This piece beautifully unpacks how ICIs may accelerate atherosclerosis, heighten ACS risk, and challenge our diagnostic instincts—especially when myocarditis and ischemia mimic one another 🎯🧬.

As we push the frontier of cancer survival, cardio-oncology must rise in parallel: better surveillance, smarter risk reduction, and deeper mechanistic insight 🚀📚.

A timely reminder that curing cancer and protecting the heart must go hand in hand 🤝❤️‍🔥.

Immanuel Kant: The Architect of Modern Reason 🧠✨

Fascinating to revisit Kant's legacy — the thinker who reshaped how we understand knowledge, morality, and human freedom. His ideas on autonomy, duty, and the categorical imperative continue to guide ethical reasoning in science, leadership, and society.

From Critique of Pure Reason to Perpetual Peace, Kant invites us to think boldly:

What can I know? What should I do? What may I hope? 🌍📚

His work still challenges us to act with integrity, respect human dignity, and build a more rational and just world.

#Kant #Enlightenment #Ethics #Reason #Leadership #Philosophy 🕊️

🚀 Immune checkpoint inhibitors have transformed cancer care—but they come with a cardiovascular shadow.

A new International Cardio-Oncology Society (IC-OS) position statement offers the clearest guidance yet on myocarditis, pericarditis, arrhythmias, ACS, and noninflammatory HF linked to ICI therapy. 🫀💡

Key insights include:

• Early recognition with troponin, ECG, and CMR 🧪📊

• Smoldering vs. nonsevere vs. fulminant myocarditis distinctions 🔍

• Steroid-first management and the evolving role of abatacept + JAK inhibitors 💊

• Nuanced approaches to ICI rechallenge when cancer control demands it 🔄🎯

• The essential role of multidisciplinary cardio-oncology teams 🤝

This is a must-read for anyone navigating the intersection of oncology, cardiology, and immunotherapy. 🌐🔥

Chronic kidney disease now affects nearly 850 million people worldwide, yet early detection and simple, evidence-based interventions can dramatically change the trajectory of both kidney and cardiovascular health. 🌍🩺

The latest Lancet Seminar highlights powerful tools—eGFR + albuminuria staging, SGLT2 inhibitors, RAS blockade, statins, and GLP-1 therapies—that allow every clinician to make a measurable impact. 💊📉

A reminder that timely action is kidney protection. 💧✨

🚀 New insights from Cell shine a light on an unexpected ally in the fight against cognitive decline. A natural experiment from Wales shows that the shingles (herpes zoster) vaccine doesn't just prevent viral reactivation—it may also reduce new mild cognitive impairment and lower dementia-related mortality over long-term follow-up.

🔍 Using a strict birthday-based eligibility cutoff, the study provides causal evidence—rare in population dementia research—that vaccination may slow disease across its entire course.

🧠✨ As we rethink neuroinflammation, immunosenescence, and healthy aging, this work opens the door to exploring broader neuroprotective effects of adult vaccines.

📄 A reminder that sometimes the smallest public health interventions carry the biggest, most surprising benefits.

📘 New NEJM Evidence for the 2025–26 Vaccine Season is out—and it delivers clarity at a time we need it most.

The systematic review of 511 studies shows strong, consistent protection against hospitalization from Covid-19, RSV, and Influenza, with reassuring safety profiles across age groups. 💉🛡️

Key insights: improved VE for updated Covid-19 strains, high efficacy of maternal RSV vaccination and nirsevimab for infants, and solid influenza performance. 📊👶

A valuable guide for clinicians, health systems, and policymakers as we prepare for the upcoming respiratory season. 🌐🏥

New Lancet Seminar on heart failure with reduced ejection fraction.

💓📘, this videocast walks listeners through the essentials of diagnosis, natriuretic peptides, imaging pathways, and the four foundational therapies shaping modern heart failure care.

It's a clear, evidence-driven journey—designed to inform, clarify, and elevate bedside practice.

Tune in to explore the science, the strategy, and the future of treating HFrEF. 🫀🔬✨

🫀🔬✨

🔍💓 Chronic Coronary Artery Disease: Seeing What Matters Before It Hurts

Just finished reviewing the 2025 Lancet paper on contemporary non-invasive imaging for chronic CAD, and the message is striking: how we see the heart shapes how well we save it.

From CT angiography that unmasks non-obstructive plaque 🖥️➡️🫀 to stress PET/CMR that maps true ischemia under load 💨📊, multimodality imaging is redefining diagnosis, risk, and long-term outcomes.

The evidence is clear: better imaging leads to better prevention—and in many cases, fewer invasive procedures and fewer missed opportunities for early therapy.

In an era of rising cardiometabolic risk, precision imaging isn't just a tool—it's a commitment to catching disease in its "quiet" phase and protecting patients long before symptoms speak.

Science, clarity, prevention. 🔬✨❤️

Exploring David Hume 🧠✨

Just revisited David Hume's extraordinary contributions to modern thought — a reminder of how deeply empiricism, skepticism, and the science of human nature shape our intellectual world. His insights on causation, the limits of reason, and the power of moral sentiment continue to resonate across philosophy, psychology, economics, and evidence-based decision-making. 🌍📚

Hume challenges us to look closely, question boldly, and reason with humility — a timeless guide for scholars, clinicians, and leaders navigating uncertainty. 🔍💡

#Philosophy #Hume #Empiricism #HumanUnderstanding #Enlightenment

The U.S. heart failure landscape is transforming—and fast. 🫀📊

A new JACC analysis reveals a 35-year shift from ischemic to metabolic drivers of heart failure, with obesity, dysglycemia, and chronic kidney disease rising sharply, even as blood pressure, cholesterol, smoking, and myocardial infarction decline. 📉⚖️

These trends demand a new generation of HF trials—more inclusive, prevention-focused, metabolism-centered, and designed to capture outcomes beyond cardiovascular death. 🚀🧬

A powerful reminder: heart failure is not inevitable—but the way we study and prevent it must evolve. 🌅💡

🧬⏳ New Insights into Organ-Specific Aging! 🧠❤️🩺

Just explored a remarkable Nature Aging study showing how organ-specific proteomic clocks can forecast disease, cognitive decline, and even longevity with impressive precision. These clocks—built from >2,900 plasma proteins—reveal that the brain, kidney, and arteries age on their own timelines, each carrying unique clues about future health.

What struck me most is how brain aging outperforms traditional risk markers, predicting dementia even after accounting for age, APOE genotype, and cognitive scores. A powerful reminder that biological age isn't a single number—it's a symphony of organ-specific rhythms. 🎼

Exciting implications for precision medicine, early detection, and preventive cardiometabolic and neurodegenerative care.

Science that helps us see aging not as fate, but as a map. 🗺️✨

Respiratory vaccines are not just infection-fighters—they're cardiovascular protectors. 💉🫀

The 2025 JACC Consensus reminds us that influenza, pneumococcal, COVID-19, RSV, and zoster vaccines reduce MI, HF decompensation, hospitalizations, and death in our most vulnerable patients.

As clinicians, we hold the power to translate evidence into prevention: strong recommendations, simple pathways, and clear conversations can save lives long before interventions do. 🌟

Vaccinate to protect the heart. Shield to preserve life. Prevent to empower patients. ❤️‍🩹

#Cardiology #Vaccination #HeartHealth #JACC #Prevention #PublicHealth

The latest JAMA article on keratinocyte carcinomas 🌞—a timely reminder that BCC and cSCC remain the world's most common cancers, with more than 5.4 million cases annually in the US alone .

The review highlights essential updates in epidemiology, high-risk features, prevention, and evidence-based management, especially the role of sun protection, actinic keratosis treatment, and risk-stratified surgical care 🔬⚕️. A great resource for clinicians committed to early detection, thoughtful treatment, and lifelong surveillance of at-risk patients 👀🛡️.

If you work in dermatology, oncology, primary care, or population health, this is well worth your time 📚✨

🚨 Food Anaphylaxis: New Mechanisms Unveiled 🍽️🧬

A superb NEJM review highlights how cysteinyl leukotrienes act as gatekeepers in the gut—opening antigen passages, expanding mast cells, and amplifying the risk of oral anaphylaxis.

The work elegantly bridges basic lipid biology with real-world food allergy challenges, and points toward new preventive strategies beyond current IgE-based therapies.

🔍 A must-read for clinicians, scientists, and anyone navigating severe food allergies.

🌿 What does the evidence really say about medical cannabis?

A new JAMA review highlights a clear message: cannabis helps few conditions—and harms may outweigh benefits for many.

📉 Small benefit for nausea

⚡ Moderate benefit for select pediatric seizures

💊 Limited evidence for pain, insomnia, or psychiatric use

❤️ Risks rise with high-potency products, especially for heart and mental health.

🧭 Clinicians: guide with evidence, screen carefully, use lowest-risk options.

Thrilled to see a major step forward in dengue prevention! 🦟💊

A new NEJM study reports that daily mosnodenvir, a first-in-class antiviral targeting the NS3–NS4B interaction, significantly reduced DENV-3 viral load and prevented infection in a controlled human challenge model. 📉🧬

It's early, but the results offer real hope for a long-awaited oral dengue prophylaxis—with encouraging safety, strong PK, and dose-dependent efficacy. 🚀🌍

Exciting moment for global infectious-disease innovation and antiviral development. 🙌✨

Delighted to share a concise update on the latest NEJM review of Long QT Syndrome 🫀📘 — a masterful synthesis by Schwartz & Crotti that reframes how we recognize risk, personalize therapy, and prevent sudden death in this genetically mediated disorder. The piece highlights ion-channel biology, gene-specific triggers, the impact of modifier genes, and the effectiveness of a tiered therapeutic approach including beta-blockers, mexiletine, and left cardiac sympathetic denervation ⚡️🧬🛡️.

For clinicians and trainees, it's a compelling reminder that precise diagnosis, careful QT interpretation, and yearly risk reassessment remain central to saving lives. Highly recommended reading for anyone involved in cardiac electrophysiology or inherited arrhythmia care 📚✨

🧠✨ Leibniz: Harmony, Logic, and the Birth of the Digital Mind

Celebrating Gottfried Wilhelm Leibniz — the mathematician-philosopher who co-created calculus, invented binary arithmetic, and envisioned a world stitched together by pre-established harmony. His Monadology reads like proto-systems theory, and his binary system is the quiet ancestor of every computer we use today.

For clinicians and scientists, his legacy whispers:

🔹 Seek the sufficient reason behind every pattern

🔹 Value multiple perspectives — every "monad" reflects a different truth

🔹 Build harmonies across disciplines, data streams, and patient narratives

🧩💡 From metaphysics to modern computing, he reminds us that insight deepens when logic meets wonder.

🧬 New insights into autism: A 2025 JCI Viewpoint highlights how hundreds of genes, polygenic risk, and specific environmental factors converge during fetal brain development to shape autism likelihood.

🧠 Early biomarkers—from infant MRI and ERPs to machine-learning models using EHR data—are accelerating earlier, more tailored interventions.

🌱 Advances in gene therapy, IGF-1 pathways, and proteomics offer emerging therapeutic possibilities.

🤝 Centering autistic voices remains essential as precision approaches evolve.

🔍 Peripheral Neuropathy: What Clinicians Should Know 🧠⚡

Peripheral neuropathy affects ~1% of adults worldwide, with diabetes accounting for more than half of all cases. The JAMA review highlights why length-dependent patterns dominate, how metabolic stress injures long axons first, and why sensory symptoms outpace motor loss. Evidence-based evaluation still begins with glucose testing, vitamin B12 with methylmalonic acid, and serum protein electrophoresis.

First-line therapies for neuropathic pain — gabapentin, pregabalin, duloxetine, and tricyclics — offer meaningful but often incomplete relief, reminding us that prevention and risk factor modification remain central.

A clear, elegant synthesis of mechanisms, diagnostics, and management — essential reading for anyone caring for patients with numbness, tingling, or burning feet. 👣✨

New NEJM insights on asymptomatic carotid stenosis 🧠🔍

The CREST-2 trials offer a landmark update: intensive medical therapy remains the cornerstone, while carotid stenting shows selective benefit when performed by expert operators. Endarterectomy, however, provides no significant advantage over modern medical management.

With stricter blood-pressure and LDL targets, plus expanding use of PCSK9 inhibitors, the future of stroke prevention is increasingly precision-driven, medically optimized, and patient-centered. 💊📉✨

A thoughtful read for all involved in vascular care, cerebrovascular prevention, and clinical decision-making. 📘🫀

The new Lancet Series on ultra-processed foods offers a striking insight: as UPFs rise globally, traditional whole-food diets decline—bringing nutrient imbalance, overeating, toxic exposures, and hyper-palatable formulations that quietly reshape health trajectories. 🍔➡️⚠️

Across more than 100 prospective studies and multiple trials, higher UPF intake consistently links to obesity, type 2 diabetes, cardiovascular disease, kidney disease, depression, and higher all-cause mortality. 📉🩺

The message is clear: reducing UPF consumption isn't a wellness trend—it's a public health imperative. Evidence-based policies and renewed investment in minimally processed, culturally rooted food systems are urgently needed. 🌱🔬🌏

#UltraProcessedFoods #PublicHealth #Nutrition #ChronicDisease #LancetSeries

Home-delivered DASH-patterned groceries paired with dietitian counseling meaningfully lowered blood pressure and LDL cholesterol among Black adults living in food deserts 🥗📉—as demonstrated in the GoFresh randomized trial (JAMA).

An accompanying editorial highlights why future "food-as-medicine" programs must prioritize underconsumed, health-promoting foods and align with modern evidence favoring higher-fat DASH/Mediterranean patterns 🌱🫒.

A powerful reminder: the right groceries can be therapeutic.

🩺 New insights in hemodialysis care.

A major New England Journal of Medicine study reports that daily supplementation with long-chain omega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid) led to a 43% reduction in serious cardiovascular events among adults receiving maintenance hemodialysis. 🐟💙

In a population where traditional cardioprotective therapies often fall short, these findings open a fresh path for investigation — and perhaps, future practice. 📉🔬

A confirmatory trial will be essential, but the signal is compelling. 🌅

🚀 A milestone moment in lipid therapeutics!

The new JAMA trial on the oral PCSK9 inhibitor Enlicitide reports a ~60% reduction in LDL-C, with parallel decreases in ApoB and Lp(a)—all on top of maximally tolerated statin therapy.

For individuals with heterozygous familial hypercholesterolemia (HeFH)—where reaching LDL targets remains a persistent challenge—this represents a major advance. An oral agent matching the potency of injectable PCSK9 inhibitors could reshape adherence, access, and long-term ASCVD prevention. 🌉💊

Safety was comparable to placebo, and effects were rapid, robust, and sustained to 52 weeks. The ongoing CORALreef Outcomes trial will determine its impact on major cardiovascular events. 🔬❤️

Innovation in lipid lowering is accelerating—and patient-centered options are expanding.

#JAMA #LipidManagement #HeFH #CardiovascularHealth #PCSK9 #Enlicitide #Prevention 🌟

☕ DECAF Trial insight!

A new JAMA study shows that daily caffeinated coffee may lower recurrence of atrial fibrillation compared with abstinence.

Patients drinking ~1 cup/day had 47% recurrence vs 64% with abstinence (HR 0.61, p=0.01) 📉💓

No major safety concerns—challenging long-held beliefs that coffee is proarrhythmic.

💡Takeaway: For many patients with AF, enjoying their morning brew may be both safe and possibly beneficial.

#AtrialFibrillation #Cardiology #JAMA #ClinicalTrials #HeartHealth ☕💓📊

🚨 New insights from The Lancet 🚨

A major individual-patient-data meta-analysis (6 RCTs, 8,836 patients) shows that complete revascularisation in acute myocardial infarction significantly reduces cardiovascular death, all-cause mortality, and recurrent MI. 💓📉

Benefits were consistent across age, sex, STEMI/NSTEMI, and lesion characteristics — strengthening the case for a more comprehensive approach beyond the culprit lesion alone. 🔬🩺

A powerful reminder: treating the whole heart saves more lives. ❤️✨

🧬 New NEJM data on Olezarsen!

In patients with severe hypertriglyceridemia, monthly RNA-targeted therapy delivered major triglyceride reductions (−62% to −72%) and a significant drop in acute pancreatitis risk (rate ratio 0.15).

✨ Improvements extended to ApoC-III, remnant cholesterol, and non-HDL cholesterol, with consistent benefits across both CORE-TIMI trials.

💡 A promising step forward in precision lipid therapy and pancreatitis prevention.

📘 New Evidence from NEJM

In a large meta-analysis of 17,801 patients with preserved LVEF after MI, beta-blockers did not reduce death, recurrent MI, or heart failure. Event rates were low, and outcomes were similar with or without therapy. 🫀📊

This clarifies practice for a growing post-MI population with LVEF ≥50%—precision matters more than tradition. 🎯

Full study: New England Journal of Medicine (2025).

#Cardiology 💙 #ClinicalEvidence #MI #HeartHealth

📢 ADAPT AF-DES Trial — A Safer Path Forward!

In patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation, NOAC monotherapy delivered striking benefits over combination therapy.

✅ Lower net adverse clinical events

✅ Marked reduction in major/CRNM bleeding

✅ Similar ischemic protection

A beautifully simple strategy with meaningful impact.

Published in NEJM (2025).

💊🛡️📉💓

🌊 OCEAN Trial offers fresh insight into antithrombotic therapy after successful AF ablation. In 1284 patients followed for 3 years, event rates were remarkably low 🌟. Rivaroxaban did not show superiority over aspirin for preventing stroke, systemic embolism, or covert embolic events, while bleeding risk was higher with anticoagulation.

🧠 96% had no new infarcts on MRI at follow-up.

Published in NEJM (2025) — a valuable contribution to nuanced AF post-ablation care.

🧠 John Locke: Experience • Liberty • Toleration

Born a physician-philosopher, Locke championed empiricism — the idea that knowledge begins with experience, not dogma. His tabula rasa shaped modern psychology, while his Two Treatises of Government defined rights, consent, and freedom that echo through modern democracies.

For clinicians, his legacy reminds us to:

🔹 Trust observation and evidence over authority

🔹 Respect patient autonomy and informed consent

🔹 Foster pluralism and toleration in care

His vision of reason and tolerance remains medicine's quiet ally.

🕊️📜💬 Observation. Reflection. Compassion.

🚀 VESALIUS-CV delivers powerful evidence: in high-risk patients without prior MI or stroke, evolocumab significantly reduced 3-point MACE by 25% and 4-point MACE by 19%, with LDL-C lowered to a median of 45 mg/dL.

💡 These results expand the horizon of prevention, showing that deep LDL reduction is both safe and effective in averting first cardiovascular events.

🫀 Strong science. Clear signal. A new chapter in preventive cardiology.

#Cardiology #LDL #Prevention #VESALIUSCV

🫀 Septic Shock, Refined at the Fingertips ⏱️

A powerful new JAMA (2025) trial brings us one step closer to truly personalized resuscitation. The ANDROMEDA-SHOCK-2 study shows that targeting capillary refill time (CRT) — a simple bedside sign — can shorten time on organ support vs usual care, without increasing mortality.

Key insight: Sometimes the most elegant solutions are low-tech, high-touch, and right at the bedside.

🧠 Precision

🤚 Physiology

💡 Pragmatism

#Sepsis #CriticalCare #PersonalizedMedicine #JAMA #Hemodynamics #ICU #Shock

🚨 SOFA-2 arrives — a thoughtful evolution in critical care scoring 🧠🫁🫀

After nearly 30 years, the SOFA score has been modernized using data from >3.3 million ICU patients across 9 countries. The updated SOFA-2 incorporates contemporary respiratory and cardiovascular supports (HFNC, NIPPV, vasopressors, ECMO) and refines thresholds while preserving simplicity and bedside usability.

A meaningful step forward in describing organ dysfunction — with room for future biologically grounded refinement.

📖 Published in JAMA

SOFA-2 is here — a major advance in assessing organ dysfunction in critical illness 🧠🫁❤️

Three decades after the original SOFA score, this updated framework reflects modern ICU practice — integrating contemporary organ support (ventilation, vasopressors, RRT), delirium recognition, and global feasibility across resource settings 🌍📊

Validated in 3.3M+ ICU patients across 9 countries — a remarkable effort in global critical care science 🏥📈

A powerful step forward in our shared language of severity and recovery.

🔗 JAMA Network Open, 2025

💔 Peripartum Cardiomyopathy: When a Mother's Heart Fights for Two

Peripartum cardiomyopathy is a leading yet often missed cause of maternal morbidity and mortality—striking late in pregnancy or months postpartum. Early suspicion, timely echo, and guideline-directed therapy save lives. 🩺

🧠 Bromocriptine, careful anticoagulation, and multidisciplinary care are reshaping outcomes, but global disparities persist. 🌍

Let's amplify awareness, strengthen systems, and protect mothers everywhere. 🤝❤️

#HeartFailure #MaternalHealth #Cardiology #GlobalHealth #PPCM

Rethinking "default lines" in the ICU 🧠🚑

A landmark NEJM trial shows that in patients with shock, deferring arterial catheterization and using automated cuff monitoring was noninferior for 28-day mortality — and reduced catheter-related complications.

A gentle reminder: not every sick patient needs a needle to be well cared for.

Precision isn't only invasive — sometimes it's thoughtful, measured, humane. 🌿💡

#CriticalCare #ICU #NEJM #Shock #Hemodynamics #PatientSafety

🌙 Bright Nights, Higher Heart Risk ❤️‍🩹

New findings in JAMA Network Open highlight that greater exposure to artificial light at night is associated with significantly increased risks of coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke — independent of sleep duration, lifestyle factors, and genetics.

💡 Clinical takeaway: Protecting circadian rhythms is cardiovascular prevention. Darker nights = healthier hearts.

🛌 Simple steps: blackout curtains, limit screens before bed, use warm/dim evening lighting.

#Cardiology #JAMANetworkOpen #CircadianHealth #SleepMedicine #PrecisionPrevention #PublicHealth

The immune clock starts earlier than we think ⏳🧬

A landmark Nature study shows that immune aging begins quietly in midlife — decades before clinical frailty.

Using >16M single-cell profiles and longitudinal vaccine responses, researchers found:

• Stable, early transcriptional drift in naïve & memory T cells

• A subtle TH2 shift that may weaken antiviral antibody quality

• Reduced IgG class-switching to repeat flu antigens (e.g., B/Phuket)

• No acceleration from CMV infection despite compositional shifts

The message?

Immune aging is gradual, not abrupt — and midlife may be the window for intervention.

Precision immunology will increasingly mean precision geroscience.

🫀 TAVR or SAVR? The 7-Year Truth

New 7-year results from the PARTNER-3 trial (NEJM) show that in low-risk patients with severe symptomatic aortic stenosis, TAVR holds pace with surgery — delivering comparable survival, stroke rates, rehospitalization, valve durability, and quality-of-life outcomes.

🔎 Highlights

• Composite events: 34.6% (TAVR) vs 37.2% (SAVR)

• Mortality: 19.5% vs 16.8%

• Valve failure: 6.9% vs 7.3%

• Aortic gradients remain low in both groups

💡 Clinical rhythm: less AF with TAVR; more pacemakers and paravalvular leak.

This study reinforces a simple truth: in the right low-risk patient, TAVR is not just less invasive — it's durable.

#Cardiology #StructuralHeart #AorticStenosis #TAVR #SAVR #NEJM

🌿 Spinoza: Reason, Nature, Freedom

Today's deck explores Baruch Spinoza — the quietly revolutionary Dutch philosopher who shaped rationalism, modern biblical criticism, and secular democracy.

He saw God = Nature, championed intellectual freedom, and argued that understanding our emotions transforms them — not far from cognitive-behavioral ideas we use in modern medicine.

His reminder feels timely: human flourishing grows where inquiry is free, passions are understood, and systems support dignity + reason.

🧠🔍💬 Clarity is liberation.

A new era for complex mitral regurgitation.

The ENCIRCLE pivotal trial in The Lancet reports that fully percutaneous, transfemoral, transseptal TMVR (SAPIEN M3) achieved durable MR reduction (≈96% ≤1+ at 1 year), low early mortality, and meaningful improvement in symptoms and quality of life for patients unsuitable for surgery or TEER.

A third pathway for mitral disease is emerging—one built on precision access, valve-in-valve durability planning, and advancing patient selection.

Innovation meeting clinical need. 🚀🫀📈

🧬 Can we rejuvenate the aging immune system?

A remarkable Nature Biotechnology study shows that a rare population of periostin-positive mesenchymal niche cells can rebuild the adult thymus, recruit new T-cell progenitors, and restore immune responses after injury.

By harnessing CCL19-expressing stromal support, the authors demonstrate a path toward immune renewal in aging, cancer therapy recovery, and HSCT survivors.

✨ A glimpse of regenerative immunology's future:

Rebuild. Recruit. Rejuvenate.

#Immunology #Aging #RegenerativeMedicine #Thymus #TCells #PrecisionMedicine #ImmuneHealth

🩺🎗️ Cardio-Oncology Insight: Not Every Breast Cancer Survivor Needs a Cardiologist

As breast cancer survivorship grows, understanding who truly benefits from long-term cardiac follow-up becomes essential. An important editorial in JAMA Oncology underscores a key principle: risk-stratified care, not reflex surveillance.

👩‍⚕️🔍 Age and traditional cardiovascular risk factors outweigh treatment exposure (including anthracyclines and ERBB2 therapy) in driving late heart failure and cardiomyopathy risk among survivors .

🏥💡 Most survivors can be safely followed by primary care clinicians focused on:

• Controlling blood pressure, diabetes, lipids

• Encouraging physical activity & healthy weight

• Monitoring symptoms and functional status

❤️📊 Select high-risk patients — older age, multiple CV risk factors, or treatment-related dysfunction — benefit most from targeted cardio-oncology evaluation.

This editorial reminds us that precision survivorship means personalizing cardiac follow-up, emphasizing prevention, equity, and collaboration between oncology, cardiology, and primary care.

🌱 Goal: Survivors who not only live longer — but live well.

#CardioOncology #BreastCancer #Survivorship #HeartFailurePrevention #PrecisionMedicine #PrimaryCare #JAMAOncology #CancerCare #CardioOnc #PopulationHealth #AcademicMedicine

🧬 Can we rejuvenate the aging immune system?

A new Nature Aging trial suggests we might be closer than we thought.

In 50 healthy adults aged 45–70, urolithin A—a mitophagy activator—improved immune fitness over just 28 days:

✅ ↑ naïve CD8⁺ T cells

✅ ↓ exhaustion markers (TOX)

✅ ↑ mitochondrial biogenesis (PGC-1α)

✅ ↑ fatty-acid oxidation capacity

✅ ↑ NK cell and monocyte function

✅ ↑ bacterial phagocytosis

💊 Well-tolerated with minimal adverse events

🔬 This builds on compelling translational work linking mitochondrial quality control to immunosenescence and "inflammaging."

A reminder that metabolism and immunity are deeply intertwined—and that targeted interventions may help preserve immune resilience across the lifespan.

🧠 Aging isn't just years lived. It's biology modulated.

#LongevityScience #Immunology #HealthyAging #Mitochondria #ClinicalResearch #TranslationalScience #Geroscience #ImmuneHealth #NatureAging

🫀 Personalizing DAPT: When "One Size Fits All" Fails 🕊️💊

The HOST-BR trial in The Lancet offers an important clinical lesson:

Bleeding risk should guide antiplatelet duration after PCI — not habit, not inertia.

🔍 Key insight

In ARC-HBR patients, 1-month DAPT was not non-inferior to 3 months
In non-HBR patients, 3-month DAPT was non-inferior to 12 months and reduced bleeding

🧠 Clinical takeaway

➡️ Ultra-short (1-mo) DAPT is risky in high-bleeding-risk patients

➡️ Short (3-mo) DAPT is safe and bleeding-sparing in lower-risk patients

🔧 Precision medicine in action:

Stratify → Tailor → Protect

📎 HOST-BR | The Lancet (2025)

A beautiful reminder that medicine advances when we match therapy to physiology — not the other way around.

🌟 "Do no harm" is evolving… now it means do no unnecessary bleeding.

#Cardiology #InterventionalCardiology #PrecisionMedicine #DAPT #PCI #BleedingRisk #Lancet

🚨 New Pharmacotherapy for Obstructive Sleep Apnoea 🌙💊

In a landmark Phase 2 trial published in The Lancet, sultiame— a carbonic anhydrase inhibitor—showed dose-dependent reduction in AHI and improved nocturnal oxygenation in adults with moderate–severe OSA.

💡 Key insights:

• 298 participants across 5 European countries

• 200 mg daily delivered the best efficacy-to-tolerability balance

• Benefits most notable in sleepy phenotypes (ESS >10)

• Mild, dose-related paraesthesia most common AE

🔬 A promising step toward precision sleep medicine and pharmacologic options for patients who struggle with CPAP.

🌬️ Better breathing by night → brighter cognition by day.

📖 Lancet, 2025 — FLOW Study (Randerath et al.)

📢 New Study Alert 🩺💊 In JAMA Internal Medicine, a national analysis reveals that using the PREVENT risk calculator (vs Pooled Cohort Equations) dramatically reduces the number of U.S. adults aged 40–59 eligible for aspirin in primary prevention of cardiovascular disease. Among 7.6 million current aspirin users, >96% wouldn't qualify by PREVENT 🤯. Time to rethink our calculators and consider deprescribing where net benefit is questionable.

📰 Read more: https://jamanetwork.com/journals/jamainternmed/fullarticle/10.1001/jamainternmed.2025.5049

🧠 TACSI Trial in NEJM (Sep 2025) challenges the status quo on dual antiplatelet therapy after CABG for ACS!

👨‍⚕️ 2201 patients across 5 Nordic countries

💊 Ticagrelor + Aspirin ≠ better outcomes vs Aspirin alone

📉 No reduction in death, MI, stroke, or revascularization

🩸 But bleeding (4.9% vs 2.0%) & dyspnea (18.2% vs 6.4%) increased

📚 Guidelines may need rethinking.

📖 Jeppsson A et al. N Engl J Med. 2025; DOI: 10.1056/NEJMoa2508026

#TACSI #Cardiology #CABG #DAPT #ACS #NEJM #PrecisionMedicine #RCT #BleedingRisk #ClinicalTrials

🧪 NEO-MINDSET Trial 🇧🇷 published in NEJM asks: Can we safely drop aspirin early after PCI in acute coronary syndromes (ACS)?

💊 Monotherapy with ticagrelor/prasugrel reduced bleeding 🩸 but increased early ischemic events 💥 vs dual antiplatelet therapy (DAPT).

❗ Noninferiority for major adverse cardiovascular events was not met.

🔍 DAPT still stands tall in early post-PCI ACS care.

Kudos to the Brazilian team for a landmark RCT!

📖 NEJM 2025 | doi: 10.1056/NEJMoa2507980

#NEOMINDSET #PCI #ACS #cardiotwitter #RCT #DAPT #P2Y12 #Bleeding #NEJM #PrecisionMedicine #InterventionalCardiology

🚨 New in NEJM — The ALASCCA Trial 🧬

Low-dose aspirin (160 mg/day) reduced colorectal cancer recurrence in patients with PIK3CA, PIK3R1, or PTEN mutations 🎯

✅ 3-year recurrence: 7.7% (aspirin) vs 14–17% (placebo)

✅ Group A HR: 0.49 | Group B HR: 0.42

✅ NNT as low as 6 in stage III rectal cancer 💥

⚠️ Slight increase in adverse events

🧠 Editorial calls it a new standard of care:

🔬 Genotype early + 💊 Start aspirin early = 📉 Lower recurrence

📖 Read both the trial and editorial in NEJM, Sept 2025

#ColorectalCancer #PrecisionOncology #Aspirin #PIK3CA #NEJM #OncologyTrials #Genomics #AdjuvantTherapy #ALASCCA #ClinicalTrials

💡 TARGET-FIRST trial (NEJM, Aug 2025) shows that in low-risk AMI patients post-PCI with complete revascularization, stopping aspirin after 1 month and continuing P2Y12 monotherapy is noninferior to dual antiplatelet therapy—with 54% fewer bleeding events 🩸🛑💊

⚖️ A modern, patient-tailored antiplatelet strategy—backed by potent P2Y12 inhibitors and smart selection—might just be the new norm in contemporary cardiology 🫀

📘 New England Journal of Medicine

🔗 https://doi.org/10.1056/NEJMoa2508808

#Cardiology #DAPT #PrecisionMedicine #NEJM #TARGETFIRST

💡 "Cogito, ergo sum" — I think, therefore I am. René Descartes laid the foundation of modern Western philosophy and scientific reasoning, linking algebra to geometry, and mind to body.

🧠📐 His legacy reminds healthcare professionals to unite reason with compassion — science with soul. ❤️⚕️

💊🫀 Aspirin in the Crosshairs?

The AQUATIC Trial (NEJM, Aug 2025) raises sharp questions on dual-pathway therapy in chronic coronary syndrome (CCS) patients already on long-term anticoagulation.

📉 Adding aspirin led to:

• ↑ Ischemic events (HR 1.53; P=0.02)

• ↑ Mortality (HR 1.72; P=0.01)

• ↑ Major bleeding (HR 3.35; P)

🧠 Takeaway: More isn't always better.* In high-risk CCS, aspirin may harm more than help.

📚 Read: https://www.nejm.org/doi/full/10.1056/NEJMoa2507532

#Cardiology #Antiplatelet #NEJM #PrecisionMedicine #AQUATICTrial*

🧠💥 Could lead poisoning have helped shape human evolution? A bold new hypothesis suggests that Homo sapiens may have survived while Neanderthals and Denisovans vanished—thanks to genetic defenses against environmental lead. 🧬

By analyzing fossil teeth 🦷 and testing brain organoids 🧪, researchers found that ancient lead exposure disrupted key language-related genes (like FOXP2)—but not in modern human variants.

👣 Sometimes, evolution turns adversity into advantage.

📖 Published in Science (Oct 2025): "Did lead poisoning help drive human evolution?"

🔗 doi:10.1126/science.aed1022

#Evolution #Neuroscience #Anthropology #Genetics #FOXP2 #NOVA1 #LeadPoisoning #Paleoanthropology #Science 🦴🧬

🚨 New in Nature 🧬: Groundbreaking study reveals how HMGN1, a dosage-sensitive epigenetic regulator on chromosome 21, reprograms atrioventricular cardiomyocytes into a ventricular fate—driving congenital heart defects in Down syndrome 💔🫀.

Using hiPSCs, single-cell RNA sequencing, and a CRISPRa CROP-seq screen, researchers pinpoint HMGN1 as a causal gene. Strikingly, reducing its dosage in a trisomy 21 mouse model reversed ventricular septal defects (VSDs) 🔧🐭.

This is a model for dissecting aneuploidy-associated disease using human cells + in vivo rescue. Epigenetics meets cardiogenesis in real time. Don't miss this paradigm-shifting work!

📖 DOI: 10.1038/s41586-025-09593-9

#DownSyndrome #Cardiology #Epigenetics #CRISPR #scRNAseq #HMGN1 #CongenitalHeartDefects #StemCells #Nature #GeneDosage #PrecisionMedicine

🚭 Lung Cancer in Nonsmokers – a hidden epidemic affecting up to 20% of global cases 🌍. Unlike tobacco-related disease, this form often strikes younger, female, and Asian populations, with EGFR and ALK mutations driving tumors 🔬.

Despite low mutation burden and no smoking history, these patients benefit immensely from targeted therapies like osimertinib and lorlatinib 🎯. Yet, there's no USPSTF recommendation for screening in this group 😔.

We must push for awareness, early detection, and precision approaches 🧬. As the review in JAMA (2025) shows, no smoke doesn't mean no risk.

🔗 doi:10.1001/jama.2025.17695

#LungCancer #PrecisionMedicine #Oncology #PublicHealth #JAMA

👟 Just 2 Days Can Make a Difference! 🧓📉

In a large cohort of 13,547 older women (mean age 72), walking ≥4,000 steps/day on even 1–2 days/week was linked to a 26% lower mortality and 27% lower cardiovascular disease risk 💥. Those walking ≥3 days/week had even greater benefits!

📉 Higher step thresholds (up to 7,000/day) showed further mortality reduction—but step volume, not frequency, drove outcomes.

🧠 Message? There's no "perfect pattern"—even weekend walks count.

💡 Time to rethink activity guidelines and empower aging with steps.

📄 Hamaya R et al, Br J Sports Med, 2025.

🔗 https://doi.org/10.1136/bjsports-2025-110311 #Longevity #CardioHealth #WomenInMedicine #PublicHealth #WeekendWarrior #HealthyAging #ExactitudeStudy #StepsToHealth #CVD #ExerciseIsMedicine

🧓 Aging skin, fading flow. This 2025 Nature study uncovers how dermal capillary-associated macrophages (CAMs) decline with age—preceding microvascular dysfunction and impaired blood flow.

🧬 Using intravital imaging and macrophage fate mapping in mice (and validating in humans!), the authors reveal that CAMs are not replenished unless triggered by injury or CSF1. 🛠️ Fascinatingly, local CSF1–Fc therapy restored CAMs and rejuvenated perfusion in aged skin. A compelling case for targeting tissue-resident immunity! 🩸

📖 doi:10.1038/s41586-025-09639-y

🫀📉 Published in The Lancet (Oct 22, 2025): SELECT trial investigators report that semaglutide reduced MACE by 20% in patients with obesity but without diabetes—independent of weight loss. Waist circumference, not weight, tracked with outcomes, yet explained only 33% of the benefit. This landmark analysis redefines GLP-1RAs as disease-modifying agents, not just weight-loss drugs.

👉 Read here: https://doi.org/10.1016/S0140-6736(25)01375-3

#SELECTTrial #Semaglutide #Cardiovascular #Obesity #GLP1RA #TheLancet

Hair Loss in Women" (The New England Journal of Medicine 2025; DOI 10.1056/NEJMcp2412146) 📄, and it's a must‑listen for anyone in clinical practice or research.

The piece highlights that female‑pattern hair loss increases with age and is closely tied to hormonal status, and that treatments span from topical 5% minoxidil or low‑dose oral minoxidil to anti‑androgens and adjunctive non‑drug approaches.

🔍 New in The Lancet! A massive network meta-analysis of 94 RCTs (105,435 patients) reveals that antidepressants impact far more than mood 🧠—they alter weight ⚖️, glucose 🩸, BP 💓, lipids 🧬, and liver enzymes 🧪.

Agomelatine 🌙 may lower weight, while nortriptyline 📈 raises heart rate. Time to rethink side-effect profiles when prescribing!

📚 Pills, Pressure, and Physiology — catch the full summary & clinical pearls now!

#Antidepressants #CardiometabolicHealth #Depression #PrecisionMedicine #Lancet 🧠💊⚖️

🧬 Her Genes, His Risk, Our Mind 💡

New insights from Thomas et al., Nature Communications (2025) — summarized beautifully by Na Cai in Nature News & Views. Women carry a heavier polygenic burden for major depressive disorder (MDD), with ~6,000 female-specific variants and stronger genetic links to metabolic traits like BMI and metabolic syndrome. 🧠

Men show a unique X-chromosome signal (IL1RAPL1), pointing to sex-specific biology in depression. Precision psychiatry must evolve to be sex-aware, data-driven, and equitable. ⚕️

#Genomics #Depression #PrecisionMedicine #SexDifferences #Neurogenetics

🦷🫀 New Findings Linking Oral Health to Heart Attacks! 🧬🧫

Groundbreaking research in JAHA reveals that viridans streptococci, common oral bacteria, form biofilms in atherosclerotic plaques that evade immune detection.

These stealthy invaders trigger innate and adaptive immune responses, correlating with plaque rupture, myocardial infarction, and sudden cardiac death.

The study combines autopsy data, endarterectomy samples, immunohistochemistry, TLR activation assays, and genome-wide expression to uncover this bacterial-inflammation nexus.

🧠 Could dental hygiene be the next frontier in cardiovascular prevention?

📖 Karhunen et al. JAHA. 2025;14:e041521

🔗 #Cardiology #Immunology #OralHealth #Atherosclerosis #Biofilm #PrecisionMedicine #JAHA #DentalHealth #SuddenCardiacDeath #MultiOmics #CHD #ViridansStreptococci #PlaqueRupture #InnateImmunity #AdaptiveImmunity #TLR2 #NFkB #Streptococcus #MI #Endarterectomy

🧠 Why Does Alzheimer's Affect More Women Than Men?

New insights from JAMA Medical News reveal that the answer goes far beyond longevity. 🌸

Biology, hormones, and even social factors intertwine — from estrogen decline and X chromosome genetics to APOE4 risks and underdiagnosis due to stronger verbal memory.

Women make up two-thirds of all Alzheimer's cases, yet most clinical trials overlook sex-based analyses. As researchers call for more inclusive designs, one thing is clear — understanding how biology and bias intersect is vital for progress. 💡

🔬 It's time for Alzheimer's research to think beyond averages — and start thinking in X and Y.

#AlzheimersDisease #WomensHealth #Neuroscience #PrecisionMedicine #JAMA #SexDifferences #Neurodegeneration

🚨 New Study Alert 🕒

Can when you eat improve how you feel?

This open-label pilot study shows that Time-Restricted Eating (TRE) — limiting food intake to an 8–10 hour window — significantly improved:

✅ Quality of Life (↑ SF-36 & ↓ MAPS scores)

✅ Orthostatic Heart Rate (↓ by 11 bpm, p

✅ Mitochondrial ATP production (↑, p

TRE may offer a safe, feasible, and non-pharmacological tool for managing Postural Orthostatic Tachycardia Syndrome (POTS) — especially in the Long COVID era.

📄 Dzotsi et al., Scientific Reports, 2025

🔗 https://doi.org/10.1038/s41598-025-16836-2

#TimeRestrictedEating #POTS #LongCOVID #CircadianMedicine #Dysautonomia #LifestyleMedicine #Mitochondria #ClinicalTrials #Cardiology #AutonomicDisorders

🌟 Guru Nanak (1469–1539 CE): The Voice of Oneness & Compassion 🌟

From Ik Onkar (One God) to Seva (selfless service), Guru Nanak's message transcends faith — reminding us that true spirituality lies in equality, honesty, and compassion. 🕊️ His principles — Naam Japo (meditate), Kirat Karo (work honestly), Vand Shhako (share with others) — continue to inspire communities and caregivers alike. 👩‍⚕️👨‍⚕️

💡 In medicine, his teaching "Serve all, see the divine in all" beautifully aligns with our duty of empathy and ethical care. ❤️

#GuruNanak #Sikhism #Compassion #Oneness #Seva #Healthcare #Ethics #Mindfulness #Inspiration

🚨 New Study Alert 🩺

Think you're low-risk? Think again. This MESA study shows that even "low-risk" individuals may harbor hidden coronary artery calcium (CAC) — and it matters.

📈 Adding CAC scoring significantly improved ASCVD risk prediction, reclassifying up to 18% into statin-eligible groups.

🧠 Implication? Precision prevention may start with a scan.

🔗 Read in American Journal of Preventive Cardiology: https://doi.org/10.1016/j.ajpc.2025.101329

#Cardiology #CAC #RiskStratification #MESA #PreventiveCardiology #PrecisionMedicine #StatinDecisions

🧬 Cellular senescence is more than just a marker of aging — it's a key driver of ❤️ cardiovascular disease. From the p53/p21 and p16/Rb axes to mTOR, SIRT1/6, NF-κB, and ROS/DDR, these molecular pathways halt cell division, fuel inflammation 🔥, and impair cardiac repair. Emerging data spotlight the roles of 💣 SASP, 🧓 senescent MSCs, and 🎯 microRNAs in accelerating vascular aging. Time to rethink how we tackle heart disease — at the cellular level. 🫀

📄 Based on: The role of cellular senescence in cardiovascular disease (doi:10.1038/s41569-023-00899-1)

#Cardiology #Senescence #CVD #Inflammaging #PrecisionMedicine #MolecularCardiology #HeartHealth

🚨 Hidden heart risks in plain sight? 🫀🩻

The latest AHA Scientific Statement unveils the power of opportunistic coronary artery calcium (CAC) detection on routine noncardiac chest CTs. With AI-driven automation, we can now detect subclinical atherosclerosis, improve preventive therapy, and bridge disparities—all without additional imaging or cost.

💡 Think Smart. Scan Smarter. Save Lives. 💊🛡️

📄 Circulation. 2025;152:e•••–e•••

🔗 DOI: 10.1161/CIR.0000000000001382

🧠 #Cardiology #CAC #AIinMedicine #PreventiveCare #Atherosclerosis #HeartHealth #CTScan #Radiology #PrimaryPrevention #HealthcareInnovation

🚨 Pickleball's Popularity Comes at a Price 🎾👁️

As the fastest-growing sport in the U.S. hits 20M players, injuries—especially eye and orthopedic—are rising sharply 📈.

New data from JAMA Ophthalmology and JAMA News & Analysis reveal alarming trends: retinal detachments, fractures, falls, and more—mostly in players over 50 👵🧓.

Time to talk prevention: 🥽 eye protection, 🦶 proper footwear, 🏋️‍♂️ conditioning, and ✅ awareness.

Stay safe on the court—don't let fun turn into a fracture! 🛡️💥

#Pickleball #SportsMedicine #InjuryPrevention #Ophthalmology #PublicHealth

🧬 New insights from Nature Medicine!

Researchers reveal that obesity caused by MC4R deficiency — the most common monogenic form — is paradoxically linked to lower LDL-cholesterol, triglycerides, and blood pressure 💡. Despite severe obesity, these individuals show a "metabolically healthier" profile, likely due to altered central melanocortin signaling and reduced sympathetic tone 🧠💓.

These findings challenge traditional views on obesity and open doors for MC4R-targeted therapies to reduce cardiometabolic risk 🚀.

📖 Nature Medicine, 2025 — "Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease risk."

🚼 Game-changer in the NICU! Same-day genome sequencing using Sequencing by Expansion (SBX) delivered actionable results in under 7 hours for critically ill infants 🧬⏱️.

Two life-altering diagnoses—including KCNQ2-related epilepsy—were identified faster than any existing rapid test. Published in The New England Journal of Medicine 📰. Precision care, now on a NICU clock.

🔗 Read more: https://www.nejm.org/doi/full/10.1056/NEJMc2512825

#Genomics #NICU #PrecisionMedicine #WGS #NEJM #RapidSequencing #Innovation #Pediatrics #DigitalHealth

🩺 Desi Hearts, Hidden Plaques, Bold Truths 💓🫀📊

In the Atherosclerosis journal, Manubolu et al. use AI-powered CCTA to expose an alarming reality:

🧬 Young South Asians have high-risk plaque—even when CAC = 0.

📉 Risk scores fail to capture this.

📸 CCTA sees what traditional tools miss.

It's time to personalize prevention for Desi hearts.

#CCTA #DesiHeart #PrecisionMedicine #ASCVD #PlaqueParadox #Atherosclerosis #ManuboluStudy #DigitalCardiology

Microplastics — once dismissed as environmental debris — are now being found in the brain, placenta, heart, and bloodstream. 🧠🫀👶 Recent JAMA (2025) and NEJM (2024) studies link them to inflammation, oxidative stress, and higher cardiovascular risk. ⚠️

From beer to baby bottles, no corner of modern life is untouched. 🍺🍼 It's time for urgent global action — from the Basel Convention to the UN Plastics Treaty — to tackle this invisible invasion before it becomes irreversible. 🌊♻️

#Microplastics #EnvironmentalHealth #CardiovascularMedicine #PrecisionHealth #PublicHealth #Sustainability #GlobalHealth #JAMA

🔬 New paradigm for HFpEF! 🧠 The Adipokine Hypothesis reframes preserved EF heart failure as an endocrine disorder driven by dysfunctional visceral fat. 🫀

Adipokines like leptin, aldosterone & neprilysin disrupt volume, inflammation & fibrosis. Target the fat ➡️ fix the heart! 💡

📄 JACC 2025 | Milton Packer MD

#HFpEF #Cardiology #Adipokines #VisceralFat #Obesity #HeartFailure

🧠 New study in Nature Medicine links shingles (herpes zoster) to increased dementia risk — but there's hope! 💉 Adults ≥50 who received zoster vaccines (ZVL or RZV) had significantly lower dementia rates 📉. Especially protective in older women 👵. Evidence mounts for VZV reactivation as a modifiable risk factor for neurodegeneration 🧬🛡️.

📚 Read more: https://doi.org/10.1038/s41591-025-03972-5

#Dementia #Neuroinflammation #VZV #Vaccines #PublicHealth #Neurology #Geriatrics #Prevention 🧬💭👩‍⚕️

🚨 Real-World vs RCT? Only 1 in 3 patients with AMI-related cardiogenic shock in Japan met the 🔬 DanGer trial criteria for Impella use. The J-PVAD registry (🇯🇵, n=3975) reveals a stark ⚖️ reality: eligibility matters, and survival varies!

🫀 Time to align practice with precision.

📖 Read the full European Heart Journal study for clinical pearls and caveats. #Impella #CardiogenicShock #DanGer #JPVAD #EHJ #MCS #RCTvsRealWorld

🚨 New Era in Medicine! 🩺🤖

JAMA Internal Medicine highlights how Generative AI (GenAI) is reshaping clinical workflows—from AI scribes 📝 to diagnostic copilots 🧠. Physicians must prompt wisely, partner smartly, and practice responsibly. A must-read to stay ahead! 💡📈

#GenerativeAI #DigitalHealth #MedicalEducation #JAMA

🔗 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2840192

🧠✨ New Science Perspective unpacks a "tripartite alliance" between TH17 cells, IL-22 cytokine signaling, and enterocytes in regulating fat absorption! 🥑🧫

Loss of Aster-A in T cells boosts IL-22, suppressing intestinal lipid uptake—a striking example of immune-metabolic crosstalk with implications for obesity and malabsorption. 🔬🛡️

📘 Science, Oct 2025

#Immunometabolism #GutImmunity #LipidAbsorption #ObesityResearch #PrecisionNutrition #TCells #IL22

🌸 Tulsidas (1511–1623 CE): India's Poet of Devotion and Duty ✨

Bridging East and West, Tulsidas transformed spiritual thought much like Dante, Milton, and Luther did in Europe. His Ramcharitmanas made divine wisdom accessible to all, blending poetry, psychology, and ethics. 🌏

A timeless voice for compassion, virtue, and inner transformation — reminding us that love is the highest law. 💫

#Tulsidas #Ramcharitmanas #Philosophy #Leadership #Spirituality #CulturalBridge #Wisdom

🧬💊 How long is too long to wait on statins?

Two new studies reveal a powerful truth: ⏳ It's not just how high your LDL is—but how long you've had it.

🔻 Delayed statin initiation (⏰ >6 months) after detecting high LDL-C is linked with increased risk of MI and stroke.

📆 Enter "Cholesterol-Years"—a concept akin to pack-years for smoking: the longer the LDL exposure, the higher the ASCVD risk.

🚨 Early cholesterol hurts more than late cholesterol.

🛠️ Statins can help—but early action is critical before damage becomes irreversible.

📚 Fascinating insights with real clinical implications for preventive cardiology and public health.

#Statins #LDL #CholesterolYears #PreventiveCardiology #ASCVD #PrecisionMedicine #PublicHealth #LipidManagement #ClinicalPearls 🫀📊

🧬 New Era in Blood-Based Biomarkers! 🩸

A pan-disease atlas of the circulating proteome across 59 diseases and 8,262 individuals reveals powerful insights into age, sex, BMI, and disease-specific protein signatures.

💡 Highlights:

🔹 Over 5,400 proteins profiled using Olink

🔹 Longitudinal stability of wellness proteome

🔹 Machine learning predicts biological age (R² = 0.85)

🔹 Shared vs disease-specific profiles across conditions

🔹 Early signals in cancers like lung and ovarian 🎯

📍 Explore the resource: proteinatlas.org/humanproteome/blood

📖 Read the study in Science: https://doi.org/10.1126/science.adx2678

#Proteomics #PrecisionMedicine #Biomarkers #MultiOmics #HumanProteinAtlas #BloodAtlas #EarlyDetection #SystemsBiology #Cardiology #Oncology #MachineLearning 🧠🔍📊

🫀 New insights from EUROMACS registry!

The latest JACC study explores the delicate ⚖️ trade-off between bleeding 🩸 and ischemic 🧠 events in LVAD patients. While HM3 reduces thrombotic risks, bleeding remains the dominant threat. Time to rethink the “one-size-fits-all” anticoagulation 🧪. Personalized strategies like LD-DOACs & lower INR targets may be the next frontier 🚀. Editorial call to action included!

📘 #Cardiology #LVAD #PrecisionMedicine #JACC #HM3 #BleedingRisk #Anticoagulation

👉 Read more & let’s discuss.

🧬 New NEJM Review Alert!

MGUS — once “undetermined,” now clinically significant.

This comprehensive update by Rajkumar & Kumar reveals how asymptomatic plasma clones may drive renal (MGRS) and neurologic (MGNS) damage 🧠🩺 even without cancer.

🔬 Dive into new diagnostic pathways, risk models (iSTOPMM), and why “watch and wait” no longer fits for all.

📚 A must-read for nephrologists, hematologists, and internists.

#MGUS #MGRS #MGNS #NEJM #Myeloma #PlasmaCellDisorders #MedicalEducation #RenalPathology #Hematology 🧪

🚨 New NEJM Study Alert! 🧬💊

Baxdrostat, a selective aldosterone synthase inhibitor, shows significant BP reduction in patients with resistant & uncontrolled hypertension despite RAAS blockade and diuretic therapy.

✅ SBP ↓ ~9–10 mmHg at 12 weeks

🧂 Targets salt-retaining physiology

⚖️ Well-tolerated: early mild hyperkalemia & hyponatremia

🔁 Durable effect even after withdrawal

A promising step toward precision therapy in tough-to-treat hypertension!

📖 Read more: NEJM Aug 2025 | BaxHTN Trial

#Hypertension #Cardiology #Baxdrostat #Aldosterone #RAAS #NEJM #PrecisionMedicine #ClinicalTrials

📣 New in NEJM: Ultraprocessed Food on an Ultrafast Track 🥫⚡️

Are ultraprocessed foods (UPFs) really the villains of modern nutrition? 🤔

This thought-provoking piece critiques the Nova classification system 🧂📊 and urges caution before reshaping national dietary policy around it.

From 🍟 glycemic spikes to 🧪 questionable additives, the debate is rich — but the evidence? Still cooking. 🔬🍽️

💡 Worth a read for clinicians, policymakers, and food thinkers alike.

#NutritionScience #UPF #PublicHealth #Policy #NEJM #FoodSystems #CarlosMonteiro #NovaClassification #DietaryGuidelines #HealthEquity 🍎🧠

🚨 New insights from the SCD-PROTECT Study! 🫀

In a nationwide German cohort of 19,598 patients with newly diagnosed NICM or MI/CAD, early use of the Wearable Cardioverter-Defibrillator (WCD) offered critical protection during the high-risk window of guideline-directed therapy initiation.

📉 Most shocks occurred in the first 200 days

📈 >50% improved LVEF beyond ICD threshold

🛡️ WCD = early shield + risk stratification tool

Let’s rethink how we protect vulnerable hearts ❤️‍🔥

#Cardiology #SCD #HeartFailure #WCD #LVEF #ICD #ClinicalResearch #HeartHealth #CardiacArrest #PrecisionMedicine

📢 New JAMA Review Alert! 🦋

Hypothyroidism remains a silent disruptor of health — often underrecognized, yet linked with fatigue 😴, weight gain ⚖️, cardiovascular disease ❤️, and reproductive health challenges 🤰.

This latest JAMA clinical review underscores:

✅ Autoimmunity (Hashimoto thyroiditis) as the leading cause

✅ Lifelong levothyroxine 💊 as first-line therapy

✅ The dangers of both over- and undertreatment ⚖️

✅ When to screen, test, and refer 👩‍⚕️

A must-read for clinicians, researchers, and anyone interested in endocrine health 🌍

🚶‍♀️🏃‍♂️⏱️ Not all movement minutes are created equal!

A major Nature Communications study using data from 73,000+ UK Biobank participants wearing accelerometers found:

1 minute of vigorous activity (VPA) = up to 9 mins moderate (MPA) or 94+ mins light (LPA) for reducing mortality, CVD, diabetes, and cancer risk.

This rewrites the old 1:2 rule and urges updates to global guidelines and wearable health metrics.

📲 Time to upgrade from steps to science.

#NatureCommunications #Wearables #ExerciseScience #PublicHealth #VPA #PrecisionHealth #CardiovascularPrevention #UKBiobank

Hidden Horns 🐏, Silent Signals ⚡, New Memories 🧠

A new Science review reframes the hippocampus beyond the classic trisynaptic loop. Once-overlooked regions like CA2, fasciola cinereum, and indusium griseum — along with enigmatic signals such as small irregular activity (SIA) and dentate spikes (DS) — emerge as crucial for social memory, novelty detection, and arousal states. Far from “junk activity,” these dynamics expand our map of hippocampal computation with deep clinical implications.

🚨 Just read the latest Lancet 2025 Seminar on Large-Vessel Vasculitis – a must-read for anyone tracking 🔍 Giant Cell Arteritis, 💥 Takayasu Arteritis, and 🧬 Isolated Aortitis. From 🚑 clinical phenotypes to 🧠 imaging advances and 🎯 targeted biologics like tocilizumab and JAK inhibitors, this article bridges inflammation with innovation.

📸 Vascular imaging, 🔬 immunopathology, and 🧪 new therapies—essential insights for rheumatology, cardiology & internal medicine teams.

📖 Read it, teach it, share it! #Vasculitis #GCA #TAK #Immunology #PrecisionMedicine #Lancet2025

🍬 Can sweeteners help you stay slim?

A new 1-year multicenter RCT in Nature Metabolism shows that replacing sugar with sweeteners & sweetness enhancers supports modest weight loss maintenance ⚖️ and beneficial gut microbiota shifts 🦠—with no adverse cardiometabolic effects 💓.

🚫 Less sugar, ✔️ better weight control, 🧬 smarter microbiota.

The future of precision nutrition may be sweet after all!

🔗 #NatureMetabolism #Obesity #Microbiome #Sweeteners #RCT #WeightLoss #NutritionScience #PrecisionHealth #Cardiology #GutHealth

🚨 Just out in NEJM! In the Phase 3 HYPERION trial, adding sotatercept early in pulmonary arterial hypertension (PAH) slashed clinical worsening risk by 76% vs placebo (HR 0.24, P

🌏 Wang Yangming (1472–1529) — the great Neo-Confucian philosopher-general of the Ming dynasty — taught that true knowledge and right action are one. 🧠💡

His School of Mind emphasized moral intuition, self-cultivation, and compassionate action — insights that still inspire clinicians to align thought, empathy, and care. ❤️‍🩹✨

🌍 Cardiovascular Health in Africa: Insights from WHO STEPS 💓📊

A landmark JAMA Cardiology study analyzed 73,000+ adults across 22 African countries (2003–2022). Findings are sobering:

✅ Only 1 in 4 achieved ideal cardiovascular health.

⚠️ Diet, physical inactivity, and uncontrolled blood pressure remain critical gaps.

👩 Women and those with less education had lower odds of good heart health.

📉 No improvement seen over 2 decades.

An accompanying editorial urges:

🎯 Reframe the focus from risk tracking to building heart health.

💡 Align with SDG 3.4 (reduce NCD deaths) and invest in scalable prevention.

🤝 Partnerships, education, and gender-sensitive policies are vital for change.

👉 Africa’s heart health is at a crossroads. The time to act is now.

#CardiovascularHealth #Africa #WHO #GlobalHealth #SDG3 #Prevention #PublicHealth

🩸🌕🧠 Menstrual Rhythms: Meddlesome Moon & Meandering Minds

Two compelling studies—one from Science Advances and another from BMJ Mental Health—reveal how lunar phases may influence menstrual cycles, and how hormonal rhythms shape psychiatric symptoms.

It’s time we treat the menstrual cycle as a vital sign in mental health, not an afterthought.

🔁 From gravitational pull to emotional flux, the moon–mind connection deserves deeper attention.

#Psychiatry #Chronobiology #WomenInScience #MenstrualHealth #MoonCycles

🚨 New NEJM study highlights a breakthrough in triglyceride management! 🧬 In the ESSENCE–TIMI 73b trial, monthly subcutaneous olezarsen targeting APOC3 cut triglycerides by ~60% at 6 months 📉—with strong safety and nearly 90% reaching normal TG levels.

A promising step in precision lipid therapy! 💉🫀 #Lipidology #RNAtherapeutics #Cardiology #NEJM #Olezarsen #APOC3

🎶 Can creativity and song keep us young? 🧠💓

New research reveals that creative pursuits — from 🎨 painting and 🎻 music to 💃 tango and 🕹️ gaming — can delay brain aging by enhancing neural efficiency and connectivity. Similarly, singing synchronizes heart rate and respiration, promoting cardiovascular balance and emotional well-being.

Both studies highlight a single truth: art heals. 🌈🫀

Whether it’s a brushstroke, a melody, or a breath between verses — creativity is medicine for the mind and heart.

#Neuroscience #Cardiology #Longevity #Creativity #MusicTherapy #BrainHealth #HeartHealth #ArtAndScience #PrecisionMedicine #WellBeing

🌍🥣 Early Breakfast & the Heart 🫀 (Early to Breakfast and Early to Bed Makes You Heart Healthy & Wise!)

From the UK to Spain to the US, evidence keeps piling up: skipping or delaying breakfast is more than a lifestyle choice — it’s linked to multimorbidity, subclinical atherosclerosis, and higher cardiovascular & stroke mortality.

🧬 Genes shape when we eat, but habits matter most.

🥐 A hearty, early breakfast may be a simple marker of resilience and healthy aging.

https://myfox28columbus.com/good-day-columbus/new-study-eat-breakfast-every-day

💡 Public health message:

"Eat like a Horse for Breakfast,

Eat like a Puppy for Lunch,

& Eat like a Birdie for Dinner" RR Baliga

Your Heart May Thank you

💪 Exercise does more than build strength — it reshapes the gut microbiome to fight cancer.

A new Cell study shows that running increases microbiota-derived formate ⚗️, which supercharges CD8 T cell immunity 🛡️ and boosts the effectiveness of immune checkpoint inhibitors 🎯.

🔬 From treadmill mice to human microbiota analyses, the evidence points to formate as a potential biomarker for enhanced cancer therapy.

🏃‍♀️ Move your body, train your microbes, empower your immunity!

#Exercise #Microbiome #Immunotherapy #CancerResearch

2025 ACC Scientific Statement on Inflammation & Cardiovascular Disease 🫀🔥.

Key insights:

✅ hsCRP is as powerful as LDL in predicting risk.

✅ Low-dose colchicine 💊 now FDA-approved for secondary prevention.

✅ Lifestyle matters—Mediterranean diet 🥗, exercise 🏃, no smoking 🚭.

✅ Future therapies: IL-1 & IL-6 inhibitors, cardioimmunology 🧬.

The science is clear—taming inflammation transforms heart health 💡💪.

#Cardiology #Inflammation #Prevention #ACC2025

🔬 Exciting new insights from Nature (2025)!

When mitochondria run low on the right building blocks (deoxyribonucleotides), they mistakenly weave ribonucleotides into their DNA 🧬. The result? Fragile mitochondrial DNA gets expelled, setting off the cGAS–STING pathway and fueling inflammation 🔥—a key feature of ageing and senescence.

🧪 In MGME1-deficient mice, this process drives renal inflammation, while supplementation with deoxyribonucleosides 💊 can calm the storm.

✨ A major step in understanding “inflammageing” and potential interventions for age-related diseases.

#Mitochondria #DNA #Ageing #Inflammation #NaturePaper

🔍 Two influential viewpoints just dropped in JAMA Cardiology on aortic valve replacement (AVR) in asymptomatic severe aortic stenosis (AS).

🫀 Lindman, Braunwald & Pellikka argue that the time has come to move from “watchful waiting” to early intervention (SAVR/TAVR), citing RCTs showing reduced stroke, heart failure hospitalization, and unplanned CV events.

⚖️ Hillis, McCann & Newby counter that the evidence is not yet strong enough for a universal shift—pointing to trial limitations, competing risks in older patients, and the danger of unnecessary procedures.

✨ The debate is clear: Act early or wait carefully?

This conversation is shaping the future of valve guidelines and clinical practice.

“The Evolution of Cancer and Ageing: A History of Constraint” (Nature Reviews Cancer). Fascinating perspective on how tumour suppression mechanisms that protect us early in life may ironically fuel age-related decline later on. ⚖️

From telomeres 🧬 to stem cells 🌱, and from mole rats 🐀 to tortoises 🐢, evolution has shaped a delicate trade-off between cancer resistance and ageing phenotypes. Interventions like rapamycin 💊 and caloric restriction 🥗 remind us that biology is a balancing act between growth, survival, and longevity ⏳.

A reminder that in medicine and science, progress often lies in understanding these evolutionary compromises 🌍💡.

#Cancer #Ageing #Longevity #Evolution #PrecisionMedicine

🌍 Cardiovascular disease (CVD) remains the leading global killer.

📊 In 2023, CVD caused 19.2M deaths and 437M DALYs (JACC).

🔮 By 2050, projections show 35.6M deaths and 1.14B cases (EJPC) — driven by ageing, hypertension, obesity, and dysglycemia.

⚠️ While age-standardized mortality is projected to fall 30%, the absolute burden will nearly double, with the steepest rise in South & East Asia.

✅ Urgent need for region-specific prevention, hypertension control, and equitable health systems to meet this challenge.

💡 The message is clear: we must act today to bend the curve for 2050. ❤️

#JACC #EJPC #GlobalHealth #Cardiology #CVD #Prevention #FutureHealth

🌍 50,000 years of India’s evolutionary history 🇮🇳🧬

New genomic research sequencing 2,762 individuals across India reveals:

✨ A major migration out of Africa ~50,000 years ago

🦴 1–2% ancestry from Neanderthals & Denisovans

🔗 Strong founder effects & endogamy raising recessive disease risk

🧩 >160,000 novel variants unique to India, some linked to immunity & drug response

These findings highlight why India’s genetic diversity must be central to global precision medicine 💊🔬

#Genomics #India #PrecisionMedicine #EvolutionaryHistory

💉 RSV Vaccines: From NEJM to JAMA, Lungs to Heart! ❤️🫁

Evidence is converging—NEJM, DAN-RSV Trial 🇩🇰, CDC real-world study 🇺🇸, and a powerful JAMA editorial 📰—that bivalent RSV vaccines protect not just against severe respiratory illness but may also lower cardiorespiratory hospitalizations in older adults 👵👴.

A new frontier where infection prevention meets cardiovascular health 🌍✨ Kudos to Dr. Tor Biering-Sørensen & Dr. Helen Chu for leading the way! 🙌

#RSV #Vaccines #NEJM #JAMA #Cardiology #PublicHealth #Prevention

🔍 William of Ockham (c.1287–1347), the Franciscan friar & philosopher, gave us Occam’s Razor ✂️—the call to seek the simplest, most evidence-based explanations.

His logic, nominalism & challenge to authority echo in today’s science, ethics & healthcare 🩺📜.

A reminder for providers: clarity, parsimony & humility in reasoning can guide better care. 🌍✨ #Wisdom #Healthcare

🦠💉 Five landmark studies shed new light on influenza vaccines!

🇪🇸 GALFLU (Spain, NEJM): High-dose vaccine cut influenza/pneumonia hospitalizations.

🇩🇰 DANFLU-2 (Denmark, NEJM & JAMA): Neutral primary outcome but signals for fewer CV & HF hospitalizations.

🇨🇳 PANDA II (China, Lancet): In-hospital vaccination lowered mortality & readmissions in acute HF.

📊 JAMA Editorial by Robert Califf: Calls for a true learning health system.

✨ Together, they show small gains per patient can yield huge public health wins!

🌟 New insights into extreme longevity! 🌟

Our latest read on the multiomics blueprint of a 117-year-old supercentenarian reveals how genetics 🧬, metabolism ⚡, microbiome 🌱, and epigenetics 🕰️ can decouple aging from disease.

📊 Findings:

Ultra-short telomeres but no cancer 📉
Protective genetic variants and robust mitochondria 💪
Efficient lipid metabolism (high HDL, low triglycerides) 💧
Low inflammation 🔥
Youth-like microbiome (rich in Bifidobacterium) 🦠
Epigenetic age decades younger than chronological age ✨

⚠️ Limitations: single-subject study, but a powerful window into healthy aging.

💡 Takeaway: Longevity isn’t just about adding years — it’s about adding healthy years. This work opens doors for biomarkers and interventions that could redefine aging.

#Longevity #Multiomics #HealthyAging #PrecisionMedicine #Epigenetics

🚨 New Evidence Alert 🚨

The SWEDEPAD 1 & 2 trials + a powerful Lancet commentary have reshaped how we view paclitaxel-coated devices in peripheral artery disease.

👉 No benefit for amputation or quality of life.

👉 A concerning signal for higher 5-year mortality in claudication.

👉 Registry-based RCTs prove invaluable for real-world insights.

⚖️ Message: Harm may outweigh benefit — time to rethink strategies and explore alternatives like sirolimus.

#PAD #ClinicalTrials #Cardiology #SWEDEPAD 🫀

🚨 Breakthrough in Huntington’s Disease 🧬🧠✨

Exciting results from the pivotal Phase I/II AMT-130 gene therapy trial show a 75% slowing of disease progression at 36 months compared to controls. Key functional and cognitive endpoints (cUHDRS, TFC, SWRT, SDMT) also demonstrated significant benefit, alongside biomarker reduction in CSF neurofilament light chain 📊🔑.

💉 Delivered via precision stereotactic neurosurgery, AMT-130 was well-tolerated and shows clear evidence of a dose–response effect. A BLA submission is planned for 2026, potentially marking a landmark shift in Huntington’s disease care.

🌍 For patients and families living with HD, these results provide long-awaited hope.

#HuntingtonsDisease #GeneTherapy #ClinicalTrials #Neurology #PrecisionMedicine #Innovation 🚀

🚨 GLP-1 Medicines: Beyond Diabetes! 💉🧠💪

From weight loss to brain health, the future of GLP-1 therapies is unfolding fast! 🌍✨

New agents like retatrutide and MariTide are redefining outcomes in obesity, neurodegeneration, and substance use disorders.

🔬 Oral options, muscle-sparing combos, and triple agonists are here.

🧪 Dive into 15+ FAQs from the latest JAMA 2025 Perspective — formatted with emojis, clinical pearls, and clear takeaways.

📥 Message me if you’d like the .pptx version!

#GLP1 #Tirzepatide #Semaglutide #ObesityCare #NeuroEndocrine #JAMA #PrecisionMedicine #PharmaInnovation #Endocrinology #MetabolicHealth #LinkedInLearning

💡 Fresh insights from a randomized crossover trial in people with Type 2 Diabetes (T2D)! 🍽️🚶‍♂️

High-fat 🥑 and high-carb 🍞 meals, with or without a light post-meal walk, showed no adverse effects on cardiac autonomic modulation or ECG intervals. ✅ Heart rate variability held steady, and walking even gave a gentle boost without risk.

🫀 Key Takeaway: Flexible dietary choices and safe postprandial walking may support everyday life in T2D without destabilizing the heart.

#DiabetesCare #Cardiology #HRV #LifestyleMedicine #ClinicalResearch #ExerciseIsMedicine #NutritionScience #AutonomicFunction #ScientificReports 📊

🚨 New Insights in Dilated Cardiomyopathy (DCM)! 🫀

Fibroblasts aren’t just bystanders — they’re mechanical rheostats shaping disease severity. 🧬

This groundbreaking study shows that blocking p38 signaling halts fibrosis, boosts contractility, and may redefine how we treat DCM. 💥

🧠 Think beyond myocytes. Think collective cell behavior.

🧪 Read the full paper in Science:

“Preventing Hypocontractility-Induced Fibroblast Expansion Alleviates DCM”

#Cardiology #HeartFailure #Fibrosis #ECM #PrecisionMedicine #Fibroblasts #DCM #p38MAPK #HeartResearch #TranslationalMedicine 🧵

🚨 New frontier in #NeuroRehab & #BioelectronicMedicine!

Just explored two groundbreaking studies on autonomic dysreflexia and implantable neurostimulation in spinal cord injury (SCI) 🧠💥

⚡ One reveals the neuronal circuitry driving dangerous BP spikes

🔌 The other shows how epidural stimulation at T11–L1 can restore BP within 2 minutes

💡 Together, they mark a paradigm shift—from managing symptoms to rewiring circuits.

#SCI #SpinalCordInjury #Neuroscience #CardiovascularHealth #ImplantableDevices #Dysreflexia #LinkedInLearning #PodcastDrop #Innovation #ClinicianScientist

🫀 NEWTON-CABG Trial: Can intensive LDL-C lowering prevent vein graft failure after CABG?

💉 Evolocumab slashed LDL-C by ~50%, but did not improve SVG patency at 2 years. Why? Timing is everything.

🧠 Early SVG failure = thrombosis & hyperplasia—not classic atherosclerosis. LDL-C ≠ magic bullet here.

#Cardiology #CABG #LDL #PCSK9 #Evolocumab #CardioTrials #Lipids #HeartHealth #GraftPatency #ClinicalResearch #JACC #TheLancet #SurgeryMeetsPrevention

🧠💤 Why do we sleep? A groundbreaking Neuron article explores this timeless question through a bold new lens:

🛌 The Motor Theory & Catecholamine Hypothesis of Sleep.

Instead of a single “sleep center,” 🧬 sleep emerges from distributed motor control circuits regulating both somatic & autonomic activity.

And the “why”? 😴 Suppressing dopamine, noradrenaline & adrenaline may be key to healing our brain, body, & immune system.

📉 Sleep isn’t passive—it’s active neural choreography for recovery.

📚 Read if you’re into neuroscience, systems biology, or sleep medicine.

🔗 https://www.cell.com/neuron/fulltext/S0896-6273(25)00623-3

#SleepScience #Neuroscience 🧠 #MotorTheory #Catecholamines #Neuron #PrecisionMedicine #BrainHealth #SleepResearch #WhyWeSleep #SystemsBiology

🚨 New insights from the Lancet! 🚑

In the OPTION–STEMI trial, immediate multivessel PCI during the index procedure failed to show non-inferiority compared to staged revascularisation in STEMI patients with multivessel disease.

🧠 Key takeaway? Timing matters.

⚠️ Higher risk in those with heart failure (Killip II/III)

💡 Safer strategy: staged PCI for high-risk patients

📊 Fractional flow reserve, procedural MI, and guideline implications all in focus.

A must-read for interventionalists & clinical guideline leaders.

🔗 https://doi.org/10.1016/S0140-6736(25)01529-6

#STEMI #PCI #InterventionalCardiology #Lancet #CardioTwitter #Revascularisation #KillipClass #FFR #ClinicalTrials #Cardiology ❤️🫀

✨ St. Thomas Aquinas (1225–1274) — Dominican friar, philosopher & theologian — is among the most influential thinkers in Western tradition. 📖 His Summa Theologica shaped Catholic theology, blending Aristotle’s philosophy with Christian faith. 🕊️ Known as the Doctor Angelicus, he championed faith & reason, natural law ⚖️, and virtue ethics 💡— principles that still guide philosophy, theology, and even modern healthcare ethics 🏥. 🌍

#Philosophy #Theology #Healthcare #Leadership #Wisdom

🚨 New Podcast Drop! 🎙️

“VICTOR, Vericiguat, and Victory?” unpacks the Lancet trilogy — the VICTOR trial, pooled analysis, and expert commentary 🧠📊💊. We explore Vericiguat’s evolving role across the heart failure spectrum 💓📉 and what it means for clinical care in HFrEF patients.

📚 Trials discussed: VICTOR, VICTORIA

🎧 Tune in for insights on risk-based treatment effects, NT-proBNP thresholds, and more!

#HeartFailure #Vericiguat #HFrEF #Lancet #Cardiology #RCT #NTproBNP #Podcast #MedicalEducation #EvidenceBasedMedicine

🎭 Just explored a landmark Nature Medicine review on how the arts can prevent noncommunicable diseases (NCDs) across 27 countries!

🎨 From dance and drama to gardening and storytelling, arts-based interventions improved physical activity, diet, and mental well-being—especially in underserved communities.

📊 A must-read for anyone interested in health equity, cultural relevance, and community-led innovation in public health.

👇 Dive into the power of creativity for prevention!

#NCDs #ArtsInHealth #HealthEquity #PublicHealth #SocialDeterminants #GlobalHealth #PreventionMatters 🎶🌱📚🩺

💊 Orforglipron: A new era in obesity treatment?

In the ATTAIN-1 trial, this oral, nonpeptide GLP-1 receptor agonist delivered up to 11.2% weight loss over 72 weeks—with significant drops in waist circumference, triglycerides, and blood pressure 📉🌡️

🔥 Nearly 1 in 5 patients lost ≥20% body weight

💡 A promising alternative to injectable therapies

Accessible. Effective. Oral.

👉 A game-changer for global obesity care?

#Obesity #GLP1 #Orforglipron #WeightLoss #CardiometabolicHealth #NEJM #Innovation #ClinicalTrials #Endocrinology #PublicHealth #Pharmacotherapy

🚨 New Podcast Drop! 🎙️

“Myosin, Metrics & Momentum 🧬📈🫀” dives into 3 landmark NEJM articles on Aficamten vs Mavacamten in hypertrophic cardiomyopathy.

We decode:

🔹 MAPLE-HCM (obstructive HCM)

🔹 ODYSSEY-HCM (nonobstructive HCM)

🔹 Expert editorial insights on PROs, EF, & trial design

🎯 Learn what matters: peak VO₂ vs PROs, safety signals, and the road ahead in precision cardiomyopathy care.

🎧 Tune in and share! #HCM #CardioTwitter #NEJM #HeartFailure #MyosinInhibitors #Podcast

💊 New Hope in a Pill for Obesity?

The 71-week OASIS 4 trial shows that oral semaglutide 25 mg led to a 13.6% weight loss, improved physical function, and reversed prediabetes in 71% of cases—all without injections.

📉 Effective. 🧬 Metabolically beneficial. 📦 Orally delivered.

#ObesityCare #GLP1 #Semaglutide #NEJM #DigitalHealth #Cardiometabolic

☀️ Walking on Sunshine? Rethinking Our Relationship with the Sun! 🧴🧬

New research—spotlighted in The Economist (Sep 20, 2025)—challenges old assumptions: Could moderate sun exposure reduce cardiovascular mortality? ❤️📉

From nitric oxide to vitamin D, this FAQ explores the science, nuance, and shifting global guidelines.

Let’s talk melanin, mortality, and medicine! 🌍💡

#Sunlight #CardiovascularHealth #TheEconomist #PublicHealth #MedicalEducation

🚨 Cardiogenic Shock—A Decade Later

The DanGer Shock Trial shows that patients with STEMI and shock treated with the Impella CP microaxial flow pump lived 600 more days over 10 years vs standard care alone.

📉 Mortality: 52.5% vs 68.8% (HR 0.70)

🛠️ Despite higher adverse events, the survival benefit endured a full decade.

📊 This changes how we think about long-term outcomes in mechanical support.

🔗 Time to revisit your shock protocols?

#DanGerShock #Impella #CardiogenicShock #STEMI #LongTermOutcomes #NEJM #MCS #Cardiology #SurvivalBenefit #ImpellaCP

🧠 Hypertrophic Cardiomyopathy — A Masterclass from Eugene Braunwald 🧬

📌 Just published in NEJM (Aug 2025): a sweeping, state-of-the-art review on HCM — from Teare’s first autopsy to myosin inhibitors, AI diagnostics, and gene therapy.

💥 Clinical insights, historical depth, trial data (EXPLORER-HCM, SEQUOIA-HCM, VALOR-HCM), and future-facing advances—all distilled into one must-read.

📉 SCD prevention, 🫀 LVOT obstruction, 🧪 MYBPC3/MYH7 mutations, 🧬 proteomics, and more.

🔗 Essential reading for cardiologists, geneticists, and translational scientists.

#HCM #Braunwald #NEJM #Cardiology #PrecisionMedicine #Mavacamten #Aficamten #GeneTherapy #MedicalEducation #SCDprevention

🚨 New NEJM Study on Olezarsen 🚨

In patients with moderate hypertriglyceridemia and elevated cardiovascular risk, monthly subcutaneous olezarsen reduced triglycerides by over 60% at 6 months! 📉💥

✅ Significant drops in APOC3, VLDL, remnant & non-HDL cholesterol

✅ No rise in LDL-C

✅ Well-tolerated with mild injection-site reactions

🔬 APOC3 inhibition emerges as a game-changer in lipidology.

📖 ESSENCE–TIMI 73b Trial | Funded by Ionis Pharmaceuticals

#Cardiology #LipidLowering #PrecisionMedicine #NEJM #Olezarsen #TGlowering #CVRisk #TIMI #Atherosclerosis #GenomicTherapy 🧬💊🫀

🌸 Dōgen Zenji (1200–1253), founder of the Sōtō Zen school in Japan, taught that true practice lies in zazen—“just sitting” 🧘‍♂️—where enlightenment and practice are inseparable.

His Shōbōgenzō continues to inspire mindfulness & presence today. ⏳✨

#Zen #Mindfulness

🚨 New Evidence in NSTEMI Care! 🫀

The SLIM Trial shows that FFR-guided complete revascularization during the index procedure in patients with NSTEMI and multivessel disease significantly reduces death, MI, stroke, and repeat PCI compared to culprit-only PCI.

🎯 Key win? Fewer revascularizations, better outcomes — physiology beats anatomy again.

📚 Published in JAMA, presented at #ESC2025

🔗 Read more: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.16189

#Cardiology #NSTEMI #FFR #InterventionalCardiology #EvidenceBasedMedicine #SLIMTrial

💥 Practice-Changing Evidence in HFpEF! 💥

In a real-world cohort of 97,000+ patients with obesity & type 2 diabetes, semaglutide and tirzepatide reduced risk of heart failure hospitalization or death by over 40% 📉

⚖️ No meaningful difference between the two agents.

🧠 Findings reinforce STEP-HFpEF & SUMMIT trials and highlight GLP-1 therapies’ expanding role in cardiometabolic HFpEF 🫀

#Cardiology #HFpEF #GLP1 #Semaglutide #Tirzepatide #T2DM #RealWorldEvidence #JAMA #HeartFailure

📢 Just read the #AMALFI trial in JAMA 📰 — a landmark remote RCT of AF screening using 14-day ECG patches mailed to older adults at stroke risk 📦🫀. At 2.5 years, the patch group had a modestly higher AF detection rate (6.8% vs 5.4%, p=0.03) and increased anticoagulation use 💊🧠. Stroke rates were similar ⚖️.

🎯 Key takeaway: Remote, mail-based AF screening is feasible and nudges diagnosis rates — but will it move the needle on outcomes?

#AFib #StrokePrevention #RemoteMonitoring #ECG #Cardiology #RCT #JAMA #DigitalHealth #Geriatrics 🧓📉

🚨 New Trial Alert 🚨

Can we safely stop anticoagulation after AF ablation? The ALONE-AF Trial 🫀 suggests yes—in selected patients with no AF recurrence, stopping DOACs reduced major bleeding 🌟 without increasing stroke risk 🧠.

📉 0.3% vs 2.2% for the composite outcome (P = .02)

📍 Carefully monitored, low-risk patients may benefit most.

📝 Editorial: Recommends shared decision-making 🤝 & individualized rhythm monitoring.

📚 A potential shift in post-ablation care.

🔗 #AFib #Anticoagulation #EPTrials #CardioTwitter #StrokePrevention #JAMA #ALONEAF #Electrophysiology #SharedDecisionMaking #ClinicalTrials

🚨 New Findings from the HELP-MI Trial! 🇸🇪🧪

Can routine Helicobacter pylori screening during acute myocardial infarction (MI) hospitalization prevent upper gastrointestinal bleeding (UGIB)?

💉 Over 18,000 patients across 35 Swedish hospitals

📉 Result: No significant reduction in UGIB overall (RR 0.90; P=0.18)

🔍 BUT: Clear benefit in patients with anemia (RR 0.44–0.64) and chronic kidney disease (RR 0.75)

🧠 Key Takeaway: Routine screening isn’t broadly warranted—but targeted testing in high-risk AMI patients may be the smarter path forward.

📊 #Cardiology #Gastroenterology #HPylori #HELPMI #EvidenceBasedMedicine #SWEDEHEART #MI #GIbleeding #RCT #PrecisionMedicine

🩺 New Insights on Apixaban for VTE!

📢 The HI-PRO trial challenges the old 3-month rule for provoked VTE.

📉 Extended low-dose apixaban (2.5 mg BID) reduced recurrent VTE from 10.0% ➡️ 1.3% with minimal major bleeding.

🎯 Editorial in NEJM urges a shift from binary labels (“provoked vs unprovoked”) to a patient-centered, risk-adapted approach.

🧠 Art meets evidence in the decision to extend anticoagulation.

💬 Let’s rethink how we label, risk-stratify, and treat.

📚 #VTE #Apixaban #Anticoagulation #NEJM #HI_PRO #Thrombosis #PrecisionMedicine #SharedDecisionMaking #EvidenceBasedMedicine #Cardiology

🌏 Zhu Xi (1130–1200), a master of Neo-Confucianism, reshaped Chinese philosophy with his focus on rationality, self-cultivation & education. His commentaries on the Four Books guided civil service exams for centuries across East Asia. 📚✨

#Leadership #Philosophy #History #Confucianism

Just read the latest from NEJM? The PIpELINe Trial 🇮🇹 changes how we approach cardiac rehab in older adults post-MI! 🧓❤️

🎯 A 12-month, multidomain intervention — risk factor control, nutrition 🥗, and Otago-based exercise 👟 — cut CV death/hospitalization from 20.6% → 12.6% (P=0.01)!

📉 Hospitalizations for heart failure dropped 7.1% → 1.5%. No serious adverse events. And yes — better gait speed, handgrip strength, and quality of life too.

This is how we shift from survival ➡️ functional independence in aging populations. 🙌

👇 Would you apply this model to your older patients post-MI? #CardioRehab #AgingWell #NEJM

🚨 New Meta-Analysis Alert! 💊🫀

Can β-blockers benefit patients post-MI with mildly reduced ejection fraction (LVEF 40–49%)?

📊 An individual patient data meta-analysis (REBOOT, BETAMI, DANBLOCK, CAPITAL-RCT) shows a 25% reduction in the composite outcome of death, MI, or HF with β-blockers vs. control (HR 0.75; p=0.031) — even in the absence of clinical heart failure.

🌍 Consistent across trials and countries. Most benefit seen in patients

🚫💊 Should We Rethink Beta-Blockers Post-MI?

In the landmark REBOOT trial (NEJM, 2025), beta-blockers failed to reduce mortality, reinfarction, or heart failure hospitalizations in post-MI patients with preserved ejection fraction (>40%).

💡 A modern, pragmatic trial across 109 centers (Spain + Italy 🇪🇸🇮🇹) with 8438 patients — shaking the foundation of our long-held post-MI practices.

👩‍⚕️ Signals of potential harm in women and STEMI subgroups raise questions, not answers.

📉 Should guidelines change? Or should practice just evolve?

#Cardiology #REBOOTTrial #BetaBlockers #NEJM #PrecisionMedicine #MedicalEducation #HeartAttack #LVEF #Guidelines #ClinicalTrials #InternalMedicine #EvidenceBasedMedicine #Revascularization

🚨 New NEJM Study Alert! 🩺💔

Do beta-blockers still help after a heart attack if there’s no heart failure? 🤔

In the BETAMI–DANBLOCK trial (🇩🇰+🇳🇴, n=5574), beta-blocker therapy in post-MI patients with preserved or mildly reduced LVEF (≥40%) modestly reduced the composite outcome of death or major cardiovascular events 🧠📉

📌 Primary endpoint: 14.2% (BB) vs. 16.3% (no BB) → HR 0.85, p=0.03

💡 Especially lowered risk of recurrent MI (HR 0.73)

🧠 Even in the era of PCI, DAPT & statins, beta-blockers may still bring benefit — especially in patients with mildly reduced LVEF (40–49%) 🫀

🔗 [Add your slide link or DOI here]

#Cardiology #NEJM #HeartAttack #BetaBlockers #PostMI #EvidenceBasedMedicine #LVEF #PrecisionMedicine #ClinicalTrials

💥 New NEJM Trial Alert!

A modest 0.3 mmol/L rise in potassium (via MRA, KCl, or diet) significantly reduced arrhythmias, ICD shocks, and hospitalizations in high-risk ICD patients ⚡🫀

📉 HR 0.76 for the composite endpoint

🔢 NNT = 12.3 over 3.3 years

🍌 Safe, scalable, and globally relevant

👉 Time to rethink “normal” K⁺ levels in cardiology!

#Cardiology #Electrophysiology #NEJM #ICD #Potassium #POTCAST

🚨 New RCT Alert from the NEJM!

Can an old 💊 make a comeback in modern 💓 failure care?

📌 The DIGIT-HF trial showed that digitoxin, a cardiac glycoside with hepatic clearance, reduced the combined endpoint of all-cause death or HF hospitalization in HFrEF patients on contemporary guideline-directed therapy — including ARNI, beta-blockers, MRAs & SGLT2i.

🩺 HR = 0.82; p = 0.03 📉

👩‍⚕️ Safe in CKD, consistent benefit in women.

⚠️ Serious AEs slightly higher (4.7% vs 2.8%)

📥 NNT = 22.

💡Is it time to reconsider digitoxin in advanced HFrEF?

#CardioTwitter #HFrEF #HeartFailure #Digitoxin #NEJM #Cardiology #SGLT2i #GuidelineTherapy

🚨 Calcific Aortic Valve Stenosis (CAVS): Beyond Wear and Tear 🫀🪨

Once thought to be “degenerative,” CAVS is now recognized as an active disease driven by oxidative stress ⚡, inflammation 🔥, and lipoprotein(a) 🧬. Despite its growing global burden, no drug therapy slows its progression.

🩺 Current management: Surgical (SAVR) or Transcatheter (TAVR) valve replacement.

💊 Emerging hope: PCSK9 inhibitors, Lp(a) lowering agents, SGLT2 inhibitors, soluble guanylate cyclase activators, and anti-inflammatory strategies.

📊 Modern tools: Aortic valve calcification on CT, PET imaging for microcalcification, and strain imaging for early detection.

🔑 Takeaway: CAVS is preventable in theory, but not yet in practice. Novel therapeutics may finally reshape its natural history.

#Cardiology #HeartValve #PrecisionMedicine #AorticStenosis

🚨 New in The Lancet (2025) 🚨

A mega meta-analysis of 484 RCTs (104K+ participants) offers a game-changing approach to hypertension management! 💊📉

Instead of guessing how much BP will drop, now you can predict it—by drug, dose, and combo! 🎯

Like statins for LDL, this study introduces low-, moderate-, and high-intensity BP regimens based on expected mmHg reductions. 💡

Use the free calculator 🔢 at www.bpmodel.org and rethink the “measure-treat-measure” loop.

🩺 Data-driven. Predictable. Efficient. Just what primary care and cardiology need.

#Hypertension #BloodPressure #Cardiology #MetaAnalysis #PrecisionMedicine #Lancet2025 #BPcalculator #MedTwitter #InternalMedicine #DigitalHealth 💻📊🧬

🧒❤️ Partial Heart Transplant: A Growing Solution for Growing Hearts! 🌱🔬

🚨 Pediatric patients with congenital heart valve disease often face multiple surgeries due to non-living valve grafts that don’t grow. This landmark study from @DukeHealth shows how living valves via partial heart transplant can change the game.

📊 In 19 patients (median age: 97 days), transplanted valves showed true annular and leaflet growth — with low immunosuppression and no valve-related reinterventions. The innovative “Living Ross” approach offers a promising path for long-term durability.

🧬 Organ stewardship, reduced surgeries, and biologic adaptation — the future is here.

🔗 Read the full JAMA study

#PediatricCardiology #HeartTransplant #InnovationInSurgery #LivingRoss #JAMA #CardiacSurgery #ValveReplacement #CongenitalHeartDisease #PartialHeartTransplant #PrecisionMedicine 🫀📈

🐖🫁 World First: Pig Lung Transplanted into Human 🧬🌍

In a groundbreaking step for xenotransplantation, a team in China successfully transplanted a genetically modified pig lung into a brain-dead human recipient. The lung functioned for 216 hours without hyperacute rejection, offering hope to thousands on organ waitlists.

🔬 Key breakthroughs:

• 6-gene-edited donor pig

• No Porcine Endogenous Retrovirus (PERV-C) detected 🦠

• Controlled immune response 🛡️

• PGD observed but stabilized 💉

📖 Published in Nature Medicine: https://doi.org/10.1038/s41591-025-03861-x

👏 A monumental leap toward clinical trials and saving lives.

#Xenotransplantation #LungTransplant #OrganDonation #Immunology #PrecisionMedicine #NatureMedicine #TranslationalScience 🚀

🧬 Pre-Heart Failure? Let Age Speak! 👵👴

New study in JACC compares fixed vs age-adjusted NT-proBNP cutoffs for defining pre–heart failure (Pre-HF) in over 22,000 adults across ARIC, MESA, and CHS cohorts.

📉 Key Insight: Age-adjusted cutoffs reduce overdiagnosis in older adults 🧓 and improve risk prediction for heart failure hospitalization 🏥.

📊 With better C-statistics, NRI, IDI, and a lower number needed to screen, the age-specific approach proves more precise—especially in those ≥75 years.

⚖️ One-size-fits-all doesn’t fit the aging heart. Time to tailor biomarkers by age! ⏳❤️

#HeartFailure #NTproBNP #Cardiology #PrecisionMedicine #Biomarkers #PreventiveCardiology #JACC #PreHF #RiskStratification #PopulationHealth

🚨 Game-Changer in Lung Cancer! 🫁💉

The 5-year results from CheckMate 816 are in! Neoadjuvant nivolumab + chemotherapy significantly improved survival in resectable NSCLC 🎯

✅ 65.4% 5-year OS vs. 55.0% with chemo alone

🧬 pCR = 95.3% survival

📉 ctDNA clearance = better outcomes

⚖️ Time to rethink neoadjuvant strategies

📚 Read in NEJM: A landmark in thoracic oncology!

#LungCancer #Immunotherapy #NSCLC #Nivolumab #Oncology #CancerResearch #PrecisionMedicine

🚨 New insights from EHJ 2025! 🚨

In statin-treated patients undergoing PCI, inflammation (hsCRP ≥2 mg/L)—not elevated LDL-C—was the strongest predictor of MACE at 1 year 🔥🧪

📊 Bay et al. show that residual inflammatory risk carries a 1.8x higher hazard for adverse events, while LDL-C alone showed no independent risk 💥

🧠 Time to shift focus beyond lipids: consider anti-inflammatory therapies, remnant cholesterol, and Lp(a) in risk stratification 🩺🎯

📖 Read the study ➡️ https://doi.org/10.1093/eurheartj/ehaf196

#Cardiology #Inflammation #ResidualRisk #PCI #Statins #PrecisionMedicine

🔎 Averroes (Ibn Rushd, 1126–1198), the “Father of Rationalism,” bridged Islam & the West through philosophy, medicine & law. 🌍

His commentaries on Aristotle, theory of the intellect, and medical insights (stroke, Parkinson’s, retina) shaped centuries of thought.

📚 His legacy reminds us that reason, faith & science can coexist in pursuit of truth.

💡 #Philosophy #Medicine #History

🚨 New Study Alert 🧬🫀

Think a CAC score of zero means you’re in the clear? Think again.

A massive cohort from the Western Denmark Heart Registry (n = 23,777) shows that elevated LDL-C is strongly associated with non-calcified plaque 🧱 and future coronary events 💥—even in those with CAC = 0.

📈 Each 1 mmol/L (~39 mg/dL) rise in LDL-C increases the odds of plaque (aOR 1.21) and risk of CHD (aHR 1.28).

🔥 Risks were highest in individuals ≤45 years—a silent threat during prime decades of life.

💡 Takeaway: No calcium ≠ No risk. LDL-C still drives subclinical disease.

👩‍⚕️👨‍⚕️ Time to rethink statin strategy in younger adults with “reassuring” scans.

📚 Read more in European Heart Journal (2025):

👉 https://doi.org/10.1093/eurheartj/ehaf497

#LDL #CAC #Cardiology #Atherosclerosis #CHD #Prevention #Lipidology #CCTA #PrecisionMedicine #Statins #EHJ #SubclinicalDisease #CardioLinked

🚨 New in NEJM 🫁: The IMPALA-2 trial shows that inhaled molgramostim significantly improves gas exchange, quality of life, and exercise capacity in patients with autoimmune pulmonary alveolar proteinosis (aPAP)—a rare disease driven by GM-CSF autoantibodies.

💨 Say goodbye to whole-lung lavage—this is a bench-to-bedside success story 30 years in the making.

🔬 From GM-CSF knockout mice ➡️ inhaled cytokine therapy ➡️ regulatory-grade RCT.

🏆 A major win for translational respiratory medicine.

#Pulmonology #RareDiseases #GMCSF #AutoimmuneDisease #Molgramostim #PrecisionMedicine #TranslationalResearch #NEJM #aPAP #LungHealth #RCT #CytokineTherapy #BenchToBedside #InhaledTherapy 🧬🫁💊

🚨 New Stroke Trial Alert! 🧠💉

Can IV alteplase help beyond the 4.5-hour mark? The HOPE trial (JAMA 2025) says YES—if perfusion imaging shows salvageable brain tissue 🧬🕑.

📊 Functional independence at 90 days improved from 26% ➡️ 40%, despite a small uptick in symptomatic ICH (3.8%).

🌍 Game-changer for patients in low-resource settings where thrombectomy isn’t an option.

📖 Read more: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.12063

#StrokeCare #Thrombolysis #Alteplase #Neuroimaging #HOPEtrial #JAMA #StrokeResearch #GlobalHealth #BrainRescue #MedicalInnovation

🚀 Exciting breakthroughs in metabolic medicine! 💊 This August 2025 Nature Reviews Drug Discovery review by Dr. Daniel Drucker dives deep into the evolution of GLP-1-based therapies—covering semaglutide, tirzepatide, multi-agonists, oral small molecules, and their growing impact beyond diabetes into obesity, liver disease, and neurodegeneration. 🧠⚖️💥

📉 From gut hormones to global health, GLP-1 therapies are redefining chronic disease care.

🔗 Read, reflect, and get ready for what’s next: #GLP1 #ObesityMedicine #IncretinTherapies #PharmaInnovation #MetabolicHealth #Tirzepatide #Semaglutide #DrugDiscovery #PrecisionMedicine #Endocrinology 💥

🚨 New insights from the European Heart Journal! 🫀✨

This study shows that where you store fat — not just how much — matters for how your heart and arteries age.

📌 Android fat (belly) = faster cardiovascular aging

📌 Gynoid fat (hips/thighs) = protective, especially in women

🧬 Using MRI (ShMOLLI), metabolomics & AI (CatBoost), researchers predicted cardiovascular age from fat patterns.

💡 A wake-up call for personalized risk, not just BMI!

#CardioMetabolic #PrecisionMedicine #VascularAging #SexDifferences #BodyFat #EuropeanHeartJournal #Cardiology 🧠📊🧘‍♀️

👨‍⚕️🔬 Just explored the latest JAMA review on Prostatitis—a masterclass in clarity and clinical relevance! From LUTS to CP/CPPS, it unpacks the full spectrum: 🧪 Meares-Stamey testing, 📊 NIH-CPSI scoring, and 🚀 modern management strategies. A must-read for anyone navigating the nuanced world of male pelvic health. #Urology #MensHealth #Prostatitis #PrecisionMedicine 🧠📘

🚨 New in JACC (Aug 2025): Evidentiary Landscape of HF Therapies 🫀

Over the last decade, the heart failure field has shifted from the “mortality reduction era” (ACEIs, β-blockers, MRAs) ➡️ to the “hospitalization reduction era” (SGLT2i, ARNI in HFpEF, iron therapy).

🔑 Key Insights:

⚖️ FDA decisions reflect both rigor and flexibility — approving sacubitril/valsartan in HFpEF despite a missed primary endpoint, while rejecting omecamtiv mecarbil despite statistical significance.

🧬 Enrichment strategies (NT-proBNP, iron indices, recent WHF) drive modern trial design, boosting efficiency but limiting mortality signals.

📊 Composite endpoints (CV death + HHF) dominate, making hospitalization reduction the most reproducible outcome.

📖 Guidelines now anchor on ARNI + SGLT2i in HFrEF and SGLT2i in HFpEF, with emerging roles for finerenone and incretin-based therapies.

👉 Big picture: Clinical practice is evolving, but the “holy grail” of new mortality-reducing therapies remains elusive.

#HeartFailure #Cardiology #ClinicalTrials #FDA #JACC

🧬 Mesenchymal Drift: A New Hallmark of Aging & Disease 🧬

Researchers uncover that Mesenchymal Drift (MD)—the widespread activation of mesenchymal genes across tissues—is a conserved feature of aging and multiple diseases.

📉 High MD = worse outcomes (e.g., in Idiopathic Pulmonary Fibrosis, survival dropped from 1,027 to 294 days).

🔄 Excitingly, partial reprogramming with Yamanaka factors (OSKM) reverses MD before cells lose their identity, restoring youthful transcriptional programs.

✨ This opens the door to new therapeutic strategies for rejuvenation and age-related diseases.

#Aging #Longevity #Epigenetics #RegenerativeMedicine #CellBiology

🚨 New insights on atrial fibrillation (AF) treatment!

A major meta-analysis in Annals of Internal Medicine 🧠📊 confirms that catheter ablation reduces stroke 🧨, heart failure hospitalizations 🏥, and mortality ⚰️—especially in patients with HF.

While surgical ablation with LAA occlusion shows benefit in stroke prevention, catheter-based strategies 💉🔥 continue to lead in outcomes and safety.

💡 Time to rewire rhythm control strategies.

#AtrialFibrillation #Cardiology #StrokePrevention #CatheterAblation #HeartFailure #EP #Guidelines #AFib #PrecisionMedicine 🫀💡📈

🚨 New insights from Annals of Internal Medicine challenge long-held beliefs about alcohol 🍷 and health 🧬.

A 2025 U.S. Surgeon General advisory links even modest drinking to increased cancer risk 🎗️—especially breast and oral cancers. Experts now urge clearer labeling, better patient counseling 🩺, and culturally normalizing abstinence 🌱.

Is it time to rethink the “glass of red wine” advice?

🧐 #PublicHealth #AlcoholAwareness #PreventiveMedicine #AnnalsOfIM

💡 Renal Denervation: A New Era in Hypertension Care 🩺

Despite decades of effective medications, only ~25% of patients worldwide achieve blood pressure control. Non-adherence remains a huge barrier. 📉

This Nature Reviews Cardiology article (Fisher & Kirtane, Sept 2025) explores the journey of renal denervation (RDN) — from Smithwick’s sympathectomy in the 1950s to today’s FDA-approved radiofrequency 🔥 and ultrasound 🔊 catheter systems.

✅ Sham-controlled trials show RDN lowers BP by 5–10 mmHg, similar to one effective antihypertensive drug.

✅ Durable safety profile, up to 10 years in registries.

✅ Best suited for resistant hypertension, drug intolerance, or pill fatigue.

✅ Implementation requires multidisciplinary teams and shared decision-making. 🤝

🚀 Future: Expanding to underrepresented populations, CKD, elderly, and even beyond hypertension (AFib, sleep apnea, metabolic syndrome).

👉 A fascinating example of how history, technology, and evidence converge to reshape cardiovascular medicine.

📘 New Insights on Diverticulitis 📊🔬💊

Did you know that while 1–4% of people with diverticulosis develop diverticulitis, it still accounts for ~200,000 hospitalizations annually in the US and >$6.3B in healthcare costs? 🚑💰

✅ CT scan remains the gold standard for diagnosis 🖼️

✅ Observation & pain control are first-line for uncomplicated cases 💊

✅ Antibiotics reserved for high-risk groups (elderly, immunocompromised, pregnant, systemic illness) ⚠️

✅ Surgery indicated for recurrent or complicated cases (fistula, stricture, perforation) ✂️

This JAMA 2025 review emphasizes precision in management—avoiding overtreatment while protecting vulnerable patients 👥.

👉 How do you approach antibiotic stewardship in diverticulitis care?

🚨 Hypertension remains the world’s #1 killer — yet fewer than 1 in 4 patients achieve control.

💊 Exciting innovations are reshaping the field:

✔️ Aprocitentan (endothelin receptor antagonist) – first new class in decades

✔️ siRNA (zilebesiran) – 6-monthly dosing, tackling adherence

✔️ Aldosterone synthase inhibitors – overcoming “aldosterone escape”

✔️ Non-steroidal MRAs & neprilysin inhibitors – precision targeting with broader benefits

✔️ Single-pill & quadpill combos – simplifying therapy, boosting adherence

🌍 Together, these therapies + smarter management could transform outcomes in resistant and uncontrolled hypertension.

🌟 Ramanuja (1017–1137 CE), one of India’s greatest theologians, shaped Vishishtadvaita Vedanta (Qualified Non-Dualism). His vision of Atman (self) and Brahman (supreme reality), united through bhakti (devotion), transformed Hindu theology and inspired generations. 🕉️📖

💡 His commentaries on the Upanishads, Bhagavad Gita, and Brahma Sutras laid the foundation of Sri Vaishnavism and emphasized a path of devotion, grace, and liberation (moksha). ✨

🙏 A reminder for today’s healthcare providers and leaders: true service blends knowledge, humility, and compassion. ❤️🩺

#Philosophy #Ramanuja #Vedanta #Leadership #Wisdom #Compassion

🧬 South Asians make up 25% of the world—yet just 3% of major cardiovascular trials.

A new systematic review (310 RCTs, 1M+ participants) reveals stark underrepresentation, especially outside India.

No South Asians in trials for heart failure, cardiac arrest, or valvular disease.

📉 The data gap is real—and it’s limiting care.

🔍 We need global trial designs that are inclusive, disaggregated, and powered for equity.

Let’s change the research playbook. 💡

#CardioTrials #SouthAsianHealth #DiversityInResearch #PrecisionMedicine #GlobalHealth 🌏🫀📊

🚶‍♀️📲 New research alert! A massive natural experiment tracking 7,447 relocations across 1,609 US cities reveals that urban walkability directly boosts physical activity 🏙️💪

📈 Moving to more walkable cities increased daily steps by ~1,100 and doubled compliance with MVPA guidelines!

🎯 A powerful case for urban design as preventive medicine.

🔗 A must-read for public health advocates, city planners, and digital health innovators!

#Walkability #UrbanHealth #DigitalEpidemiology #MVPA #SmartCities #BuiltEnvironment #PublicHealth 🏃‍♂️🌆

🧂 Salt sensitivity of blood pressure (SSBP) is an independent risk factor for CVD.

🚹🚺 Women are more salt-sensitive than men, especially after menopause.

⚙️ Key drivers: RAAS, ENaC, natriuresis, and immune pathways.

💉 Estrogen protects, testosterone raises pressure, menopause tips the balance.

🐀 From Dahl’s rats to Conn’s syndrome, SSBP research shows why sex-specific, personalized therapy is the future of hypertension care.

🔗 Nature Reviews Cardiology

Liver, Lipids, and the Left Ventricle 🩸🫀🧬

The NEJM review reminds us that fatty liver isn’t just a liver problem. MASLD drives risk for heart disease, diabetes, kidney dysfunction, and even cancers. 🚨

Cardiovascular disease remains the leading cause of death in MASLD—outpacing cirrhosis and cancer. 🫀💔

With new tools like FIB-4, VCTE, ELF, and promising drugs such as resmetirom and GLP-1/GIP agonists, we’re entering an era where treating the liver can protect the heart. 💊🌱

#MASLD #LiverHeartConnection #NEJM #CardiometabolicHealth

🧓💊 The COMBINE-AF substudy offers important guidance for managing frail, elderly, VKA-experienced patients with atrial fibrillation.

Switching to standard-dose DOACs reduced stroke/systemic embolism risk and cut intracranial & fatal bleeding 🧠🛡️, but raised gastrointestinal bleeding rates 🍽️🩸—especially with certain agents.

Sensitivity analyses show apixaban & edoxaban may offer a safer bleeding profile.

These findings highlight the need for shared decision-making ⚖️ and integrated ABC pathway care ❤️ to balance prevention, safety, and patient preferences. #AFib #Cardiology #PrecisionMedicine

🧠 Meet the Northwestern SuperAgers—individuals 80+ with memory scores rivaling those decades younger! 📚

They show thicker cortices, more von Economo neurons, fewer neurofibrillary tangles, and remarkable social engagement. 🏆

Their brains offer clues to resisting age-related decline—reshaping how we view aging potential. ✨

#SuperAgers #HealthyLongevity #BrainHealth

🚨 Hot off the press! The 2025 ACC/AHA High Blood Pressure Guidelines are here 🩺📊 — bringing sharper strategies to detect, treat & prevent hypertension. From HBPM 🏠 to PREVENT risk scoring 🎯 and protecting against end-organ damage 🫀🧠, these updates empower clinicians & patients alike.

Measure it. Manage it. Maintain it. 💪🌟 #Hypertension #Cardiology #Guidelines

🌳 Trees aren’t just trees – they’re bustling holobionts 🌱🧫! New Nature research reveals that living wood hosts vast, specialized microbiomes, with heartwood and sapwood fostering distinct microbial worlds.

These microbes shape carbon & nitrogen cycling 🌍, influence tree health 🌳💪, and reflect deep host–microbe coevolution 🧬. Rethinking forests as holobionts could transform conservation, climate strategies, and sustainable forestry. #Nature #Microbiome #Holobiont #Forests

💙 Heart failure prevention is a lifelong journey – from identifying those at risk 🩺, to managing pre-HF 🚦, to optimizing care in advanced stages 🫀.

This joint HFSA & ASPC statement bridges primary, secondary & tertiary prevention, targeting traditional risks (HTN, diabetes, obesity) ⚠️, non-traditional risks (genetics, SDOH) 🌍, and leveraging tools like biomarkers 🔬, cardiac rehab 🏃, and heart-healthy diets 🥗.

Detect early. Act decisively. Prolong life. #HeartHealth #Prevention #Cardiology

🦠 Your gut is home to trillions of microbes shaping digestion, immunity, and even mood! 🌿 This new study of 150 adults over 12 weeks found 📈 higher alpha diversity (p=0.003) and clear shifts in microbiome composition, with Faecalibacterium ↑ and Bacteroides ↓. Such changes could boost metabolic and immune health—but more research is needed for long-term insights. 💡 Nurture your inner ecosystem with smart diet and lifestyle choices! 🥗⚖️ #GutHealth #Microbiome #PrecisionMedicine

🚀 Breaking News in Cardio-Oncology! 🫀🎗️

A new randomized trial in European Journal of Heart Failure shows that low-dose sacubitril/valsartan (an angiotensin receptor–neprilysin inhibitor) given before adjuvant therapy in early breast cancer patients completely prevented cancer therapy-related cardiac dysfunction (CTRCD) over 12 months — 0% vs 26.3% in standard care (p=0.006, NNT=3.8).

💡 Why it matters: CTRCD remains a major risk with anthracyclines and HER2-targeted therapy. Early ARNI initiation, guided by global longitudinal strain (GLS) monitoring, may offer a powerful primary prevention strategy.

📈 Takeaway: This could reshape cardio-oncology practice, but larger Phase III trials are needed to confirm long-term benefits.

#CardioOncology #HeartFailurePrevention #ARNI #BreastCancer #EJHF #CTRCD #GLS #LVEF #PrecisionMedicine #ClinicalTrials

🧬 Geroscience is redefining how we think about aging — shifting focus from treating one disease at a time to targeting the biological processes that drive all age-related conditions.

From 🍽️ caloric restriction and 💊 metformin, to 🛡️ rapalogs and 🔍 senolytics, the evidence is mounting: intervening in aging biology may improve healthspan, resilience, and quality of life.

📊 The latest JAMA review highlights promising strategies, gaps in clinical evidence, and the urgent need for long-term trials to bring these approaches into mainstream medicine.

💡 Imagine a future where we delay multiple diseases at once, keeping people healthier, longer. That’s the promise of geroscience.

#Geroscience #HealthyAging #Longevity #PrecisionMedicine #JAMA #Healthspan

🚨 New Insights in HFpEF Therapy! 🫀🔬

A groundbreaking JACC: Basic to Translational Science study shows that hydrogen sulfide (H₂S) deficiency is not just a byproduct—but a central driver of cardiometabolic heart failure with preserved ejection fraction (HFpEF).

Using human plasma analysis + two robust preclinical models, researchers found:

⚠️ ~80–90% reduction in circulating H₂S

💔 Diastolic dysfunction, fibrosis, vascular impairment linked to low H₂S

💊 H₂S donors (JK-1, DATS) improved heart, liver, and vascular health

🤝 Synergy with Survodutide (GLP-1/glucagon agonist) boosted metabolic & cardiac outcomes

Why it matters: HFpEF is a multisystem syndrome—this study highlights a multi-target approach that restores redox balance, improves exercise capacity, and tackles metabolic drivers.

💡 Could H₂S-based combination therapies be the next frontier in HFpEF care?

#Cardiology #HFpEF #HydrogenSulfide #GLP1 #MetabolicTherapy #TranslationalResearch #HeartFailure #PrecisionMedicine #RedoxBiology #JACC

🌟 Al-Ghazali (1058–1111 CE) – The “Proof of Islam” 🌟

A Shafi’i jurist, Ash’arite theologian, Sufi mystic, and philosopher, Al-Ghazali transformed Islamic thought by uniting orthodox theology with spiritual depth. 📜✨

From his Tahafut al-Falasifa 🧠🔥 (Incoherence of the Philosophers) challenging Aristotelian science, to his Ihya Ulum al-Din 📖💫 reviving the heart of the Islamic faith, he inspired generations in the Islamic world and beyond—shaping Christian, Jewish, and modern philosophical thought. 🌍🤝

💡 Lesson for today’s professionals: Seek truth with humility, blend rational inquiry with moral purpose, and never let status eclipse meaning. ❤️⚖️

#Leadership #Wisdom #IslamicPhilosophy #AlGhazali #Ethics #History

💖 Fabry Disease & the Heart 🫀

A rare genetic condition with a big cardiac footprint—Fabry disease can cause left ventricular hypertrophy, arrhythmias, microvascular angina, and heart failure even when ejection fraction is preserved.

🔍 Early detection is key – Genetic testing, advanced imaging (CMR with T1 mapping, strain echocardiography), and awareness of “red flag” signs can change outcomes.

💊 Therapies are evolving – From enzyme replacement therapy to migalastat, and promising gene and substrate reduction approaches, science is bringing new hope.

🌍 Let’s spread awareness, support advocacy, and push for earlier diagnosis to prevent irreversible heart damage.

#FabryDisease #Cardiology #RareDisease #Genomics #HeartHealth #MedicalImaging

🚶‍♀️💨 Small Steps, Big Gains for Frail Adults! 🏆📈

A new study in PLOS ONE shows that prefrail and frail older adults can safely increase walking cadence — and that even a modest boost of +14 steps/min can raise the odds of hitting a clinically meaningful improvement in the 6-Minute Walk Test by ~10%.

📊 High-intensity walking participants averaged 100 steps/min vs. 77 in casual walkers, with 65% achieving the Minimal Clinically Important Difference (MCID) in functional capacity.

💡 Takeaway: Cadence is a practical, objective measure of walking intensity — and a powerful lever to improve mobility in older adults.

#Frailty #Geriatrics #Rehabilitation #ExerciseScience #MobilityMatters #PLOSONE #HealthyAging

💨 Cleaner Air, Healthier Hearts! 🫀

A new JACC randomized crossover trial shows that in-home HEPA filtration near high-traffic roads can lower systolic blood pressure by ~3 mm Hg in people with elevated baseline BP—even in areas with low PM₂.₅ levels.

🔍 Why it matters: Small BP reductions at the population level translate into meaningful drops in heart attack and stroke risk. The study also highlights the Wilder Principle—those starting with higher BP benefit the most.

🛡️ Takeaway: HEPA air purifiers are a low-risk, potentially impactful tool for cardiovascular prevention, especially for vulnerable groups living close to busy roads.

#AirQuality #Cardiology #Prevention #PublicHealth #HEPA #HeartHealth

🔬🧠 New Insights into the Brain’s Role in Energy Balance! ⚖️🍽️

Cutting-edge research reveals how the hypothalamus, brainstem, and reward pathways integrate hormonal, neural, and environmental signals to regulate appetite, energy expenditure, and body weight. From POMC & AgRP neurons to the gut–brain axis and dopaminergic reward circuits, this work unravels the mechanisms behind obesity, leptin resistance, and metabolic regulation—and highlights promising targets like GLP-1 receptor agonists for lasting weight loss. 💊🥗

📚 A must-read for clinicians, neuroscientists, and anyone passionate about the science of metabolism.

#Neuroscience #Metabolism #ObesityResearch #BrainHealth #Endocrinology #GLP1 #EnergyBalance #PrecisionMedicine

🚨 New Insights from HELIOS-B 🫀✨

In patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), the RNA interference therapy vutrisiran not only reduced mortality and cardiovascular events, but also showed measurable benefits in cardiac structure and function over 30 months.

📉 Thinner LV walls & lower LV mass index

💪 Preserved ejection fraction & stroke volume

⚙️ Improved diastolic function – better E/e′ & e′ velocity

🏆 Benefits seen even with substantial tafamidis use

These findings support early initiation of vutrisiran to protect the heart and slow disease progression.

#Cardiology #HeartFailure #ATTRCM #RNAi #Vutrisiran #HELIOSB #Echocardiography #HeartHealth ❤️

🧠✨ New hope for Alzheimer’s treatment — A Nature study reveals that low brain lithium levels may drive memory loss, amyloid plaques, and tau tangles. Researchers found that lithium orotate, a form less likely to bind amyloid, restored brain lithium, reduced pathology, and even reversed memory loss in mice — without kidney or thyroid toxicity.

💡 If confirmed in clinical trials, this low-cost, multitarget approach could transform care for millions with Alzheimer’s and potentially benefit older adults with bipolar disorder.

🔗 Read more: https://doi.org/10.1038/d41586-025-02471-4

#Alzheimers #Neuroscience #Innovation #Neuroprotection #DementiaResearch 🧬💊

🚨 New Guidance Alert!

The 🆕 2025 ACC Expert Consensus on Pericarditis is out — and it’s a game-changer.

🔍 Clearer diagnostic criteria

🖥️ Emphasis on multimodality imaging

💊 Refined therapeutic pathways (NSAIDs, colchicine, IL-1 blockers)

🏥 Stronger case for Pericardial Disease Centers

Whether you’re managing acute chest pain or complex recurrences, this concise clinical guidance 📘 brings clarity, structure, and strategy.

📎 #Pericarditis #Cardiology #CMR #Guidelines #ACC2025 #Inflammation #MultimodalityImaging #HeartHealth

🚀 New in Nature: Groundbreaking study reveals how the origin of your genes — from mom 👩‍🍼 or dad 👨‍🍼 — can push human growth 📏 and metabolism 🔥 in opposite directions!

🧬 Using data from 236,781 people across UK Biobank, Estonian Biobank, and MoBa, researchers uncovered 30+ parent-of-origin effects (POEs), many showing bipolar impacts — boosting traits when inherited from one parent, reducing them from the other.

⚖️ Findings support the parental conflict hypothesis: paternal genes tend to promote growth 🚀, while maternal genes conserve resources 🛡️. These insights were invisible to standard GWAS, proving the power of family-rich biobanks in unlocking hidden genetic layers.

🔗 Read the paper: https://doi.org/10.1038/s41586-025-09357-5

#Genomics #GWAS #Biobanks #ParentOfOrigin #Growth #Metabolism #PrecisionMedicine

🚨 New AHA Scientific Statement 🚨

“Food Is Medicine” isn’t just a slogan—it’s a growing clinical movement. 🍎💉 This systematic review of 14 U.S.-based RCTs explores how Produce Prescriptions (PRx), Medically Tailored Groceries (MTG), and Meals (MTM) impact diet, food insecurity, and health outcomes.

📊 Results show improvements in diet quality and food security, with mixed effects on clinical outcomes.

🧠 Key takeaway: We need better-designed, longer-term trials and real-world implementation science to truly integrate food into healthcare.

#FoodIsMedicine #Nutrition #CardiometabolicHealth #PublicHealth #RCT #HealthEquity #ImplementationScience #AHA #HealthcareInnovation

🔬 New study in Nature Medicine reveals that not all healthy diets are created equal — even when nutrient content is matched, 🍞 ultra-processed foods (UPFs) hinder weight loss compared to 🥗 minimally processed foods (MPFs).

📉 Participants lost twice as much weight on MPF diets, with greater reductions in fat mass and cravings.

🔍 This landmark trial urges public health policy to consider food processing—not just nutrients.

📎 A must-read for clinicians, policymakers, and anyone shaping the future of nutrition:

👉 https://doi.org/10.1038/s41591-025-03842-0

#NutritionScience #Obesity #UPF #PublicHealth #RCT #NatureMedicine

🚨 New Insights in Heart Failure Management! 💡🫀

Just explored the latest 2025 European Journal of Heart Failure review by Hulot et al. redefining how we view HF recovery. No longer just “improvement” – we now distinguish HFimpEF, remission, and recovery as stages along a phenotypic spectrum.

🔬 Key takeaways:

✅ Relapse still occurs in ~10%/year

🧬 TTN variants, GLS, and LA strain guide prognosis

💊 Stopping GDMT? Think twice (TRED-HF: 44% relapse!)

Essential read for anyone managing HF patients or designing future trials. Let’s rethink what recovery really means.

#HeartFailure #Cardiology #HFimpEF #PrecisionMedicine #EJHF #RecoveryNotCure #CardiacRemodeling #HeartHealth 💓📊🩺

📘 New JAMA Review: Ovarian Cancer – From Symptoms to Survival 🌸

Approximately 21,000 women are diagnosed with ovarian cancer annually in the U.S.—and 80% present with advanced-stage disease.

The latest JAMA review by Caruso, Weroha, and Cliby (2025) offers a comprehensive update on:

🧬 Evolving genetic insights (BRCA1/2, HRD, Lynch)

🩺 Diagnostic strategies beyond CA-125

💊 State-of-the-art therapies: surgery, chemo, PARP inhibitors, bevacizumab

📉 Declining mortality trends due to prevention and early detection

With clear tables, evidence-based algorithms, and nuanced discussion on fertility-sparing surgery and maintenance therapy, this is a must-read for oncologists, gynecologists, and policy advocates alike.

#JAMA #OvarianCancer #WomensHealth #Oncology #BRCA #PARPinhibitors #GeneticTesting #CancerCare #GynecologicOncology #PrecisionMedicine

🚨 New Insights in Heart Failure Care! 🫀💉

A landmark meta-analysis in Nature Medicine shows that intravenous iron therapy significantly reduces heart failure hospitalizations and cardiovascular deaths — especially in the first year of treatment. 📉💪

With over 7,000 patients across 6 RCTs, this study reinforces IV iron as a safe, outcome-improving therapy in HFrEF with iron deficiency. 🔬✅

💡 Curious about TSAT, RR, or sex-specific effects? 📊 This is essential reading for cardiologists, internists, and heart failure teams

#HeartFailure #IronTherapy #Cardiology #EvidenceBasedMedicine #HFpEF #HFrEF #IVIron #MedicalEducation #ClinicalTrials #NatureMedicine

🚨 Spotlight on Medieval Thought! 🧠📜

Explore the legacy of Anselm of Canterbury—father of Scholasticism and originator of the Ontological Argument for God’s existence. His fusion of faith 🙏 and reason 🧩 shaped Western theology.

🎓 #Philosophy #MedievalStudies #Anselm #Theology

Tropical cyclones don’t just shake buildings — they shake hearts too.

A powerful multicountry study in Science Advances links 🌊 storm exposure to a 13% rise in cardiovascular hospitalizations, especially ischemic heart disease and stroke.

Vulnerable groups? Men, adults aged 20–59, and socioeconomically deprived communities.

🧠 The risk peaks ~2 months post-cyclone and lasts up to 6 months.

🧭 It’s time to rethink disaster response — beyond winds and water, to hearts and health equity.

#Cardiology #ClimateHealth #PublicHealth #DisasterPreparedness #GlobalHealth #CVD #Epidemiology #ClimateChange 🌍

🚗 42,939 lives lost in 2021 — the U.S. motor vehicle fatality rate remains far higher than other high-income nations.

The NEJM review on Motor Vehicle Crash Prevention highlights the Safe System Approach:

🛣️ Safer roads

🚘 Safer vehicles

👥 Safer people

⚡ Safer speeds

🚑 Better postcrash care

🔍 From graduated driver licensing to automated emergency braking (AEB) and driver-monitoring tech, the future of crash prevention lies in data, design, and shared responsibility.

Question: What innovations do you believe will move us closer to zero traffic deaths? 💡

#RoadSafety #PublicHealth #InjuryPrevention #SafeSystemApproach #NEJM #AutomotiveSafety

🎙️ New Podcast Episode!

“Hole in the Heart, Stroke on the Brain, Science at the Core” 🧠❤️🔬

Discover how a tiny opening—present in 1 in 4 adults—can lead to devastating strokes 🩺⚠️. We unpack the latest JAMA review on PFO, cryptogenic stroke, and how RoPE and PASCAL scores guide who benefits from closure. 🎯💉

🔗 Tune in to learn about cutting-edge trials, real-world risks, and how precision matters in stroke prevention.

#Stroke #PFO #Cardiology #Podcast #RoPE #PASCAL #ClinicalTrials #HeartBrainAxis #Neurocardiology #MedicalEducation 🎧📡

🧬 Just explored the largest GWAS on stuttering—over 1 million participants!

🎵 Fascinating link uncovered between impaired rhythm and speech disfluency, supporting the Atypical Rhythm Risk Hypothesis.

🧠 Genes like VRK2 and FANCL connect beat synchronization and stuttering risk.

🚀 A big step toward precision care in developmental speech disorders.

#Genetics #Stuttering #GWAS #Neurodevelopment #PrecisionMedicine #SpeechTherapy #RhythmAndSpeech

🎙️ From MRAs to ASIs: Rewriting Heart Failure’s Aldosterone Story

🚨 New Episode Alert! 🎧

Title: From MRAs to ASIs: Rewriting Heart Failure’s Aldosterone Story

💔🧬💊

In this episode of Got Knowledge Doc, we unpack the double-edged role of aldosterone in heart failure and kidney disease—from its genomic mischief to its nongenomic chaos via GPER.

We dive into:

✅ Why MRAs aren’t enough

🔬 What ASIs bring to the table

📉 How new trials like FIDELIO, FIGARO, and PREVENT-HF are shaping the future

If you treat heart failure, study hormones, or love precision medicine—this one’s for you.

🎧 Listen now and rethink the RAAS:

#HeartFailure #Aldosterone #CKD #Finerenone #ASIs #MRAs #RAAS #CardioRenal #Podcast #PrecisionMedicine #GPER

🚫💊➡️⚖️ The GLP-1 Comeback: Weight Regain After the Stop”

📊 Based on the 2025 BMC Medicine meta-analysis, we explore what happens after stopping anti-obesity meds like GLP-1 receptor agonists.

👀 Key takeaways:

– Weight regain begins as early as 8 weeks after stopping

– GLP-1 drugs show the highest rebound 📈

– Lifestyle changes alone may not prevent regain 🥗🏃‍♂️

– Long-term weight management may require long-term therapy 🔁

🎙️ Tune in to understand the science behind the yo-yo and what it means for clinical practice and patient counseling.

#ObesityCare #GLP1 #WeightRegain #PrecisionMedicine #Endocrinology #MetabolicHealth #MedicalPodcast 🎙️

🚨 Podcast Alert: “Move. Breathe. Beat AF 🏃‍♂️🫀💥”

The latest Cochrane systematic review + meta-analysis shows that exercise-based cardiac rehabilitation (ExCR) meaningfully reduces:

✅ AF recurrence

✅ Symptom severity

✅ AF burden and frequency

✅ And improves VO₂ peak & mental health—all without increased serious events.

📢 Time to rethink rhythm control—beyond the pill and catheter.

#AtrialFibrillation #Cardiology #ExerciseMedicine #CardioOncology #Rehabilitation #Podcast

Let me know if you’d like a graphic or slide preview to go with it.

Titrate, Train, Triumph 🧬🏋️‍♀️🎯”

Obesity medications like semaglutide and tirzepatide are game-changers—but managing GI side effects, sarcopenia risk, and long-term adherence requires nuance, nutrition, and teamwork. 💡

From nausea to nutrition, and from missed doses to muscle mass—this episode offers practical, evidence-based strategies to optimize incretin therapy. 💊🥦⚖️

🎧 Tune in to learn how to tailor treatment, counsel patients, and build sustainable weight loss plans.

#ObesityMedicine #GLP1 #Tirzepatide #Semaglutide #LifestyleMedicine #WeightLoss #Cardiology #Endocrinology #PatientCare #Pharmacotherapy #MedicalEducation

🔬 New Insights in Lipidology! 🫀 A landmark study in European Heart Journal (2025) shows that Apolipoprotein B (ApoB) particle count is a more powerful predictor of coronary artery disease than traditional LDL cholesterol. While VLDL particles are more atherogenic per unit, LDL dominates by count — making total ApoB count + Lipoprotein(a) the gold standard for risk assessment. 🧪📊

👩‍⚕️👨‍⚕️ Time to rethink lipid panels and embrace particle-based precision.

#Cardiology #Lipidology #ApoB #Lp(a) #PrecisionMedicine #HeartHealth #CVPrevention #RiskStratification #EHJ #UKBiobank #FutureOfCare ❤️

🧠✨ Just read a thought-provoking article in JAMA on the US POINTER trial!

Structured lifestyle changes (think 🏃‍♀️🥗🧩) showed modest but real gains in cognition for older adults at risk of dementia. But here’s the twist: even light-touch self-guided changes yielded nearly similar benefits. 🤯

So… 💬 Is intensity always worth the investment? Or can simplicity scale smarter?

🔗 Worth pondering as we shape the future of brain health! #DementiaPrevention #CognitiveHealth #LifestyleMedicine #PublicHealth #BrainAging 🧠📈

🔬 New Review Alert! 🫀

South Asians face one of the highest global burdens of premature heart disease — and Lp(a) may be the silent culprit. 📈 In a comprehensive JAHA 2025 review, researchers reveal how 25% of South Asians have dangerously elevated Lp(a) levels, doubling their risk of myocardial infarction. 🧬💥

Key takeaways:

✅ Lp(a) is genetically driven & unaffected by lifestyle

✅ Risk is underestimated by standard calculators

✅ Novel therapies (PCSK9i, siRNA, ASOs) are on the horizon

✅ One-time testing is now strongly recommended in all South Asians 🧪

📚 Based on INTERHEART, UK Biobank, PROMIS, and MASALA — this is a must-read for anyone tackling health disparities in cardiology.

📢 New insights on education & brain aging! 🧠📉

A mega-analysis across 33 countries (170K+ participants, 15K+ MRIs) shows 📚 higher education boosts baseline memory—but doesn’t slow brain aging or cognitive decline over time. ❌🧓

✅ Early-life traits (like childhood cognition & environment) drive the advantage.

🔗 Education matters—but not in the way we thought.

Full story: “Reevaluating the role of education on cognitive decline and brain aging” in Nature Medicine 🧬🌍

#CognitiveHealth #BrainAging #LifelongLearning #Neuroscience #Education #DementiaPrevention #NatureMedicine

🧬 Just dropped: our latest podcast episode 🎙️ dives into Lipoprotein(a) and its powerful role in predicting vascular disease beyond the heart 🫀—including PAD 🦵 and stroke 🧠.

📊 Based on a massive UK Biobank study (n=460K+), high Lp(a) levels (≥150 nmol/L) were linked to:

• 18% ↑ risk of PAD

• 17% ↑ risk of carotid stenosis

• 60% ↑ risk of major limb events

⚠️ Lp(a) is more than a lab value—it’s a Vascular Crystal Ball.

#LipoproteinA #PAD #Stroke #VascularMedicine #PrecisionCardiology #CardioPodcast #Biomarkers #Atherosclerosis #UKBiobank 🧠🩸🔍

🧠✨ Dive into the mind of Avicenna (Ibn Sina) — the Persian polymath who shaped medicine, metaphysics, and logic for centuries.

From the Canon of Medicine to the Book of Healing, his legacy lives on in modern science and thought. 🎓📚 #Philosophy #Medicine #Avicenna

📢 New Data Drop! 🫀💥

South Asian adults in the U.S. have an earlier and sharper rise in coronary artery calcium (CAC) — a silent marker of heart disease risk! 🇮🇳📊

In a first-of-its-kind study combining MASALA & DILWALE cohorts (n=2,743), 65% of South Asian men and 30% of women had CAC >0 by age 55 — and women catch up fast after menopause. 🚹➡️🚺

📌 Sex-specific CAC percentiles = smarter screening, better prevention.

💡 Time to rethink traditional risk calculators for this high-risk group.

🎙️ Podcast title: “Men First, Women Fast 🚹🚺⚡: The CAC Climb in South Asians”

#Cardiology #SouthAsianHealth #HeartDisease #CACScore #PrecisionMedicine #DEIinMedicine #ASCVD #MASALAStudy #DILWALEStudy #JACCAdvances #PreventiveCardiology

🚨 New Insights from Nature Medicine 🧠🍕

Can cookies and chips hijack your brain like cocaine? A compelling new article argues that ultra-processed food addiction mirrors classic substance use disorders — down to the cravings, compulsive use, and reward circuit disruption.

With GLP-1 drugs bridging obesity and addiction treatment, is it time the DSM-5 recognized food addiction?

🧬 Science says yes.

⚖️ Policy is lagging.

📢 Let’s start the conversation.

#FoodAddiction #UltraProcessedFoods #DSM5 #GLP1 #PublicHealth #Neuroscience #Obesity #HealthPolicy #Cravings #NutritionScience

🚨 New Hypertension Guidance Alert! 🩺💡

The British & Irish Hypertension Society now recommends treating all adults with sustained BP ≥135/85 mmHg—regardless of CVD risk—and targeting

🧠🏃‍♂️ Can running rewire the Alzheimer’s brain? New study in Nature Neuroscience shows how exercise transforms cell-specific gene expression in the dentate gyrus of AD mice!

Using single-nucleus RNA-seq, researchers found that voluntary running reversed transcriptional dysregulation in key cell types—especially immature neurons, astrocytes, and microglia.

💡Highlights:

✅ Neurogenesis boosted

✅ Disease-associated microglia reprogrammed

✅ Novel astrocyte subpopulation rescued

This could pave the way for targeted therapeutics rooted in the biology of movement.

#Neuroscience #Alzheimers #RNAseq #Neurogenesis #ExerciseIsMedicine #PrecisionMedicine #Neuroinflammation 💪🧬🧠

🚨 Statins & Diabetes: Dose Matters, But So Does Perspective 💊📉

A 2024 CTT Collaboration meta-analysis of 154,664 participants confirms:

✅ Statins modestly increase risk of diabetes (10% with moderate, 36% with high-intensity)

📈 Small upticks in HbA1c and glucose

🧪 But most new cases were already teetering near the threshold

🩺 Bottom line? Cardiovascular benefits far outweigh the diabetes risk.

💡 It’s a reminder: precision prevention is about balancing risk, not eliminating it.

📚 Ref: Lancet Diabetes Endocrinol 2024 | DOI: 10.1016/S2213-8587(24)00040-8

#Statins #Diabetes #Cardiology #EvidenceBasedMedicine #Prevention #Lipids #RCT #CTTCollaboration #BalancingBenefits #MedicalResearch

🧬 Just explored a groundbreaking 50-year proteomic atlas that charts how our proteins evolve with age across 13 human tissues!

🧠 Key insights? Aging inflection around 50, transcriptome-proteome decoupling, amyloid buildup, and senoproteins like GAS6 & GPNMB driving vascular & systemic aging.

📊 Proteomic clocks, plasma biomarkers, and tissue-specific aging maps may redefine how we measure and manage aging.

🔗 Dive into the protein-powered future of aging science! #Proteomics #AgingResearch #Biomarkers #Senescence #PrecisionMedicine

🧬 New findings from Science Signaling reveal that deleting PTP1B in cardiomyocytes protects the heart from high-fat diet–induced cardiomyopathy! 🛡️❤️

This elegant study shows how metabolic rewiring—boosting fatty acid oxidation, enhancing AMPK, and preserving mitochondria—prevents cardiac hypertrophy and dysfunction. 🚫🍔➡️💪💓

Could targeting the PTP1B–PKM2–AMPK–NAD⁺ axis be the future of cardio-metabolic therapy?

#Cardiology #Metabolism #HeartFailure #Obesity #PrecisionMedicine #FAO #AMPK #PTP1B #ScienceSignaling #Innovation

🚨 Just in: The 2024 KDIGO guidelines are here to delay CKD progression! 🩺💡 With updated insights on protein intake, SGLT2 inhibitors, and BP targets, this is a must-read for every internist and nephrologist. 🚱💊 Highlights include use of finerenone, combo therapies, and emerging role of GLP-1RAs. 🧬📉

🔗 Dive into the new JAMA summary and elevate your CKD care! #Nephrology #CKD #KDIGO #CardioRenal #PrecisionMedicine

🚶‍♀️ How many steps a day keep the doctor away? 📉🧠 A sweeping meta-analysis in The Lancet Public Health reveals that just 7000 steps/day (not 10,000!) can reduce the risk of death, cardiovascular disease, cancer, dementia, diabetes, depression, and falls—with benefits starting as low as 4000 steps. 🩺👟 Every step counts.

🔗 Read more. #PublicHealth #MetaAnalysis #PhysicalActivity #Wearables #HealthOutcomes #StepsToHealth

🔬 Just explored a brilliant review in Nature Reviews Cancer on how ageing shapes cancer evolution 🧓🧬

From clonal expansions and inflamm-ageing to cutting-edge models like GEMMs, CRISPR, and epithelioids, this article reframes how we study cancer through the lens of time ⏳

🎧 Check out our latest podcast: “Mutations, Microenvironments & Mortality” — a deep dive into ageing, adaptation, and malignancy

#CancerResearch #AgeingBiology #Geroscience #Oncology #ClonalEvolution #PrecisionMedicine #NRReviews #PodcastDrop 🎙️📡

🚨 New Podcast Alert! 🎙️

🧬 “Genes, Hearts, and Hope: Precision Therapies for Cardiomyopathy” is LIVE!

From sarcomeres to splicing, from fibrosis to fixable mutations—this episode unpacks cutting-edge treatments like myosin modulators 🧪, gene therapy 🧠, and antisense oligonucleotides 💉.

If you’re a cardiologist, geneticist, or just curious about the future of heart care ❤️—this one’s for you.

🎧 Tune in, share, and let’s rethink cardiomyopathy together!

#Cardiomyopathy #PrecisionMedicine #HeartFailure #GeneTherapy #Podcast #MedTech 💡💓

📢 Just read a landmark study in Nature Medicine—over 5 million participants across ancestries! 🧬

The new multi-ancestry polygenic risk score (PRS-CSx) predicts BMI & obesity from early life to adulthood 🌍👶📈.

Strong implications for personalized prevention, though disparities persist in African ancestry populations ⚖️.

Precision meets public health—time to rethink obesity prediction.

#Genomics #Obesity #PrecisionMedicine #PRS #GWAS #HealthEquity 🧠💡

🔬🫀 When Troponin Lies: A Case of Macrotroponin 🧪❗

We’ve all seen elevated troponins trigger cath lab calls—but what if the numbers don’t add up? This fascinating case from EHJ Case Reports reveals how an IgG–troponin T complex (macrotroponin) mimicked an acute coronary syndrome in a patient with a structurally normal heart and clean coronaries.

📈 Persistently high cTnT

🧪 Normal cTnI

🧫 Confirmed macrotroponin via SDS-PAGE + immunoblotting

🤝 Biochemistry + Clinical Team = Diagnostic Clarity

This is your reminder: always match the lab to the patient, not the other way around.

🎧 Catch our new podcast episode: “Troponin Trickery: When the Lab Lies, Not the Heart”

#Cardiology #LabMedicine #Troponin #Macrotroponin #Diagnostics #ClinicalPearls #CardiacBiomarkers #Podcast #MedEd #EHJCaseReports

🎓 Dive into the profound legacy of Abu Nasr al-Farabi—the “Second Master” after Aristotle 🧠🎼

From logic to music, metaphysics to political philosophy, his thought shaped both East & West. 🕌🌍

#Philosophy #IslamicPhilosophy #AlFarabi #Neoplatonism #KnowledgeIsPower #WisdomWednesday ✨📚

🚨 New Advances in Heart Transplantation! 🫀✨

Curious about how we’re expanding the donor pool and saving more lives? 🌍 Learn the differences between DCD (Donation after Circulatory Death) and DBD (Donation after Brain Death)—from ethics and outcomes to innovation and global trends.

💡 Techniques like REUP and on-table reanimation are reshaping what’s possible—even in pediatrics! 👶💓

📈 Survival is up. Ethics are evolving. The future of heart transplant is here.

#TransplantInnovation #Cardiology #Bioethics #DCD #HeartTransplant #GlobalHealth #OrganDonation #PrecisionMedicine

🚨 New Study Alert! 🧠🧪

How does your brain handle a blocked drain — and does age make it worse? 🤔💧

This podcast dives into how chronic impairment of deep cervical lymphatic drainage affects brain fluid dynamics and triggers low-grade neuroinflammation — all in an age-dependent manner. 🧓⚖️👶

🔍 Using DCE-MRI, proteomics, and metabolomics, we found that:

✅ Young brains adapt with increased clearance and extracranial drainage

⚠️ Middle-aged brains show blunted responses and molecular signs of stress

🧬 Both age groups reveal early markers of neurodegeneration and BBB leakage

📖 Read the full study in JCI

#Neuroscience #GlymphaticSystem #Lymphatics #BrainHealth #Aging #MRI #Neuroinflammation #TranslationalResearch #CSF #PrecisionMedicine

🚨 New Podcast Episode! 🎙️

“🦵 Swell, Strain, Support: Tackling Chronic Venous Insufficiency”

Millions silently suffer from leg swelling, fatigue, and ulcers — but did you know most cases don’t need surgery? 🧦💡

We unpack the latest NEJM insights on functional vs. structural CVI, the underrated power of calf pumps 💪, compression therapy 🧘‍♀️, and when to skip diuretics 💊.

Whether you’re a vascular pro or a primary care frontline hero, this one’s for you. 🎧

#VascularMedicine #CVI #VenousHealth #CompressionTherapy #FunctionalMedicine #NEJM #Podcast #MedicalEducation #PrimaryCare #LegHealth

New Study Alert! 🧠💉📉

Exciting real-world evidence shows that GLP-1 receptor agonists—semaglutide and tirzepatide—not only help with type 2 diabetes and obesity but may also reduce the risk of dementia, stroke, and all-cause mortality! 🙌📊

In a cohort of over 60,000 patients, these agents delivered neuroprotective and cerebrovascular benefits beyond glycemic control. Benefits were especially notable in older adults, women, and those with BMI 30–40. 💪👵🧬

🔗 If you’re passionate about brain health, diabetes, and the expanding therapeutic role of GLP-1RAs—this is a must-read!

📄 Published in JAMA Network Open | July 2025

📌 #GLP1 #Semaglutide #Tirzepatide #Dementia #Stroke #Diabetes #Neuroprotection #CardiometabolicHealth #JAMA #RealWorldEvidence #LongevityMedicine

🧬 New Insights into Gut–Heart Axis 🫀💡

Groundbreaking research published in Nature shows that Imidazole propionate (ImP)—a metabolite produced by gut bacteria—drives atherosclerosis by hijacking immune pathways in myeloid cells via the I1R–mTORC1 axis 🔥🧫.

📈 Elevated ImP levels predicted subclinical atherosclerosis independently of cholesterol in two large cohorts (PESA & IGT).

💊 Blocking this pathway with AGN192403 prevented plaque buildup—offering a novel, cholesterol-independent therapeutic target.

📚 Time to rethink cardiovascular prevention beyond lipids?

#Cardiology #GutMicrobiome #Atherosclerosis #PrecisionMedicine #Inflammation #NatureMedicine

🚨 New Podcast Alert! 🎙️🧬

Curious about how modern medicine is tackling devastating mitochondrial DNA diseases like MELAS, LHON, and NARP? Our latest podcast dives into four landmark NEJM articles covering cutting-edge advances—from embryo screening (PGT) to groundbreaking mitochondrial replacement therapy (MRT). 🧪👶

Join us as we explore science, ethics, and hope at the frontier of germline medicine.⚖️💡

#MitochondrialMedicine #Genetics #PrecisionMedicine #ReproductiveHealth #NEJM #Podcast #PGT #PNT #Bioethics #ThreeParentBaby

🚨 AI meets ECG 🧠⚡

New insights show that a simple ECG — when powered by deep learning — can detect structural heart diseases like LV systolic dysfunction, HCM, and aortic stenosis with AUROCs >0.90! 🫀📈

📊 Sample size: 54,000+ | NPV >98% | p < 0.001

✅ Low-cost, non-invasive, high-accuracy screening? Yes, please.

🧠 Time to rethink the ECG as a frontline diagnostic tool.

#Cardiology #ArtificialIntelligence #ECG #StructuralHeartDisease #DigitalHealth #MedTech #MachineLearning #HCM #LVSD #AorticStenosis #Innovation #PrecisionMedicine #HealthcareAI 💡🩺💻

New Podcast Episode Alert! 🎙️

“💧Block, Burst, or Both?💥 Understanding Male LUTS”

Up to 40% of men over 50 face lower urinary tract symptoms—from weak stream to nocturia. This week, we unpack the landmark JAMA 2025 review by Drs. Wei, Dauw, and Brodsky. 🧠💊

Tune in as we explore:

🔹 BPH vs Overactive Bladder

🔹 When to treat—and how

🔹 Meds, muscles, and minimally invasive magic

🔹 What every clinician should know before referring 🚑

🎧 Whether you’re a primary care doc, urologist, or just curious—this episode is worth the wait.

🔗 Listen now: [Insert Podcast Link]

#LUTS #MensHealth #Urology #BPH #MedicalPodcast #EvidenceBasedMedicine #JAMA #GotKnowledgeDocPod 🎓🎙️🫁

🚀 Just out in European Heart Journal! A novel AI model detects cardiac amyloidosis 🫀 using only a single apical 4-chamber echo clip 🎥🤖

Trained on a multiethnic, multisite cohort 🌍, this deep learning tool achieved AUROC 0.93—outperforming traditional risk scores like TCAS and IWT 📈💥

💡 Smarter screening, faster referrals, fewer missed diagnoses.

🔗 Read more and explore how AI is reshaping heart failure diagnostics👇

#Cardiology #AIinMedicine #Echocardiography #HeartFailure #DigitalHealth #PrecisionMedicine

🧠✨ New Insights into Why We Sleep! ✨🛏️

Just read a groundbreaking study in Nature showing that leaky mitochondria in sleep-inducing neurons (dFBNs) drive the pressure to sleep! 😴🧬

Turns out, electron overflow and oxidative stress during wakefulness aren’t just metabolic side effects—they’re biological signals telling the brain it’s time to rest. 🔋➡️💥➡️🛌

Mitochondrial fission decreases sleep, fusion promotes it, and sleep literally resets neuronal metabolism.

A must-read for anyone interested in neuroscience, metabolism, or the biology of rest. 🧪🧠🔄

#SleepScience #Mitochondria #Neurobiology #OxidativeStress #Drosophila #NaturePaper #PrecisionHealth #RestIsRepair

🚨 New Insights on Heart Attack Risk! 🧬❤️

A must-read from Circulation: Genomic and Precision Medicine—Bhattacharya et al. show that Polygenic Risk Score (PRS) rivals traditional giants like hypertension in predicting MI! 💥

📊 With an R² loss of 12.4% and PAR of 38.4%, PRS isn’t just academic—it’s actionable. Add in hsCRP and Lp(a), and we’re entering a new era of CAD risk stratification.

🔍 From base to full model:

➡️ R²: 0.021 → 0.053

➡️ C-statistic: 0.65 → 0.73

➡️ PAR: 84.3%

Let’s embrace the fusion of clinical + genetic + biomarker data to better prevent cardiovascular disease. 🧠💡 #Cardiology #Genomics #PrecisionMedicine #CAD #PRS #RiskPrediction #Circulation #HeartHealth #FutureOfMedicine #Biomarkers #PreventionIsPower

🚨 New Research Alert! 💡 Just explored a fascinating preclinical study on apigenin 🧪—a flavonoid found in parsley & chamomile 🌿—that prevents muscle loss in aging, obese rats 🐀💪.

📉 While it didn’t stop weight gain or fat buildup, apigenin boosted muscle mass, reduced fibrosis 🦵, and activated anabolic signaling (p70S6K) 🔁.

💊 Could this be a future nutraceutical for sarcopenic obesity and healthy aging? More clinical research needed—but the signal is strong. 🚦

#Apigenin #Flavonoids #Sarcopenia #Obesity #MuscleHealth #Aging #Nutraceuticals #PrecisionMedicine #Geroscience #Phytochemicals 🍊🧬

🚨 New in 2025! The ACC/AHA Appropriate Use Criteria for ICDs, CRT, and Pacing just got a major upgrade! 🫀📊 Covering 335 real-world scenarios, this document is your go-to guide for when (and when not) to implant. 💡

What’s 🔥 in the update?

⚡ Leadless & conduction system pacing

🔁 CRT refined for better outcomes

🧠 Smart use in LVADs, post-transplant, & more

👩‍⚕️ Clinicians: Make device decisions with clarity, confidence, and evidence.

📥 Download our podcast + slides to stay ahead.

#Cardiology #ICD #CRT #Pacing #AUC #HeartFailure #EP #PrecisionMedicine #MedEd #2025Guidelines

🧘‍♂️📿 Discover the timeless wisdom of Adi Shankaracharya (788–820 CE) — the master of Advaita Vedanta who redefined spirituality with concepts like Atman, Brahman & Sanyasa. His teachings on non-duality still inspire seekers worldwide. 🌍📚 #Philosophy #Vedanta #Spirituality

🫀 New insights from Covani et al. and Ben-Yehuda’s editorial reveal a striking paradox: more cardiovascular risk factors 🔥 = more plaque rupture, but less erosion! 🧊

Using OCT imaging, they show how traditional risks drive inflammatory, rupture-prone plaques, while erosion may follow a different path altogether—less lipid, less inflammation, more mystery. 🧬

🎯 Takeaway: Precision prevention must evolve. Not all plaques (or patients) follow the same script.

🔗 Dive into this convergence of epidemiology & imaging 👉 #PlaqueVulnerability #STEMI #NSTEMI #OCT #Cardiology #Prevention #PrecisionMedicine

🌍🔬 What’s shaping your health beyond your genes?

Introducing our latest Got Knowledge Doc podcast episode: “Beyond Genes, Beneath the Skin 🧬🌫️” — a deep dive into the exposome, the totality of your environmental exposures from womb to tomb.

From microplastics to sleep, PFAS to social stress, we’re mapping the missing link in precision medicine.

🎧 Tune in to explore why the future of health might depend less on your DNA and more on your data trail.

🧠 Prevention. 📊 Policy. 💊 Personalization.

#Exposome #PrecisionMedicine #EnvironmentalHealth #PublicHealth #WearableTech #GotKnowledgeDoc

🚨 New Insights in Hypertrophic Cardiomyopathy (HCM)! 💓

Groundbreaking research shows that regulatory T cells (TREGs) can reduce fibrosis, suppress inflammation, and even improve heart function in HCM 🧬🛡️

From adoptive TREG transfer to IL-2 therapy, immunomodulation is emerging as a promising strategy alongside genetic and myosin-targeted treatments 💉📉

🧠 A must-read for cardiologists, immunologists & translational researchers!

📄 Wang et al., Sci. Transl. Med. 2025

🔗 #Cardiology #HCM #TREG #Immunotherapy #Fibrosis #PrecisionMedicine #TranslationalScience #HeartFailure #IL2 #CellTherapy

🧠💤 Just dropped our latest Got Knowledge Doc podcast:

“Flush, Sleep, Forget: The Glymphatic Code in Alzheimer’s Disease” 🧬🎧

We explore how the brain’s nighttime rinse cycle clears toxic proteins like amyloid β and tau—and what happens when that system breaks down. From rodent models to human MRI, it’s a story of sleep, science, and hope. 🌙🔬

Listen in to learn how advancing glymphatic research might open doors to early detection and prevention of Alzheimer’s. 🧪🧩

#AlzheimersDisease #GlymphaticSystem #Neuroscience #SleepScience #BrainHealth #AQP4 #CognitiveDecline #PrecisionMedicine #Neuroimaging #MedicalPodcast 🎙️

🚨 New Podcast Episode!

🎙️ “Gut Talks to the Heart 🥗💓🧠: The Incretin Connection”

Did you know that GLP-1 and GIP do far more than control blood sugar?

These humble gut hormones orchestrate perfusion, reduce inflammation, protect the brain, heart, kidneys—and may even slow cognitive decline.

💊 From diabetes care to cardio-renal-neuro protection, incretin-based therapies are rewriting the rules of metabolism.

🔗 Tune in to learn how your next meal could be triggering an endocrine symphony.

#Cardiology #Endocrinology #Incretins #GLP1 #GIP #Metabolism #Neuroprotection #DiabetesCare #PrecisionMedicine #MedicalPodcast 🎧

Exciting new insights from Science Translational Medicine (2025)!

Researchers uncovered how the GAS6–AXL–FAK axis determines whether wounds heal with scars or regeneration. 🧬💉

💡 Activating AXL with GAS6 rewires fibrotic healing into scarless repair — especially in the oral mucosa.

💥 Blocking AXL flips the script, leading to fibrosis even in normally regenerative tissues.

This could revolutionize how we approach scar prevention and tissue regeneration. 🩹✨

#RegenerativeMedicine #WoundHealing #Fibrosis #AXL #FAK #PrecisionMedicine #GAS6 #scRNAseq #Biotech #Innovation #TranslationalScience

☕💓 Is your daily brew helping or harming your heart?

New evidence from a comprehensive European Heart Journal review suggests that moderate coffee consumption (1–4 cups/day) is linked to reduced risks of hypertension, type 2 diabetes, coronary artery disease, heart failure, stroke, and even mortality.

🧬 Benefits often persist regardless of caffeine content, and filtered coffee appears safest for lipid profiles.

⚠️ But beware: excessive intake and unfiltered brews may raise LDL.

📊 Great read for clinicians navigating patient questions on coffee and cardiovascular risk.

🔗 #Coffee #Cardiology #CME #HeartHealth #LifestyleMedicine #PreventiveCardiology #EvidenceBasedMedicine

🧠🧬 New research alert! Plasma proteomics from 44,000+ UK Biobank participants reveals that the brain and immune system are powerful predictors of longevity.

A youthful brain and immune system cut mortality risk nearly in half—more so than any other organ. This could reshape how we think about aging, diagnostics, and preventive medicine.

📊 Machine learning + blood proteins = next-gen aging biomarkers.

🔗 Study link: https://doi.org/10.1038/s41591-025-03798-1

#Longevity #Proteomics #BrainHealth #ImmuneSystem #Aging #Biomarkers #PrecisionMedicine #UKBiobank #HealthyAging #Neuroimmunology #PlasmaProteomics #OrganAging

📣 New insights from a global study on cardiovascular disease! 🌍❤️

Even without traditional risk factors, your lifetime risk of CVD isn’t zero — but midlife action can add a decade or more of healthy life. 🧠💡

Key takeaway: Knowing is not enough — we must apply. 🩺📊✅

#CardiovascularHealth #PreventionMatters #GlobalHealth #PrecisionMedicine #PublicHealth 💪🌎🧬

🔬 Just read a fascinating News & Views in Nature on how weight loss reshapes adipose tissue beyond just shedding fat! 🧬 Using single-nucleus RNA-seq and spatial profiling, researchers found that bariatric surgery reverses stress, inflammation, and senescence in fat depots—yet some immune memory lingers. 🧠🔥

A compelling case for adipose plasticity—and why cellular “memory” may be the key to sustained metabolic health. 💡💪 #ObesityResearch #AdiposeRemodeling #WeightLossScience #Senescence #PrecisionMedicine #Nature

🧠💓 Just read a fascinating new study in Cell Metabolism (July 2025): dislocation of hexokinase 1 from mitochondria increases O-GlcNAcylation in endothelial cells — a hidden driver of HFpEF!

Reversing this sugar-tagging with OGA overexpression or OGT inhibition restores heart function in mice. Precision metabolism meets cardiology. 🔬❤️‍🔥

#HFpEF #OGlcNAcylation #EndothelialDysfunction #CardioResearch #MetabolicTherapeutics #CellMetabolism

🐾 New Research Alert! 🧠

Owning a dog or cat may do more than warm your heart — it could help preserve your mind! 🐶🐱 A large 18-year study across Europe found that pet owners experienced slower cognitive decline, especially in memory and verbal fluency.

🧪 No boost seen with fish or birds 🐠🐦, but fur friends = brain gains!

🔗 Let’s rethink aging — with tails, not pills. #HealthyAging #PetScience #CognitiveHealth #Longevity #BrainHealth 🧓💡

🧠✨ New Stroke Breakthrough!

The ASSET-IT trial shows that early infusion of tirofiban after thrombolysis significantly boosts recovery in noncardioembolic stroke patients — with 65.9% achieving excellent outcomes at 90 days vs 54.9% with placebo 📈💉

✅ Improved function

⚠️ Slightly higher bleeding risk

🌏 Study conducted across 38 centers in China

📚 Read the trial in NEJM (July 2025)

#Stroke #Tirofiban #Neurology #RCT #PrecisionMedicine #Thrombolysis #CardiovascularResearch

📚✨ Just explored Boethius: The Consolation of Philosophy — a timeless journey from despair to divine reason. Written in prison, this masterpiece blends Roman philosophy with Nicene Christian theology, standing firm against Arianism. 🕊️⚖️

🎧 Listen now: Dr. Baliga’s Got Knowledge Doc Podkast

#Boethius #Theology #FaithAndReason #Podcast 💡🎙️📜

💡 New Study Alert! 🏃‍♂️🧪

Kidney-derived betaine mimics long-term exercise—blocking TBK1, reducing inflammation, and reversing aging markers.

This multi-omics human + mouse study uncovers betaine as a precision geroprotector for those who can’t hit the gym.

📈 A leap toward exercise mimetics in aging science!

#Geroprotection #PrecisionMedicine #ExerciseScience #Betaine 🧬🧓🔥

🧬 Rewinding Cellular Time with Chemistry! 🧪

A groundbreaking study just showed that a two-chemical cocktail (2c) — Tranylcypromine + Repsox — can reverse aging markers in human cells and extend C. elegans lifespan by 42%! 🐛💥

Unlike gene-based reprogramming, this method is safer, scalable, and preserves cell identity. Think of it as “Yamanaka lite” — with big implications for aging and longevity science. 🧠💊

#Longevity #Epigenetics #Rejuvenation #Biotech #AgingResearch #Lifespan

🚶‍♂️💔 Just recorded a podcast on Peripheral Artery Disease (PAD) – a silent threat affecting 200M+ people worldwide.

We unpack the latest 2024 ACC/AHA guidelines:

✅ When to screen

💊 What therapies work

🦿 How to save limbs & lives

Tune in to walk away smarter. 👣🎙️ #PAD #Cardiology #Guidelines #Prevention #LimbSalvage

Just finished reviewing the latest JAMA 2025 article on osteoporosis by Morin et al. — a must-read for anyone managing bone health in aging adults!

📉 Despite advances, 70% of fractures occur in those without DXA-defined osteoporosis.

💊 Treatment isn’t just about T-scores — it’s about fracture risk, fall prevention, and smart sequencing of antiresorptive and anabolic therapies.

🏋️‍♀️ Plus, lifestyle matters: resistance training, calcium, vitamin D, and proactive screening save lives.

📈 Fracture Liaison Services (FLS) boost treatment initiation from 17% ➡️ 38%. Let’s bridge the gap between diagnosis and action.

🔗 If you work in internal medicine, endocrinology, geriatrics, or public health — this is worth your time.

#Osteoporosis #FracturePrevention #BoneHealth #JAMA2025 #DXA #PrecisionMedicine #HealthyAging

🚨 New breakthrough in hypertension care!

💊 The Launch-HTN trial shows lorundrostat — a selective aldosterone synthase inhibitor — significantly lowers systolic BP in patients with uncontrolled or treatment-resistant hypertension.

📉 −16.9 mmHg vs −7.9 mmHg with placebo (P < .001)

🧪 Safe, well-tolerated, and effective across subgroups.

A potential game-changer in aldosterone-targeted therapy! 🔄💥 #Hypertension #Cardiology #ClinicalTrials #PrecisionMedicine

Our latest podcast episode unpacks the 2025 JAMA Review on Type 2 Diabetes 🔬💊

We explore:

✅ New diagnostic strategies

✅ Why GLP-1s & SGLT2is are game-changers

✅ How lifestyle change can lead to remission

✅ Individualizing A1C goals in real-world care

🎙️ Episode Title: “Diagnose, Personalize, Optimize: The 2025 Diabetes Blueprint”

📈 Essential listening for clinicians, educators, and innovators in endocrine & cardiometabolic care.

👉 Tune in now and share with your network! #Type2Diabetes #CardiometabolicCare #GLP1 #SGLT2 #PrecisionMedicine #GotKnowledgeDoc 🎧

How we sleep tonight shapes how we move tomorrow! 📉🏃‍♂️

In a large-scale wearable study (📱WHOOP & Fitbit data from >25,000 adults), researchers found:

✅ Sleeping earlier than usual boosts next-day physical activity

❌ Longer or later sleep = less movement

🔥 Max gains came from consistent sleep duration + early bedtime

Let’s rethink our 💤 to power our 💥!

📣 Public health campaigns should promote sleep and exercise together—not in competition.

📄 PNAS, June 2025 | doi: 10.1073/pnas.2420846122

#SleepHealth #PhysicalActivity #WearableTech #Chronobiology #PublicHealth #WHOOP #Fitbit #MVPA #HealthOptimization #BehavioralScience

🧬 Curious why we age? 🕰️ From DNA damage to developmental programs gone rogue, this new podcast episode dives deep into 17 theories of ageing — some classic, some controversial.

🔍 We explore wear-and-tear, free radicals, telomeres, mitochondria, stem cell exhaustion, and the rising stars of epigenetic drift and hyperfunction theory.

🎙️ Whether you’re a scientist, clinician, or just fascinated by the biology of time, tune in to uncover what really drives the ageing process—and what might one day slow it down.

🧠 Listen now: “Wrinkle, Rust, and Rewind: 17 Theories of Why We Age”

#AgeingScience #Longevity #Geroscience #MolecularBiology #Epigenetics #Senescence #HealthcareInnovation

Refractory Angina: Time to Rethink the Diagnosis 🫀💥

Chest pain that defies stents and statins? It may not be your typical obstructive CAD. This podcast unpacks the redefinition of refractory angina — spotlighting INOCA, CMD, vasospasm, and myocardial bridging 🔬⚙️

We explore PET, CMR, CFVR, and wire-based diagnostics 🔎 — and why a multidisciplinary Angina Heart Team is key to transforming care 👩‍⚕️👨‍⚕️🧠

🎧 Listen in as we chart a course from frustration to precision — because even stubborn angina has a story and a solution.

#RefractoryAngina #INOCA #CMD #PrecisionMedicine #Cardiology #MedicalPodcast #PETimaging #StratifiedCare #AnginaHeartTeam #GotKnowledgeDoc 🎙️

🔬🌍 New insights from Nature Aging: Inflammaging isn’t universal!

A fascinating cross-cultural study comparing Italy 🇮🇹, Singapore 🇸🇬, Bolivia 🇧🇴, and Malaysia 🇲🇾 shows that age-related inflammation—long considered a hallmark of aging—may actually be a product of industrialized environments.

Populations like the Tsimane (Bolivia) and Orang Asli (Malaysian), despite high infection loads, show minimal correlation between cytokines and age-related disease.

📉 Conclusion: Inflammaging is not destiny—it’s context.

🧪 Read the full study to explore how culture, infection, and environment shape aging biology.

#Inflammaging #AgingBiology #GlobalHealth #PrecisionMedicine #Immunology #Epidemiology #NatureAging

🚨 AI vs Sudden Cardiac Death in HCM 🫀🤖

Exciting new study published in Nature Cardiovascular Research showcases MAARS, a multimodal AI model that dramatically improves risk prediction for sudden arrhythmic death in hypertrophic cardiomyopathy patients.

📊 MAARS outperformed current guidelines with AUROC of 0.89 (internal) and 0.81 (external)

🧠 Integrated data: LGE-CMR 🧲, EHR 📋, and echo/CMR reports 💻

⚖️ Demonstrated fairness across age and sex subgroups

🔍 Transparent predictions via Shapley values and attention heatmaps

A leap toward personalized, preventative cardiology 💡🩺

#AI #Cardiology #HypertrophicCardiomyopathy #SuddenCardiacDeath #MachineLearning #PrecisionMedicine #DigitalHealth #MAARS #RiskStratification #HCM

“Vax to the Future: Cancer Immunity Revolution 🧬💉”

Cancer vaccines are no longer a promise — they’re a precision revolution. From HBV and HPV to cutting-edge mRNA-based neoantigen vaccines, we explore how tumor sequencing + AI + immune checkpoint inhibitors are reshaping oncology.

📈 Real data from trials in melanoma, ccRCC, and pancreatic cancer

⚔️ PD-1 inhibitors meet targeted T cells

🌍 A safer, scalable future for cancer care

🎧 Tune in to Got Knowledge Doc as we decode this game-changing viewpoint from JCI — “Vaccines in Cancer Treatment and Prevention: The Time is Now.”

#CancerVaccines #mRNA #Immunotherapy #PrecisionOncology #Neoantigens #Podcast #GotKnowledgeDoc 🎙️

🚨 New Findings on Aspartame & Heart Health! 🍬🫀

A groundbreaking study in Cell Metabolism reveals how aspartame, a common artificial sweetener, may worsen atherosclerosis via an insulin-triggered inflammatory pathway involving the CX3CL1-CX3CR1 axis.

🧪 Key insights from mice and monkeys:

– Aspartame spikes insulin via vagus nerve stimulation

– Elevated insulin boosts CX3CL1 expression in endothelial cells

– CX3CL1 recruits inflammatory monocytes ➡️ plaque growth & instability

🧬 Blocking CX3CR1 in monocytes stopped plaque progression entirely.

⚠️ Implications for diabetics, sweetener users, and those at risk of cardiovascular disease are profound.

#Atherosclerosis #Aspartame #Cardiology #PrecisionMedicine #Inflammation #Insulin #CX3CL1 #MedicalResearch #Podcast #CardioMetabolism

Saint Augustine of Hippo (354–430 CE), a prominent theologian, philosopher, and bishop in Roman North Africa, profoundly influenced Western Christianity and philosophy.

Known for works like Confessions, The City of God, and On Christian Doctrine, he developed doctrines on original sin, grace, just war, and ecclesiology.

His thoughts shaped medieval theology, inspired Protestant Reformers, and continue to impact Christian teachings.

🚨 Just out in JAMA!

💡 PanEcho, a multitask AI model trained on over 1.2 million echo videos, can automate complete echocardiographic interpretation — from LVEF to valvular disease — with diagnostic AUCs up to 1.00 and MAE as low as 4.2%.

🌍 Validated across international cohorts, including point-of-care settings, this tool could redefine access, accuracy, and efficiency in cardiac imaging.

🫀🤖 A major leap toward AI-assisted cardiovascular diagnostics.

🔗 Read the study

#AIinMedicine #Cardiology #EchoRevolution #PanEcho #DigitalHealth #JAMA #MachineLearning #CardioAI #MedicalImaging #DeepLearning

🚨 New insights from cancer neuroscience! 🧠🧬

A groundbreaking Nature study reveals that cancer cells can steal mitochondria from nearby neurons via tunneling nanotubes — supercharging their metabolism, stemness, and metastatic potential 🌪️💥

Using a clever tool called MitoTRACER, researchers traced this “mitochondrial hijack” across cancers (breast, prostate, melanoma) and showed that recipient cells were more likely to seed distant metastases — especially in the brain 🧳🧠

🧪 Targeting this nerve–tumor energy axis may open new doors to stop metastasis in its tracks 🛑🛤️

#CancerResearch #Neuroscience #Metastasis #Mitochondria #Innovation #NaturePaper #Oncology #TumorMicroenvironment #Stemness #CellBiology #MedicalBreakthrough

🧠💓 Cognitive decline and cardiovascular disease often go hand in hand — but they don’t have to spiral together.

In our latest breakdown, we explore how cardiologists can detect, manage, and even improve cognitive impairment through smart risk factor control, lifestyle changes, and a multidisciplinary approach. From MoCA to memantine, TAVR to team-based care — it’s time to connect the mind and the heart.

📊 Evidence-based strategies

🩺 Practical tools for clinicians

💡 Insights from JACC’s state-of-the-art review

👉 Let’s build heart-smart, brain-friendly care — together. #Cardiology #CognitiveHealth #Geriatrics #HeartBrainConnection

🧠💉 Can vaccines protect the mind? New research suggests that AS01-adjuvanted vaccines like Shingrix and Arexvy may reduce the risk of dementia—possibly by stimulating immune pathways like IFN-γ and TLR4, not just by preventing infection.

📊 In a large US-based EHR study, those who received the RSV or shingles vaccine had a significantly lower 18-month dementia risk than flu-vaccinated peers.

🔬 The common thread? The AS01 adjuvant.

🛡️ Could this be a new frontier in neuroprotection? Let’s discuss. #Vaccines #Dementia #RSV #AS01 #Neuroimmunology #PublicHealth #Alzheimers #PrecisionMedicine

New Insights from the DanGer Shock Trial! 🫀💡

Can early left ventricular unloading with a microaxial flow pump (mAFP) save lives in STEMI-related cardiogenic shock?

This compelling substudy shows that mAFP not only boosts cardiac output and power, but also reduces pulmonary pressures—all while using less pharmacologic support. 📉💊

🧪 Native CO improved steadily over 48 hours, hinting at myocardial recovery.

📊 PAC data gives us a front-row seat to the physiology behind the survival curves.

🔬 The editorial dives deeper: timing, technique, and future questions.

👉 Time to rethink shock care? Dive in.

#Cardiology #STEMI #CardiogenicShock #CriticalCare #mAFP #PAC #Impella #HeartFailure #DanGerShock #LVUnloading #MechanicalSupport #JACC 🩺📉🫁

🚨 New Breakthrough in Type 2 Diabetes Care! 💊🧬

The ACHIEVE-1 trial shows that Orforglipron, a once-daily oral, nonpeptide GLP-1 receptor agonist, delivers significant reductions in HbA1c and body weight—without injections and with minimal restrictions! 🌍📉

👨‍⚕️ 559 patients across 5 countries

⏱️ 40 weeks, 3 dosing arms (3, 12, 36 mg)

📊 HbA1c ↓ by up to 1.48%, weight ↓ up to 7.6%

✅ No severe hypoglycemia

📌 Mild GI side effects during dose titration

This is a potential gamechanger for early T2DM care—simple, effective, and patient-friendly. 🚀

#Type2Diabetes #GLP1 #Orforglipron #Endocrinology #ClinicalTrials #PrecisionMedicine #Innovation #NEJM #ACHIEVE1 #OralTherapeutics 💥

🚨 Frailty matters — even in the cath lab! 🧓🫀

A new NCDR registry analysis of 1.3M+ older adults shows a clear gradient: as frailty increases, so do complications, mortality, and procedural risks during PCI. Severely frail patients faced a striking 20.3% in-hospital mortality and >50% mortality with cardiogenic shock.

🧠 It’s time to treat frailty as a vital sign — embedded in our workflow, guiding shared decisions, and shaping post-PCI care.

📊 Let’s bring team-based, geriatric-informed strategies to the forefront of interventional cardiology.

#Cardiology #Frailty #PCI #PrecisionMedicine #AgingWell #GeriatricCardiology #NCDR #HealthcareInnovation #PatientCenteredCare

🚨 Major breakthrough in obesity pharmacotherapy!

The REDEFINE-1 & REDEFINE-2 trials show that once-weekly CagriSema (Cagrilintide + Semaglutide) delivers up to 20% weight loss in people with obesity—and significant glycemic improvements in those with type 2 diabetes. 💉📉

🌍 Global, double-blind RCTs

⚖️ >90% lost ≥5% body weight

🩺 SBP ↓, QoL ↑, prediabetes reversed in 88%

⚠️ GI side effects common but mostly mild

💡 CagriSema is redefining the weight loss frontier—with dual satiety and metabolic action.

#Obesity #GLP1 #Cagrilintide #Semaglutide #CagriSema #WeightLoss #RCT #MetabolicHealth #Prediabetes #NovoNordisk #Endocrinology #InternalMedicine #PrecisionMedicine #Pharma #ClinicalTrials #ObesityMedicine #Amylin #GLP1Agonist #T2D #LifestyleMedicine

🔥 New Study Alert! 🩺

Wildfire smoke isn’t just a respiratory threat — it’s taking a toll on the heart, especially in older adults.

📊 A nationwide Medicare cohort (~22M) shows that long-term exposure to wildfire-specific PM2.5 is linked to significantly higher heart failure risk — more so than urban pollution.

📍 Vulnerable groups — women, Medicaid-eligible individuals, and low-income communities — face the highest burden.

🌫️ Tiny particles. Massive impact.

📚 Read the study: Hao et al, JACC July 2025

#Cardiology #AirPollution #WildfireSmoke #HeartFailure #EnvironmentalJustice #PM25 #PublicHealth #Epidemiology

🧠💊 Appetite Meets Its Match: The Amylin Advantage”

In this episode of Got Knowledge Doc, we explore how amylin, the lesser-known hormone co-secreted with insulin, is making a comeback — this time as part of a dual receptor strategy with GLP-1.

💡 Learn how amylin:

🧠 Activates brainstem satiety centers
⏳ Delays gastric emptying
📉 Suppresses glucagon
🔁 Synergizes with GLP-1 & leptin

We break down the science behind amycretin, the first oral dual GLP-1/amylin agonist, and what it could mean for the future of obesity and metabolic care.

🧠💉 When should you start anticoagulation after an ischaemic stroke in atrial fibrillation? The CATALYST meta-analysis may have the answer!

📊 5,441 patients from 4 RCTs

⏱️ Early DOAC (≤4 days) reduced recurrent stroke risk at 30 days

⚖️ No increased bleeding, even in moderate stroke severity

🚫 But patients with PH2 or very severe strokes were excluded

Individual Participant Data Meta-Analysis allowed detailed subgroup analysis and minimized bias

💡 Clinical Takeaway: In most mild-to-moderate strokes, don’t delay—start DOACs early!

📄 #Stroke #AtrialFibrillation #CATALYST #DOAC #Neurology #Cardiology #MetaAnalysis #IPDMA #ClinicalTrials #PrecisionMedicine #StrokePrevention

🚨 Breakthrough in Type 1 Diabetes! 🧬💉

A new study in NEJM shows that zimislecel, a fully differentiated stem cell–derived islet therapy, restored insulin production and led to insulin independence in 83% of participants! ✅

📉 HbA1c dropped, 📈 time-in-range soared to 93%, and ⚖️ glucose variability was dramatically reduced.

This marks a major step toward curing—not just managing—Type 1 diabetes.

🔬 Precision science. 💪 Real-world impact. 🌍 Hope for millions.

#Type1Diabetes #StemCellTherapy #IsletTransplant #Zimislecel #NEJM #Innovation #RegenerativeMedicine #Vertex #Endocrinology #DiabetesCure

🧘‍♂️ How Well Can You Sit and Rise from the Floor? 🪑⬆️

That simple motion might say more about your longevity than you think.

A 12-year study of 4,282 adults found that lower Sit–Rise Test (SRT) scores predicted 3.8x higher natural death and 6x higher cardiovascular death rates. 😱

✅ No equipment

✅ Under 2 minutes

✅ Predicts survival

Why aren’t we using this more in routine clinical exams? 🩺

💡 If you score a 10, your 10-year survival is 97%.

Score 0–4? It drops to 73%.

🔍 Let’s rethink non-aerobic fitness in preventive cardiology.

#PreventiveCardiology #Longevity #FunctionalFitness #SitRiseTest #PublicHealth #CardiovascularRisk #ExerciseIsMedicine #HealthSpan #BalanceMatters #ClinicalInsights

Aristotle (384–322 BC), a Greek philosopher and polymath, founded the Peripatetic school and Lyceum in Athens.

His extensive works spanned diverse fields, including logic, ethics, politics, biology, and metaphysics, profoundly influencing Western thought, science, and philosophy.

⚡Gatekeepers of Strength: Allopurinol, Calcium & the RyR Revolution”!

Did you know that an old gout drug might hold the key to reversing age-related muscle weakness and heart failure? Using cryo-EM, researchers found that allopurinol and xanthine derivatives directly activate ryanodine receptors—calcium channels essential for muscle contraction.

💡 This could change how we think about cardiac therapeutics and sarcopenia. Tune in for the full story—explained for med students, researchers, and curious minds alike.

🎧 Listen. Learn. Share. Let’s unlock the power within. 💪🧠 #PrecisionMedicine #Cardiology #MuscleScience #Allopurinol #RyR #MedicalEducation #GotKnowledgeDoc

🧠🔥 Neuroinflammation: The Common Flame in MS, Stroke, Alzheimer’s & Parkinson’s

Why do microglia flip from guardians to arsonists?

How does immune cell infiltration differ between MS and AD?

And which CNS-penetrant therapies show the most promise in dousing the inflammatory fire?

In our latest Got Knowledge Doc podcast, we decode the science behind neuroinflammation, explore treatment frontiers like BTK inhibitors and TREM2 agonists, and highlight key clinical insights for neurologists and internists.

🎧 Listen now to “Brains on Fire: Can CNS Drugs Cool the Heat?”

💊 Backed by the June 2025 Science review by Shi & Yong.

#Neuroinflammation #MultipleSclerosis #Alzheimers #Parkinsons #Stroke #Microglia #Neurodegeneration #CNS #BTK #DMT #GotKnowledgeDoc

🔬💓 New Insights on HFimpEF 💓🔬

Heart Failure with Improved Ejection Fraction (HFimpEF) is no longer just a transition phase—it’s a distinct, dynamic phenotype with its own risks and management needs.

From biomarkers and imaging to the latest trials like PROSPER-HF and FINEARTS-HF, we’re entering an era of more personalized care for these patients.

📈 Better EF ≠ Complete Recovery.

💊 Continued GDMT, careful ICD decisions, and ongoing surveillance are key.

Let’s discuss: Are we ready to rethink “recovery” in heart failure?

#Cardiology #HFimpEF #HeartFailure #PrecisionMedicine #ReverseRemodeling #JACC

🧠 Is your brain orchestrating how fast you age?

New insights suggest that aging isn’t just about wear and tear—it may be centrally coordinated by the brain through molecules like GDF15, responding to stress, senescence, and energy demands.

💬 Fascinating findings from Nature (June 2025) show how psychological stress accelerates aging at a cellular level—and how lifestyle interventions like exercise may help reverse it.

👇 How are you integrating brain–body science into your approach to aging and wellness?

#AgingScience #BrainHealth #Longevity #PrecisionMedicine #GDF15 #Epigenetics #Nature2025 #StressBiology #Healthspan #Telomeres #Neuroscience #PublicHealth #Geroscience

“Obesity Rx 💊❤️🔥: Hormones, Hearts, and Hope”

The 2025 ACC guidance reframes obesity as a chronic disease—with precision therapies like GLP-1/GIP agonists now essential in cardiology.

We explore NuSH therapies (semaglutide, tirzepatide), the latest trial data, clinical thresholds for risk reduction, and practical steps for de-stigmatizing care.

👉 Tune in if you’re ready to treat obesity like the cardiovascular disease it truly is.

#Cardiology #ObesityMedicine #GLP1 #Tirzepatide #NuSH #MASLD #ACC2025 #MedicalWeightLoss #HFpEF #PrecisionMedicine #GotKnowledgeDoc

🔬 New meta-analysis alert! 🧪 Researchers compared rapamycin and metformin to dietary restriction across 167 studies in 8 vertebrate species.

📈 Key finding: Rapamycin mirrors dietary restriction’s longevity benefits—but metformin falls short.

⚠️ High heterogeneity and species bias remind us: translation to human health still needs careful navigation.

🧠 Full of insights for aging science, pharmacology, and precision medicine!

#LongevityScience #Rapamycin #AgingResearch #MetaAnalysis #LifespanExtension #PrecisionMedicine 👩‍🔬📊🧬

🫀 The Heart Ages—But Can We Intervene?

New insights from Nature Reviews Cardiology highlight how endothelial dysfunction, inflammageing, CHIP, and senescence-associated secretory phenotypes (SASP) drive cardiovascular ageing. Promising interventions—from gerotherapeutic diets and exercise to NAD+ boosters, senolytics, and ACBP neutralization—may help delay decline and promote resilience.

💡 Can we target the biology of ageing to extend cardiovascular healthspan, not just lifespan?

👇 Join the conversation: Which intervention holds the most promise—and what are the biggest challenges in translating this to clinical practice?

#Cardiology #Longevity #Geroscience #HeartHealth #Innovation #PrecisionMedicine #HealthyAgeing

We unpack the UN Scientific Advisory Board Brief on Aging—from telomeres and epigenetic clocks 🧫 to senolytics 💊 and AI-driven geroscience 🤖.

Why does aging matter to every clinician?

Because aging is the common soil of all chronic disease. 🌱

🔗 Listen now and join the longevity conversation!

#Aging #UNBrief #Geroscience #Epigenetics #Healthspan #GotKnowledgeDoc

🚨 Game-changing breakthroughs in chimaera research! 🧬💓

From beating human hearts grown in pig embryos to human organoids integrating into mouse intestines and brains via amniotic injection—two bold advances are reshaping the future of organ transplantation and regenerative medicine.

But with scientific promise comes ethical complexity. How far should we go in creating human–animal hybrids? What safeguards are needed?

👇 Join the conversation:

Are we building miracles—or crossing lines?

#StemCells #RegenerativeMedicine #Bioethics #ChimaeraResearch #Transplantation #FutureOfMedicine

🌞 New Guidelines on Vitamin D Supplementation! 💊🧪

JAMA’s latest synopsis recommends empirical vitamin D dosing—without routine testing—for children, the elderly, pregnant women, and those with prediabetes. The evidence? Conditional, with wide confidence intervals—but the low cost and minimal harm may tip the scales.

Let’s discuss: Is this the dawn of “test less, dose more” in preventive medicine? #VitaminD #PublicHealth #Endocrinology #JAMA #ClinicalGuidelines #PreventiveCare

🚨 One in five people carry a hidden cardiovascular risk—do you?

The Brussels Declaration on Lipoprotein(a) calls for global, once-in-a-lifetime Lp(a) testing to prevent premature heart disease and stroke. With strong scientific backing and health equity at its core, this is a pivotal step toward personalized cardiovascular prevention.

🧬 Let’s test early. Act early. Save lives. #LipoproteinA #BrusselsDeclaration #CVDprevention #PrecisionMedicine #HeartHealth

From baby blood to breakthrough cures — we explore how unlocking fetal hemoglobin through gene editing (exa-cel/Casgevy) is transforming treatment for sickle cell disease and β-thalassemia. 🧬✂️

Featuring the science of BCL11A, CRISPR therapies, and what the future holds for global access 🌍💉

🎧 Tune in: “Switching Gears: From Fetal Hemoglobin to Gene Therapy”

#GeneTherapy #CRISPR #HbF #BCL11A #Casgevy #SickleCell #Thalassemia #Innovation #PrecisionMedicine

Treat it Early. Treat it Right. Treat it Once.

New Lancet comment calls for a paradigm shift in heart valve disease care—advocating early referral, multidisciplinary heart networks, and lifetime management strategies that prioritize durability over delay.

Surgery isn’t the villain—delay is.

#Cardiology #HeartValveDisease #PrecisionMedicine #SurgicalInnovation #Lancet2025 #LifetimeCare #MultidisciplinaryCare

Vasubandhu was a 4th–5th century Indian Buddhist monk, philosopher, and co-founder of the Yogācāra school of Mahayana Buddhism.

Renowned for his works on Abhidharma, he developed key philosophical concepts such as “consciousness-only” (vijñaptimātra) and authored texts on Buddhist metaphysics, logic, and meditation.

His influential treatises, including Abhidharmakośa and Thirty Verses, significantly shaped Buddhist thought in India, Tibet, and East Asia.

🧠💥 New spin on stroke care!

The Milli-Spinner thrombectomy device shrinks clots by up to 95% using shear + compression — no rupture, no fragments.

🚑 Achieves revascularization in 90%+ cases, even when aspiration fails.

#Stroke #Innovation #NeuroTech 🔄🩸🔬

📖 https://doi.org/10.1038/s41586-025-09049-0

🔥 Immunosenescence + Inflammaging = Aging’s hidden engines.

🧬 New studies link immune decline to frailty, dementia, and disease.

🥗💉 Sleep, diet, vaccines, and GLP-1s may slow the clock.

#Healthspan > #Lifespan 💡👴🛡️

Derived from Dr. Eric Topol’s Ground Truths on Substack.

Heart attacks & strokes are down, but guess what’s rising?

⚡ Atrial fibrillation, 🫀 valve disease, & 🩸 VTE are taking the lead!

It’s time to rethink prevention: from plaque to pulse to prognosis.

🧠💊📊 #CardioTwitter #HeartHealth #TheLancet

https://doi.org/10.1016/S0140-6736(25)00990-0

🧠🍬 New study in Nature reveals: High-fructose exposure in early life impairs brain development by suppressing microglial phagocytosis via GLUT5 ➡️ HK2-driven metabolic rewiring.

Result? 🐭 develop anxiety-like behavior.

Cut the sweet talk. Think before you drink. #NeuroScience #FructoseFacts #MentalHealth 🧪🍼

🚨 New 2025 ACC Statement!

Obesity worsens heart failure—but weight loss changes the game.

🏃‍♂️ Lifestyle helps.

💊 Semaglutide & tirzepatide show promise in HFpEF.

🔬 Rethink BMI.

⚖️ Precision + empathy = better outcomes.

👇 Dive into key takeaways.

#CardioTwitter #Obesity #HeartFailure

👵🍽️ Malnutrition in aging isn’t just about food — it’s frailty, forgetfulness, and function.

The DoMAP model 🧠🔺 reveals how low intake, high needs, and poor absorption collide with social, physical & mental challenges.

Let’s fix the hidden hunger. 🥣❤️ #Geriatrics #Malnutrition #HealthyAging

🚨 New BMJ meta-analysis!

After PCI & stopping DAPT, P2Y12 inhibitor monotherapy 💊 reduces MACCE 🧠❤️ (HR 0.77) vs aspirin — without more major bleeding 💉

🫀 MI & stroke ↓

📊 16,117 pts, 5 trials

🧠 Smarter post-PCI strategy?

#CardioTwitter #BMJ #PCI #P2Y12 #Aspirin 🚫

🧬 New study in Aging Cell finds immune resilience—anchored by TCF7 expression—confers a 🚀 15.5-year survival advantage!

💥 SAS-1 high / MAS-1 low = 🔑 to longevity

👵 Midlife is the window.

🧠 Age is biology, but resilience is destiny.

#Longevity #Aging #Immunology #TCF7

🫀 Cardiovascular breakthroughs abound—yet millions still die needlessly.

🌍 Innovation without equity is like a heart without a pulse.

💡 From molecules to communities, it’s time to turn science into survival. #GlobalHealth #CardioCare #EquityMatters

🚨New insights from the PRODROME trial!

💊 Ubrogepant 100mg, given before the migraine hits, reduced photophobia, fatigue & brain fog—within hours!

🧠 Targets the prodrome, not just the pain.

📈 A paradigm shift in migraine care?

#Migraine #CGRP #NeuroTwitter N

🔗 https://doi.org/10.1038/s41591-025-03679-7

💊 Big win for kidneys! In the CONFIDENCE trial, combo therapy with #Finerenone + #Empagliflozin 📉 slashed albuminuria 29–32% more than either alone in CKD + T2D patients 🧪🛡️

Safe, fast, and promising! 👥⏱️✅

#Nephrology #CardioRenal #SGLT2i #NEJM 🧬🩺

👁️✨ Scientists have restored infrared vision using tellurium #nanowires implanted in the retina!

🧪 Mice and primates regained light sensitivity and behavioral vision.

🚀 A bold leap toward restoring sight without bulky tech.

#VisionScience #NeuroTech #Retina #Innovation

🍷 Is a glass of wine a heart helper or hidden hazard?

The 2025 AHA Statement says:

⚠️ Moderate = uncertain

🚫 Heavy = harmful

🫀 Risks include AFib, stroke, CAD, HF & sudden death

📊 New genetic studies challenge old myths.

👇 Know your limits. Rethink the drink. #CardioTwitter #MedEd #AHA2025

Patanjali, an ancient Indian sage, is credited with authoring foundational texts in Sanskrit grammar (Mahābhāṣya), yoga philosophy (Yoga Sutras), and possibly medicine (Patanjalatantra).

Revered as a mystic and philosopher, his works laid the groundwork for classical yoga and linguistics, profoundly influencing Indian philosophical traditions.

Though scholarly debates persist about his identity, Patanjali remains a significant figure in Hinduism, particularly in yoga and linguistic studies.

🏃‍♂️💪 New NEJM study shows structured exercise after chemo boosts survival in colon cancer patients!

📈 5-yr DFS: 80.3% vs 73.9%

❤️ 8-yr OS: 90.3% vs 83.2%

🧬 Fitness = longevity

👟 Time to prescribe steps, not just scripts?

#Oncology #ExerciseIsMedicine #CHALLENGEtrial

🚨 New trial alert! In youth with type 1 diabetes, adding #SGLT2i 💊 (dapagliflozin) to insulin:

✅ Reduced glomerular hyperfiltration

✅ Lowered HbA1c 📉

✅ Boosted time-in-range ⏱️

😌 Safe with DKA precautions in place

📄 #ATTEMPTTrial | @NatureMedicine

🔗 https://doi.org/10.1038/s41591-025-03723-6

📉 New study alert!

Patients with diabetes using GLP-1 receptor agonists had 2x higher risk of developing neovascular macular degeneration 😮

Longer use = greater risk 📈

Clinicians, keep an 👀 on ocular safety!

#GLP1 #Diabetes #EyeHealth #nAMD #JAMAOphthalmology

🧲 New twist in sex determination!

Maternal iron levels shape whether XY embryos become male 🧬👶.

Low iron ➡️ silenced Sry gene ➡️ female development 💡🧪.

Epigenetics meets nutrition in utero—stay iron-clad, moms!

#Epigenetics #IronMatters #SexDetermination

🔬 New in @ScienceMagazine:

Researchers grew mini human organs (gastruloids) with real blood vessels! ❤️🧠

Using stem cells + special cocktails, they modeled early heart & liver development in a dish.

A leap for organoids & regenerative medicine! 🧪🧬 #Biotech #StemCells #Organoids

🧬 Is taurine the secret to youth? Not quite.

📈 New study shows taurine levels 📈 with age—especially in women.

🙅‍♂️ Not a reliable aging biomarker: too much variability, too many mixed signals.

🧠 Context matters. Supplement wisely. #Longevity #AgingResearch #Taurine #Science 🧪

🧬 New vascular villain? It’s not always clots.

💥 Necroptosis of endothelial cells triggers red blood cell rupture.

🩸 Sticky RBC fragments form “endo-seals” that block blood flow—especially in COVID-19, stroke, and MI.

🎯 Targets? Think MLKL & complement, not just platelets.

#MedTwitter #COVID19 #VascularBiology #Pathology

🧬 New study reveals 4 stable #Immunotypes in healthy adults!

Each with unique 🔥inflammatory, 🦠CMV-driven, 💧quiet, or 🔥aging-linked immune traits.

They predict LPS response better than age or sex.

Welcome to the era of immune fingerprinting! 🧪🧠

#PrecisionMedicine #Immunology #Multiomics

🥖 Not all carbs are created equal — or digested the same!

A new study shows glycemic responses vary wildly by individual 🍚🥔🍞🍇

Your microbiome, metabolism, and ethnicity all matter!

Precision nutrition is the future 🔬🧬📊

#GlycemicResponse #CGM #NutritionScience #T2D 🍽️

🧬 A new epigenetic clock predicts your functional age — not just birthdays!

🕰️ Built from 91 CpGs, the IC Clock outperforms GrimAge & others at predicting mortality

💪 Linked to T-cell health, 🫁 lung function & 🐟 omega-3 intake

📖 Nature Aging: https://doi.org/10.1038/s43587-025-00883-5

#Aging #Epigenetics #Longevity #Immunosenescence Doximity

🥜 Daily almonds = big wins for metabolic health!

✅ ↓ LDL & total cholesterol

✅ ↑ Vitamin E (α-tocopherol)

✅ ↓ Gut inflammation (calprotectin, MPO)

❌ No change in systemic inflammation or weight

Crunch wisely, live heart-smart! ❤️🧠 #Nutrition #MetabolicSyndrome #RCT #Almonds #GutHealth

🧪 Can we turn back the clock? A new RCT shows TPE + IVIG reversed biological age by 2.6 years in older adults! 🔄🧬

✅ Boosted naïve T cells

⚠️ Small sample, no clinical endpoints

🔍 Personalized markers predict response

#Aging #LongevityScience #Epigenetics 🧓📉✨

🥗 New study in Nature Food: Greater diversity of flavonoid intake—not just quantity—linked to ↓ risk of death, diabetes, heart disease & more 🌈🍇🍵

Eat the rainbow daily: apples, tea, berries, citrus, greens = longevity boost 💪🧬

#Nutrition #Longevity #Flavonoids

Marcus Aurelius (121–180 CE), a Roman emperor and prominent Stoic philosopher, ruled from 161 to 180 CE.

As the last of the Five Good Emperors, his reign marked the end of the Pax Romana, a period of relative peace in the Roman Empire.

Known for his military campaigns against Parthians and Germanic tribes, he also endured the devastating Antonine Plague.

His philosophical reflections, compiled in Meditations, offer insight into Stoic ethics and personal leadership.

Marcus was succeeded by his son Commodus, whose rule marked a decline in Rome’s stability. His legacy endures in both historical and philosophical contexts.

🩸 New JCI study reveals how RBC-derived EVs 🧬 in #Type2Diabetes sneak into endothelial cells 🧫, delivering arginase-1 & sparking oxidative stress 🔥—a hidden cause of vascular dysfunction.

Blocking EV uptake = 💡 new therapy?

📖 https://doi.org/10.1172/JCI180900

#CardioTwitter #Diabetes #VascularBiology

Big shift in Alzheimer’s care!

We can now predict it years in advance using 🩸 biomarkers like p-tau217, 🧬 genetic risk, & 🤖 AI-analyzed retina scans.

Prevention = lifestyle 🥦🏃‍♂️💤, vaccines 💉, & maybe GLP-1s 💊.

Why wait to treat when you can PREVENT? 🔍

#Alzheimers #PrecisionMedicine #AI

🧬 Did you know your blood cell metabolism could fuel heart disease?

🔁 Disrupted haematometabolism = more inflammation, less cleanup

🧹 Efferocytosis fails → plaques grow

🧠 Aging + CHIP mutations = 🔥 risk

🥗 Fix it with fasting, fitness & future therapies!

#CardioTwitter #MedEd #Haematometabolism ❤️

🧬 The microbiome is medicine’s next frontier!

From Fecal Transplants 💩 to probiotics 🦠, diagnostics 🔍 to designer bugs 🧪—we’re decoding disease, predicting treatment, and redefining care.

But challenges remain.

🎙️ Dive into the FAQs with Got Knowledge Doc! #Microbiome #GutHealth #MedTwitter 🚀

📢 New from the SOUL trial!

💊 Oral semaglutide cuts heart attack risk in T2DM 🫀 but shows no benefit for stroke 🧠 or kidney disease 🧫.

A win for adherence, a push for CKM integration! 🔄💡 #Diabetes #Cardiology #NEJM #CKM #GLP1RA @doximity

🏌️‍♂️⛳ Living near golf courses may increase Parkinson’s risk!

📊 Case-control study: Risk highest within 1–3 miles

💧 Contaminated groundwater & pesticides likely culprits

🧠 aOR up to 2.98 for 6 miles!

📉 Risk ↓ 13% per mile after 3 miles

🔗 [JAMA 2025] #Neurology #Parkinsons #EnvironmentalHealth #GolfRisk @doximity

🚨 BREAKING: Sotatercept cuts risk by 76% in advanced #PAH!

💉 Targets activin signaling

🫁 Fewer deaths, transplants & hospitalizations

📉 HR 0.24 | Trial stopped early for efficacy

⚠️ Epistaxis, ↑Hgb, telangiectasia noted

🔬 A new era in pulmonary hypertension care! #ZENITHTrial #CardioTwitter 🫀📊 @doximity

🚨New COPD diagnosis alert!🫁

A multidimensional schema using CT 🖼️ + symptoms 😮‍💨 + spirometry 📉 identified high-risk patients missed by GOLD!

📈↑Mortality (HR 1.98)

📉FEV1 decline (–7.7 mL/y)

📊 Reclassified 15% w/o obstruction as COPD!

👉CT matters. #PulmTwitter #COPD #MedTwitter @doximity

🚨 New data! In the KARDIA-2 trial, 🧬 zilebesiran—an RNAi therapeutic—cut SBP by up to 12 mmHg when added to common antihypertensives

💊. One shot, 6 months of BP control!

📉 Promising for poor adherence.

Mild AEs. #Hypertension #Cardiology #RNAi 🌍【JAMA 2025】

🧬 Big win for longevity!

A Nature Aging study shows that combining 💊 trametinib + rapamycin extends lifespan, reduces tumors, and tames inflammation in mice 🐭🔥

Dual geroprotectors = additive benefits without added toxicity 🛡️🕰️

Future of anti-aging? Watch this space 👀

#Aging #Longevity #Geroprotectors #Science 🧪 @doximity

🧠💉 New Lancet study (OPTIMISTmain) shows low-intensity monitoring after thrombolysis in mild strokes may be just as safe as standard care!

💤 Less sleep disruption, 🧑‍⚕️ lighter nursing load, ⚖️ similar outcomes.

Could this change global stroke care? 🌍🏥

#Stroke #Thrombolysis #OPTIMISTmain #Neurology

🚨New A2B Trial in JAMA!

Can 🧪dexmedetomidine or clonidine beat 💉propofol in sedating ICU patients on ventilators?

❌ No faster extubation

⚠️ More bradycardia & agitation

⚖️ Similar mortality

Verdict: No clear winner—tailor sedation to patient needs 🛌👨‍⚕️

#CriticalCare #ICU #SedationTrial

🚨🧠 BREAKING: Tenecteplase before thrombectomy boosts chances of stroke recovery!

💉 Faster reperfusion

📈 Higher functional independence (mRS 0–2 at 90d: 52.9% vs 44.1%)

⚠️ Slight ↑ in sICH, but no major safety red flags

🧪 #BRIDGE_TNK trial rewrites the stroke playbook!

#Stroke #Tenecteplase #NeuroTwitter

Nāgārjuna (c. 150 – c. 250 CE) was an Indian Buddhist monk and philosopher, regarded as the founder of the Madhyamaka (Middle Way) school of Mahāyāna Buddhism.

His most famous work, Mūlamadhyamakakārikā (Root Verses on the Middle Way), presents the concept of śūnyatā (emptiness) and the two truths doctrine, emphasizing dependent origination and rejecting inherent existence.

Nāgārjuna’s philosophy has profoundly influenced Mahāyāna thought and continues to shape Buddhist studies and practice today.

📢 New RCT in Nature Medicine 🎯

Can zapping low-voltage areas (LVAs) reduce AF recurrence after PVI?

🔬 SUPPRESS-AF Trial

👥 342 pts with persistent AF

📉 1-yr AF/AT-free: 61% (PVI+LVA) vs 50% (PVI)

❌ Not statistically significant

🧠 Subgroup benefit in high-risk pts

#EPeeps #AFib #CardioTwitter 🫀

🧠💪 Can blood biomarkers of Alzheimer’s predict who’ll lose muscle strength with age?

In a 12-year study, higher p-tau, NfL & GFAP levels forecasted faster decline in grip & leg power — even before dementia onset.

🧬🪑✊ #Aging #Alzheimers #Sarcopenia #Biomarkers #Longevity

📉 New JAMA study tracks U.S. #SedentaryBehavior from 2013–2023:

🪑 Sitting time fell from 7.1 to 5.9 hrs/day pre-COVID

🦠 But plateaued post-pandemic at 6.0 hrs/day

🚶‍♀️ Progress stalled—time to get moving again!

#PublicHealth #NHANES #PhysicalActivity 🏃‍♂️📊🛋️

🐒 New study finds no disorganized attachment in wild chimpanzees!

🧠 Only secure & avoidant types observed—just like humans, but without the trauma.

🌿 Evolution favors calm, connected bonds.

📍Taï National Park, Côte d’Ivoire

🔗 Nature knows best. #PrimateScience #AttachmentTheory #Chimpanzees

💡World’s tiniest pacemaker—smaller than a grain of rice!

🫀Leadless, wireless & bioresorbable

🔦 Powered by NIR light

🧬 Perfect for post-op pacing & TAVR

🌱 No wires, no scars, no removal!

#MedTech #Cardiology #Bioengineering #Innovation @Nature

Cutting cysteine = 🔥 30% weight loss in 7 days!

🧬 Triggers stress pathways (ISR/OSR)

❌ CoA & glutathione drop

🔥 Browning fat, futile cycling, energy drain

💡 Reversible & promising for obesity research!

#Metabolism #Obesity #AminoAcids #Science 🧪⚖️🧠

🚨 TAVI Trials Update!

🆚 COMPARE-TAVI 1: 🇮🇳Myval = 💪SAPIEN 3 in safety & efficacy

🆚 ACURATE IDE: ACURATE neo2 ❌not non-inferior to 💥SAPIEN/EVOLUT

📊 Valve wars intensify! #TAVI #HeartValve #Cardiology 🫀

🌶️ Not all chili heat is created equal!

Scientists found hidden compounds—like capsianoside I & roseoside—that cool the burn without changing flavor 🔬❄️

Your next spicy dish might be hot… but not hurt.

#FlavorScience #Capsaicin #TRPV1 #FoodTech 🍽️🧠🔥

📊 New study shows Topological Flow Data Analysis (TFDA) 🌀 detects early cardiac dysfunction in childhood cancer survivors—before LVEF or strain drop!

🔍 A game-changer in cardio-onc surveillance. #CardioOncology #TFDA #EchoRevolution

📉 Mucus plugs matter! In COPD, persistent or new plugs accelerate FEV₁ decline 🫁💨

🖥️ CT imaging tracks their impact

🚬 Smoking worsens the hit

👉 Clear the plugs, preserve the lungs!

#COPD #LungHealth #NEJM #FEV1 #Pulmonology

🩺 New hope for #ResistantHypertension!

A 12-week RCT 🇰🇷 shows 💊 amiloride is noninferior to spironolactone in lowering SBP 📉

Fewer side effects, similar BP drop!

But spironolactone may still reign 👑 for organ protection 🫀🧠

🧪 #Hypertension #Cardiology #JAMA2025

🧬✨ A baby with deadly CPS1 deficiency (which results in elevated ammonia levels) gets a custom-made gene edit—delivered by lipid nanoparticles—in just 6 months! 🚀

Ammonia levels down, no hospitalizations, and hope up.

N-of-1? More like Future-of-Many. 💡👶🔬 #GeneTherapy #PrecisionMedicine #RareDisease

🚨 New framework alert!

Systemic Metabolic Disorder (SMD) gets a clinical staging makeover 🧬

From reversible risks 🌱 to systemic damage 🔥—this EAS consensus guides timely, targeted care 🎯

#MetabolicHealth #Cardiology #PrecisionMedicine #SMD 🩺📊

Pyrrho of Elis (c. 360–270 BCE) was an ancient Greek philosopher and founder of Pyrrhonism, a school of philosophical skepticism.

He advocated for epoché (suspension of judgment) as a path to ataraxia (peace of mind).

Influenced by his travels to India with Alexander the Great, Pyrrho believed that nothing could be definitively known and that by refraining from beliefs, one could achieve tranquility.

His teachings laid the foundation for later skeptical thought in philosophy and medicine.

🧬 New hope for lipid warriors!

Solbinsiran (siRNA) slashed apoB 🩸, TGs 🍟, LDL-C 💔 & liver fat 🫀 in just 205 pts with mixed dyslipidaemia.

Safe ✅ Durable ✅ Quarterly dosing? Maybe ✅

Let’s talk outcomes! 🎯

#PROLONGANG3 #RNAtherapy #CardioTwitter #LipidLowering

🧔‍♂️ Prostate cancer is the most common cancer in US men.

🧪 PSA testing? 🔍 It’s all about shared decision-making.

🧬 From Gleason scores to PSMA-PET, precision reigns.

💉 ARPIs & ADT = survival gains in advanced disease.

⚖️ Screen smart. Treat right. Save lives.

#ProstateCancer #MensHealth #Oncology 🧠💪

🚨 New frontier in lipid-lowering!

🧬 Blocking ANGPTL4 with MAR001 slashed triglycerides & remnant cholesterol by >50%

🛡️ Safe, well-tolerated, no lymph node issues

💡 Promising for residual ASCVD risk

Next step? Big trials, big answers! 📊🫀

#LipidScience #CardioTwitter #PrecisionMedicine

Why do some people sleep just 4 hours and feel great? 😴💪

A new study links the 🧬 SIK3-N783Y mutation to natural short sleep!

Less sleep, more delta power 🧠⚡

🚀🛌

#SleepScience #Genetics #SIK3 #ShortSleepers

🫀 Post-op AFib? Blame IL-6!

New @JClinInvest study shows IL-6 ➡️ STAT3 ➡️ CaMKII ➡️ RyR2 leak triggers post-op AFib.

🧬 Macrophage IL-6Rα is the match.

🧯 TTI-101 & KN-93 douse the flame.

⚡ Targeting IL-6 signaling = future Rx?

#CardioTwitter #AFib #Inflammation #JCI

🥦🍎 Want to age like fine wine? Choose high-quality carbs!

In a 32-year study of 47K women, fiber-rich carbs (from 🌾, 🥗, 🌱) boosted odds of healthy aging 🧠💪🧘‍♀️

Refined carbs? Not so kind.

#HealthyAging #NutritionMatters #WomensHealth 🧬📊💚

🧠🫀🧫 New study in Nature Medicine shows that multiorgan MRI predicts both 💔 cardiovascular and 🩸 liver events.

Cardiac (LVEF ≤50%) + Liver (cT1 ≥800ms) = 🚨 higher risk & earlier events.

Integrated imaging = smarter prevention! 🔍📊

#Cardiology #Hepatology #MRI #MASLD #CVD

🚀 New Breakthrough in Liver Cancer! 🌟

The CheckMate 9DW trial shows that Nivolumab + Ipilimumab significantly improves survival in unresectable #HCC compared to lenvatinib/sorafenib! 🧬💪

#Immunotherapy #CancerResearch #LiverCancer #Oncology 💉

🧠💔 Atrial Fibrillation (AF) disrupts brain glymphatic function, leading to cognitive decline! 😓

Catheter ablation may help restore rhythm and brain clearance. More research needed! 📊

#Cardiology #BrainHealth #AF #Cognition 💡

🧠💡 New Insights! The brain isn’t as “immune privileged” as once thought!

🌊🔄 Glymphatics & meningeal lymphatics reveal how the CNS clears waste & connects to immunity.

🦠 Aging & neurodegeneration challenge this balance. #Neuroscience #Immunology #BrainHealth 🧬🚀

🚦 Tricuspid Regurgitation (TR) Troubles! 💔

Despite promising interventions, recent trials show no survival benefit. Patient selection & procedural success are key! 📝

Focus on quality of life, not just longevity. #Cardiology #HeartHealth #TRManagement 💙

🌱💊 Unlocking the Power of Food! #NutritionDarkMatter holds 139,000+ molecules with therapeutic potential.

🍎 AI-driven research is paving the way for #PrecisionNutrition & innovative healthcare solutions! 🌟 #FoodAsMedicine #HealthRevolution 🚀

🚨 FAME 3 at 5 years: FFR-guided PCI 🛠️ vs CABG 🫀 in 3-vessel CAD — no difference in death/stroke, but more MI & revascularization with PCI ⚠️.

Heart team matters 🤝.

#CardioTwitter #FAME3 #Revascularization 🩺📊

Zeno of Citium (c. 334 – c. 262 BC) was a Hellenistic philosopher from Cyprus and the founder of Stoicism.

His philosophy emphasized living in harmony with nature and practicing virtue to attain peace of mind (ataraxia).

Zeno’s teachings influenced ethics, logic, and natural philosophy, laying the foundation for Stoicism’s prominence during the Roman era and beyond.

Despite losing his original writings, Zeno’s ideas survived through the works of later Stoics like Cleanthes and Chrysippus.

🚨 New from #FLAVOURII: Angio-FFR vs IVUS to guide PCI 🫀

🎯 Similar outcomes

📉 Fewer stents

🧠 Smarter decisions

Is flow-based guidance the future? 🌍

#CardioTwitter #FFR #IVUS #Intervention

📰 Lancet 2025 | 📊 RCT | 🇨🇳 1839 patients

🚀 Tirzepatide Triumphs! 💪 In a head-to-head trial, #Tirzepatide led to greater weight loss (-20.2%) compared to #Semaglutide (-13.7%) over 72 weeks!

📉🌟 Superior waist reduction too!

#ObesityManagement #WeightLoss #GLP1 #GIP 🩺💊 #CardiometabolicHealth #ClinicalResearch

🏈💥 Concussions in football don’t just hit the brain—they impact the heart too! 📈🫀

New study shows increased BP, arterial stiffness, and cardiac risks in NCAA athletes post-concussion.

🧠➡️❤️ #Cardiology #SportsMedicine #ConcussionRisk #HeartHealth

🧬 A molecule from aging gut bacteria—ADP-heptose—enters the bloodstream, activates ALPK1, and triggers NF-κB signaling, driving the expansion of mutant blood stem cells. 🦠🧓

This discovery links gut health to leukemia risk and reveals new targets like ALPK1 and UBE2N for cancer prevention. 💥🩸

🧠 Big win for brains & blood pressure!

In a massive rural China trial (n=33,995), lowering BP with non-physician care ↓ dementia risk by 15%!

A scalable, lifesaving model for LMICs. 🌾💊📉

#Dementia #Hypertension #GlobalHealth

🚀🌬️ Nasal vaccines: A breath of fresh air in respiratory infection prevention!

🌟 Boosts mucosal immunity (SIgA & IgG) 💪, reduces transmission 🌡️, and protects against COVID-19, influenza, RSV, and more!

#Vaccines #PublicHealth #Innovation 🦠💉

🚨 New hope for high Lp(a)!

💉 Lepodisiran, a long-acting siRNA, slashed Lp(a) by 94% with just 2 shots/year.

🔬 RNA precision meets cardiac prevention.

📉 Silent killer, silenced.

#CardioTwitter #RNAtherapy #LipoproteinA

🌬️🚶‍♂️ COPD comes in many forms! From chronic bronchitis 🪫 to emphysema 💨, frequent exacerbators 🚨, asthma-COPD overlap 🌪️, and eosinophilic type 🧫.

Tailoring treatment to phenotype is key! #COPD #PrecisionMedicine #RespiratoryCare

🚀 TANDEM Trial: Combining Obicetrapib & Ezetimibe for a powerful LDL reduction! 💊

✅ -48.6% vs placebo, -27.9% vs Ezetimibe, -16.8% vs Obicetrapib

💪 Safe, effective, and oral! #Cardiology #LipidManagement #ASCVD

A gut fungus 🍄 (Fusarium foetens) secretes FF-C1 🧪, a metabolite that inhibits CerS6 and lowers ceramides 🩸—shielding mice from MASH 🛡️.

Fungi aren’t just freeloaders—they may be our next therapeutic allies! 💊🧠

#Microbiome #LiverHealth #FungalTherapy #Science

🚀 Obicetrapib: A Breakthrough in LDL Lowering!

📉 Reduced LDL by 29.9% in high-risk patients (p

Here’s a tweet with emojis based on the article:

🧬 Middle-age spread decoded!

🕰️ Visceral fat grows in midlife not from bigger cells—but new ones!

🎯 CP-A cells fire up fat formation via LIFR–STAT3 🔥

💊 Targeting them may halt metabolic disease before it starts.

#Aging #Obesity #CellBiology #Metabolism 🧫

Would you like a version with a more humorous tone or one tailored for clinicians?

🚨 New era in heart disease prediction!

🧬 + 🧪 + 🤖 = Meta-prediction model that beats PCE & QRISK3

📈 Detects hidden CAD risk in young, women & “low-risk” groups

🎯 Precision prevention just got personal.

🫀 Published in Nature Medicine

#CardioTwitter #AI #Genomics #CAD

Epicurus (341–270 BC) was an ancient Greek philosopher who founded Epicureanism, emphasizing the pursuit of a tranquil, happy life through ataraxia (freedom from fear) and aponia (absence of pain).

His teachings combined atomism, ethics, and naturalistic theology, advocating simple living, friendship, and the rejection of superstition.

🚨ECLIPSE Trial Results🚨

Orbital atherectomy 🌀 vs. balloon angioplasty 🎈 before stenting in severe coronary calcification 💔

🎯 No added benefit with atherectomy

🧠 Balloon-first + imaging = smart strategy

📊 Lancet 2025 | #CardioTwitter #InterventionalCardiology #ECLIPSETrial

“Your DNA 🧬 is just half the story — your exposome 🌍 writes the rest! From air 🌫️ to food 🍎 to stress 😰, exposomics unlocks the hidden drivers of health 🔍💥.

Predict. Prevent. Prosper. 🚀

#Exposomics #PrecisionMedicine”

🫀💊 Scientists found a way to trick heart cells into calming down! Blocking stiffness signals with a smart drug combo reduced scarring and helped hearts pump better in mice.

A big step toward #mechanotherapy! 🧠🔬🐭 #CardioTwitter #Fibrosis #HeartHealth

🧪 Routine scans after cancer treatment: lifesaver or false security?

😰 Evidence shows no survival benefit, but lots of scanxiety, cost, and early toxicity.

💡 Sometimes, less is more. Ask why before you scan. #CancerSurveillance #Oncology 🩺📉

⏰🫀 Your heart heals differently depending on the time of day!

A protein duo—BMAL1 + HIF2α—peaks in the afternoon, boosting AREG, a heart repair helper.

💔 Morning heart attacks? Worse outcomes.

🕒 Timing meds = better healing.

#Chronotherapy #HeartHealth #CircadianScience

🧬💉 Bitten 200+ times, one man’s blood helped create a universal antivenom! 🦸‍♂️🐍

Human antibodies + varespladib = protection from 19 deadly snake venoms 🛡️🔥

Science just took a big bite out of snakebite! 🌍🔬 #Snakebite #Antivenom #Innovation

🏃‍♂️ Cardiac arrests in marathons stable, but deaths cut in half!

🫀 CAD now the top cause, not HCM.

🚑 Quick CPR + AED saves lives.

📈 Poisson stats confirm the trends!

#Running #HeartHealth #MarathonMedicine

🤖 Moravec’s Paradox shows that what’s easy for humans—like walking, seeing, or grasping—is hard for AI, while abstract tasks like math or chess are easier for machines.

🧠 Evolution honed our sensorimotor skills over millennia, making them intuitive for us but deeply complex to replicate in code.

🚶‍♂️ So while AI can solve equations, it still stumbles at stairs.

🚀 Lorundrostat lowers 24-hour systolic BP in resistant hypertension! 🎯

🔬 Selective aldosterone synthase inhibition shows promise but watch for hyperkalemia ⚠️

🌟 New hope for tough-to-treat BP!

#Hypertension #Cardiology #NEJM

Semaglutide 2.4 mg weekly led to significant resolution of MASH and reduction in fibrosis after 72 weeks 🌟🧬.

Patients lost more weight ⚖️, showed better liver markers 📉, and had improved metabolic profiles 💉.

GI side effects were common 🤢, but no new safety signals emerged ✅.

Promising dual-action therapy for liver and cardiometabolic health! ❤️🩺

🏥 Enteral nutrition is a vital therapy for malnourished hospitalized adults, yet remains underused.

📉 It reduces mortality, readmissions, and complications when oral intake is inadequate.

🧪 Trials show early full feeding may harm in critical illness—underfeeding can be safer.

🧠 Success depends on timing, dose, route, and a team-based, patient-centered approach.

Mencius (c. 371–289 BC) was a prominent Confucian philosopher known as the “Second Sage” after Confucius.

He emphasized the innate goodness of human nature, advocating for humane governance, moral cultivation, and the welfare of citizens.

His teachings greatly influenced Confucianism and later Neo-Confucian thought.

🧬 Clonal haematopoiesis (CH)—especially with DNMT3A-R882 mutations—increases with age and raises leukemia risk.

💊 New studies reveal that metformin targets mutant blood stem cells by suppressing mitochondrial metabolism, sparing healthy cells.

📉 UK Biobank data shows lower CH prevalence in metformin users.

🔋 Targeting oxidative phosphorylation may offer a safe, preventative strategy against CH progression.

In this large real-world study 🧪 using electronic health records 📊, GLP-1RAs and SGLT2is—two diabetes drugs 💉—were associated with a lower risk of Alzheimer’s and related dementias 🧠 in people with type 2 diabetes 🍬.

Both showed protective effects 🛡️, with no significant difference between them, suggesting promise for drug repurposing ♻️ in brain health strategies.

🧠 Regular endurance exercise boosts brain health by increasing blood flow 💓, enhancing neuroplasticity 🔁, and reducing inflammation 🔥.

🏃‍♂️ High cardiorespiratory fitness (CRF) lowers dementia risk 🧩, supports memory 📝, and promotes the release of powerful brain molecules like BDNF 🧬 and irisin 💪.

✨ In short: Move more, age slower, think sharper!

👁️ Cataracts are a common cause of vision loss in older adults, leading to blurry vision, glare, and difficulty with daily tasks.

💉 Surgery is safe, quick, and effective — restoring clarity, reducing fall risk, and even lowering dementia risk.

🔬 Advanced lenses can reduce dependence on glasses, while intraocular antibiotics help prevent rare infections.

⚠️ Watch out for meds like tamsulosin that may complicate surgery — always inform your eye doctor!

🦠 Staphylococcus aureus bacteremia (SAB) is a deadly bloodstream infection with high rates of complications like endocarditis and abscesses.

💉 Early detection, MRSA coverage with vancomycin/daptomycin, and source control (🪛 remove catheters, drain abscesses) are critical.

🔍 Use echocardiography and VIRSTA score to guide management.

✅ Once susceptibilities return, de-escalate and tailor therapy—MSSA loves cefazolin!

🧠 People often say they want big wins (like lotteries), but in practice, they choose what wins more often—even if it pays less.

🎮 In experiments, when outcomes are shown side-by-side, we tend to favor the “frequent winner.”

📉 This bias can make us overlook rare, high rewards—shaping real-world choices in money, health, and risk.

🔍 Bottom line: It’s not just what we choose, but how the choice is shown that changes everything.

Zhuang Zhou, also known as Zhuangzi, was an influential 4th-century BCE Chinese philosopher during the Warring States period.

As a foundational figure of Taoism, he authored the Zhuangzi, a text known for its profound philosophical insights, parables, and critiques of societal norms, emphasizing personal freedom and harmony with the Tao.

His ideas remain central to Chinese philosophy and continue to inspire discussions on ethics, metaphysics, and human nature.

🧴 Delgocitinib cream outperformed oral alitretinoin in treating severe chronic hand eczema over 24 weeks.

📉 Greater reduction in HECSI, 😊 better quality of life, and ⚠️ fewer side effects make it a promising non-steroidal alternative.

💊 Time to rethink systemic pills — topical wins hands down! 🖐️✅

🧬 Human pelvic evolution reflects a tug-of-war between 🚶‍♀️ efficient walking, 🧠 growing brains, and 🚼 safe childbirth.

Using AI and genetic data from 31,115 individuals, Xu et al. found the pelvis is highly heritable, sex-dimorphic, and shaped by multiple selective pressures—not just bipedalism or birth.

Larger canals ease delivery but risk 💥 pelvic floor disorders, while narrower ones boost mobility but raise ⚠️ labor complications.

This study reframes the “obstetrical dilemma” as a 🔄 multifactorial evolutionary compromise.

🩸 Summary:

Lung interstitial macrophages, activated by tumor-derived CXCL13, release integrin β2⁺ extracellular vesicles (sEVs) 🧬 that bind platelet GPIb 🧲, triggering clot formation across the body.

These sEVs are both a driver of cancer-associated thrombosis and a potential biomarker for early risk detection 🎯, offering safer, targeted therapeutic opportunities 💉.

Cancer cachexia isn’t just weight loss—it’s a hijacking of motivation 😔. Elevated IL-6 🔥 activates a brainstem-to-basal ganglia circuit 🧠 that suppresses dopamine 💊 in the nucleus accumbens, leading to effort-based apathy 💤.

Blocking IL-6 or boosting dopamine restores drive without changing weight, revealing a treatable neuroimmune pathway 💡.

🧪 SMART-CHOICE 3 in a Nutshell

🟣 Clopidogrel beat 🟠 aspirin post-PCI:

📉 Fewer MACCE (4.4% vs 6.6%)

🩸 Same bleeding risk

🍽️ Fewer GI events

⚠️ Editorial: Fragile stats, late benefit, open questions on lifelong therapy.

🎯 Verdict: Promising—but not bulletproof.

🔋 Mitochondrial transplants are emerging as a powerful therapy to repair damaged cells, boost energy, and even reverse aging.

From saving 🫀 baby hearts to protecting 🧠 stroke-affected brains, this tiny powerhouse may revolutionize medicine—one cell at a time. 🧬💉✨

Plato (c. 428-348 BCE), a foundational figure in Western philosophy, was a student of Socrates and teacher of Aristotle.

He established the Academy in Athens and is known for his theory of Forms, dialogues on justice, ethics, and politics, and lasting influence on philosophy, science, and education.

🧬 Mitochondria are on the move!

Once thought to stay put, these powerhouses travel between cells 🚀—healing neurons 🧠, boosting immunity 🛡️, and even aiding cancer cells ⚠️. Scientists are now exploring how to harness this dynamic dance for future therapies 💉.

❄️ Conceived in the Cold? Individuals conceived during colder months show higher brown fat activity, increased thermogenesis, and lower BMI as adults.
🔬 Using PET/CT, NIR-TRS, and doubly labeled water (DLW), the study linked preconception cold exposure to greater energy expenditure and reduced visceral fat.
🧬 The key factor: Temperature and its diurnal variation before conception — not birth season — predicts adult brown adipose tissue (BAT) function.
📉 Cold-induced BAT activation leads to better cold adaptation, improved CIT, DIT, and total energy expenditure (TEE) — even years later.
🧠 Researchers propose PfOHaD (Pre-fertilization Origins of Health and Disease) — expanding DOHaD to include paternal cold exposure as a metabolic epigenetic switch.

Colchicine 💊, once a humble gout remedy, is now reshaping coronary care 🫀. Trials show it reduces events in stable CAD ✅, but its benefit post-MI ⛑️ depends on timing ⏰. Inflammation matters — and so does when we strike.

Colchicine in CAD: Small Pill, Big Debate 💊🔥🫀

An ancient anti-inflammatory has found new life in cardiology — reducing heart attacks when started late, but disappointing when given early after an MI.

Bottom Line: Timing matters. Too soon, and it fizzles. Wait until the fire cools, and colchicine shines. ⏰✨

🌿 Switching to a Western diet 🍔 increased inflammation 🔥 and metabolic dysfunction.

🍌 Mbege and traditional foods calmed the immune system 🧘 and boosted IL-10 🕊️.

Not all salts are created equal! 🧂 Sodium chloride raises blood pressure and harms the heart 😈, while sodium bicarbonate may protect kidneys and improve outcomes in CKD/HF patients 🛡️🫀.

Chloride channels (CLICs) play a hidden but vital role in heart health 🔌❤️.

We need large RCTs 🧪📊 to guide smarter, personalized salt strategies for better cardiovascular care 🎯🌍.

The SOUL trial 🧪 showed that oral semaglutide 💊 significantly reduced major cardiovascular events ❤️ (MACE) in people with type 2 diabetes 🩸 and ASCVD/CKD 🚑.

Over ~4 years, it cut heart attacks 💥, lowered HbA1c 📉, reduced weight ⚖️, and inflammation 🔥 — all with a once-daily pill 🕊️ and no rise in serious side effects.

Mozi, a prominent Chinese philosopher during the Warring States period, founded Mohism, a school of thought emphasizing universal love, meritocracy, anti-war principles, and consequentialist ethics.

He advocated for frugality, social welfare, and pragmatic governance guided by Heaven’s will.

The Lancet Commission calls for a shift from focusing on late-stage ischaemia to targeting early atherosclerosis (ACAD) 🫀🔍. By detecting and treating plaque early, we can prevent heart attacks, reduce deaths, and promote lifelong heart health 🌍❤️💡.

💉 A natural experiment in Wales showed that the shingles vaccine (Zostavax) reduced dementia risk by 20% over 7 years.

🧠 The study used a clever birthdate cutoff to mimic randomization and avoid confounding.

👩‍🔬 Women benefited more, suggesting immune or viral mechanisms beyond shingles prevention.

📊 Findings offer hope for low-cost, brain-protective interventions in aging populations.

🚶‍♂️ The STRIDE trial tested semaglutide in patients with PAD and type 2 diabetes.

💉 Weekly injections for 52 weeks improved walking distance, pain-free mobility, and quality of life.

📊 Results showed significant gains vs placebo, with low adverse events.

🌟 Semaglutide may offer a new stride forward in treating functional limitations in PAD.

🧬 Xenotopic synthetic biology explores using enzymes from microbes (like bacteria and yeast) to reprogram human metabolism and delay aging.

🔋 These “borrowed” enzymes target amino acid levels, mitochondrial function, and redox balance to boost healthspan and fight age-related diseases.

🦠 From methioninase to NDI1 and AOX, these tools may turn microbial chemistry into tomorrow’s longevity medicine.

🏃‍♂️💔 In a study of 29 million race finishers (2010–2023), cardiac arrest rates during marathons and half-marathons stayed steady, but deaths dropped by half.

🧠⚡ Rapid CPR and AED use saved lives, with coronary artery disease—not hypertrophic cardiomyopathy—being the top culprit. 🫀🚑

🧠 Exercise is a powerful neuroprotective tool—it boosts memory, preserves brain volume, and reduces dementia risk.

💪 Through exerkines like BDNF and irisin, it sparks neurogenesis, clears inflammation, and enhances brain plasticity.

🌱 It also nurtures your gut microbiome and rewires your genes, making movement medicine for the mind.

A brief overview of Socrates, the classical Greek philosopher widely regarded as the founder of Western philosophy.

Known for his Socratic method of questioning, he profoundly influenced ethical thought, epistemology, and later philosophical traditions.

🍎 In this episode, we unpack a 30-year study on how diet influences aging.

🥗 AHEI, DASH, and Mediterranean diets boost your odds of healthy aging—by as much as 86%!

⚠️ But not all plant-based diets are equal: hPDI underwhelms, likely due to excluding protective animal foods like fish and dairy.

🚫 Ultra-processed foods, sugary drinks, and trans fats? Aging’s worst enemies.

🎯 Bottom line: Eat smart, age strong.

🫀 Heart transplantation is a life-saving treatment for end-stage heart failure, but donor hearts are scarce.

🔍 Donor selection is complex, involving factors like age, heart size, LV function, and comorbidities.

🌍 The U.S. is more conservative than Europe, with higher donor heart nonuse rates.

⚙️ New tools like Predicted Heart Mass (PHM), Organ Care Systems, and AI models improve matching and outcomes.

💉 Donation after Circulatory Death (DCD) is expanding the donor pool.

⚖️ Ethical concerns and upcoming policy shifts aim for more equitable, data-driven heart allocation.

🚑 A rapid-fire guide to cardiogenic shock — from first suspicion to life-saving interventions.

🩺 ACC’s latest on Cardiogenic Shock:

👁️ Early detection with SUSPECT CS

💉 First-line meds: norepinephrine & dobutamine

🛠️ tMCS for refractory cases (Impella, VA-ECMO)

🏥 Transfer to Level 1 centers

🤝 Team-based care = better outcomes

💡 Act fast, save lives!

🧪 A randomized clinical trial in older adults (65+) found that Vitamin K2 (menaquinone-7, 180 μg/day) significantly reduced nocturnal leg cramps in terms of frequency, severity, and duration—with no adverse effects reported. 🌙🦵💊

This safe (?), over-the-counter supplement may offer a simple, science-backed solution for painful nighttime cramps—avoid it if you’re on warfarin. 🚫💉✅

📊 Too much sitting hurts the heart.

🧍‍♂️ Ajufo et al. (2024) tracked 89,530 people using accelerometers and found that 🪑 >10.6 hours/day of sitting sharply increases the risk of ❤️ heart failure, 💔 heart attacks, 💓 AFib, and ⚰️ cardiovascular death.

🏃 Even active people aren’t fully protected.

🔁 Replacing just 30 minutes of sitting with movement—🕺 light or 🏋️‍♂️ vigorous—reduces risk.

🧠 The takeaway? Sit less, move more, live longer.

🧑‍⚕️💔 Young, Fit… Gone?

Every year, thousands of seemingly healthy young adults suffer sudden cardiac arrest (SCA) outside the hospital.

📉 Only 9–16% survive to discharge — yet 90% of survivors leave with good brain function.

🔍 Many have hidden risk factors — hypertension, diabetes, even genetic arrhythmia syndromes like Brugada or Long QT.

⚡ Rapid CPR, AED use, and targeted evaluation (ECG, imaging, genetics) save lives and prevent recurrence.

🧬 Survivors—and their families—may carry silent genetic signals.

🔁 The takeaway? SCA isn’t random. It’s a warning shot. One we can catch—if we’re ready.

Siddhartha Gautama, known as the Buddha (“the awakened one”), was a spiritual teacher who founded Buddhism in the 5th or 6th century BCE in South Asia.

His core teachings include the Middle Way, the Four Noble Truths, and the Noble Eightfold Path, emphasizing mindfulness, ethics, and liberation from suffering.

•Olive. Canola. Soybean. •Not just flavor—they’re lifelines. 🌱 •Every 10g a day drops mortality by 16%. •They don’t just cook food—they cook up longevity? 🔥⏳

🧬 Your mother’s X chromosome may shape how your brain ages.

In female mice, when only the maternal X chromosome (Xm) is active, older animals show worse memory 🧠🕳️ than those with random X-inactivation. This is due to imprinted genes — some only expressed from the paternal X (Xp) — which are silent when Xm dominates.

🧠💡 Using CRISPR–Cas9, researchers reactivated 3 Xm-silent genes (Sash3, Tlr7, Cysltr1) and saw improved memory and mitochondrial function ⚡🔋.

👩‍🔬 This highlights inter-female variation in aging and memory — and suggests that epigenetic inheritance from mothers may shape how well we remember… or forget. 🧓🧠❓

🔬 Confounding, Clarity, and Causality

Family-based biobanks 🧬 are the next frontier in genetic research—tackling bias 🧠, boosting causal inference 🎯, and revealing insights hidden in the noise of population studies 🌍. It’s not just about big data—it’s about better data 👨‍👩‍👧‍👦.

🧠 Brain Aging & Research Advances

🔍 Key Findings:

• Brain Age Gap (BAG): Difference between estimated and chronological brain age.

• 64 genes identified as influencing brain aging.

• 13 proteins in blood linked to accelerated/slowed brain aging.

🩺 Potential Interventions:

• 13 anti-aging drugs (e.g., Rapamycin, Dasatinib) show promise in slowing decline.

• Plasma proteomics reveals key biomarkers for early intervention.

🌍 Influencing Factors:

• Socioeconomic status, pollution, and gender inequality impact brain aging.

• Functional connectivity decline linked to cognitive disorders.

🚀 Future Directions:

• Clinical trials needed for drug validation.

• Genetic & proteomic studies should expand to diverse populations.

The blood-brain barrier (BBB) 🛡️ protects the brain from harmful molecules but weakens with aging 🧓, leading to neuroinflammation 🔥 and cognitive decline 📉.

Mucins 🧬, slippery proteins in the glycocalyx 🏗️, help maintain BBB integrity 🧠. This study found that mucin loss 🚨 increases BBB permeability, allowing toxins to enter.

Using gene therapy 🧪, researchers restored mucins, improving memory and learning 📈 in aged mice.

This breakthrough suggests that mucin-based treatments 🏥 could prevent neurodegenerative diseases like Alzheimer’s and Parkinson’s 🎯 while also enhancing brain drug delivery 🚀.

🧠 Migraine is a complex neurological disorder affecting 1 billion people worldwide.

Historically misunderstood, it was once seen as a vascular or psychological issue but is now recognized as a brain network dysfunction involving the hypothalamus and limbic system.

💊 Gepants and CGRP blockers have revolutionized treatment, though they only work for some patients.

Triggers like stress, hormones, diet, and environmental factors play a role, and genetics influences susceptibility.

🤖 AI-driven research is helping predict attacks and personalize treatments, while new studies are shifting focus beyond headaches to cognitive and systemic symptoms.

Future research aims to uncover additional pathways and improve long-term management. 🚀

Alcohol is a proven carcinogen 🚨, increasing the risk of at least 7 cancers (mouth, throat, breast, liver, etc.) 🦠💀.

Even small amounts (5g ethanol/day) raise cancer risk, with no safe threshold 📊🚫.

Similarly, exceeding 14 drinks/week (men) or 7 (women) raises CHD risk by up to 43% 💔📈.

Past claims of heart benefits from moderate drinking are now being challenged 🧐❓.

Best advice? Limit or avoid alcohol for better long-term health 🚫🥃✔️.

Heraclitus (c. 500 BC), a pre-Socratic philosopher from Ephesus, is renowned for his doctrine of perpetual change and the unity of opposites, encapsulated in the phrase “Everything flows” and “No man ever steps in the same river twice.”

His concept of logos as the rational order of the universe influenced ancient and modern philosophy, including thinkers like Plato, Aristotle, and Hegel.

Known as “the dark” philosopher for his cryptic style and paradoxical ideas, Heraclitus viewed strife as fundamental to justice and saw fire as the primal element of existence. His legacy endures in the study of cosmology, metaphysics, and dialectics.

☕ Coffee & Gut Microbiome 🦠

🔬 A multi-cohort study (N = 22,867) found a strong link between coffee consumption and the gut bacterium Lawsonibacter asaccharolyticus.

🧪 Metabolomics identified key coffee-derived metabolites like quinic acid, hippurate, and trigonelline.

📊 Machine learning (AUC = 0.89) confirmed microbiome composition predicts coffee intake.

🧫 In vitro studies showed coffee stimulates L. asaccharolyticus growth.

⚙️ Findings suggest polyphenols in coffee shape gut microbiota and metabolic pathways.

🚀 Future research aims to explore dose-dependent effects, health benefits, and microbiome-driven nutrition.

🔬 Antioxidants & Health: Myths vs. Reality ❌🍊💊

Despite popular belief, vitamins C & E do not reduce the risk of cancer, heart disease, or chronic illness 🚫❤️.

High doses of vitamin A increase the risk of hip fractures & prostate cancer ⚠️🦴, while vitamin E is linked to respiratory infections, prostate cancer, and even death 😷❌.

However, a specific combination of antioxidants (C, E, zinc, copper, lutein, zeaxanthin) slows vision loss in age-related macular degeneration (AMD) 👁️🧡.

A multiomic study identified GSTO1 as the best biomarker for zinc deficiency 🧪🔍, but further validation is needed.

Takeaway? Antioxidants have specific benefits, but not as universal disease preventers! ⚖️🚀

🔬 Anemia & Folate: Key Insights

🩸 Anemia is primarily caused by iron deficiency in the U.S., especially in pregnancy (30% prevalence).

📊 NHANES data shows high iron deficiency in young females (up to 77.5% at ferritin 45 mg/day may cause nausea & constipation.

👶 Maternal iron status affects infant birth weight, and delayed cord clamping improves newborn iron stores.

🌍 In low-income countries, anemia is also linked to malaria, parasites, and hemoglobinopathies.

🍞 Folic acid fortification since 1998 has reduced neural-tube defects, making folate deficiency rare in the U.S.

Vitamin B12: Essential for Health 🩸🧠

Vitamin B12 is crucial for red blood cell formation, brain function, and DNA synthesis.

Found in animal-based foods 🥛🍳🐟, those on vegan diets need fortified foods or supplements 💊.

Deficiency can cause anemia, neurological issues, and cognitive decline ⚠️.

High-risk groups include vegans, vegetarians, older adults, and individuals with malabsorption conditions 🏥.

Maternal deficiency affects fetal development 🤰👶.

Absorption declines with age, and severe cases (e.g., pernicious anemia) may require high-dose supplements or injections 🚑.

Research on its role in preventing cognitive decline remains inconclusive 🤔.

Vitamin D is essential for bone health 🦴, immune function 🛡️, and muscle strength 🏋️.

Deficiency is common and affects women 👩‍⚕️, young adults 🧑‍🎓, and non-Hispanic Black Americans. Main sources include sunlight ☀️, oily fish 🐟, eggs 🥚, and fortified foods 🥛.

Recommended intake is 600-800 IU/day 💊.

Studies show mixed results 📊, but it may help with cancer prevention 🎗️, autoimmune diseases 🧬, and cognitive function 🧠.

Excessive intake ⚠️ can cause kidney stones 🩺 and hypercalcemia.

🧠 High-dose Vitamin D (100,000 IU biweekly) reduced disease activity in Clinically Isolated Syndrome (CIS) of MS 🌞📉.

Patients had fewer MRI lesions 🖥️, longer time to disease activity ⏳, but no significant impact on relapses ❌.

Well-tolerated with minimal side effects ⚕️,

These findings support further research on Vitamin D as an MS therapy 🔬🚀.

🔬 BEAM-302 is a liver-targeting gene therapy using base editing to correct the PiZ mutation in Alpha-1 Antitrypsin Deficiency (AATD). 🧬 I

t increases functional AAT 🫁 while reducing toxic Z-AAT, showing up to 78% reduction at the 60 mg dose. 📊

The Phase 1/2 trial demonstrated dose-dependent efficacy, a well-tolerated safety profile, and no serious adverse events (SAEs). 🛡️

With ongoing dose escalation and expansion to liver disease patients, BEAM-302 could be a one-time curative therapy 🚀, with further data expected in late 2025. 📅

Confucius (c. 551–479 BCE), a renowned Chinese philosopher and teacher, founded Confucianism, emphasizing morality, family loyalty, social harmony, and virtuous governance.

His teachings, compiled in the Analects, profoundly influenced Chinese culture, ethics, and education.

This study identifies the Median Raphe Nucleus (MRN) 🧠 as a behavioral switchboard 🔄, regulating perseverance 🛑, exploration 🚀, and disengagement ❌ through distinct neuron types.

GABAergic neurons 🟢 promote perseverance, Glutamatergic neurons 🔵 drive exploration, and Serotonergic neurons 🟠 maintain engagement.

Using optogenetics 💡, fiber photometry 📈, and circuit tracing 🔗, researchers demonstrated how MRN integrates signals from the lateral hypothalamus (LHA) 🌟 and lateral habenula (LHb) ⚡ to control decision-making.

These findings have clinical implications 🏥 for disorders like OCD 🔄 and depression 😞, suggesting MRN as a potential therapeutic target 🎯.

🔬 Study Overview: A meta-analysis comparing alternative LDL cholesterol-lowering strategies (moderate-intensity statins + ezetimibe) vs high-intensity statins in patients with ASCVD.

📊 Key Findings:

✅ No significant difference in 3-year cardiovascular events (7.5% vs 7.7%)

📉 Lower LDL cholesterol in the alternative strategy (64.8 vs 68.5 mg/dL)

🩸 Reduced risk of new-onset diabetes (10.2% vs 11.9%)

💊 Fewer therapy discontinuations due to intolerance (4.0% vs 6.7%)

⚖️ Conclusion: The alternative strategy offers comparable efficacy with better tolerability and safety, making it a viable option for patients intolerant to high-intensity statins.

🦴 USPSTF Osteoporosis Screening Summary 📋

🔍 Why? Prevent fractures, disability, and mortality.

👩‍⚕️ Who? Women 65+ ✅, at-risk postmenopausal women ✅, men ❌ (insufficient evidence).

🩻 How? DXA scan (bone density test) is the gold standard.

⚠️ Risk Factors: Age, low weight, family history, smoking, alcohol, medications.

✅ Benefits: Reduces fracture risk with moderate evidence.

⚠️ Harms: Minimal risks, rare side effects from treatment.

📌 Takeaway: Screen women 65+ and younger high-risk women!

🫀 Cardiac CT Calcium Score: Key Insights 🔬📊

🔍 What is CAC?

✅ Measures calcified plaque in coronary arteries via cardiac CT 📸

✅ Higher CAC = Higher cardiovascular risk ⚠️

✅ Agatston Score: 0 (None) → >400 (Severe Atherosclerosis)

📊 Clinical Impact:

✅ Strong predictor of ASCVD events (MI, stroke, CHD death) 📉

✅ MESA Study: CAC >300 → 10-year CHD risk: 13-25%

✅ CAC = 0 → Low risk, even for some statin-eligible patients 🚀

🎯 Guidelines & Utility:

📢 Used for risk stratification in intermediate-risk patients (7.5%-20% ASCVD risk)

💊 Guides statin therapy decisions (CAC >100 = Strong statin recommendation)

⚖️ Not useful for symptomatic patients needing revascularization

🔬 Takeaway: CAC scoring enhances risk prediction, supports precision medicine, and helps optimize cardiovascular prevention strategies! 🚀

Tirzepatide & Weight Maintenance 💊📉

A phase 3 clinical trial (SURMOUNT-4) showed that continued use of tirzepatide helps maintain weight loss in adults with obesity.

Participants on tirzepatide lost an extra 5.5%, while those on placebo regained 14%.

✅ 89.5% maintained at least 80% of their weight loss, compared to 16.6% on placebo.

Common side effects were mild gastrointestinal issues 🤢.

Stopping treatment led to significant weight regain, reinforcing the need for long-term therapy. 🔬

🫀 CAUGHT-CAD Trial Summary 🔬

🔍 Objective: Investigated whether CAC scoring combined with a prevention strategy slows plaque progression in intermediate-risk patients with a family history of CAD.

📊 Key Findings:

✅ LDL Reduction: -51 mg/dL (CAC group) vs. -2 mg/dL (Usual Care) 📉

✅ Slower Plaque Progression: +15.4 mm³ vs. +24.9 mm³ (p=0.009) 🏥

✅ Less Noncalcified Plaque Growth: +5.6 mm³ vs. +15.7 mm³ (p=0.002) 🔬

✅ Regression in High-Risk Plaque (Fibrofatty/Necrotic Core): -0.8 mm³ vs. +4.5 mm³ (p=0.02) 🚀

🎯 Clinical Impact: CAC-informed strategies enhance risk stratification, reduce plaque burden, and support early statin therapy for CAD prevention. 🔄💊

🩸 Bleeding & Cancer Risk in AF Patients on Anticoagulants 🏥

🔎 Study Goal: Investigate the link between bleeding after anticoagulation for atrial fibrillation (AF) and new cancer diagnoses.

📊 Findings:

✅ Bleeding 4X increases the risk of cancer diagnosis (HR: 4.0).

🔴 GI Bleeding → 15.4X risk of GI Cancer

🟠 GU Bleeding → 11.8X risk of GU Cancer

🟡 Respiratory Bleeding → 10.1X risk of Lung Cancer

⏳ Median time to cancer diagnosis: 45 days.

🚑 Earlier-stage cancers detected after bleeding (Stage 4: 27.6% vs. 31.3%).

💡 Clinical Takeaways:

🛑 Don’t ignore bleeding! It may indicate occult cancer.

🔬 Prioritize timely investigations (e.g., endoscopy, cystoscopy).

📑 Guidelines needed for cancer screening after bleeding in anticoagulated patients.

The RENOVE trial compared reduced-dose versus full-dose DOACs for extended venous thromboembolism VTE treatment in high-risk patients.

While the reduced dose cut major bleeding risk by 39% 🚨, it did not meet non-inferiority criteria for preventing VTE recurrence 🔄.

Laozi, a legendary Chinese philosopher and author of the Tao Te Ching, is regarded as the founder of Taoism.

His teachings emphasize living in harmony with the Tao (the Way), advocating simplicity, humility, and wu wei (effortless action) for a balanced life.

This study explores how environmental exposures (exposome) 🌍 and genetics 🧬 contribute to aging ⏳ and mortality ⚰️.

Using UK Biobank data 📊, researchers found that the exposome explains 17% of mortality risk, while genetics accounts for only 2%.

Smoking 🚬, socioeconomic status 💰, and physical activity 🏃‍♂️ are major environmental influences, whereas genetics plays a stronger role in dementia 🧠 and cancers 🦠.

The findings highlight the need for public health policies 🏥 targeting modifiable lifestyle factors over genetic interventions.

🩺 Lithocholic Acid (LCA) – A Caloric Restriction Mimetic for Clinical Use 💊

✅ Mimics caloric restriction by activating AMPK – key for metabolism & longevity.

✅ Enhances muscle strength & regeneration 🏋️ – potential for frailty & sarcopenia treatment.

✅ Improves insulin sensitivity & lipid metabolism 🔥 – aiding in diabetes & metabolic syndrome.

✅ Reduces inflammation & supports cardiovascular health ❤️ – protective against aging-related diseases.

🚀 Future Potential: LCA could be a novel therapeutic strategy in geriatrics & metabolic medicine.

📌 Summary of Findings

🔬 Studies: Three large cohort studies explored the impact of flavonoid-rich foods on aging and mental health in women.

✅ Key Findings:

• 🍊 Higher citrus and flavonoid intake linked to lower depression risk, especially in older women.

• 💪 Flavonoid-rich diets associated with better physical function and reduced frailty.

• 🦠 Increased F. prausnitzii (gut microbiome) with citrus intake may enhance serotonin & dopamine pathways.

📝 Conclusion: Eating flavonoid-rich foods like citrus, berries, tea, and red wine may support healthy aging and mental well-being in women.

🩺 2025 ACS Management Guidelines Summary 💊

• 🩸 DAPT recommended: Ticagrelor or prasugrel preferred over clopidogrel in PCI patients.

• 🎯 Lipid management: High-intensity statins + ezetimibe; PCSK9 inhibitors if LDL-C ≥70 mg/dL.

• 🔬 Invasive approach: Recommended for intermediate/high-risk NSTE-ACS; radial access preferred for PCI.

• 🚑 Revascularization: Complete revascularization advised for STEMI/NSTE-ACS; intracoronary imaging for complex lesions.

• ❤️ Cardiogenic shock: Emergency PCI for culprit vessel; microaxial flow pump may help select patients.

• 🏥 Secondary prevention: Lipid monitoring, cardiac rehab, and long-term risk reduction strategies are key.

🔬 DO-HEALTH Trial Summary 🏋️‍♂️💊🧬

A randomized controlled trial (RCT) with 777 participants aged 70+ investigated the effects of omega-3 (🧴 1g/day), vitamin D (☀️ 2000 IU/day), and exercise (🏃‍♂️ 30 min, 3x/week) on biological aging using DNA methylation clocks.

📊 Key Findings:

✅ Omega-3 alone slowed biological aging by 2.9–3.8 months over 3 years.

✅ Combined interventions further reduced biological aging and improved health outcomes.

✅ Health benefits: 🔽 10% fall reduction, 🦠 13% lower infection rates, 💪 39% less prefrailty, 🛡️ 61% lower invasive cancer risk.

🔍 Conclusion: Omega-3, vitamin D, and exercise may slow biological aging and enhance healthspan. Further research is needed to assess long-term benefits. 🚀

🧠⚡🌊 Aging in Waves: How Your Brain, Body, and Organs Age at Different Speeds

1️⃣ Rapid Brain Aging Occurs at Three Distinct Ages 🧠⚡📆

• Scientists found that brain aging accelerates at ages 57, 70, and 78.

• These shifts impact memory, cognition, and neurodegeneration risks.

• Lifestyle choices like a healthy diet, exercise, and mental stimulation can help slow brain aging.

2️⃣ Feeling Suddenly Older? Scientists See Aging ‘Waves’ at 44 and 60 ⏳😲🌊

• Aging doesn’t happen gradually but in distinct waves, especially at ages 44 and 60.

• Researchers found biomolecular shifts that may explain why people feel sudden declines.

• This suggests targeted interventions at key aging milestones could improve longevity.

3️⃣ Aging Isn’t One-Size-Fits-All: How Your Organs Age at Different Speeds 🏥⏱️🔬

• Different organs age at different rates, meaning some parts of the body may wear out faster than others.

• Blood-based tests can now predict which organs are aging faster, helping detect early disease risks.

• This insight could personalize medicine, allowing for organ-specific interventions to slow aging.

🔍 Takeaway: Aging is not a smooth process—it happens in waves, varies by organ, and accelerates at key ages. Scientists are uncovering ways to track and slow these changes for better health and longevity. 🚀🧬

📌 Study Alert:

A longitudinal study across 23 countries (87,000 adults aged 50+) found that internet use 💻 is linked to better mental health 😊, fewer depressive symptoms 😌, and higher life satisfaction 🌟.

💡 Key Findings:

✅ Reduced depression in physically inactive & disabled individuals 🏥

✅ Improved well-being through social connections 🗣️

✅ Stronger benefits in China, England, & the U.S. 🇨🇳🇬🇧🇺🇸

⚠️ Challenges: Limited internet access & digital literacy in some regions 🌍❌

📢 Policy Implications: Expand internet access, promote digital literacy, and use online interventions for mental health 📶📚

Pythagoras of Samos (c. 570–495 BCE) was an ancient Greek philosopher and mathematician, best known for founding Pythagoreanism and the Pythagorean theorem.

His teachings combined mathematics, mysticism, and philosophy, influencing Plato, Western thought, and early science.

👁 JAMA Ophthalmology Study: Curcuma-based supplements (CBNS) may reduce AMD risk by 77% 📉, with 89% lower risk of advanced AMD and 54% lower risk of blindness 👀. More research is needed to confirm safety & efficacy 🔍.

🔬 Turmeric & Lead Contamination: 14% of South Asian turmeric samples contain lead chromate ⚠️, with hotspots in Patna, Karachi, and Peshawar 📍. Bangladesh successfully eliminated adulteration through strict regulations & awareness ✅.

⚖ Key Takeaways: Turmeric’s dual nature 🌿—health benefits vs. lead risks ☠️—highlights the need for regulation, consumer awareness & safety measures ⚖️.

Nerinetide is a neuroprotective eicosapeptide designed to reduce ischemic brain injury by disrupting the interaction between N-methyl-D-aspartate (NMDA) receptors and downstream excitotoxic signaling.

It was tested in two major clinical trials for acute ischemic stroke:

• ESCAPE-NEXT Trial: Assessed Nerinetide in patients undergoing endovascular thrombectomy (EVT) without prior thrombolysis, finding no significant improvement in functional independence at 90 days.

• FRONTIER Trial: Evaluated prehospital Nerinetide administration within 3 hours of stroke onset, showing no overall benefit but potential efficacy in ischemic stroke patients receiving reperfusion therapy.

Although Nerinetide was safe, its clinical benefit remains uncertain, with timing and patient selection emerging as key factors for its potential role in stroke treatment. Further studies are needed to refine its use in combination with reperfusion therapies.

Acute hearing loss can be an early sign of posterior circulation stroke, particularly in anterior inferior cerebellar artery (AICA) infarctions.

However, hearing assessments are often overlooked due to the NIH Stroke Scale’s focus on anterior strokes.

Real-world data showed missed diagnoses of vascular events when hearing loss was not evaluated. Integrating portable audiometry into stroke protocols could improve diagnostic accuracy and lead to timely interventions.

Three recent trials investigated the effectiveness of endovascular treatment (EVT) in ischemic stroke.

The OPENS-2 trial (Lancet 2025) found that normobaric hyperoxia combined with EVT improved 90-day functional outcomes for large-vessel occlusion stroke without increasing adverse events.

The DISTAL trial (NEJM 2025) reported no significant benefit of EVT over medical therapy for medium/distal vessel occlusions and noted a higher risk of hemorrhage.

Similarly, the ESCAPE-MeVO trial (NEJM 2025) found no improvement with EVT in medium-vessel occlusion stroke, alongside increased mortality and intracranial hemorrhage. Collectively, these findings suggest that EVT’s benefits depend on vessel size and may be enhanced with adjunctive treatments like hyperoxia in specific cases.

🚨 VANISH2 Trial Alert! 🚑💙

Catheter ablation 🩺 proves superior to antiarrhythmic drugs 💊 for ventricular tachycardia in ischemic cardiomyopathy, reducing ICD shocks & VT storms! ⚡⬇️ #Cardiology #Electrophysiology #VT #ICD @NEJM

The Endocannabinoid System plays a crucial role in regulating cardiovascular, neurological, and immune functions through CB1 and CB2 receptors.

• CB1 Activation: Associated with oxidative stress, inflammation, and increased cardiovascular risks such as myocardial infarction (MI), arrhythmias, and heart failure.

• CB2 Activation: Primarily found in immune cells and linked to anti-inflammatory and protective cardiovascular effects.

• Cannabis Use: High THC content or synthetic cannabinoids (e.g., Spice, K2) significantly increases the risk of cardiovascular diseases and psychiatric disorders.

• Cannabis Use Disorder (CUD): Characterized by compulsive use despite adverse consequences, often co-occurring with depression, PTSD, and anxiety.

• Potential Therapeutic Targets: CB1 antagonists (e.g., Genistein) and CB2 agonists are being explored for their ability to reduce inflammation and vascular damage while minimizing psychiatric side effects.

Future research is needed to clarify long-term cardiovascular effects, optimize cannabinoid therapies, and inform public health policies.

The SUMMIT trial investigated tirzepatide, a dual GIP and GLP-1 receptor agonist, in 731 patients with HFpEF and obesity.

This randomized, placebo-controlled study found that tirzepatide reduced heart failure-related events (HR 0.62, P=0.026) and significantly improved quality of life (KCCQ-CSS +19.5 vs. +12.7, P

Summary on Kaṇāda

Kaṇāda, also known as Ulūka or Kashyapa, was an ancient Indian natural philosopher and the founder of the Vaisheshika school of Indian philosophy. He is often regarded as the earliest proponent of atomism in the world, proposing that the universe is composed of indivisible, eternal atoms (paramanu), which combine in various ways to form different substances. His ideas were recorded in the seminal text Vaiśeṣika Sūtra, which outlined a realistic and pluralistic ontology.

Estimated to have lived between the 6th century BCE and 2nd century BCE, Kaṇāda’s philosophy explains the creation and functioning of the universe through six fundamental categories (padarthas): dravya (substance), guna (quality), karma (motion), samanya (generality), visesha (particularity), and samavaya (inherence). These categories encompass everything that can be experienced and known.

Kaṇāda’s atomistic theory influenced later Hindu, Jain, and Buddhist philosophies and may have inspired thinkers in fields like medicine and physics, including scholars like Charaka. Though primarily focused on physical phenomena, Kaṇāda also integrated metaphysical ideas, such as the concept of Atman (soul) and the pursuit of moksha (liberation) through knowledge.

Key Contributions:

Atomism: Proposed that all matter is made of indestructible atoms.
Nine Substances: Identified nine dravyas (substances) including earth, water, fire, air, ether (akasha), time, direction, mind, and soul.
Non-Theistic Approach: Suggested that natural laws, rather than a deity, govern the universe.
Empirical Observations: Explained natural phenomena such as fire rising upwards, magnetism, and rainfall using logical reasoning.
Ethical Framework: Defined dharma as that which leads to material progress and spiritual liberation.

Kaṇāda’s logical and analytical approach laid the groundwork for scientific inquiry in India and significantly influenced the Nyaya school of philosophy, which emphasized logic and epistemology. His ideas on atoms and matter predated similar concepts proposed by Greek philosophers like Democritus.

The study investigates the K210del mutation in genetic cardiomyopathy, which impairs myocardial contractility due to calcium discoordination in the troponin complex.

Using a structure-based drug repurposing approach, researchers identified risedronate, an FDA-approved bisphosphonate, as a structural corrector that restores the calcium-binding domain’s normal configuration.

Experiments with patient-derived iPSC cardiomyocytes and a mouse model demonstrated that risedronate normalized calcium sensitivity, improved contraction velocity, and restored left ventricular function.

The findings highlight the potential of repurposing existing drugs to treat genetic cardiomyopathies.

Recent randomized trials, including EARLY TAVR, AVATAR, RECOVERY, and EVOLVED, suggest benefits of early aortic valve replacement (AVR) in asymptomatic severe aortic stenosis (AS).

Early AVR reduces stroke, heart failure hospitalizations, and cardiovascular events, with a trend toward improved survival.

The data support shifting from clinical surveillance to early intervention?

The EVOLVED trial investigated whether early aortic valve intervention could improve outcomes in asymptomatic patients with severe aortic stenosis and myocardial fibrosis.

The randomized, multicenter study of 224 patients found no significant difference in all-cause mortality or unplanned aortic stenosis-related hospitalizations between early intervention and guideline-directed conservative management.

However, early intervention was associated with lower rates of NYHA class II-IV symptoms and fewer unplanned hospitalizations. The trial highlights the potential symptomatic benefits of early intervention but underscores the need for further research to assess long-term outcomes.

Summary: Cold-Related Deaths in the US (1999–2022)

Overview and Trends

• Cold-related deaths more than doubled over the study period.

• 40,079 deaths recorded; age-adjusted mortality rate (AAMR) rose from 0.44 (1999) to 0.92 (2022) per 100,000 population (109% increase).

• A significant upward trend began in 2017, with an annual percentage change (APC) of 12.1%.

Demographic Insights

• Age: Mortality was highest among individuals aged ≥75 years (4.23/100,000 in 2022).

• Largest Increase: Adults aged 45–74 years experienced the steepest rise (APC: 4.8%).

• Gender: Males consistently exhibited higher mortality than females, although both increased significantly.

• Race/Ethnicity:

• Highest Rates: American Indian/Alaska Native populations (6.26/100,000).

• Fastest Growth: Hispanic populations (APC: 4.1%).

Regional Patterns

• Midwest: Highest mortality (1.41/100,000) and steepest increase (APC: 4.3%).

• Northeast: Recorded the smallest increase.

Public Health Implications

• Rising Deaths Despite Global Warming: Likely driven by extreme winter events, homelessness, and social isolation.

• At-Risk Populations: Older adults and marginalized communities face the greatest risk.

• Recommendations:

• Expand access to warming centers.

• Enhance community awareness of cold-related risks.

• Support research into climate change impacts on health.

Conclusion:

The sharp increase in cold-related mortality rates highlights the growing importance of climate-adaptive health strategies and targeted interventions for vulnerable populations.

The AZALEA–TIMI 71 trial compared abelacimab, a monoclonal antibody targeting factor XI, with rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk.

🚨 New study: Abelacimab vs. Rivaroxaban in AFib 📊

✅ 62-69% lower bleeding risk than rivaroxaban ✅ 5x lower GI bleeding ⚠️ Slightly higher ischemic stroke rates

A promising safer anticoagulant? 🔬 More data needed! #CardioTwitter #CardioEd #MedEd

Abelacimab significantly reduced bleeding compared to rivaroxaban (HR: 0.38 for 150 mg, 0.31 for 90 mg, p

The Tri.Fr Randomized Clinical Trial evaluated the efficacy of Transcatheter Edge-to-Edge Repair (T-TEER) + Optimized Medical Therapy (OMT) versus OMT alone in 300 patients with severe, symptomatic tricuspid regurgitation (TR) across 24 centers in France and Belgium.

At 1-year follow-up, 74.1% of patients in the T-TEER group improved, compared to 40.6% in the OMT-alone group (P < .001). T-TEER significantly reduced TR severity, improved NYHA class, patient global assessment (PGA), and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores, and had a high procedural success rate (97.3%) with a low 30-day major adverse event rate (0.7%).

The findings support T-TEER as an effective intervention for symptomatic severe TR, warranting long-term follow-up to assess mortality and hospitalization impact.

Three studies examined the health impacts of aircraft noise exposure.

The Heathrow Study (2023) found that nighttime aircraft noise increased cardiovascular events, particularly between 22:00–23:00 and 04:30–06:00, likely due to sleep disturbance and stress-related mechanisms.

🚨 New studies link aircraft noise to serious health risks! 🛩️🔊

📌 Nighttime noise boosts heart disease risk 🫀

📌 Increases cognitive decline & dementia risk 🧠

📌 Alters heart structure, raising cardiac event risk 💔

Time for stronger noise regulations! #Health #NoisePollution

The Swedish Longitudinal Cohort (2024) linked long-term exposure to aircraft and railway noise to faster cognitive decline and a higher risk of cognitive impairment, while road traffic noise showed no significant effect.

The UK Biobank Study (2025) revealed that higher nighttime aircraft noise exposure was associated with adverse cardiac remodeling, leading to an increased risk of major adverse cardiac events, with obesity and hypertension acting as mediators.

🚨 Air traffic controllers face severe fatigue due to the 2-2-1 shift system, causing sleep loss, cognitive impairment & safety risks. 🛑 FAA & NATCA now plan to replace it with a safer schedule to enhance aviation safety. ✈️ #Fatigue #AviationSafety #ATC

The 2-2-1 shift system in air traffic control (ATC) compresses five shifts into four days, leading to severe fatigue due to counterclockwise rotation and insufficient rest periods.

The FAA’s 2024 study found that this schedule causes sleep deprivation, cognitive impairment, and increased safety risks, with 77% of controllers unintentionally falling asleep on duty and 36% falling asleep while driving home.

The FAA and NATCA have now agreed to replace this system with a new schedule that prioritizes fatigue management and aviation safety through improved rest periods and scheduling practices.

The POPular PAUSE TAVI trial investigated whether continuing or interrupting oral anticoagulation during transcatheter aortic valve implantation (TAVI) affected clinical outcomes.

The randomized, open-label, noninferiority study included 858 patients and assessed a composite primary outcome of cardiovascular death, stroke, myocardial infarction, major vascular complications, or major bleeding at 30 days.

The trial found that continuation was not noninferior to interruption, with higher bleeding risk but no significant difference in thromboembolic events, supporting interruption of anticoagulation in high-bleeding-risk TAVI patients.

The six orthodox Indian schools of philosophy—Nyaya, Vaisheshika, Samkhya, Yoga, Mimamsa, and Vedanta—offer valuable insights into the mind-body connection, ethics, logic, and holistic well-being.

Understanding these systems can benefit healthcare providers and patients in promoting mental, emotional, and physical health.

The TCW Trial compared TAVI + FFR-guided PCI versus SAVR + CABG in patients with severe aortic stenosis and complex coronary artery disease.

This multicenter, randomized controlled trial included 172 patients aged ≥70 years. At 1 year, the primary composite endpoint (death, MI, stroke, revascularization, valve reintervention, or major bleeding) was significantly lower in the TAVI + PCI group (4%) compared to SAVR + CABG (23%), meeting both noninferiority and superiority criteria.

The study suggests TAVI + PCI as a safer, less invasive alternative with reduced mortality and bleeding risks in selected patients.

🚑 New studies on #OHCA: No significant survival benefit of intraosseous (IO) over IV access. IV remains the preferred route, with IO as backup. #EmergencyMedicine #CPR #CardiacArrest

These 2 randomized clinical trials compared intraosseous (IO) vs. IV vascular access in out-of-hospital cardiac arrest (OHCA).

The first study (Denmark) found no significant difference in return of spontaneous circulation (ROSC), 30-day survival, or neurological outcomes between IO and IV access.

The second study (UK) showed slightly higher ROSC in the IV-first group but no survival advantage. Both studies suggest IV access should remain the first choice, with IO as a backup when IV is not feasible.

🚨 New study: Evolocumab shows strong CV benefits in older adults (≥75 yrs) with ASCVD! 📉 Lower LDL-C, reduced events (HR: 0.79, NNT: 19), & no major safety concerns. Time to rethink lipid guidelines for seniors? 🔬💙 #Cardiology #LipidLowering #Evolocumab

Lipoprotein(a) [Lp(a)] is a genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Traditional lipid-lowering therapies have minimal impact on Lp(a), necessitating novel treatments.

Zerlasiran, a small-interfering RNA (siRNA), significantly reduces Lp(a) (~85%) by inhibiting hepatic apolipoprotein(a) synthesis via subcutaneous injection.

Muvalaplin, an oral small-molecule inhibitor, prevents Lp(a) particle formation, reducing levels by up to 85.8%. Both drugs were well-tolerated in Phase 2 trials, with further studies needed to evaluate cardiovascular event reduction.

NEJM Article (2024): A 30-year study of 27,939 U.S. women found that high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) independently predicted cardiovascular risk. Higher levels of these biomarkers increased the risk of major cardiovascular events, emphasizing the need for early screening and prevention in women.
BrJSportsMed Article (2024): A study of 13,018 women found that even 1–3 minutes/day of vigorous intermittent lifestyle physical activity (VILPA) significantly reduced cardiovascular risk. Women engaging in 3.4 minutes/day had a 45% lower MACE risk and 67% lower heart failure risk, highlighting VILPA as a simple yet effective prevention strategy.

“Bioaccumulation of Microplastics in Decedent Human Brains” (Nature Medicine, 2024)

This study confirms the presence of microplastics and nanoplastics (MNPs) in human brain tissue, particularly the frontal cortex. Researchers used pyrolysis gas chromatography-mass spectrometry (Py-GC/MS) and electron microscopy to analyze postmortem samples, finding polyethylene (PE) as the dominant plastic type. Brain tissue exhibited significantly higher plastic concentrations than the liver or kidney, with even greater MNP accumulation in individuals diagnosed with dementia. The findings raise concerns about potential neuroinflammation and long-term neurological effects, though causality remains unproven.

“Microplastics and Nanoplastics in Atheromas and Cardiovascular Events” (New England Journal of Medicine, 2024)

This study investigates the presence of microplastics in atherosclerotic plaques and their potential role in cardiovascular disease. Analyzing carotid artery plaques from patients undergoing endarterectomy, researchers found polyethylene (PE) and polyvinyl chloride (PVC) in 58.4% of plaques. Patients with MNP-containing plaques had a 4.53 times higher risk of heart attack, stroke, or death over a three-year follow-up. The study also linked MNP presence to elevated inflammatory markers (IL-18, IL-1β, TNF-α, IL-6), suggesting that microplastics might exacerbate cardiovascular disease progression.

Kapila: Founder of Samkhya Philosophy

Kapila (7th–6th century BCE) is regarded as the founder of the Samkhya school, one of the six orthodox systems of Hindu philosophy. Known for his rational and dualistic approach, he emphasized the distinction between Purusha (consciousness) and Prakriti (matter).

His teachings are captured in the Samkhya Sutras and the Bhagavata Purana, where he elaborated on metaphysics, self-realization, and liberation from suffering.

Kapila’s influence extends to Hinduism, Buddhism, and Jainism, making him a pivotal figure in ancient Indian philosophy.

Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT- HEART randomised controlled trial in Scotland

Michelle C Williams, Ryan Wereski, Christopher Tuck, Philip D Adamson, Anoop S V Shah, Edwin J R van Beek, Giles Roditi, Colin Berry,Nicholas Boon, Marcus Flather, Steff Lewis, John Norrie, Adam D Timmis, Nicholas L Mills, Marc R Dweck, David E Newby, on behalf of theSCOT-HEART Investigators*

Summary Background The Scottish Computed Tomography of the Heart (SCOT-HEART) trial demonstrated that management guided by coronary CT angiography (CCTA) improved the diagnosis, management, and outcome of patients with stable chest pain. We aimed to assess whether CCTA-guided care results in sustained long-term improvements in management and outcomes.

Methods SCOT-HEART was an open-label, multicentre, parallel group trial for which patients were recruited from 12 outpatient cardiology chest pain clinics across Scotland. Eligible patients were aged 18–75 years with symptoms of suspected stable angina due to coronary heart disease. Patients were randomly assigned (1:1) to standard of care plus CCTA or standard of care alone. In this prespecified 10-year analysis, prescribing data, coronary procedural interventions, and clinical outcomes were obtained through record linkage from national registries. The primary outcome was coronary heart disease death or non-fatal myocardial infarction on an intention-to-treat basis. This trial is registered at ClinicalTrials.gov (NCT01149590) and is complete.

Findings Between Nov 18, 2010, and Sept 24, 2014, 4146 patients were recruited (mean age 57 years [SD 10], 2325 [56·1%] male, 1821 [43·9%] female), with 2073 randomly assigned to standard care and CCTA and 2073 to standard care alone. After a median of 10·0 years (IQR 9·3–11·0), coronary heart disease death or non-fatal myocardial infarction was less frequent in the CCTA group compared with the standard care group (137 [6·6%] vs 171 [8·2%]; hazard ratio [HR] 0·79 [95% CI 0·63–0·99], p=0·044). Rates of all-cause, cardiovascular, and coronary heart disease death, and non-fatal stroke, were similar between the groups (p>0·05 for all), but non-fatal myocardial infarctions (90 [4·3%] vs 124 [6·0%]; HR 0·72 [0·55–0·94], p=0·017) and major adverse cardiovascular events (172 [8·3%] vs 214 [10·3%]; HR 0·80 [0·65–0·97], p=0·026) were less frequent in the CCTA group. Rates of coronary revascularisation procedures were similar (315 [15·2%] vs 318 [15·3%]; HR 1·00 [0·86–1·17], p=0·99) but preventive therapy prescribing remained more frequent in the CCTA group (831 [55·9%] of 1486 vs 728 [49·0%] of 1485 patients with available data; odds ratio 1·17 [95% CI 1·01–1·36], p=0·034).

Interpretation After 10 years, CCTA-guided management of patients with stable chest pain was associated with a sustained reduction in coronary heart disease death or non-fatal myocardial infarction. Identification of coronary atherosclerosis by CCTA improves long-term cardiovascular disease prevention in patients with stable chest pain.

Anaximander of Miletus (c. 610 – c. 546 BCE), a pre-Socratic philosopher and student of Thales, was a pioneer of cosmology, astronomy, and natural philosophy.

He introduced the concept of the apeiron (infinite) as the origin of all things, developed early theories on evolution, and created one of the first world maps.

His revolutionary ideas laid the groundwork for scientific thinking and inspired generations of philosophers and scientists.

“The Protein Puzzle: Debunking Myths About Protein Deficiency in India”

This episode explores and debunks the myth of protein deficiency in India, highlighting that most Indians meet their protein needs through balanced diets.

It explains the Protein-to-Energy Ratio (PER) and how traditional food pairings like cereals and legumes enhance protein quality.

Key insights include varying protein needs across age groups, the risks of overconsumption, and practical tips for improving dietary protein through affordable, accessible options.

The episode emphasizes that protein is a vital part of a holistic diet, naturally achieved through thoughtful planning and traditional practices.

Gargi Vachaknavi, an esteemed philosopher and Vedic scholar of ancient India, is celebrated as one of the earliest female intellectuals in recorded history.

Known for her profound knowledge of Brahma Vidya, she engaged in rigorous philosophical debates, including a renowned discourse with sage Yajnavalkya on the nature of existence and the ultimate reality.

Revered as a Brahmavadini, Gargi contributed significantly to the intellectual and spiritual traditions of Vedic India, inspiring generations with her wisdom and critical thinking.

“Discover the legacy of Thales of Miletus, the first Greek philosopher and one of the Seven Sages. Known for proposing ‘all is water,’ pioneering geometry, and predicting a solar eclipse, he laid the foundation for science and rational inquiry. #Philosophy #Thales”

Explore timeless wisdom with Dr. RR Baliga’s Philosophical Discourses!

Dive into the teachings of Yajnavalkya: Vedic Sage and Philosopher and more, blending ancient philosophy with modern insights.

Amaya-Garrido A, et al. Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease. Sci Transl Med. 2023 Sep 6;15(712):eabn5939. doi: 10.1126/scitranslmed.abn5939. Epub 2023 Sep 6. PMID: 37672568.

Dr RR Baliga's Internal Medicine Podcast for Physicians: "GOT KNOWLEDGE DOC" Podcast

This podcast is for physicians and physician extenders

Not medical advice or opinion

Dr RR Baliga's Internal Medicine Podcast for Physicians: "GOT KNOWLEDGE DOC" Podcast

This podcast is for physicians and physician extenders

Not medical advice or opinion

Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Statistics--Descriptive versus Inferential

Descriptive versus Inferential Statistics

Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Statistics.

derived from

Donna Windish, Statistics in Baliga's Textbook of Internal Medicine: An Intensive Board Review with 1480 MCQs--an eBook available www.MasterMedFacts.com

Twitter @mastermedfacts1

Not medical advice or opinion

COVID-19 in Patients with Heart Disease and Cancer

Dr RR Baliga's 'Got Knowledge Doc' Podcasts for Physicians

Coronaviruses and the Cardiovascular System
Coronavirus Fulminant Myocarditis Case Review
COVID-19 in Patients with Cardiovascular Disease and Cancer Sarju Ganatra, Sarah P. Hammond, Anju Nohria JACC: CardioOncology:Accessed online March 20, 2020

Not Medical Advice or Opinion

Hyperviscosity Syndrome + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

Superior Vena Cava Syndrome + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

Malignant Pericardial Effusion & Cardiac Tamponade + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

Hyperleukocytosis & Leukostasis + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

Brain Metastases + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

Malignant Spinal Cord Compression (MSCC) + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

Tumor Lysis Syndrome + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

Neutrophil Extracellular Traps (NETs) as Biomarkers and Therapeutic Targets?

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

References

Yang L, Liu Q, Zhang X, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25 [published online ahead of print, 2020 Jun 11]. Nature. 2020

Thålin C, et al. Neutrophil Extracellular Traps: Villains and Targets in Arterial, Venous, and Cancer-Associated Thrombosis. Arterioscler Thromb Vasc Biol. 2019;39(9):1724-1738.

Döring Y, Libby P, Soehnlein O. Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights. Circ Res. 2020;126(9):1228-1241.

Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Neoplasia and The Heart

Neoplasia and the HeartPathological Review of Effects With Clinical and Radiological Correlation

Joseph J. Maleszewski, Melanie C. Bois, John P. Bois, Philip M. Young, John M. Stulak, Kyle W. Klarich Journal of the American College of Cardiology July 10, 2018, 72 (2) 202-227 Not Medical Advice or Opinion

Dr RR Baliga's 'Got Knowledge Doc?' PodKasts for Physicians| Is Cardiac Magnetic Resonance Imaging Useful in Chemotherapy Induced Cardiotoxicity

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis European Heart Journal, Volume 41, Issue 18, 7 May 2020, Pages 1733–1743,
Immune checkpoint inhibitor cardiotoxicity: what can we learn from real life data on CMR as a diagnostic tool? European Heart Journal, Volume 41, Issue 18, 7 May 2020, Pages 1744–1746
Can Quantitative CMR Tissue Characterization Adequately Identify Cardiotoxicity During Chemotherapy? Impact of Temporal and Observer Variability. JACC Cardiovasc Imaging 2020;13:951-962.

🎧 Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Androgen Deprivation Therapy & Cardiovascular Disease.

Not Medical Advice or Opinion

Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX Registry- European Heart Journal 7th May 2020 | Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians| Not Medical Advice or Opinion

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians| CARAVAGGIO Trial: Is Apixaban safe and efficacious in Cancer Venous Thromboembolism?-NEJM April 2020 | Not Medical Advice or Opinion

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer N Engl J Med 2020; 382:1599-1607
Anticoagulant Therapy for Venous Thromboembolism in Cancer N Engl J Med 2020; 382:1650-1652
Tukaye DN, Brink H, Baliga R. Venous thromboembolism in cancer patients: risk assessment, prevention and management. Future Cardiol. 2016;12(2):221‐235. doi:10.2217/fca.15.87
Arcopinto M, Cella CA, Wesolowski R, et al. Primary prevention of cancer-related thrombosis: special focus on ambulatory patients. Int J Cardiol. 2014;173(3):583‐584. doi:10.1016/j.ijcard.2014.03.109

Therapy of Transthyretin Cardiomyopathy

Dr Baliga's MUST KNOW FACTS PODCASTS FOR PHYSICIANS

derived from a chapter authored by

Taimur Sher, MD

Faculty Hematologist & Associate Professor,

Mayo Clinic, Jacksonville

&

Moire A Gertz, MD

Emeritus Chair & Consult Hematologist,

Mayo Clinic, Rochester, MN

in

Color Atlas and Synopsis of Heart Failure

edited by RR Baliga, MD

McGraw Hill Education

-

Not Medical Advice or Opinion

Cardiovascular Events with CHOP/RCHOP in Non-Hogkin's -

Dr RR Baliga's 'Got Knowledge Doc' PODCASTS for Physicians

Published in Lancet Hematology Online March 2nd, 2020 https://doi.org/10.1016/S2352-3026(20)30031-4

Not Medical Advice or Opinion

Oncometabolites and The Heart

Dr RR Baliga 'Got Knowledge Doc' PodKasts for Cardio-Oncologists

Baliga RR, Young JB. Energizing Diastole Heart Fail Clin. 2008;4(1):ix‐xiii.

Energizing Diastole

Sulkowski, P.L., Oeck, S., Dow, J. et al. Oncometabolites suppress DNA repair by disrupting local chromatin signalling. Nature (2020).

Tumour metabolites hinder DNA repair Krebs Cycle Nobel Lecture Ivosidenib and Cardiogenic Shock Oncometabolite d-2-hydroxyglutarate impairs α-ketoglutarate dehydrogenase and contractile function in rodent heart. Proc Natl Acad Sci U S A. D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice. Genes Dev. Changes in Citric Acid Cycle and Nucleoside Metabolism Are Associated with Anthracycline Cardiotoxicity in Patients with Breast Cancer. J Cardiovasc Transl Res. Krebs Cycle Primer Khan Academy Taegtmeyer H, et al Oncometabolic Tracks in the Heart. Circ Res. 2017

Fasting for Chemotherapy Induced Heart Failure?

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

de Groot S, Lugtenberg RT, Cohen D, et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat Commun. 2020;11(1):3083. Published 2020 Jun 23. doi:10.1038/s41467-020-16138-3

Byrne NJ, Soni S, Takahara S, et al. Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure. Circ Heart Fail. 2020;13(6):e006573. doi:10.1161/CIRCHEARTFAILURE.119.006573 Not Medical Advice or Opinion

Connecting the Dots Between Cardio-Oncology & Door-to-GDMT Time for Heart Failure

HYPOXEMIA AND HYPERCAPNIA

from a chapter titled

Critical Care

authored by

Shyoko Honiden, MD & Mark D Siegel, MD

Yale University School of Medicine

from

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

Not Medical Advice or Opinion

Lactic Acidosis in Malignancies + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians | Does Pulmonary Rehab Save Lives after COPD Hospitalizations? JAMA May 12, 2020 | Not Medical Advice or Opinion

Lindenauer PK, Stefan MS, Pekow PS, et al. Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries. JAMA. 2020;323(18):1813–1823. doi:10.1001/jama.2020.4437

Rochester CL, Holland AE. Pulmonary Rehabilitation and Improved Survival for Patients With COPD. JAMA. 2020;323(18):1783–1785. doi:10.1001/jama.2020.4436

Management of AL Cardiac Amyloidosis

Dr Baliga's MUST KNOW FACTS PODCASTS FOR PHYSICIANS

derived from a chapter authored by

Taimur Sher, MD

Faculty Hematologist & Associate Professor,

Mayo Clinic, Jacksonville

&

Moire A Gertz, MD

Emeritus Chair & Consult Hematologist,

Mayo Clinic, Rochester, MN

in

Color Atlas and Synopsis of Heart Failure

edited by RR Baliga, MD

Series Editor: William T Abraham, MD

McGraw Hill Education

-

Not Medical Advice or Opinion

Cardiac Amyloidosis-2

Dr Baliga's MUST KNOW FACTS PODCASTS FOR PHYSICIANS

derived from a chapter authored by

Taimur Sher, MD

Faculty Hematologist & Associate Professor,

Mayo Clinic, Jacksonville

&

Moire A Gertz, MD

Emeritus Chair & Consult Hematologist,

Mayo Clinic, Rochester, MN

in

Color Atlas and Synopsis of Heart Failure

edited by RR Baliga

Series Editor: William T Abraham, MD

McGraw Hill Education

-

Not Medical Advice or Opinion

Cardiac Amyloidosis-1

Dr Baliga's MUST KNOW FACTS PODCASTS FOR PHYSICIANS

derived from a chapter authored by

Taimur Sher, MD

Faculty Hematologist & Associate Professor,

Mayo Clinic, Jacksonville

&

Moire A Gertz, MD

Emeritus Chair & Consult Hematologist,

Mayo Clinic, Rochester, MN

in

Color Atlas and Synopsis of Heart Failure

edited by RR Baliga

Series Editor: William T Abraham, MD

McGraw Hill Education

-

Not Medical Advice or Opinion

🎧 Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about 2018 Hypertension Guidelines

Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/MultiSociety guideline for the prevention, detection, evaluation, and management of high blood pressure in adults J Am Coll Cardiol 2018;71:e127-248.

Not Medical Advice or Opinion

Subscribe on iTunes

🎧 Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Jugular Venous Pulse

Not Medical Advice or Opinion

Cardiac Rehab--Primer | Dr. RR Baliga's "Got Knowledge Doc" Podkast for Physicians

Why Combination Lipid-Lowering Therapy Should be Considered Early in the Treatment of Elevated LDL-C For CV Risk Reduction Mini G Varughese, MD; Matthew Deshotels, MD; Christie M. Ballantyne, MD, FACC

Sodium Glucose Transporter-2 (SGLT2) Inhibition to Prevent Chemotherapy Induced Cardiotoxicity?

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

References

Scafoglio C, et al. Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A. 2015

Scafoglio CR, et al. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. Sci Transl Med. 2018

Martinez CA, Scafoglio C. Heterogeneity of Glucose Transport in Lung Cancer. Biomolecules. 2020

Paternostro G, Camici PG, Lammerstma AA, Baliga RR, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest. 1996;98(9):2094‐2099.

Bassi NS, Ziaeian B, Yancy CW, Fonarow GC. Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy With Outcome for Patients With Heart Failure [published online ahead of print, 2020 May 6]. JAMA Cardiol. 2020

Fang JC. Heart-Failure Therapy - New Drugs but Old Habits?. N Engl J Med. 2019

McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995‐2008.

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2203690#.YsoGdaAS_fY.twitter
DESTINY-Changing Results for Advanced Breast Cancer | NEJM https://www.nejm.org/doi/full/10.1056/NEJMe2206661#.YsoGjty1ahE.twitter
Early Detection and Monitoring of Vulnerable Myocardium in Patients Receiving Chemotherapy: Is It Time to Change Tracks? https://www.heartfailure.theclinics.com/article/S1551-7136(11)00037-7/fulltext#.YsoHTLcs3-M.twitter
Using a Magnet to Strike Gold https://www.heartfailure.theclinics.com/article/S1551-7136(09)00026-9/fulltext#.YsoG3Cq5rAs.twitter

Yamanaka Factors for the Cardio-Oncologist

Dr RR Baliga's 'Got Knowledge Doc' Podkasts for Physicians

Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006 Aug 25;126(4):663-76. doi: 10.1016/j.cell.2006.07.024. Epub 2006 Aug 10. PMID: 16904174.

Sharma A. Stem cells to help the heart. Science. 2020 Mar 13;367(6483):1206. doi: 10.1126/science.aba6111. PMID: 32165579. Sayed N, Ameen M, Wu JC. Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell. Cardiovasc Res. 2019 Apr 15;115(5):949-959. doi: 10.1093/cvr/cvz024. PMID: 30768178; PMCID: PMC6933506. Yoshida Y, Yamanaka S. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications. Circ Res. 2017 Jun 9;120(12):1958-1968. doi: 10.1161/CIRCRESAHA.117.311080. PMID: 28596174. Lu Y, Brommer B, Tian X, Krishnan A, Meer M, Wang C, Vera DL, Zeng Q, Yu D, Bonkowski MS, Yang JH, Zhou S, Hoffmann EM, Karg MM, Schultz MB, Kane AE, Davidsohn N, Korobkina E, Chwalek K, Rajman LA, Church GM, Hochedlinger K, Gladyshev VN, Horvath S, Levine ME, Gregory-Ksander MS, Ksander BR, He Z, Sinclair DA. Reprogramming to recover youthful epigenetic information and restore vision. Nature. 2020 Dec;588(7836):124-129. doi: 10.1038/s41586-020-2975-4. Epub 2020 Dec 2. PMID: 33268865. Litviňuková M, Talavera-López C, Maatz H, Reichart D, Worth CL, Lindberg EL, Kanda M, Polanski K, Heinig M, Lee M, Nadelmann ER, Roberts K, Tuck L, Fasouli ES, DeLaughter DM, McDonough B, Wakimoto H, Gorham JM, Samari S, Mahbubani KT, Saeb-Parsy K, Patone G, Boyle JJ, Zhang H, Zhang H, Viveiros A, Oudit GY, Bayraktar OA, Seidman JG, Seidman CE, Noseda M, Hubner N, Teichmann SA. Cells of the adult human heart. Nature. 2020 Sep 24:1–7. doi: 10.1038/s41586-020-2797-4. Epub ahead of print. PMID: 32971526; PMCID: PMC7681775.

EKG Sunday | Is this benign? |Dr RR Baliga's "MUST KNOW EKG" Podkast for Physicians

Not Medical Advice or Opinion

Artificial Intelligence & Machine Learning Primer for PHYSICIANS

Dr RR Baliga's GOT KNOWLEDGE DOC PodKasts

associated with

Baliga's Textbook of Medicine with 1480 MCQs

available at

www.MasterMedFacts.com

Door-to-Guideline Directed Medical Therapy Time & Door to Max Dose GDMT Time for Heart Failure

MINOCA=Myocardial Infarction with Non-Obstructive Coronary Arteries

🎧 Transthyretin (TTR) Amyloid: Dr RR Baliga "Got Knowledge Doc" PodKast for Physicians

1. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry Scott M. Damrauer, MD; Kumardeep Chaudhary, PhD; Judy H. Cho, MD; et al. JAMA. Dec10th, 2019;322(22):2191-2202. doi:10.1001/jama.2019.17935

Treatment of Cardiac Transthyretin Amyloidosis: Emdin M, Aimo A, Rapezzi C, et al. An Update. Eur Heart J 2019;40:3699-3706.
Treatment of Cardiac Transthyretin Amyloidosis Dec 13, 2019 | RR. Baliga, MD, FACC

Transthyretin (TTR) Amyloid: "Hot-off-the-Press Dr RR Baliga MUST KNOW FACTS PodKast"

1. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry Scott M. Damrauer, MD; Kumardeep Chaudhary, PhD; Judy H. Cho, MD; et al. JAMA. Dec10th, 2019;322(22):2191-2202. doi:10.1001/jama.2019.17935

Treatment of Cardiac Transthyretin Amyloidosis: An Update. Eur Heart J 2019;40:3699-3706.
Treatment of Cardiac Transthyretin Amyloidosis Dec 13, 2019 | RR. Baliga, MD, FACC

Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

References

Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/NEJMc2000343

Benitez R, Delgado-Maroto V, Caro M, et al. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. J Immunol. 2018;200(11):3697-3710. doi:10.4049/jimmunol.1800122 Not Medical Advice or Opinion

🎧 Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Hyponatremia.

from a chapter on

Electrolyte Disorders

by

John J Chang, MDAssistant Professor

&

Aldo J Pexioto, MD

Professor of Medicine (Nephrology);

Vice Chair for Quality & Safety, Department of Internal Medicine; Clinical Chief, Section of Nephrology

Yale School of Medicine

Not Medical Advice or Opinion

Fluoropyrimidine Cardiotoxicity

|Not Medical Advice or Opinion|

Dr RR Baliga's 'GOT KNOWLEDGE DOC' Podcasts for Physicians: Cardio-Oncology Rehabilitation in Cancer Patients and Survivors

derived from

Cardio-Oncology Rehabilitation in Cancer Patients and Survivors: AHA Scientific Statement

Circulation. 2019;139:e997–e1012

Not Medical Advice or Opinion

🎧 Dr RR Baliga's IGot Knowledge Doc?" Podkasts for Physicians: MUST KNOW FACTs about AHA Scientific Statement on Cardio-Oncology: Vascular and Metabolic Perspectives

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association. Circulation 2019;Feb 21

Campia U, Moslehi JJ, Amiri-Kordestani L, et al., on behalf of the American Heart Association Council on Peripheral Vascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Cardiovascular and Stroke Nursing.

Not Medical Advice or Opinion

Radiation Associated Cardiac Disease (Management)-4

Dr RR Baliga's "Got Knowledge Doc" Podkasts for PHYSICIANS

Not Medical Advice or Opinion

Radiation Associated Cardiac Disease (Diagnosis, Screening and Monitoring)-3

Dr RR Baliga's "Got Knowledge Doc" Podkasts for PHYSICIANS

Not Medical Advice or Opinion

Radiation Associated Cardiac Disease (Non-coronary Manifestations)-2

Dr RR Baliga's "Got Knowledge Doc' Podkasts for PHYSICIANS

Not Medical Advice or Opinion

Radiation Associated Cardiac Disease (Coronary Disease)-1

Dr RR Baliga's "Got Knowledge Doc' Podkasts for PHYSICIANS

Not Medical Advice or Opinion

Chronochemotherapy & Cardiotoxicity?

Dr RR Baliga's "Got Knowledge Doc" Podkast for Cardio-Oncologists

Reference

Sancar A, Van Gelder RN. Clocks, cancer, and chronochemotherapy. Science. 2021 Jan 1;371(6524):eabb0738. doi: 10.1126/science.abb0738. PMID: 33384351.

1. Uncoupling DNA damage from chromatin damage to detoxify doxorubicin Xiaohang Qiao,......Jacques Neefjes Proceedings of the National Academy of Sciences Jun 2020, 117 (26) 15182-15192; DOI: 10.1073/pnas.1922072117https://www.pnas.org/content/117/26/15182

Jocelyn Kaiser. New forms of ‘red devil’ cancer drug could spare hearts https://www.sciencemag.org/news/2020/07/new-forms-red-devil-cancer-drug-could-spare-hearts

Not Medical Advice or Opinion

🎧 Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Anthracycline Cardiotoxicity.

Not Medical Advice or Opinion

from

Anthracycline Cardiotoxicity: An Update on Mechanisms, Monitoring and Prevention. Heart 2017;Dec 7; Volume 104, Issue 12

Not Medical Advice or Opinion

🎧 Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Fluoropyramidine Cardiotoxicity.

Not Medical Advice or Opinion

from

Fluoropyramdine Cardiotoxicity

Ibrutinib Associated Cardiotoxicity

Dr RR Baliga's MUST KNOW FACTS PODCASTs for PHYSICIANS

www.MasterMedFacts.com

Not Medical Advice or Opinion

References:

Nicolás-Ávila JA,et al, Hidalgo A. A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart. Cell. 2020 Oct 1;183(1):94-109.e23. doi: 10.1016/j.cell.2020.08.031. Epub 2020 Sep 15. PMID: 32937105. Bartelt A, Weber C. Mitochondrial Ejection for Cardiac Protection: The Macrophage Connection. Cell Metab. 2020 Oct 6;32(4):512-513. doi: 10.1016/j.cmet.2020.09.014. PMID: 33027673. Bordon Y. Macrophages clean up to keep the heart pumping. Nat Rev Immunol. 2020 Nov;20(11):648-649. doi: 10.1038/s41577-020-00459-x. PMID: 32989291. Burridge PW, Thorp EB. Doxorubicin-Induced Ascension of Resident Cardiac Macrophages. Circ Res. 2020 Aug 14;127(5):628-630. doi: 10.1161/CIRCRESAHA.120.317626. Epub 2020 Aug 13. PMID: 32790526; PMCID: PMC7430044. Kolodgie FD, , Narula J. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation. 2003 Dec 23;108(25):3134-9. doi: 10.1161/01.CIR.0000105761.00573.50. Epub 2003 Dec 15. PMID: 14676140. McNally EM. Cardiac Macrophages - Keeping the Engine Running Clean. N Engl J Med. 2020 Dec 17;383(25):2474-2476. doi: 10.1056/NEJMcibr2030271. PMID: 33326720. Zhang WY, Ebert AD, Narula J, Wu JC. Imaging cardiac stem cell therapy: translations to human clinical studies. J Cardiovasc Transl Res. 2011 Aug;4(4):514-22. doi: 10.1007/s12265-011-9281-3. Epub 2011 May 3. PMID: 21538182; PMCID: PMC3657500.

Pfizer-BioNTech Vaccine 101 for Physicians| Dr RR Baliga's 'Got Knowledge Doc' Podkasts for Physicians

References

Pfizer-BioNTech COVID-19 Vaccine
FACT SHEET FOR RECIPIENTS AND CAREGIVERS
NEJM Research Summmary

Bladder Cancer + MCQ

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Arjun V. Balar, MD

Director, GenitoUrinary Medical Oncology Program

at NYU Langone's Perlmutter Cancer Center

&

Matthew I Milowsky, MD

The George Gabriel Villere Distinguished Professor of Bladder & Genitourinary Cancer Research

Section Chief, Genitourinary Oncology &

Co-Director, Urologic Oncology Program

UNC Lineberger Comprehensive Cancer Center

Not Medical Advice or Opinion

Cancer of Unknown Origin (Summary PodCast)

From

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Mark Agulnik, MD

Professor of Internal Medicine

Northwestern University Feinberg School of Medicine

& Sarah Yentz, MD

Assistant Professor of Medicine

University of Michigan

Ann Arbor

Not Medical Advice or Opinion

Cancer of Unknown Origin

From

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Mark Agulnik, MD

Professor of Internal Medicine

Northwestern University Feinberg School of Medicine

& Sarah Yentz, MD

Assistant Professor of Medicine

University of Michigan

Ann Arbor

Not Medical Advice or Opinion

Lymphoid Malignancies

Dr RR Baliga's "Got Knowledge Doc" PodKasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Makiko Ben-Hoefen, MD

Clinical Assistant Professor, University of Rochester

&

Jonathan W Friedberg, MD

Professor - Department of Medicine , Hematology/Oncology

Director of the James P. Wilmot Cancer Institute, and Director of Hematological Malignancies Clinical Research.

Samuel E. Durand Chair in Medicine - Department of Medicine

University of Rochester Medical Center

Not Medical Advice or Opinion

Non-Hodgkin Lymphomas

Dr RR Baliga's "Got Knowledge Doc" PodKasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Makiko Ben-Hoefen, MD

Clinical Assistant Professor, University of Rochester

&

Jonathan W Friedberg, MD

Professor - Department of Medicine , Hematology/Oncology

Director of the James P. Wilmot Cancer Institute, and Director of Hematological Malignancies Clinical Research.

Samuel E. Durand Chair in Medicine - Department of Medicine

University of Rochester Medical Center

Not Medical Advice or Opinion

Hodgkin Lymphoma + MCQ

Dr RR Baliga's "Got Knowledge Doc" PodKasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Makiko Ben-Hoefen, MD

Clinical Assistant Professor, University of Rochester

&

Jonathan W Friedberg, MD

Professor - Department of Medicine , Hematology/Oncology

Director of the James P. Wilmot Cancer Institute, and Director of Hematological Malignancies Clinical Research.

Samuel E. Durand Chair in Medicine - Department of Medicine

University of Rochester Medical Center

Not Medical Advice or Opinion

Lymphadenopathy + MCQ

Dr RR Baliga's "Got Knowledge Doc" PodKasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Makiko Ben-Hoefen, MD

Clinical Assistant Professor, University of Rochester

&

Jonathan W Friedberg, MD

Professor - Department of Medicine , Hematology/Oncology

Director of the James P. Wilmot Cancer Institute, and Director of Hematological Malignancies Clinical Research.

Samuel E. Durand Chair in Medicine - Department of Medicine

University of Rochester Medical Center

Not Medical Advice or Opinion

GenitoUrinary Cancers + MCQ

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Arjun Balar, MD

Director, GenitoUrinary Medical Oncology Program

at NYU Langone's Perlmutter Cancer Center

&

Matthew I Milowsky, MD

The George Gabriel Villere Distinguished Professor of Bladder & Genitourinary Cancer Research

Section Chief, Genitourinary Oncology &

Co-Director, Urologic Oncology Program

UNC Lineberger Comprehensive Cancer Center

Not Medical Advice or Opinion

Testicular Cancer + MCQ

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Arjun Balar, MD

Director, GenitoUrinary Medical Oncology Program

at NYU Langone's Perlmutter Cancer Center

&

Matthew I Milowsky, MD

The George Gabriel Villere Distinguished Professor of Bladder & Genitourinary Cancer Research

Section Chief, Genitourinary Oncology &

Co-Director, Urologic Oncology Program

UNC Lineberger Comprehensive Cancer Center

Not Medical Advice or Opinion

Kidney Cancer (Summary Points) + MCQ

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Arjun Balar, MD

Director, GenitoUrinary Medical Oncology Program

at NYU Langone's Perlmutter Cancer Center

&

Matthew I Milowsky, MD

The George Gabriel Villere Distinguished Professor of Bladder & Genitourinary Cancer Research

Section Chief, Genitourinary Oncology &

Co-Director, Urologic Oncology Program

UNC Lineberger Comprehensive Cancer Center

Not Medical Advice or Opinion

Kidney Cancer + MCQ

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Arjun Balar, MD

Director, GenitoUrinary Medical Oncology Program

at NYU Langone's Perlmutter Cancer Center

&

Matthew I Milowsky, MD

The George Gabriel Villere Distinguished Professor of Bladder & Genitourinary Cancer Research

Section Chief, Genitourinary Oncology &

Co-Director, Urologic Oncology Program

UNC Lineberger Comprehensive Cancer Center

Not Medical Advice or Opinion

Prostate Cancer-3 (Summary) with MCQ

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Arjun Balar, MD

Director, GenitoUrinary Medical Oncology Program

at NYU Langone's Perlmutter Cancer Center

&

Matthew I Milowsky, MD

The George Gabriel Villere Distinguished Professor of Bladder & Genitourinary Cancer Research

Section Chief, Genitourinary Oncology &

Co-Director, Urologic Oncology Program

UNC Lineberger Comprehensive Cancer Center

Not Medical Advice or Opinion

Prostate Cancer-2 (Therapy) +MCQ

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Arjun Balar, MD

Director, GenitoUrinary Medical Oncology Program

at NYU Langone's Perlmutter Cancer Center

&

Matthew I Milowsky, MD

The George Gabriel Villere Distinguished Professor of Bladder & Genitourinary Cancer Research

Section Chief, Genitourinary Oncology &

Co-Director, Urologic Oncology Program

UNC Lineberger Comprehensive Cancer Center

Not Medical Advice or Opinion

Prostate Cancer-1 + MCQ

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Arjun Balar, MD

Director, GenitoUrinary Medical Oncology Program

at NYU Langone's Perlmutter Cancer Center

&

Matthew I Milowsky, MD

The George Gabriel Villere Distinguished Professor of Bladder & Genitourinary Cancer Research

Section Chief, Genitourinary Oncology &

Co-Director, Urologic Oncology Program

UNC Lineberger Comprehensive Cancer Center

Not Medical Advice or Opinion

Head & Neck Malignancies -3

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Glen Hanna, MD

Assistant Professor, Harvard Medical School

&

Jochen H Lorch, MD

Associate Professor, Harvard Medical School

Dana-Farber Cancer Institute

Not Medical Advice or Opinion

Head & Neck Malignancies -2

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Glen Hanna, MD

Assistant Professor, Harvard Medical School

&

Jochen H Lorch, MD

Associate Professor, Harvard Medical School

Dana-Farber Cancer Institute

Not Medical Advice or Opinion

Head & Neck Malignancies -1

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Glen Hanna, MD

Assistant Professor, Harvard Medical School

&

Jochen H Lorch, MD

Associate Professor, Harvard Medical School

Dana-Farber Cancer Institute

Not Medical Advice or Opinion

LUNG CANCER-4 -Summary

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Mohammad Raza, MD &

Scott Gettinger, MD

Professor, Yale University School of Medicine @YaleCancer @YaleMed @YaleIMed

Not Medical Advice or Opinion

LUNG CANCER-3 (Treatment)

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Mohammad Raza, MD &

Scott Gettinger, MD

Professor, Yale University School of Medicine @YaleCancer @YaleMed @YaleIMed

Not Medical Advice or Opinion

LUNG CANCER-2

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Mohammad Raza, MD &

Scott Gettinger, MD

Professor, Yale University School of Medicine @YaleCancer @YaleMed @YaleIMed

Not Medical Advice or Opinion

LUNG CANCER-1

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

chapter authored by

Mohammad Raza, MD &

Scott Gettinger, MD

Professor, Yale University School of Medicine @YaleCancer @YaleMed @YaleIMed

🎧 Ovarian Cancer -3

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

from chapter authored by

Kelsey LaPenas, BSc,

Michael J Birrer, MD Professor Harvard Medical School

John O. Schorge, MD

Director of Gynecologic Oncology, Tufts Medical Center

Richard T Penson, MD, MRCP

Medical Director, Gynecologic Oncology, Massachusetts General Hospital

Not Medical Advice or Opinion

🎧 Ovarian Cancer -2

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

from chapter on Ovarian Cancer authored by

Kelsey LaPenas, BSc,

Michael J Birrer, MD Professor Harvard Medical School

John O. Schorge, MD

Director of Gynecologic Oncology, Tufts Medical Center

Richard T Penson, MD, MRCP

Medical Director, Gynecologic Oncology, Massachusetts General Hospital

Not Medical Advice or Opinion

🎧 Ovarian Cancer -1

Dr RR Baliga's "Got Knowledge Doc" Podkasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

from chapter authored by

Kelsey LaPenas, BSc,

Michael J Birrer, MD Professor Harvard Medical School

John O. Schorge, MD

Director of Gynecologic Oncology, Tufts Medical Center

Richard T Penson, MD, MRCP

Medical Director, Gynecologic Oncology, Massachusetts General Hospital

🎧 Breast Cancer PodCast2

Dr RR Baliga's 'GOT KNOWLEDGE DOC' PodKasts for Physicians

from a chapter in

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

Authored by

Robert Wesolowski, MD

Associate Professor,

The Ohio State University Wexner Medical Center

&

Charles Shapiro MD

Professor, Mt. Sinai University School of Medicine, NY

Not Medical Advice or Opinion

🎧 Breast Cancer Risk

Dr RR Baliga's 'GOT KNOWLEDGE DOC' PodKasts for Physicians

from a chapter in

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

Authored by

Robert Wesolowski, MD

Associate Professor,

The Ohio State University Wexner Medical Center

&

Charles Shapiro MD

Professor, Mt. Sinai University School of Medicine, NY

Dr RR Baliga's Internal Medicine "Got Knowledge Doc' Podkasts for Physicians: MUST KNOW FACTs about Cardiovascular Disease & Breast Cancer

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect:

A Scientific Statement From the American Heart Association

https://doi.org/10.1161/CIR.0000000000000556 Circulation. 2018;137:e30–e66 Not Medical Advice or Opinion

🎧 Cancer Risk Podcast 3

Dr RR Baliga's "Got Knowledge Doc" PodCasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

from a chapter authored by

Galena Salem MD &

Bhuvaneswari Ramaswamy, MD

Professor, Internal Medicine &

Head, Breast Cancer Section

OSU James Cancer Center & OSU Wexner Medical Center

🎧 Cancer Risk Podcast 2

Dr RR Baliga's "Got Knowledge Doc" PodCasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

from a chapter authored by

Galena Salem MD &

Bhuvaneswari Ramaswamy, MD

Professor, Internal Medicine &

Head, Breast Cancer Section

OSU James Cancer Center & OSU Wexner Medical Center

🎧 Cancer Risk

Dr RR Baliga's "Got Knowledge Doc" PodCasts for Physicians

from

Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

from a chapter authored by

Galen Salem MD &

Bhuvaneswari Ramaswamy, MD

Professor, Internal Medicine &

Head, Breast Cancer Section

OSU James Cancer Center & OSU Wexner Medical Center

🎧 Dr RR Baliga's Internal Medicine "Got Knowledge Doc" Podcasts for Physicians: MUST KNOW FACTs on Analysis of Acid-Base Disorders

from chapter titled

Acid-Base Disorders by John J Chang, MD & Aldo J Pexioto, MD

Yale University School of Medicine

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

Not Medical Advice or Opinion

Dr RR Baliga's Internal Medicine "Got Knowledge Doc" Podcasts for Physicians.

Not Medical Advice or opinion

🎧 Dr RR Baliga's Internal Medicine "Got Knowledge Doc" Podcasts for Physicians: MUST KNOW FACTs about Acid and Base Physiology-A Simplified Version.

Not Medical Advice or Opinion

derived from the chapter

Acid-Base Disorders

by John J Chang, MD & Aldo J Peixoto, MD,

Yale University School of Medicine

in Baliga's Textbook of Internal Medicine with 1480 MCQs

www.MasterMedFacts.com

🎧 Dr RR Baliga's Internal Medicine "Got Knowledge Doc" Podkasts for Physicians: MUST KNOW FACTs about Potassium Homeostasis.

Not Medical Advice or Opinion

Hypercalcemia of Malignancy + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

🎧 Dr RR Baliga's Internal Medicine "GOT KNOWLEDGE DOC" Podcasts for Physicians: MUST KNOW FACTs about Hypernatremia

Not Medical Advice or Opinion

Derived from a chapter titled

Electrolytes, authored by John J Chang, MD & Aldo J Pexioto, MD, from Yale University School of Medicine in

Baliga's Textbook of Internal Medicine with ~1480 Multiple Choice Questions.

www.MasterMedFacts.com

🎧 Dr RR Baliga's Internal Medicine 'Got Knowledge Doc' Podcasts for Physicians: MUST KNOW FACTs about Hyperkalemia.

Not Medical Advice or Opinion.

🎧 Dr RR Baliga's "Got Knowledge Doc' Podcasts for Physicians: MUST KNOW FACTs about Hypokalemia.

Not Medical Advice or Opinion

Dr RR Baliga's Internal Medicine Podkasts for Physicians: GOT KNOWLEDGE DOC Podkasts about Long-Term Risk of HF with Chemotherapy with Trastuzumab

Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab. JACC Heart Fail 2019;7:217-224.

Not Medical Advice or Opinion

Neutropenic Fever + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

🎧 Dr RR Baliga's Internal Medicine 'Got Knowledge Doc' Podkasts for Physicians: on Immune Check Point Inhibitor Cardiotoxicity.

Not Medical Advice or Opinion

🎧 Dr RR Baliga's Internal Medicine 'Got Knowledge Doc' Podkasts for Physicians: about Screening for Colorectal Cancer

Not Medical Advice or Opinion

Dr Baliga's 'Got Knowledge Doc' PODKASTS for Physicians: on 'Hypertension in the Cardio-Oncology Clinic'

Not Medical Advice or Opinion

🎧 Transthyretin (TTR) Amyloid: "Hot-off-the-Press Dr RR Baliga 'Got Knowledge Doc' PodKast"

1. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry Scott M. Damrauer, MD; Kumardeep Chaudhary, PhD; Judy H. Cho, MD; et al. JAMA. Dec10th, 2019;322(22):2191-2202. doi:10.1001/jama.2019.17935

Treatment of Cardiac Transthyretin Amyloidosis: Emdin M, Aimo A, Rapezzi C, et al. An Update. Eur Heart J 2019;40:3699-3706.
Treatment of Cardiac Transthyretin Amyloidosis Dec 13, 2019 | RR. Baliga, MD, FACC

Podkast derived from chapter on

Pleural Disease

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Jeremy B Richards, MD

Assistant Professor

Director of the Medical Education Research Laboratory, Shapiro Institute of Education, Beth Israel Deaconess Medical Center

&

Richard M. Schwartzstein, MD,

Professor of Medicine

Harvard Medical School

Chief of the Division of Pulmonary, Critical Care and Sleep Medicine

Beth Israel Deaconess Medical Center (BIDMC)

Professor of Medicine

Global Initiative for Asthma Update 2019 & 2020

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

derived from chapter on

Asthma

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Christopher H. Fanta, MD

Professor of Medicine

Harvard Medical School

&

Director

Partners Asthma Center

a collaboration of Brigham & Women's Hospital &

Massachusetts General Hospital

Not Medical Advice or Opinion

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

&

Breaking Free of Sample Size Dogma to Perform Innovative Translational Research

Peter Baccetti, Steven G Deeks, Joseph M. McCune

Science Translational Medicine 15 June 2011 Vol 3, issue 87

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

&

D.R. Cox, B.Efrom. Statistical Thinking for 21st Century Scientists Sci Adv 3, e1700768 (2017)

&

Nichole Carlson. A new Look at Longitudinal Data 21st April 2010, Vol 2 issue 28 pp 28ec64

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

&

Statistical Errors

by

Regina Nuzzo

Nature Vol 506, page 150-152, 13 Feb 2014

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

from the chapter

'Statistics in Medicine'

in

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Donna Windish, MD, MPH

Associate Professor of Medicine (General Medicine);

Director, ACES Faculty Development Program, Internal Medicine; Director, Resident Research, Yale Primary Care Residency Program, Internal Medicine;

Program Director, General Internal Medicine Medical Education Fellowship, Internal Medicine

Yale University School of Medicine

Geriatrics

Chapter from

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Jeanette Ross, MD

Professor/ Clinical Associate Program Director, Geriatric Medicine Fellowship Department of Family & Community Medicine and Department of Medicine

University of Texas San Antonio

&

Eric Widera, MD

Professor of Medicine, Director, Hospice & Palliative Care Service (SFVAMC), Program Director, Geriatric Medicine Fellowship Program (UCSF)

University of California San Francisco

Geriatrics

Chapter from

Baliga's Textbook of Internal Medicine

www.MasterMedFacts.com

authored by

Jeanette Ross, MD

Professor/ Clinical Associate Program Director, Geriatric Medicine Fellowship Department of Family & Community Medicine and Department of Medicine

University of Texas San Antonio

&

Eric Widera, MD

Professor of Medicine, Director, Hospice & Palliative Care Service (SFVAMC), Program Director, Geriatric Medicine Fellowship Program (UCSF)

University of California San Francisco